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A novel application of the Pauson-Khand reaction was applied to the synthesis of 
a series of bridged azatricyclic piperazines.  This method represents the first application 
of the Pauson-Khand reaction to synthesize azabridged scaffolds.  The ubiquity of 
bridged azabicyclic ring systems in biologically active natural product skeletons has 
provided the synthetic chemist with a wealth of opportunity for development over the last 
century.  To this day, the development of new methodologies to tackle these structurally 
challenging systems remains at the forefront of synthetic chemistry. 
During our efforts to achieve a total synthesis of the stemofoline alkaloids, we 
have thus far developed a novel and scalable synthetic strategy to access the fully 
functionalized caged azatricyclic core of these challenging alkaloids.  The overall 
synthetic strategy we have implemented began with the commercially available and 
 vi 
affordable 2-deoxy-D-ribose as a chiral starting material.  Furthermore, we have 
developed a novel 1,3-dipole cascade cycloaddition, which was successfully employed as 
the key step in the construction of the bridged azatricyclic core of the stemofoline 
alkaloids. 
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Chapter 1 – The Dipolar Cycloaddition Reactions of Azomethine Ylides 
and their Applications in Natural Product Total Synthesis 
1.1 AZOMETHINE YLIDES AS USEFUL SYNTHONS IN THE PREPARATION OF 
HETEROCYCLES 
1.1.1 Introduction 
Few reaction classes are as ubiquitous in the heterocyclic field as the 1,3-dipolar 
cycloaddition (1,3-DPC).  When the synthesis of 5-membered heterocyclic ring systems 
is required, no reaction has provided the synthetic chemist with a more expedient and 
versatile technique to construct these systems.  From a retrosynthetic perspective, this 
class of reactions provides a well-studied and predictable synthon for designing the 
blueprint of complex heterocyclic targets (Scheme 1.1).  The general structure of a 1,3-
dipole 1.1 is a triatomic array that allows for a wide degree of elemental diversity (e.g. C, 
N, O, and S) at all three positions (X-Y-Z).  Reactions of 1,3-dipoles with unsaturated 
compounds is a highly modular way to synthesize a plethora of 5-membered heterocyclic 
scaffolds with a great deal of elemental and stereodiversity.  
Scheme 1.1.  Retrosynthetic Analysis of a 1,3-Dipolar Cycloaddition Reaction 
 
Time and again the application of dipolar cycloadditions has proven productive in 
the synthesis of small heterocycles, and sufficiently general to tackle even the most 
demanding substrate configurations.  Many reviews have been written regarding the 
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efficacy of 1,3-dipolar cycloadditions in the construction of pyrrolidine ring systems,1 
however a comprehensive review of the applications of azomethine ylides (AMY) as 
applied to complex natural product targets in particular is lacking in the literature.  The 
azomethine ylide 1.2 is a very important class of 1,3-dipole inasmuch as the pyrrolidine 
ring systems resulting from the cycloadditions of these intermediates are highly prevalent 
in the structure of a vast array of naturally occurring alkaloids and biologically relevant 
molecules.  The basic structure of the azomethine dipole is based on a C-N-C array, and 
when reacted with alkenes and alkynes give rise to pyrrolidine ring systems (Scheme 
1.2). 
Scheme 1.2.  Retrosynthesis of Pyrrolidine-Like Ring Systems 
 
It is the aim of this review to study and survey the known applications of the 
azomethine ylide 1,3-dipolar cycloaddition to further advance the understanding of this 
powerful transformation in the context of complex molecule synthesis, and to help better 
equip the synthetic chemist for the successful implementation of this technology.   
1.1.2 Azomethine Ylide Structure and Stereochemistry 
When planning a synthesis around a 1,3-DPC of an azomethine ylide, one must 
first account for the substitution of the resulting pyrrolidine that will be required.  In 
considering the 2,5-substitution of the target pyrrolidine, there are techniques to access 
just about any substitution pattern that can be conceived.  There are six possible 
substitution patterns that azomethine ylides can possess, which translate directly into the 
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substitution patterns of the resulting pyrrolidine.  Careful choice of the appropriate 
synthetic method is necessary to ensure that the azomethine ylide is generated with the 
desired substitution pattern and geometry.   Outlined below (eq 1.1-1.5), are the different 
substitution patterns of azomethine ylides that can be accessed, the corresponding 
pyrrolidine systems that will result upon completion of a 1,3-DPC, as well as the 
establishment of a cursory nomenclature for these systems which will help with later 
discussion.   
Scheme 1.3. Substitution Patterns of Azomethine Ylides & the Resulting 
Pyrrolidine Cycloadducts 
 
 The 1,3-disubstited azomethine ylides (1.7, eq 1.3) in particular are important 
because of their discrete and predictable geometric shapes that directly relate to the 2,5-
stereochemistry that will result in the pyrrolidines after 1,3-DPC (eq 1.7-1.9).  Depending 
on the synthetic method that is chosen for generating the target azomethine ylide, 
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different stereochemical outcomes will result as a consequence of the ylide geometry.  
The trans-ylide, known as the S-shaped ylide 1.15, gives rise to the corresponding 2,5-
trans-pyrrolidine 1.16 (eq 1.7).  For the cis-ylides, however, both the W-shaped ylide 
1.17 and U-shaped ylide 1.19, will result in the 2,5-cis-pyrrolidines 1.18 (eq 1.8 & 1.9).  
Typically untethered azomethine ylides of this substitution pattern inherently favor the S-
shaped geometry; however, the W-shaped ylide can form depending on the steric 
environment or the synthetic method chosen to generate the ylide.  The U-shaped ylide 
1.19 on the other hand is much less common, and typically reserved for cyclic ylides, 
which lead to bridged bicyclic structures.  It is important to note that trisubstituted ylides 
(1.11, eq 1.5) and tetrasubstituted ylides (1.13, eq 1.6) can also be characterized as having 
cis- or trans-geometries, however these distinctions are typically harder to make.  
 
The consequence of endo/exo-selectivity in these reactions is another variable to 
consider in designing a synthetic plan, in that the substitution pattern and stereochemistry 
at the 3- and 4-positions of the resulting pyrrolidine product are a result of the alignment 
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of the dipolarophile relative to the azomethine ylide in the transition state.  Fortunately, 
as with the geometry of the targeted azomethine ylide, the outcome tends to be 
predictable.  In fact, the shape of the targeted ylide itself is often a determining factor in 
the reaction outcome with respect to endo/exo-selectivity (eq 1.10 & 1.11).  As a rule of 
thumb, both S- and W-shaped ylides (1.15 & 1.17) tend to give high levels of endo-
selectivity (via 1.20) during the cycloaddition event; S-shaped systems, however, are 
more prone to deterioration in selectivity.   
 
U-shaped ylides, which are much less common, tend to give high levels of exo-
selectivity; presumably as a result of more sterically demanding endo-transition states 
such as 1.24 (eq 1.12).   
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Furthermore, the regiochemical outcomes of these cycloadditions are also highly 
predictable.  With a polarized ylide such as 1.20 and 1.22 (eq 1.10 & 1.11), a majority of 
the electron density of the triatomic species will reside alpha to the electron withdrawing 
group.  Thus, a cycloaddition with a polarized dipolarophile (such as acrylates) will occur 
to give a pyrrolidine ring with the substitution pattern represented by 1.21 and 1.23 (eq 
1.10 & 1.11), where a carbon-carbon bond forms between the most electron-rich atom of 
the ylide and the most electron-poor β-atom of the dipolarophile.  
1.1.3 Methods for the Generation of Azomethine Ylides Structures 
1.1.3.1 Introduction 
The dipolar cycloaddition reactions of azomethine ylides have the potential to 
construct a vast amount of functional, positional, and stereodiversity into the synthesis of 
pyrrolidine ring systems, as described in the previous section; and, as a testament to the 
ubiquity of this ring system in organic chemistry, there has been an extensive set of 
unique methods developed in the literature for the generation of various types of 
azomethine ylide structures.  These methods provide the synthetic chemist with a large 
toolbox to engineer a target-oriented synthesis utilizing this disconnect, as each method 
presents a choice of specific starting materials and reaction conditions that are often 
complimentary in addressing the unique concerns of any synthetic plan.  The following 
subsections attempt to therefore establish a set of classifications that define the general 
strategies that have been used to generate the azomethine ylide synthon.  In this way, the 
natural product total syntheses that are covered in this review can be segregated based on 
these classifications.  For the most part, the formation of an iminium ion by some sort of 
condensation process is the first operation in generating an ylide.  The condensation of 
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amines with aldehydes (via expulsion of a molecule of water) is a typical way to 
accomplish this; however, there are a number of different processes for preparing 
iminium ions in the literature.  When an iminium ion is formed first, then the method will 
be classified by the proceeding mechanistic step that creates the azomethine ylide species 
directly.  There are also methods that generate the azomethine directly from a neutral 
species, and typically these involve the manipulation and/or decomposition of 
heterocyclic species.  Some methods are better suited for specific scenarios than others, 
so a general understanding of the options available is useful way to understand the 
synthetic design and context of the 1,3-DPC in each individual total synthesis.   
1.1.3.2 Methods Involving the Desilylation & Destannylation of Iminium Ion 
A commonly employed method for the generation of azomethine ylides is the 
disilylation or destannylation of iminium ions of type 1.29 (eq 1.13).  Treatment of such 
species with a nucleophile, typically fluoride ion, results in the azomethine ylide 1.30 and 
loss of the silyl- or stannousflouride.  The strength of the silicone-fluorine and tin-
fluorine bonds drive this type of reaction, and often these reactions can be performed at 
mild temperatures, making them ideally suited for sensitive substrates.  A typical set of 
starting materials for this process are α-aminosilanes or α-aminostannanes (such as 1.28) 
and aldehydes.  With respect to this type of method’s application in total synthesis, a 
number of different substitution patterns have been accessed including simple-, mono-, 
and disubstituted ylides.  A limiting factor to this strategy is that complex α-
aminostannanes 1.28 required extra synthesis prior to the cycloaddition step, however, 
methods have been developed to accomplish this. 
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1.1.3.3 Methods Involving the Decarboxylation of Iminium Ions 
The decarboxylation of iminium ions such as 1.33 is probably the most 
fundamental method to generate azomethine ylides (eq 1.14).  Typically the loss of 
carbon dioxide of the iminium ion requires elevated temperature; however, these 
reactions can be done at neutral pH providing them with an inherent benefit in some 
cases to the desilyation/destannylation techniques.  The standard starting materials for 
this method are amino acid derivatives 1.32 and aldehydes.  The applications of this type 
of method in the realm of natural products have only been used to access simple and 
mono-substituted azomethine ylides. 
 
1.1.3.4 Methods Involving the Deprotonation of Iminium Ions 
Another powerful method for generating azomethine ylides, and also the most 
commonly exploited tactic, is the deprotonation of iminium ions of type 1.37 (eq 1.15).  
In this type of system, the R-group must be an electron withdrawing group to increase the 
acidity of the α-proton.  This type of azomethine ylide formation benefits from the 
availability of various different conditions that are known to effect the transformation.  
The reactions can be performed under mildly basic (typically with NEt3), neutral, and 
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even acidic conditions (typically with sulfonic acid catalysts).  Depending on the 
particular set of conditions chosen, the reactions can often be performed at mild 
temperatures, making this type of method ideally suited to general application.  The 
typical starting materials for this transformation are aldehydes and N-substituted amino 
esters 1.36, however, non-substituted amino esters have found limited use.  This type of 
method is typically used to access higher substituted azomethine ylides, but most 
commonly the 1,3-disubstituted class.  When N-substituted amino esters are used, the S-
shape is generally preferred; on the other hand, non-substituted amino esters can be used 
to deliver the W-shaped ylide under certain conditions. 
 
1.1.3.5 Methods Involving the Ionization of Metalloiminium Ions 
The metallation of iminium ions sets up a number of different potential 
transformations to generate metallo-azomethine ylides of type 1.42 (eq 1.16).  The only 
type of method for the ionization of metalloiminium ions that has found application in 
total synthesis, however, is the deprotonation of a metalloiminium ion of type 1.41.  
While these methods are mechanistically similar to some of the other methods (vide 
supra), the metallation procedures deserve special consideration due to a number of 
unique factors.  First, these methods allow access to non-nitrogen substituted pyrrolidine 
systems directly, whereas the other methods would require the use of N-alkyl 
substitution.  Second, the typical ylide geometry that this method affords is the W-shaped 
ylide, which is harder to access with other similar methods.  Finally, the use of a metal 
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catalyst provides this class of reaction with the potential to be rendered catalytic 
asymmetric; in fact, a number of synthetic methods to that end have been reported in the 
literature (see Section 1.1.4 for further discussion of asymmetry in 1,3-DPC reactions of 
azomethine ylides).  Depending on the tactic used to generate a metallo-azomethine ylide, 
the R-group can vary; however, for the more commonly employed tactic of iminium 
deprotonation, the R-group must be electron withdrawing.  Thus the typical starting 
materials for this type of reaction are aldehydes and unsubstituted amino esters of type 
1.40.  There is only one example of this type of transformation in total synthesis to access 
a W-shaped-1,3-disubstituted azomethine ylide, however the reaction was not performed 
in a catalytic asymmetric fashion, which still represents an area for potential 
development.  
 
1.1.3.6 Methods Involving the Thermolysis/Photolysis of Heterocycles 
The thermolytic or photolytic decomposition of heterocyclic ring systems such as 
aziridines of type 1.46 and oxazolidines of type 1.47 represents another tactic for 
generating azomethine ylides that has attracted considerable attention in total synthesis 
(eq 1.17).  One advantage of this type of method is that the azomethine ylide can be 
masked in the molecule and handled undisturbed until the targeted cycloaddition step.  
These types of heterocycles are relatively stable, and can withstand a number of different 
reaction conditions which allows the masked ylide function to be carried though a 
multistep sequence if desired.  Also, the unmasking of the azomethine ylide from these 
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heterocycles does not require any added reagents, and can be generated under neutral pH 
by exposure to heat or light.  There are a variety of methods for the generation of 
aziridines and oxazolidines, which makes choosing starting materials more challenging; 
however, the R-group in most cases must be an electron withdrawing group.  The 
applications of these methods to natural product total synthesis have been used to access 
various mono- and disubstituted azomethine ylides. 
 
1.1.3.7 Methods for the Generation of Conjugated Azomethine Ylides via 
Oxopyridinium & Oxopyrizinium Ions  
Conjugated azomethine ylides represent an important addition to the variety of 
tactics available for constructing pyrrolidine based heterocycles.  One such method for 
generating these types of azomethine ylides is the deprotonation of oxopyridinium ions 
(1.50, where Y=C) and oxopyrizinium ions (1.50, where Y=N), which give rise to cyclic 
U-shaped azomethine ylides (eq 1.18).  The generation of these types of stabilized ylides 
is generally very facile and can be done at ambient temperature; however, the 
cycloaddition event usually requires more energy.  The product of dipolar cycloadditions 
of these types of ylides are bridged azabicyclic ring systems.   
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1.1.4 Common Tactics for Asymmetric Induction in 1,3-Dipolar Cycloadditions 
The parameters for the induction of stereochemistry in the 1,3-DPC cycloaddition 
reactions of azomethine ylides can be defined in several ways.  Intramolecular 
cycloadditions are the easiest systems to control in that the stereochemistry that results 
from the cycloaddition reaction is substrate dependent, and thus the chirality of the 
system must be built in prior to the cycloaddition event.  Substrate control can also be 
highly effective in intermolecular examples for control of diastereoselectivity.  The most 
common tactic for chiral induction in achiral systems is the employment of a chiral-
auxiliary, which can be used to modify the dipolarophile or the azomethine ylide (Figure 
1.1).  The most commonly employed tactic is rendering the dipolarophile chiral 
(exemplified by 1.52, 1.53 & 1.54).  Chiral amines such as 1.55 and 1.56, however, have 










Figure 1.1.  
 
There are a other potential chiral auxiliaries that are not shown that can 
potentially serve these same purposes, but it should be noted that the Oppolzer sultam 
auxiliary (as in 1.52 & 1.55) is the most frequently used auxiliary for 1,3-DPC 
applications.  Typically when other auxiliaries were assayed, the Oppolzer auxiliary gave 
far and away the best overall results.  The use of chiral azomethine ylides is less 
common, however, the Williams group has extensively developed the chiral amino acid 
derivative 1.56 as a general way to prepare S-shaped-1,3-disubstituted azomethine ylides.  
Finally, the potential for forming chiral metallo-azomethine ylides (such as 1.57) using 
chiral metal catalysis serves as a potential area of development; however, there are no 
applications of this type of strategy to natural product total synthesis. 
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1.2 APPLICATIONS OF AZOMETHINE YLIDE 1,3-DIPOLAR CYCLOADDITION REACTIONS 
IN NATURAL PRODUCT TOTAL SYNTHESIS 
1.2.1 Introduction 
While there are many useful methods for the formation of azomethine ylides and 
many examples applications targeting unnatural heterocycles, it is the application of these 
technologies to the realm of natural product total synthesis that truly highlight the 
importance and versatility of the azomethine ylide synthon.  The following review seeks 
to not only highlight these applications, but to characterize the syntheses in terms of the 
method that was used to generate the azomethine ylide itself.  In this way we hope to 
fully illuminate this reaction as a general and truly unrivaled tactic for the preparation of 
the pyrrolidine ring systems.  It is also important to put the cycloaddition reaction in the 
context of the total syntheses that they reside, by discussing the way the reaction was set-
up and how the functionality of the cycloadduct itself was utilized going forward.  As 
was described in the previous section, the various methods available allow for a great 
deal of diversity to be built into the ylide synthon by providing the synthetic chemist with 
a wide range of starting materials to design their syntheses around. 
1.2.2 Applications Involving the Destannylation/Desilylation of Iminium Ions 
1.2.2.1 Indolizidine 239CD 
The alkaloid indolizidine 239CD (1.58, Scheme 1.4) belongs to a family of 
similar naturally occurring toxins, isolated from the poison frog Dendrobates 
histrionicus, which act as competitive blockers of neuromuscular transmission.  A great 
example of the power of the azomethine ylide dipolar cycloaddition, comes out of the 
 15 
Pearson synthesis of 1.58.2  He sought to employ a method developed in his group to 
form azomethine ylides via fluoride mediated destannylation of iminium ions, which has 
shown utility in generating diverse non-stabilized 1,3-substitued azomethine ylides.3  
Applying this method, indolizidine 239CD was envisioned to come from a key dipolar 
cycloaddition of ylide 1.60 produced from a destannylation of an iminium ion (Scheme 
1.4).   
Scheme 1.4. Retrosynthesis of Indolizidine 239CD 
 
The cycloaddition step was set up by synthesizing two similarly sized fragments 
aldehyde 1.61 and α-aminostannane 1.62 (Scheme 1.5), bringing with them nearly all the 
total atoms in the final target minus the two provided by the dipolarophile.  This highly 
convergent route commenced by addition of lithium tributyltin to commercially available 
aldehyde 1.61, and conversion of the corresponding α-hydroxystannane to bromide 1.62 
under Appel conditions in 86% yield.  The requisite α-aminostannane fragment 1.64 was 
finally synthesized by nucleophilic displacement of the secondary bromide with K-
phthalimide (1.63) and deprotection of the N-phthalimido moiety with hydrazine to give 
1.64 in good overall yield.  The aldehyde fragment 1.65i was then condensed with α-
aminostannane 1.64 to give imine 1.66.  This then set up the key cycloaddition reaction 
                                                 
i Synthesized in 5 steps from 6-hexenol in 39% overall yield. 
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whereupon imine 1.66 was heated with HF·pyridine to generate an azomethine ylide that 
underwent facile cycloaddition with phenyl vinyl sulfone to give pyrrolidine 1.68 as a 
mixture of four diastereomers in 53% yield.   The lack of regioselectivity in this 
reaction is not surprising considering the non-stabilized nature of the azomethine ylide.  
With near symmetric substitution and no apparently electronic bias, the 1,3-resonance 
forms of this ylide should contribute equally to the overall structure and thus the 
reactivity of the azomethine ylide.  The complete lack of endo/exo-selectivity, however, 
is harder to rationalize.  Fortunately in this application the regio- and endo/exo selectivity 
were inconsequential, as the mixture of diastereomers converged to a single diastereomer 
when subjected to dissolving metal conditions, thus removing the sulfone stereocenter(s).  
The nonnegotiable 2,5-stereoselectivity, however, was excellent since the azomethine 
ylide reacted out of a discrete S-shaped ylide geometry to provide the desired 2,5-anti 
relationship in the pyrrolidine product.  The synthesis of indolizidine 239CD was then 
finalized in three additional operations following the cycloaddition event to give 1.58 in 










Scheme 1.5. 1,3-DPC via Iminium Destannylation in Indolizidine 239CD Total 
Synthesis 
 
1.2.2.2 Erythrina & Homoerythrina Alkaloids 
The erythrinane alkaloids constitute a large family of natural products, including 
the erythrina and homoerythrina alkaloids varying in the size of the C-ring (Scheme 1.6).  
These natural products exhibit a variety of interesting biological properties, including 
curare, sedative and hypotensive effects, as well as neuromuscular and CNS activities.  
Furthermore the unique, highly-fused azatetracyclic architecture has inspired a great deal 
of synthetic interest.  Both Pearson and Livinghouse have developed strategies to 
construct the erythrina and homoerythrina core via comparable 1,3-dipolar cycloaddition 
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reactions of azomethine ylides such as 1.70 derived from both destannylation and 
desilylation of iminium ions.4, 5   
Scheme 1.6. Retrosynthesis of the Erythrina & Homoerythrina Alkaloids 
 
Livinghouse’s work was published first in 1986, and involved a desilylation approach 
(Scheme 1.7).4  This strategy began with the alkylation of the metalloenamine derived 
from imine 1.71 with iodide 1.72 to give dihydroisoquinoline 1.73.  The cycloaddition 
method they targeted was earlier developed within their own group, which was applied to 
the much simpler natural products eserethole and deoxyeseroline.6  In the event, the 
alkylation of the imine with the reagent 1.74 gave an intermediate iminium ion.  CsF was 
then introduced to effect the iminium desilyation, which provided azomethine ylide 1.75, 
notably bearing acidic α-protons.  These types of tautamerizable ylides are notoriously 
difficult to form and successfully employ in synthesis, and not surprisingly in this case, 
ylide 1.75 was rapidly quenched under the conditions of the reaction to form enamine 





Scheme 1.7. Livinghouse - 1,3-DPC Attempt on Substrate with Acidic α-Protons 
 
In a subsequent iteration of his approach, Livinghouse synthesized a 
cycloaddition precursor with a fully substituted α-position not capable of tautamerization 
(Scheme 1.8).  Two different acylimine substrates (1.79), varying in the saturation of the 
side chain, were synthesized by reaction of isonitrile 1.77 with an acid chloride of type 
1.78, followed by subsequent treatment with Lewis acid to facilitate the cyclization.  
Applying their cycloaddition chemistry to the erythrina core, this time with a more stable 
imine, the reaction successfully proceeded via alkylation/desilylation of imine 1.79 to 
give azomethine ylide 1.80.  This ylide then underwent an intramolecular cycloaddition 
with the tethered alkene or alkyne (depending on the substrate) to give the erythrina core 
1.81 in moderate yields.  The target natural product core would require unsaturation in 
the A or B ring of the natural product, which makes the alkyne substrate the more 
synthetically interesting example; in this case, however, the cycloaddition with the alkyne 
was the lower yielding of the two substrates tested.  While this revision of the 
Livinghouse approach was an excellent improvement, the presence of the superfluous 
ketone moiety, which was required to stabilize the azomethine ylide, was less than 
optimal.  
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Scheme 1.8.  Livinghouse - 1,3-DPC via Desilylation to Build Erythrina Core 
 
A later attempt to access the homoerythrina core by Pearson in 2007 yielded an 
important extension of the cycloaddition approach to these types of molecules.  Pearson 
aimed to apply his destannylation technology to these alkaloids similar to that which he 
used for indolizidine 239CD (vida supra).  Cognizant of his method’s suitability for 
forming and employing tautamerizable azomethine ylides, he turned his attention to the 
homoerythrina core intending to address one of the key deficiencies of the Livinghouse 
approach.  A strategy was thus devised to unite fragments 1.82ii and 1.83iii to form 
iodoketone 1.84 over a five step synthetic sequence.  With all but one of the carbons 
present in the natural product core built into this compound, they next tested an 
expansion of their group’s cycloaddition methodology.  In the event, formation of an 
imine with α-aminostannane 1.85 set up an intramolecular alkylation to give a 
corresponding iminium ion.  The liberated iodide anion then served to destannylate the 
iminium ion to give azomethine ylide 1.87, which underwent cycloaddition with the 
appended vinyl sulfoxide.  Furthermore, the vinyl sulfoxide product that was initially 
                                                 
ii Synthesized in 2 steps from 6-bromopiperonal in ~80% overall yield. 
iii Synthesized in 4 steps from ethyl vinyl sulfide in 64% overall yield. 
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formed underwent spontaneous syn-elimination to give the homoerythrina core 1.88 in 12 
synthetic steps in 7% overall yield from commercially available materials.   
This impressive cascade reaction is unique in that the construction of the entire 
heterocyclic core was accomplished in one operation (See Sections 1.2.4.6 & 1.2.4.7 for 
discussion of similar cascade processes).  Furthermore, the use of a vinyl sulfoxide as an 
alkyne surrogate could be a useful general tactic in controlling the regioselectivity of less 
selective cycloaddition reactions with alkynes. 
Scheme 1.9.  Pearson - 1,3-DPC via Destannylation to Build Homoerythrina Core 
 
1.2.2.3 (-)-Kainic Acid 
Kainic acid (1.89) has taken its place among some of the most highly studied 
natural products from both a biological and synthetic perspective.  The CNS activities of 
this alkaloid in mammalian systems has made kainic acid an important tool in 
neuropharmacology since it can be used to stimulate nervous system functions; and has 
helped facilitate advancements in the understanding of diseases such as epilepsy, 
 22 
Alzheimer’s, and Huntington’s disease by allowing researchers to administer kainic acid 
and mimic these types of disease states for further study.  Efficient syntheses of kainic 
acid have become ever important because of the increasingly dwindling natural supply of 
this important compound.  Since its first synthesis in 1979, kainic acid has succumb to 
dozens of total syntheses, allowing synthetic chemists to highlight a great deal of novel 
synthetic methods.7  Fukuyama envisioned kainic acid coming from bicyclic lactone 
1.90, which could be derived from a diastereoselective intermolecular 1,3-DPC of chiral 
dipolarophile 1.91 and simple azomethine ylide 1.92 (Scheme 1.10). 
Scheme 1.10. Retrosynthesis of Kainic Acid 
 
The Fukuyama synthesis of kainic acid employed an interesting intermolecular 
azomethine ylide cycloaddition via desilylation of an iminium ion derived from N,O-
acetal 1.93 to give the simple azomethine ylide 1.92 (Scheme 1.11).7, 8, 9  The ylide 
reacted with dipolarophile 1.91iv via transition state 1.94 to give bicycle 1.90 as nearly a 
single diastereomer in 83% yield.  Most notably, however, the chirality of the butenolide 
dipolarophile 1.91 had a profound effect on the stereochemistry of the cycloaddition 
reaction forcing the ylide to react on virtually only one face of the olefin.  With 
pyrrolidine 1.90 in hand, Fukuyama carried this material through a 7 step sequence to 
access the refunctionalized 1.95, in order to attempt an interesting α-lithiation reaction 
                                                 
iv Synthesized in 2 steps from furfural using an enzymatic kinetic resolution in ~49% overall yield.  
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with (+)-sparteine surrogate 1.96.  This ligand controls the regio- and stereoselectivity of 
the initial deprotonation, and a subsequent reaction with carbon dioxide of the resulting 
organolithium species provided the fully functionalized kainic acid core 1.978 in 
moderate yields.  An additional 9 steps provided (-)-kainic acid (1.89) so concluding a 20 
step total synthesis in ~2% overall yield. 
Scheme 1.11. 1,3-DPC via Iminium Desilylation to Kainic Acid Total Synthesis 
 
1.2.2.4 Amaryllidaceae Alkaloids 
The amaryllidaceae alkaloids constitute a large class of interesting alkaloids of 
which the subclass crinine and montanine alkaloids reside.  With the natural source of 
these alkaloids, the amaryllidaceae flowering plants, suffering a decline in population 
 24 
because of habitat loss, the natural supply for these important alkaloids is quickly 
diminishing.  Thus, a great deal of synthetic effort has been directed toward the synthesis 
of these valuable alkaloid natural products.  The subclass of crinine alkaloids, 
exemplified by martidine (1.99, Scheme 1.12), consists of greater than 50 different 
alkaloids, mostly biologically active.  Martidine exhibits interesting cytotoxic properties, 
and has served as a standard for the crinine class with respect to organic synthesis.   The 
montanine subclass, exemplified by pancracine (1.100, Scheme 1.12), have shown 
anxiolytic, antidepressive, anticonvulsive, and hypotensive activities.   
Scheme 1.12.  Retrosyntheis of Amaryllidaceae Alkaloids 
 
These structurally and biologically intriguing alkaloids have been the focus of 
extensive synthetic investigations, of which the efforts of Pandey have championed a 
general strategy using an azomethine ylide dipolar cycloaddition.  Pandey developed a 
novel desilylative approach to azomethine ylides in 1993,10 and in extending this 
methodology has targeted azomethine ylides of type 1.101 as a general synthon for both 
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martidine and pancracine.  The first synthesis of pancracine (1.100) was reported in 2005, 
which targeted a system where the R3-substituent of the alkene dipolarophile (1.108) 
would be an electron withdrawing group to influence the cycloaddition’s regioselectivity 
in favor of the pancracine skeleton (Scheme 1.12).11  In 2009, he employed essentially 
the same tactic for martidine (1.99), but this time the R2-substituent would bear the 
electron withdrawing group to enforce an inverted regioselectivity in the cycloaddition 
event to give the martidine core.12 
Scheme 1.13. 1,3-DPC via Iminium Desilylation in Martidine Total Synthesis  
 
The synthesis of martidine (1.99) began with alkylation of bis-silylamine 1.106v 
with diiodide 1.105,vi followed by a Stille cross-coupling with vinyl stannane 1.107 to 
give cycloaddition precursor 1.108 in 73% yield (Scheme 1.13).12  The strategy that 
Pandey employed for synthesizing this precursor is a general approach to N-alkyl-3-
                                                 
v Synthesized in a presumed ~7 steps from N-Boc-4-amino-2-butanol in ~35% overall yield, however 
specific details for each step were not provided.  These data are derived from previously reported syntheses 
of similar compounds via similar synthetic strategies. 
vi Synthesized in two steps from 2-iodo-4,5-dimethoxybenzyl alcohol 78% overall yield.  
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substituted azomethine ylides, which his research group had previously developed.  Any 
number of aminoalcohol starting materials, with a variety of substitution, can be quickly 
converted to bis-silylamines of type 1.103, whereupon a subsequent alkylation to install a 
desired side chain provides diverse starting materials for azomethine ylides.  In the case 
of martidine, the cycloaddition precursor 1.108, when treated with two equivalents of 
Ag(I)F gave an azomethine ylide through a novel bis-desilylation reaction.  The ylide 
reacted spontaneously with the tethered olefin via the described transition state 1.109 
which aligns the more electron rich primary carbon of the azomethine ylide to react with 
the more electrophilic β-carbon of the enoate to give cycloadduct 1.110 in 56% yield.  
Seven more steps were then required to convert 1.110 into martidine, resulting in a ~17 
step total synthesis in approximately 3% overall yield.  Compound 1.111 was also 
applied to this exact same sequence in a later publication (substituting for 1.111 for 














Scheme 1.14. 1,3-DPC via Iminium Desilylation in Pancracine Formal Synthesis 
 
Following a nearly identical approach as the aforementioned martidine synthesis, 
Pandey also targeted a formal total synthesis of pancracine via the same disilylative 
azomethine ylide formation method (Scheme 1.14).  The formal synthesis of pancracine 
(1.100) began with alkylation of bis-silylamine 1.112vii with diiodide 1.111viii, followed 
by a Heck cross-coupling with methyl vinyl ketone to give cycloaddition precursor 1.113 
in 81% yield (Scheme 12).11  Treatment of 1.113 with two equivalents of Ag(I)F resulted 
in an azomethine ylide, which underwent intramolecular 1,3-DPC with the tethered 
enoate via transtition state 1.114 to give the pancracine core 1.115 in 56%.  Five 
additional steps were required to convert 1.115 into the tetracycle 1.116, thus completing 
a formal total synthesis of pancracine in 16 steps and in 8% overall yield. 
                                                 
vii Synthesized in 5 steps from 3-amino propanol in 57% overall yield. 
viii Synthesized in 2 steps from 6-Iodo-3,4-methylenedioxybenzyl alcohol in 78% overall yield.13) Reissig, 
H.-U.; Khan, F. A.; Czerwonka, R.; Dinesh, C. U.; Shaikh, A. L.; Zimmer, R. "Benzannulated Cyclooctanol Derivatives by Samarium 
Diiodide Induced Intramolecular Carbonyl-Alkene Coupling - Scope, Limitations, Stereoselectivity" Eur. J. Org. Chem. 2006, 4419-
4428. 
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1.2.2.5 Stemofoline Alkaloids 
The stemofoline alkaloids, represented here by stemofoline (1.117, Scheme 1.15), 
comprise a very important part of the stemona family of natural products, named as such 
due to their isolation across a number of Stemona plant species.  The roots and stems of 
these plants have long been used in traditional Asian medicine to treat symptoms 
associated with bronchitis and tuberculosis, and to also treat pest and lice infestations in 
both agricultural and human cases.  The stemofoline alkaloids not only mirror the 
biological activity of the bulk plant, but also have shown anticancer activity.  
Additionally, these alkaloids present arguably the greatest synthetic challenge of all the 
stemona alkaloids owing to their dense caged hexacyclic architecture.  These alkaloids 
have succumb to only two separate total syntheses, and recently Gin has reported 
progress toward these alkaloids aiming to apply an iminium desilylation to access 
azomethine ylide 1.119, and thus the tricycle 1.118 upon intramolecular cycloaddition 
(Scheme 1.15).14, 15 
Scheme 1.15. Retrosynthesis of the Stemofoline Alkaloids 
 
The Gin partial synthesis of stemofoline began with commercially available (-)-
2,3-O-isopropylidine-D-erythronolactone (1.120), which was converted over a seven step 
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sequence to silyl thioamide 1.121 in 7 steps and 27% overall yield (Scheme 1.16).  Next, 
a rapid assembly of the requisite functionality required for the targeted cycloaddition was 
performed, which included a Wittig olefination of thiolactam to install the vinylogous 
amide, addition of ethynyl Grigrand to install the unsaturated side chain, and a final 
polarization of the ynone to give the vinylogous thioester 1.122 in 47% over the three 
step sequence.  With the required functionality to generate the azomethine ylide and the 
appended dipolarophile installed, 1.122 was treated concurrently with triflic anhydride 
and tetrabutylammonium trifluorosilicate (TBAT), resulting in the formation of an 
azomethine ylide 1.119, which reacted via transition state 1.123 with the tethered 
activated olefin to give the tricyclic core of stemofoline 1.118 in 71% yield.  The tricyclic 
compound was then further elaborated to install and refunctionalize the C(3) and C(9) 
side chains to give 1.124 in 50% over a four step sequence.  While a majority of the 
required functionality of stemofoline is accounted for in 1.124, the challenge of 
selectively removing the thio-group at C(6) and the alcohol at C(1), while maintaining the 
C(2) alcohol, would have to be addressed.  Additionally, a stereochemical inversion of 
the C(2) alcohol must also be performed.  It is noteworthy, however, that the tricyclic 
core of these challenging alkaloids was accessed in asymmetric fashion in 15 total 








Scheme 1.16. 1,3-DPC via Iminium Desilylation in Stemofoline Partial Synthesis 
 
1.2.3 Applications Involving the Decarboxylation of Iminium Ions 
1.2.3.1 (-)-Horsfiline 
The vast family of spirooxindole type natural products has proven to be a classic 
set of targets for total synthesis.  Additionally the 3,3′-pyrrolidinyl-spirooxindole subclass 
has proven to be a privileged scaffold in that most of the known natural products in this 
family exhibit anticancer activities.  Horsfiline (1.125) represents one of the most 
structurally simple and fundamental of this class.  There have been many synthetic 
approaches to horsfiline, including the efforts of Palmisano that probed the variables of 
an asymmetric intermolecular 1,3-DPC to install the spiropyrrolidine moiety (Scheme 
1.17).16, 17  Two different approaches were studied which investigated the placement of a 
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chiral auxiliary on the dipolarophile in order to induce high asymmetry in an 
intermolecular 1,3-DPC with simple azomethine ylide 1.26. 
Scheme 1.17. Retrosynthesis of (-)-Horsfiline 
 
 Palmisano’s first strategy was to perform the dipolar cycloaddition with the indole 
moiety intact.16  Starting with isatin derivative 1.129, a Wittig olefination with chiral 
phosphorane 1.130ix delivered the chiral dipolarophile 1.131 in 76 % yield (Scheme 
1.18).  Dipolarophile 1.131 was then refluxed with paraformaldehyde and sarcosine 
resulting in a facile 1,3-DPC to give a mixture (1:1) of diastereomers 1.133 in 80% yield.  
While the cycloaddition itself worked in high yield, the menthyl derived auxiliary had no 
impact on the facial selectivity of the cycloaddition event.  Several additional non-chiral 
derivatives of 1.131 were also reported and applied successfully to racemic syntheses of 
the horsfiline core.  After separation of the diastereomers of 1.133, the synthesis of (-)-
horsfiline was completed in three additional steps to give 1.125 in 7 total synthetic steps 




                                                 
ix Synthesized in two steps from menthol and bromoacetic acid in an undisclosed overall yield. 
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Scheme 1.18. 1,3-DPC via Iminium Decarboxylation in Horsfiline Total Synthesis 
 
 While the first approach did provide horsfiline in enantiomerically pure form, the 
efficacy of the 1,3-DPC was less than desired.  In a second attempt to construct the 
horsfiline core with an asymmetric 1,3-DPC, Palmisano turned his attention to chiral 
dipolarophile 1.135, which could be accessed in five steps and 25% overall yield from p-
nitroanisole (1.134, Scheme 1.19).17  The cycloaddition was then performed with 
paraformaldehyde and sarcosine to give pyrrolidine 1.137 in 78% as a mixture (93:7) of 
diastereomers, which was enhanced to >99:1 after a single recrystallization.  The total 
synthesis was completed by hydrogenolysis of the nitro moiety, resulting in concomitant 
cyclization to give 1.125 in 7 total synthetic steps in ~13% overall yield.  It is interesting 
to note that by moving the chiral auxiliary closer to the aryl group and thus performing 
the cycloaddition on a 1,1-disubstituted olefin provided a very significant enhancement in 
stereoselectivity of the 1,3-DPC event.  It is also important to note that a number of chiral 
auxiliaries were screened and that the 2-phenyl-2-cyclohexanol auxiliary used in 1.135 
gave the best diastereoselectivity as well as the most favorable mobility on silica gel 
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during purification.  Unfortunately, the overall yield of this approach was lower than the 
first generation approach due to the inefficiency of their synthesis of dipolarophile 1.135. 
Scheme 1.19. 1,3-DPC via Iminium Decarboxylation in Horsfiline Total Synthesis 
 
1.2.3.2 Nicotine 
The alkaloid nicotine (1.138) needs no introduction with respect to its role in 
society.  In medicine, nicotine and its analogues have been investigated as medicines to 
treat disorders such as Alzheimer’s, Parkinson’s, and Tourette’s diseases.  The synthesis 
of nicotine has been reported a number times since its first synthesis in 1904; however, 
there is one synthesis of the pyrrolidine ring using a 1,3-DPC.  Bashiardes reported an 
intriguing 1,3-DPC, wherein a silicone tether was employed to facilitate an 
intramolecular cycloaddition of a mono-substituted azomethine ylide (1.140, Scheme 
1.20) with an unactivated olefin to give tricycle 1.139.  A cascade desilylation of 1.139 
would then deliver nictone.18 
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Scheme 1.20. Retrosynthesis of Nicotine 
 
 The approach to nicotine began with an ortho-lithiation reaction of 
nicotinaldehyde (1.141) followed by silylation with vinyldimethyl silyl chloride (1.142) 
to give aldehyde 1.143 in 63% yield (Scheme 1.21).  Next, by heating with sarcosine in 
refluxing xylenes, an iminium decarboxylation gave azomethine ylide, which reacted via 
the cycloaddition transition state 1.144 to furnish pyrrolidine 1.145 in 91% yield.  A 
global desilylation with TBAF gave nicotine (1.138) in a short three step sequence in 
35% overall yield.  Also important to note, is that the Bashiardes approach also was 
useful in making a small library of nicotine analogues by the same approach.  This tactic 
represents an interesting strategy for facilitating a cycloaddition with an unactivated 
olefin.  A common approach to simple pyrrolidines would generally require the use of 
vinyl sulfones, which typically give a mixture of diastereomers that can all be converged 
on to the desired product by desulfurization (see section 1.3.2.1 for an example).  While 
the Bashiardes approach is not necessarily more efficient, it provides a complimentary 







Scheme 1.21. 1,3-DPC via Iminium Decarboxylation in Nicotine Total Synthesis 
 
1.2.3.3 Martinellic Acid 
The Martinella alkaloids, isolated from the South American plant Martinella 
iquitosensis, are non-peptidic antagonists for the bradykinin B1 and B2 receptors, which 
make these compounds interesting as potential anti-hypertensive agents.19  Furthermore, 
the novel tetrahydroquinoline structure has inspired a number of synthetic investigations 
into the synthesis of this class of molecules.  Martinellic acid (1.146) is a classic 
representative of this alkaloid family and has been the target of numerous approaches to 
employ a 1,3-DPC to construct the natural product core.  Two discrete approaches 
exploiting this disconnect can be defined that both construct the pyrrolidine ring via 
similar mono-substituted azomethine ylides (Scheme 1.22).  Path A targets an 
azomethine ylide of type 1.147, which would access the martinellic acid core directly, 
and has been explored by both the Snider and Lovely groups.20-22  Path B, investigated 
by the Miyata group, targeted azomethine ylide 1.148 for use in a 1,3-DPC to construct a 
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carbocyclic ring system, which was expanded to the tetrahydroquinoline core via a 
nitrene-type ring expansion reaction.23 
Scheme 1.22. Retrosynthesis of Martinellic Acid 
 
 The first synthesis of martinellic acid using the 1,3-DPC approach came out of the 
Snider research group, which began with aniline 1.149x and Meldrum’s acid-activated 
cyclopropane 1.150xi (Scheme 1.23).  Heating both components in toluene gave rise to 
the corresponding pyrrolidinone which was oxidized with MnO2 to give aldehyde 1.151 
in 54% yield over two steps.  A decarboxylative cycloaddition was thus carried out with 
N-benzylglycine in refluxing toluene to effect an intramolecular 1,3-DPC via ylide 1.152 
to give the tricyclic martinellic acid core 1.153 in 60% yield in high diastereoselectivity.  
The tetracyclic cycloadduct was then converted in martinellic acid in an additional 10 
synthetic steps, corresponding to a 15 step total synthesis of 1.146 in 2% overall yield.  
                                                 
x Synthesized in one step from methyl 4-bromoanthranilate in 81% yield. 
xi Synthesized in one step from 2-vinyl-1,1-cyclopropanedicarboxylic acid  and isopropenyl acetate in 60% 
yield. 
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This total synthesis served as a crucial benchmark for this type of general strategy toward 
martinellic acid, not only with respect to the cycloaddition itself, but also established a 
useful endgame for the total synthesis. 
Scheme 1.23. Snider – 1,3-DPC via Iminium Decarboxylation in Martinellic Acid 
Total Synthesis 
 
 The Lovely group ultimately adopted the aforementioned Snider strategy in their 
own work while focusing on an asymmetric approach to martinellic acid (Scheme 1.24).  
Setting up an almost identical cycloaddition reaction with enantiopure aldehyde 1.155, 
which was derived from pyrrolidinone 1.154 over a 9 step (11% overall) sequence.  
Refluxing aldehyde 1.155 with N-benzylglycine in benzene resulted in a decarboxylative 
azomethine ylide formation followed by an 1,3-DPC via 1.156 to give pyrrolidine 1.157 
in 74% yield with good diastereoselectivity.  An additional 9 steps were thus required to 
convert cycloadduct 1.157 into intermediate 1.158 following the general endgame 
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strategy Snider previously established.  This effort constitutes a formal total synthesis of 
enantioenriched martinellic acid in 19 total steps and in ~1% overall yield. 
Scheme 1.24. Lovely – 1,3-DPC via Iminium Decarboxylation in Martinellic Acid 
Formal Synthesis 
 
 Another cycloaddition strategy from the Lovely research group was subsequently 
reported wherein the core of martinellic acid was targeted using an intramolecular 1,3-
DPC of ylide 1.160 (Scheme 1.25).  This strategy would allow for a more accessible 
starting material to be applied to the cycloaddition.  In their first attempt, the use of 
aldehyde 1.159 was probed, and interestingly no cycloaddition reaction was observed; 
rather the formation of amide 1.164 was the operable reaction pathway.  Presumably this 
reaction did not work because the less favorable S-cis conformation of the amide was 
required for the cyclization.  The more favorable S-trans conformer, on the other hand, 
cannot cyclize and thus hydrolyses, by virtue of the reversible nature of the reaction, 
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liberating N-benzyl-N-methylamine.  This amine then reacts with the eneamide via an 
aza-Michael reaction to give amide 1.164 as the only identifiable product. 
Scheme 1.25. Lovely – Failed Attempt at 1,3-DPC in Martinellic Acid Synthesis 
 
 The S-cis/S-trans equilibrium of secondary amides is well-known to hinder 
cyclization reactions, and as such the use of an extra substituent on the amide nitrogen 
can be used to lower the barrier of rotation between the two conformers.  To that end, 
amide 1.165xii was synthesized bearing a fully substituted amide nitrogen, and the 
cycloaddition reaction was tested again (Scheme 1.26).  This time, heating the aldehyde 
with N-benzylglycine in refluxing toluene resulted in a facile cycloaddition reaction to 
give a mixture of three products.  The desired cycloadduct 1.169 was formed in 51% 
yield, along with 7% of the undesired epimer 1.167.  The elimination product 1.168 was 
also formed in 16% under the reaction conditions.  With cycloadduct 1.169 in hand, this 
                                                 
xii Synthesized in three steps from methyl 4-bromoanthranilate in an undisclosed overall yield. 
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intermediate was advanced to amino compound 1.170 in five additional steps to complete 
a formal total synthesis of martinellic acid in eight total steps. 
Scheme 1.26. Lovely – 1,3-DPC via Iminium Decarboxylation in Martinellic Acid 
Formal Synthesis 
 
 The final cycloaddition approach to martinellic acid comes out of the Miyata 
group, which aimed to employ a cascade ring-expansion/Mannich reaction that was 
previously been developed in their own group (Scheme 1.27).  To set up this cascade 
reaction, the aldehyde 1.172 was prepared in four steps from acetal 1.171 in 66% overall 
yield.  Refluxing the aldehyde with N-benzylglycine in refluxing toluene resulted in an 
intramolecular 1,3-DPC to give cycloadduct 1.174 in 78% yield as a mixture (3:2) of 
diastereomers.  In four additional steps, 1.174 was converted to hydroxylamine 1.175, at 
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which point their key cascade reaction could be employed to access the martinellic acid 
core.  In the event, treatment of 1.175 with excess allyl Grignard resulted in a facile ring 
expansion to give the corresponding dihydroquinoline, which was subsequently alkylated 
with an additional equivalent of Grignard reaction via a Mannich-type reaction to give 
1.176 in 94% yield.  This molecule was then converted to aryl bromide 1.177 in three 
additional steps to give an intermediate which Snider used in his total synthesis of 
martinellic acid (refer to Scheme 1.23). 
Scheme 1.27. Miyata – 1,3-DPC via Iminium Decarboxylation in Martinellic Acid 
Formal Synthesis 
 
1.2.3.4 Crispine A 
Crispine A (1.178) is a fairly simple alkaloid isolated from the Carduus crispus 
plant.  The extracts from this plant have been used in Chinese folk medicine to treat 
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symptoms of cold, stomach ache, and rheumatism.  Moreover, the extracts have been 
shown to possess in vitro anticancer and cytotoxic activity.  While there have been quite a 
few syntheses of crispine A since its isolation, the Coldham synthesis serves as an 
example of a very efficient construction of this molecule using a novel 1,3-DPC cascade 
reaction, which has been investigated extensively in his group.24, 25  The pyrrolidine ring 
of crispine A (1.178) was envision coming from an intermolecular 1,3-DPC reaction of 
ylide 1.179 and an activate dipolarophile of type 1.180 (Scheme 1.28).  On the surface, 
this strategy seems quite straightforward; however, the formation of the azomethine ylide 
was accomplished using a very novel intramolecular imine alkylation/iminium 
decarboxylation cascade. 
Scheme 1.28. Retrosynthesis of Crispine A 
 
 The Coldham synthesis of the crispine A core was accomplished by heating 
chloroaldehyde 1.181xiii with bisphenylvinylsufone 1.182 and glycine in refluxing 
toluene (Scheme 1.29).  After condensation of the aldehyde moiety with glycine, an 
intramolecular imine alkylation of 1.183 delivered the requisite iminium ion, which 
spontaneously decarboxylated to give azomethine ylide 1.179.  This azomethine ylide 
then underwent intermolecular 1,3-DPC to give the crispine A core 1.180 in 70% yield as 
an undisclosed mixture of diastereomers favoring that shown.  The efficiency of this 
                                                 
xiii Synthesized in two steps from 3,4-dimethoxyphenethyl alcohol in 32% overall yield. 
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cascade reaction is quite remarkable in that the tricyclic core of crispine A was 
constructed in one operation from mostly acyclic starting materials.  With 1.180 in hand, 
two additional steps were required to desulfurize the pyrrolidine ring and deliver crispine 
A in a synthetic sequence requiring 5 total steps and in 10% overall yield. 
 Scheme 1.29. 1,3-DPC via Imine Alkylation/Decarboxylation Cascade in Crispine A 
Total Synthesis 
   
1.2.3.5 Aspidosperma Alkaloids 
The synthesis of crispine A itself was not as remarkable as the efficiency of the 
cascade strategy that the Coldham group has developed.  In an effort to further showcase 
this methodology, an impressive approach to the aspidosperma alkaloids was thus 
developed (vide infra).26, 27  The aspidosperma alkaloids are arguably some of the most 
well studied class or natural products, not only with respect to their synthetic studies 
dating back almost 50 years, but these alkaloids exhibits a wide range of interesting 
biological activity.  A common intermediate, often targeted by synthetic groups, is ketone 
1.184 (Scheme 29), which was first elaborated into aspidospermine (1.182) and 
quebrachamine (1.183) by Stork in 1963.  Coldham similarly targeted this ketone; 
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however, he aimed to apply his imine alkylation/iminium decarboxylation cascade 
reaction to target ylide 1.185. 
Scheme 1.30. Retrosynthesis of Aspidosperma Alkaloids 
 
 Coldham’s approach to the aspidosperma alkaloids began with the expeditious 
assembly of aldehyde 1.190 via a two-step alkylative coupling of fragments 1.186, 1.187, 
and 1.188 followed by DIBAL reduction of the resulting cyano-compound 1.189 to give 
aldehyde 1.190in 69% overall yield (Scheme 1.31).  Aldehyde 1.190 was then heated 
with glycine and catalytic camphorsulfonic acid in refluxing toluene to give an 
intermediate imine, which underwent intramolecular alkylation and decarboxylation of 
the resulting iminium ion to give azomethine ylide 1.185.  This ylide then reacted with 
the tethered, unactivated olefin via the transition state 1.192 to give the aspidosperma 
core 1.193 in 79% yield.  This cascade reaction very efficiently constructed the target 
tricyclic core in one operation from acylic starting materials, which could subsequently 
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be hydrolyzed to give the Stork ketone 1.184 in 6 total synthetic steps and in an 
impressive 40% overall yield. 
Scheme 1.31. 1,3-DPC via Imine Alkylation/Decbaroxylation Cascade in 
Aspidosperma Alkaloid Synthesis 
 
 The intermediate Stork ketone 1.184 was then elaborated, using literature 
conditions, into aspidospermine (1.182), aspidospermidine (1.181), and quebrachamine 
(1.183) through three separate sequences involving a Fischer indole synthesis to install 






Scheme 1.32. Utilizing the 1,3-DPC Product as a Common Synthetic Intermediate 
in the Total Syntheses of Aspidosperma Alkaloids 
 
1.2.4 Applications Involving the Deprotonation of Iminium Ions 
1.2.4.1 Quinocarcin & Quinocarcinamide 
Quinocarcin (1.195) is a natural secondary metabolite isolated from Streptomyces 
melanovinaceus, which has been shown to exhibit antimicrobial activity against several 
Gram-positive microbes, and has also exhibited anti-tumor activity as its citrate salt.  The 
naturally occurring oxidative byproduct quinocarcinamide (1.194), however, has shown 
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to be biologically inactive.  These alkaloids have succumb to many syntheses, and, in 
particular, the work of Williams has illuminated a strategy toward the construction of the 
azabicyclic framework via a novel 1,3-DPC cycloaddition (Scheme 1.33, see also 
Sections 1.2.6.3, 1.2.5.1, and 1.2.7.2 for a related discussion of these alkaloids).28-31  The 
original method used was aimed at creating the pyrrolidine ring system in 1.196 using the 
1,3-disubstituted azomethine ylide 1.197 in an intermolecular 1,3-DPC with an acrylate 
dipolarophile.  As described earlier in this review, most acyclic 1,3-disubstituted 
azomethine ylides tend to favor the S-shape, however, in this case they were hoping to 
access the cis-ylide of type 1.197 (W- or U-shaped). 
Scheme 1.33. Retrosynthesis of Quinocarcin & Quinocarcinamide 
 
Their first attempt to execute the cycloaddition strategy started with aldehyde 
1.198 (Scheme 1.34).  Heating 1.198 with benzyl N-methylgylcinate and triethylamine in 
refluxing THF furnished an azomethine ylide via iminium deprotonation, which reacted 
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with methyl acrylate to give pyrrolidine 1.200 via the endo-transition state 1.199.  It was 
hoped that the stereochemistry at C(5) would be sufficient in directing the facial 
selectivity of the cycloaddition event, however a mixture (1:1) of syn- and anti-
diastereomers was obtained (relative to C(5) and C(11)).  In assigning the 
stereochemistry of the pyrrolidine ring it was determined that the ring possessed a 2,5-
anti-relationship, which would suggest the reaction proceeded though an S-shaped 
azomethine ylide 1.199 and not the desired cis-ylide.  With the incorrect stereochemistry 
from the cycloaddition to continue forward with the total synthesis, a revised route was 
drafted to address the azomethine ylide geometry. 
Scheme 1.34. Initial Attempt at 1,3-DPC via Iminium Deprotonation to Form 
Quinocarcinamide Core 
 
 In the revised approach, Williams next aimed to employ the cyclic azomethine 
ylide 1.202, which would, by virtue of the cyclic nature of the reactive species, give the 
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desired U-ylide geometry (Scheme 1.35).  This cycloaddition would give direct access to 
the quinocarcin core 1.201. 
Scheme 1.35. Revised Retrosynthesis of Quinocarcin & Quinocarcinamide 
 
 The second approach to the cycloaddition used piperazine derivative 1.203xiv, 
which was first activated as a highly conjugated iminium salt 1.204 by treatment with 
NBS (Scheme 1.36).  This salt was an isolable green solid that, when treated with base, 
formed a cyclic azomethine ylide and reacted in an intermolecular 1,3-DPC via transition 
state 1.205 to give a 55% yield of a mixture (1:5) of diastereomers favoring 1.206.  In 
both of the diastereomers, the cycloaddition was exo-selective to give the desired 
stereochemistry of the azabicyclic moiety.  The major product, however, had the 
incorrect stereochemistry at C(5) due to approach of the diapolarophile from the face 
opposite the methanol side chain.  Fortuitously, the C(5) stereocenter could be 
                                                 
xiv Synthesized in 16 steps from o-anisaldehyde in 8% overall yield. 
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equilibrated to the desired relative stereochemistry via oxidation and thermodynamic 
equilibration of the corresponding aldehyde.  In this way, the major product of the 
cycloaddition could be efficiently converted to the desired product 1.201.   
Scheme 1.36. 1,3-DPC via Iminium Deprotonation in the Quinocarcinamide Total 
Synthesis 
 
 With the quinocarcin core 1.201 in hand, the synthesis of quinocarcinamide 
(1.195) could be completed in 4 additional steps to complete the total synthesis in 25 total 
synthetic steps in 2% overall yield (Scheme 1.37).  The intermediate 1.207 en route to 
quinocarcinamide was previously carried forward to quinocarcin by Garner, which would 
also constitute a Williams formal total synthesis of quinocarcin.32  It is important to note, 
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that this synthetic effort further highlights the preference for acyclic 1,3-disubstituted 
azomethine ylides to favor the S-shaped geometry.  In order to access cis-ylides of this 
type, extra measure and consideration must be taken.  In the case of the quinocarcinamide 
total synthesis, the strategy that worked best was tying the ylide in a cyclic conformation. 
Scheme 1.37. Completion of Quinocarcinamide (1.194) Synthesis and Quinocarcin 
(1.195) Formal Synthesis 
 
1.2.4.2 Manzamine A 
Manzamine A (1.208) was isolated from the blue Caribbean marine sponge 
Haliclona caerulea, and has been shown to exhibit potent antitumor and antimalarial 
activity.  While this incredibly unique architechtural framework has garnered much 
attention from the synthetic community on a few total syntheses have been completed.  A 
majority of the synthetic efforts which have been reported focus on the construction of 
the ABC and ABCE core of the molecule.  One such report by Coldham targeted the C-
ring using an intramolecular 1,3-DPC reaction via an S-shaped-1,3-disubsituted 
azomethine ylide 1.210 (Scheme 1.38).33  This reaction would give the ABC ring system 
1.209 directly, which would contain the requisite stereochemistry and functionality to 
construct the E ring. 
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Scheme 1.38. Retrosynthesis of Manzamine A 
 
The synthesis began with aldehyde 1.211xv, which was elaborated into aldehyde 
1.212 in 6 steps and 39% overall yield (Scheme 1.39).  This aldehyde was then heated 
with a variety of glycinate esters in refluxing toluene to give a mixture of azomethine 
ylides 1.210 and 1.213 bearing the S- and W-geometry, respectively.  The S-ylide was 
generally favored and thus gave the desired cycloadduct 1.209, bearing the 2,5-trans-
pyrrolidine moiety.  Since the N-methyl example was not synthetically viable, the use of 
ethyl N-allylglycinate was used for subsequent progress in the total synthesis.  It is also 
noteworthy, that the non-substituted nitrogen example (using glycine ethyl ester) led to a 
complete inversion of the stereoselectivity giving primarily pyrrolidine 1.214.  As was 
discussed earlier in this review, acyclic azomethine ylides tend to inherently favor the S-
geometry, due to minimization of pseudo-A1,3 strain between the group on the nitrogen 
and the group at the 1-position of the ylide.  As is sometimes the case with protonated 
ylides (exemplified in Scheme 1.39), adopting the W-geometry can be the more favorable 
option.  With pyrrolidine 1.209 in hand, Coldham further elaborated the manzamine core 
                                                 
xv Synthesized in five steps from arecoline in 52% overall yield. 
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though a 9 steps series of refunctionalizations and construction of the E-ring using a ring 
closing metathesis strategy to deliver 1.215.  The overall synthesis of the tetracyclic 
manzamine core 1.215 was accomplished in 21 total synthetic steps and in 1% overall 
yield. 




1.2.4.3 Nakadomarin A 
Nakadomarin A (1.216), which was first isolated from the sponge Amphimedon 
sp. (SS-264), is a manzamine alkaloid thought to be a biogenetic precursor to manzamine 
A (1.208).  Nakadomarin A exhibits an array of biological activities including 
cytotoxicity against murine lymphoma, inhibition of cyclin dependent kinase 4, 
antimicrobial, and antibacterial activity.  Additionally, the furan C ring of nakadomarin A 
makes it unique in the manzamine family; the ADE rings, however, are closely related to 
the other manzamine alkaloids.  In fact, similar to the manzamine synthesis described in 
the previous section, the pyrrolidine ring in 1.216 was targeted by Williams for 
construction using a novel asymmetric 1,3-DPC reaction (Scheme 1.40).34, 35  Targeting 
a chiral S-shaped azomethine ylide of type 1.220, a 1,3-DPC was envisioned occurring 
with the activated exocyclic olefin 1.219 in an endo-fashion to give the 2,5-anti-













Scheme 1.40. Retrosynthesis of Nakadomarin A 
 
 The Williams cycloaddition addresses two critical issues related to azomethine 
ylide 1,3-DPCs.  First, the general formation of 1,3-disubsituted azomethine ylides 
bearing a discrete S-shape, and second, the induction of asymmetry using a chiral 
azomethine ylide.  For the most part, the asymmetric examples of 1,3-DPC mostly rely 
on chiral dipolarophiles as a source of asymmetric induction.  The Williams group, on the 
other hand, has developed a class of chiral azomethine ylides based on condensation of 
amine 1.56xvi with a desired aldehyde (Scheme 1.41).   The azomethine ylides that form 
from this process always bear an S-shaped azomethine ylide, a consequence of the side 
chain from the aldehyde taking up the least hindered hemisphere to avoid a steric 
interaction with the benzyl amine stereocenter.  This method of generating azomethine 
ylides has been very thoroughly explored by the Williams group and has been developed 
                                                 
xvi Synthesized in one step from the commercially available N-Boc analogue.  
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into a general method for the construction of 2,5-trans-pyrrolidines.  In the case of 
nakadomarin A, the multicomponent 1,3-DPC cycloaddition with 1.221, 1.219xvii, and 
1.56xviii was performed by heating the three components with p-TsOH in benzene, which 
resulted in an S-shaped-1,3-disubstituted azomethine ylide.  This ylide underwent 
intermolecular 1,3-DPC with 1.219 via the endo-transition state 1.222 to give pyrrolidine 
1.223 in 35% yield, which constitutes construction of the A and D rings of nakadomarin 
A.  It is important to note, that enolizable aldehydes are notoriously difficult to employ in 
this type of azomethine ylide formation reaction, which may explain the lower yield of 
the cycloaddition.  Considering, however, that the cycloaddition reaction delivered the 
complex and enantiopure 1.223 in a single operation, this cycloaddition reaction was still 
highly effective.  An additional 4 steps set up an olefin metathesis of 1.224 to construct 










                                                 
xvii Synthesized in two steps from N-Boc-piperidone in ~50% yield.  Note: enone is unstable and was used 
immediately following preparation. 
xviii Synthesized in one step from 1,2,5,6-di-O-isopropylidine-D-mannitol. 
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Scheme 1.41. Asymmetric 1,3-DPC via Iminium Deprotonation in Nakadomarin A 
Partial Synthesis 
 
1.2.4.4 Spirotryprostatin A & B 
The spirotryprostatins were isolated from Aspergillus fumigatus are part of the 
larger class of tryprostatin alkaloids, which have potential as antimitotic arrest agents.  
The spirotryprostatins in particular, have shown moderate cell progression inhibition.  
The Williams group targeted spirotryprostatin A (1.225) and B (1.226) using an 
asymmetric intermolecular 1,3-DPC with a chiral azomethine ylide possessing the S-
geometry (1.229), which would give access to the proline derivative 1.227 (Scheme 
1.42).36-38  In order to accomplish the asymmetric 1,3-DPC, the Williams group aimed to 
further explore the chiral azomethine ylide technology that they previously developed 




Scheme 1.42. Retrosynthesis of Spirotryprostatin A 
 
 The asymmetric cycloaddition reaction was assayed to discover an optimal 
dipolarophile and set of conditions for constructing the partial spirotryprostatin core 
1.232 (Scheme 1.43).  Along with chiral amine 1.56 and aldehyde 1.230, a series of 
oxindole derivatives 1.228a-fxix were screened, and upon mixing in toluene, the mixture 
surprisingly gave two different azomethine ylides.  Both ylides underwent cycloaddition 
via their respective intermolecular exo-transition states 1.231 and 1.232 to yield the 
corresponding pyrrolidines 1.233 and 1.234, respectively.  Surprisingly, no observable 
endo-products formed during the course of the reaction; however, a significant steric 
clash with the vicinal phenyl groups on the chiral auxiliary and the R-group of the 
dipolarophile can be envisioned encumbering the endo-transtition states.  Also not 
                                                 
xix Oxindole 1.228a was synthesized in one step from isatin in 84% yield.  Oxindole 1.228e was 
synthesized in two steps from 6-methoxyisatin in ~80% and was found to be unstable. 
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expected, was the formation of the olefin products such as 1.234.  The possibility of these 
forming after the cycloaddition event, by elimination of 1.233, was ruled out by 
resubjecting the ether products to the cycloaddition conditions and only starting materials 
were recovered.  It was thus postulated that the eliminated cycloadducts 1.234 were 
formed from a discrete azomethine ylide species 1.232, which suggests that the 
elimination occurred during or prior to the ylide formation. 
Scheme 1.43. 1,3-DPC via Iminium Deprotonation in Spirotryprostatin A/B Total 
Syntheses 
 
The formation of ylides 1.232 in the above cycloaddition examples, serve to 
illuminate the challenge of using enolizable aldehydes in ylide formation reactions.  From 
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a mechanistic perspective, the conjugated ylides 1.232 were presumably formed by 
tautamerization of the iminium species 1.235 to give enamine 1.236 (Scheme 1.44).  
Since the enamine is essentially a vinylogous N,O-acetal, the elimination of a molecule 
of MeOH is very facile, and results in ylide 1.237.  In cycloaddition reactions where 
enolizable aldehydes are used, and there is no β-leaving group, the formation of enamines 
by this mechanism is what presents the biggest hurdle to successfully performing 1,3-
DPC of this type. 
Scheme 1.44. Elimination Mechanism for the Formation of Ylide 1.237 
 
A majority of the effort that went in to optimizing the cycloaddition reactions for 
the spirotryprostatins was focused simply on avoiding the elimination problem.  The 
eliminated products, despite mapping on to the natural products, were not found to be 
compatible with the conditions for removal of the chiral auxiliary; therefore conditions 
that gave 1.233 preferentially were required for progress going forward.  With respect to 
spirotryprostatin B (Scheme 1.43, entries a and b, R′=H), it was discovered that lower 
reaction temperatures and longer reaction times were crucial to avoid the eliminated 
cycloadducts.    With respect to spirotryprostatin A (Scheme 1.43, entries c-f, R′=OMe), a 
number of different systems were investigated to avoid the eliminated product.  The t-
butyl ester (entry d) gave the best result for the carboxylated entries, however, subsequent 
steps in the synthesis revealed that the Hunsdiecker reaction that was envisioned for 
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removal the carboxylic acid failed to provide the desired product.  It was necessary to 
therefore perform the cycloaddition to give the hydro-derivatives directly (Scheme 1.43, 
entries e & f).  Initially, as exemplified by entry e, these cycloaddition reactions gave 
mostly the undesired elimination product.  It was eventually found that low temperatures 
(<0 ºC) and longer reaction times were crucial to obtain any synthetically useful amount 
of the desired product 1.233.   
The synthesis of spirotryprostatin B was completed using the cycloadduct 1.233b, 
which could be converted to carboxylic acid 1.238 in an additional five steps and 59% 
overall yield following the cycloaddition (Scheme 1.45).  Next, a Barton-modified 
Hunsdiecker was used to install a bromide, which was subsequently eliminated to give a 
mixture (2:1) of spirotryprostain B (1.226) and 12-epi-spirotryprostatin B (1.240) in 40% 
yield over the two step sequence.  The total synthesis of 1.226 was thus accomplished in 
10 total synthetic steps and in 10% overall yield. 
Scheme 1.45. Completion of Spirotryprostatin B (1.226) and 12-epi-
Spirotryprostatin B (1.240) 
 
 The completion of the spirotryprostatin A total synthesis involved the use of yet 
another azomethine ylide (Scheme 1.46).  The chiral auxiliary of 1.233f was removed by 
 62 
hydrogenolysis, and the corresponding amino acid was heated with catalytic 
butyraldehyde to accomplish epimerization of the amino acid stereochemistry via 
azomethine ylide 1.242 to give a mixture of amino acid diastereomers 1.243.  This 
mixture was then taken on to construct the final two rings of the natural product to give a 
mixture (~1:1) of diketopiperazines 1.244 and 1.245 in ~20% over the four step 
sequence.  A final elimination of 1.244 gave spirotryprostatin A (1.225) in 9 total 
synthetic steps and in ~2% overall yield. 
Scheme 1.46. Completion of Spirotryprostatin A Total Synthesis 
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1.2.4.5 The Stemofoline Alkaloids 
The stemofoline alkaloids were isolated from the Stemona japonica plant and 
constitute a series of similarly substituted alkaloids, represented by stemofoline (1.117, 
Scheme 46).  As outlined in section 1.2.2.5 in this review, these alkaloids have an 
impressive array of biological properties.  The Martin and Gin groups have reported three 
separate accounts of the construction of these alkaloids using three separate novel 1,3-
DPC methods reactions in the construction of the tricyclic core of these alkaloids (see 
section 1.2.6.4 for the second Martin group approach and section 1.2.2.5 for the Gin 
account).14, 39-41  The Martin group, in attempting to generate a 1,1-disubsituted 
azomethine ylide (nor-cyano-1.247), discovered a novel oxidative azomethine ylide 
formation, which maintained the cyano function to give the S-shaped trisubsituted 
azomethine ylide 1.247 (Scheme 1.47).39 This ylide reacted in an intramolecular 1,3-
DPC reaction with the tethered unactivated olefin to give the tricyclic core 1.246 of the 
stemofoline alkaloids.  
Scheme 1.47. Retrosynthesis of Stemofoline 
 
 The first Martin group account began with 1-pentenaldehyde (1.248) and 
sulfonamide 1.249 and employed chemistry developed by Davis for the general synthesis 
of 5-substituted pyrrolidinones. In this way, pyrrolidinone 1.250 was synthesized over a 
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six step sequence in 48% overall yield (Scheme 1.48).  Pyrrolidinone 1.250 was 
refunctionalized to give aminonitrile 1.251 in 84% yield over the three step sequence.  
The original plan was to expel the cyano group and form an iminium ion, which could 
undergo deprotonation to give the corresponding azomethine ylide.  This transformation 
proved elusive; however, under Swern oxidation conditions it was discovered that a 
cycloaddition took place unexpectedly.  Interestingly, the cyano function was maintained 
during the course of the 1,3-DPC, which suggested that the azomethine ylide 1.247 
formed via an oxidative iminium ion formation.  Since the reaction was inherently basic, 
the azomethine ylide was formed by deprotonation of the iminium ion, which reacted out 
of two regioisomeric transition states 1.252 and 1.253 to give a mixture (ca. 5:1) of the 
corresponding cycloadducts 1.254 and 1.255 in 69% yield.  The removal of the cyano-
group from 1.255 under a variety of conditions in an attempt to access the nor-cyano core 













Scheme 1.48. 1,3-DPC via Iminium Deprotonation in Stemofoline Partial Synthesis 
 
 Cycloadduct 1.255 could be further elaborated to the more advanced tricyclic 
compound 1.257 bearing the butyl side chain and the appropriate alcohol stereochemistry 
over a five step sequence (Scheme 1.49).  The overall sequence to the fully functionalized 
stemofoline core 1.257 was thus accomplished in 15 total synthetic steps and in 9% 
overall yield.  Unfortunately, the cyano-group again proved too robust to be removed 
from the tricyclic core at this stage.   
Scheme 1.49. Elaboration of Cycloadduct 1.255 toward Stemofoline 
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1.2.4.6 Sarain A 
Isolated from the marine sponge Reniera sarai, sarain A (1.258) has inspired a 
number of innovative synthetic efforts due to its very unique caged/macrocyclic 
architecture.  Interestingly, as enforced by the rigidity of the caged core structure, the 
proximal aldehyde and amino residues are bonded causing the sarain alkaloids to exist as 
zwitterionic-like compounds.  The biological activity of the sarain alkaloids also adds to 
their intrigue, in that they have been shown to exhibit antitumor, antibacterial, and 
insecticidal activities.  There have been three accounts of synthetic efforts towards sarain 
A involving nearly identical 1,3-DPC strategies, two by Heathcock and another by 
Weinreb (see section 1.2.6.2 for additional discussion).42-48  One of the strategies 
reported by Heathcock involves the formation of the 1,1-disubsituted azomethine ylide 
1.261 via iminium deprotonation in the construction of the bicyclic compound 1.260 













Scheme 1.50. Retrosynthesis of Sarain A 
 
 The Heathcock approach began with compounds 1.261, 1.262, and 1.263, which 
were elaborated into amino ester 1.264 over five total steps (Scheme 1.51).46, 49  The 
desired azomethine ylide 1.261 was then generated by heating the amino ester with 
paraformaldehyde in refluxing toluene, which underwent an intramolecular 1,3-DPC 
reaction with the tethered unactivated olefin via the chair-like transition state 1.265 to 
give the bicycle 1.260 in 78% yield as a single diastereomer.  This bicyclic compound 
was then subjected to a 14 step sequence to prepare the bridged compound 1.266 in 14% 
overall yield.  Elimination of the alcohol followed by removal of the nosyl-protecting 
group of 1.266 resulted in a Michael reaction, which furnished the caged tricyclic core of 





Scheme 1.51. 1,3-DPC via Iminium Deprotonation in Sarain A Partial Synthesis 
  
1.2.5 Applications Involving the Ionization of Metalloiminium Ions 
1.2.5.1 Cyanocycline A & Bioxalomycin β2 
Structurally similar to the quinocarcin alkaloids (refer to sections 1.2.4.1, 1.2.6.3, 
and 1.2.7.2 for related discussions of these types of alkaloids), the cyanocycline and 
bioxalomycin alkaloids have been shown to exhibit broad-spectrum antibiotic and 
antimicrobial activity.  Isolated from Streptomyces species, these alkaloids contain a 
densely fused polycyclic ring system making them attractive targets for chemical 
synthesis.  The Garner group targeted these alkaloids using metallo-azomethine ylide 
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1.271 (Scheme 1.52).50  The ionization of metalloiminium ions deserve special 
consideration due to subtle differences in reactivity that can lead to different types of 
pyrrolidine than those directly accessible by the deprotonation of alkyl iminium ions.  For 
one, the chelation ability of most metals capable of forming this type of azomethine ylide 
can enforce a W-shaped ylide leading to 2,5-syn-pyrrolidines.  Also, these types of ylides 
hold the promise of catalytic asymmetric techniques by virtue of the tunability of the 
ligands on the metal center.  In this case, however, Garner aimed to employ a chiral 
auxiliary instead of a chiral metal catalyst to induce asymmetry. 
Scheme 1.52. Retrosynthesis of Cyanocycline A 
 
 The Garner synthesis began with aldehyde 1.272, which was elaborated into 
aldehyde 1.273 in 5 steps and in 37% overall yield (Scheme 1.53).  The formation of the 
metallo-azomethine ylide was conducted with the glycine modified Oppolzer’s-L-
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camphorsultam chiral auxiliary 1.55 as the amino component, which was condensed with 
aldehyde 1.273 in the presence of a Ag(I) catalyst to give azomethine ylide 1.274.  
Reaction with methyl acrylate via the endo-1,3-DPC transition state gave the 2,5-syn-
pyrrolidine 1.275 in 74%.  It is important to note that this type of cycloaddition method, 
not only provided the syn-stereochemistry where most similar azomethine ylide 
formations give the anti-result, but it provided direct access to the NH-substituted 
pyrrolidine.  This can be useful if either direct N-functionalization is required in the 
synthesis, or if a non-amine protecting group is required for the remainder of the 
synthesis.  Pyrrolidine 1.275 was then elaborated to the tetracyclic compound 1.269 over 
a six step sequence, which employed the C(1)-amino group to cyclize into the C(4)-ester 
to construct the C-ring, and the C(2)-amino group to form the B-ring via a Pictet-
Spengler reaction.  The tetracycle 1.269 was then converted to 1.267 in another 6 steps to 
constitute a 21 step total synthesis of cyanocycline A in <1% overall yield.  Cyanocycline 
A (1.267) has also been shown to be an intermediate in the synthesis of bioxalomycin β2 












Scheme 1.53. Asymmetric 1,3-DPC via Imine Metallation in Cyanocycline A (1.267) 
Total Synthesis & Bioxalomycin β2 (1.268) Formal Total Synthesis 
 
1.2.6 Applications Involving the Thermolysis/Photolysis of Heterocycles 
1.2.6.1 Pyrrolizidine, Kanoid & Mesembrine Alkaloids 
There are a plethora of natural occurring pyrrolizidine alkaloids, of which 
dihydroxylheliotridane (1.276 & 1.277) and platynesine (1.278) are representative; they 
hold promise as antitumor, antiviral, and diabetic drugs by virtue of their broad range of 
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activities as glycosidase inhibitors (Scheme 1.54).  The kanoid alkaloids, represented here 
by acromelic acid (1.280), have been studied and employed as useful tools in 
neurobiology due to their ionotropic glutamate receptors agonisim properties.  Finally, 
mesembrine (1.279) isolated from the South African plant Sceletium toruosum (known as 
Kanna), has been shown to be a serotonin reuptake and PDE4 inhibitor, and is thought to 
contribute to the antidepressant effect of natural Kanna.  While these alkaloids have little 
in common, the Ogasawara group has developed a 1,3-DPC strategy, which allowed 
access to a common class of bicyclic intermediates of type 1.281, which have proved 
viable intermediates in the syntheses of all of these alkaloids (Scheme 1.54).51-54  A 
similar disconnect is outlined in Section 1.2.4.6 and 1.2.6.2 toward the synthesis of sarain 














Scheme 1.54. Asymmetric 1,3-DPC via Aziridine Thermolysis in Pyrrolizidine, 
Kanoid & Mesembrine Alkaloid Total Syntheses 
 
. In order to access the common bicyclic intermediates 1.281, Ogasawara 
developed a common synthetic strategy to synthesize the various aziridines required for 
the cycloaddition reaction starting with chiral epoxide 1.283 (Scheme 1.55).  Addition of 
the appropriate carbon nucleophile (Grignards, lithium acetylides, and nitrile anions all 
proved competent) gave the corresponding alcohol products.  For the pyrrolizidine 
alkaloids, vinyl magnesium bromide was used to give the homoallylic alcohol 1.284 in 
70% yield.  This alcohol was then functionalized to install the acylaziridine component 
by acylation of the alcohol with acid chloride 1.285, followed by double alkylation of 
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benzyl amine with the resulting dibromide to give the aziridine 1.286 in 87% yield 
(Scheme 1.55).   
Scheme 1.55. Synthesis of Aziridine Starting Materials using a General Strategy 
 
For acromelic acid, the pyridyl lithium acetylide 1.287 was used to open epoxide 
1.283 to give homopropargyl alcohol 1.288 in 76% yield.  The alkyne was then reduced 
to the trans-homoallylic alcohol then the acylaziridine moiety was installed in the same 
 75 
fashion as described above using reagent 1.285 to give aziridine 1.289 in 65% over the 
two step sequence (Scheme 1.55). 
Finally for mesembrine, the nitrile anion of 1.290 opened 1.283 to give the cyano-
compound 1.291 in 64% yield.  The benzonitrile group was then converted to the 
corresponding styrene moiety and the resulting homoallylic alcohol was functionalized in 
the same fashion using reagent 1.285 to give aziridine 1.292 in 63% yield over the five 
step sequence (Scheme 1.55).   
 With aziridine 1.286 in hand, the syntheses of the various pyrrolizidine alkaloids 
could be advanced using an intramolecular 1,3-DPC reaction (Scheme 1.56).  
Thermolysis of aziridine 1.286 resulted in an azomethine ylide which reacted via the 
chair-like transition state 1.293 to give the bicyclic lactone 1.294 in 70%.  This type of 
transition state model works to describe each of the following cycloaddition reactions for 
explaining the resulting stereochemical outcome in each case.  Bicycle 1.294 was 
subsequently converted into (-)-dihydroxyheliotridane (1.276) in an additional 11 steps 
and 14% overall yield.  The (+)-enantiomer 1.277 and (-)-platynesine (1.278) were also 
synthesized using comparable synthetic methods to that described for 1.276.  The total 
asymmetric synthesis of 1.276 was thus accomplished in 14 total synthetic steps and in 
6% overall yield. 
Scheme 1.56. Asymmetric 1,3-DPC via Aziridine Thermolysis in (-)- 
Dihydroxyheliotridane Total Synthesis 
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 The preparation of aziridine 1.289, set up the completion of the synthesis of 
acromelic acid (Scheme 1.57).  The thermolysis of 1.289 resulted in an azomethine ylide, 
which reacted with the tethered unactivated olefin via transition state 1.295 to give the 
bicyclic lactone 1.296 in 85% as a single diastereomer.  Lactone 1.296 was then 
converted to acromelic acid (1.280) in an additional 9 steps in just under 10% overall 
yield.  The total synthesis of acromelic acid was thus accomplished in 13 total synthetic 
steps and in ~4% overall yield. 
Scheme 1.57. Asymmetric 1,3-DPC via Aziridine Thermolysis in Acromelic Acid 
Total Synthesis 
 
 In a similar fashion as described above, aziridine 1.292 was subjected to 
thermolysis to give an azomethine ylide, which reacted with the appended olefin via the 
transition state 1.297 to give cycloadduct 1.298 in 73% yield as a single diastereomer 
(Scheme 1.58).  The bicyclic lactone 1.298 was then advanced to mesembrine (1.279) in 
an additional 8 steps and in approximately 10% yield.  The total synthesis of mesembrine 





Scheme 1.58. Asymmetric 1,3-DPC via Aziridine Thermolysis in Mesembrine Total 
Synthesis 
 
1.2.6.2 Sarain A 
Sarain A (1.258) was isolated from the marine sponge Reniera sarai, and as 
outlined in section 1.2.4.6 of this review, these alkaloids have an impressive array of 
biological properties and a very unique architecture.  A synthetic approach involving 
aziridine thermolysis to access azomethine ylide 1.301 was developed almost 
simultaneously by both the Weinreb and Heathcock groups, and both approaches studied 
essentially the exact same cycloaddition reaction to prepare the bicyclic lactam of type 










Scheme 1.59. Retrosynthesis of Sarain A 
 
 A series of aziridine amides 1.302xx were synthesized by both the Weinreb 
(Scheme 1.60, entries a-h) and Heathcock groups (Scheme 1.60, entry i), and tested in the 
key intramolecular 1,3-DPC.42, 43, 45, 47, 48  Thermolysis of the aziridines of type 1.302 
gave azomethine ylides, which underwent intramolecular 1,3-DPC reactions with the 
tethered unactivated olefins via the transition state of type 1.303 to give the bicyclic 
lactams 1.300.  In all cases the protecting group on the aziridine nitrogen (R′) was a 
benzyl group, however, a fairly extensive screen of the other substituents was performed.  
In the examples where the lactam nitrogen was an alkyl group (R′′=Bn) the 1,3-DPC 
consistently gave higher yields.  It is notable that when the lactam was unsubsituted 
(R′′=H) a majority of what was isolated from the reaction was cyclization of the lactam 
nitrogen into the iminium ion of the azomethine ylide.  This can be explained by the less 
favorable S-trans conformation of the amide being required for the cycloaddition (see 
                                                 
xx Aziridine 1.302d was synthesized in 6 steps from dihydroanisole and N-benzyl-2-aziridine carboxylic 
acid in 44% overall yield.  Aziridine 1.302i was synthesized in 11 steps from ethyl malonate and cyclohex-
4-enone in ~9% overall yield.  
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Section 1.2.3.3 for a similar discussion).  The cycloaddition also seemed to tolerate a 
wide array of olefinic side chains and even an acetal functional group (entry d).  When 
the aziridine was further substituted at the R-group to give 1,1-disubstituted ylides, 
however, the reaction yields were far less favorable.  It is noteworthy that in the case 
where the azomethine ylide was further stabilized with a dicarbonyl substitution (entry i, 
R=CO2Et) that the temperature required to achieve complete conversion was much lower 
than the other examples. 
Scheme 1.60. 1,3-DPC via Aziridine Thermolysis in Sarain A Partial Synthesis 
 
 Heathcock used the cycloadduct 1.300i to advance to the enoate 1.304 using a 6 
step synthetic sequence; however, the targeted Michael reaction to construct the tricyclic 
sarain core was unsuccessful with the N-tosyl compound (Scheme 1.61).  In later efforts, 
the Heathcock group advanced this synthetic approach using an N-nosyl group, and by 
applying a modified cycloaddition method (see Section 1.2.4.6 in this review for further 
discussion). 
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Scheme 1.61. Heathcock – Attempt to Advance Cycloadduct to Sarain Core 
 
 Weinreb applied cycloadduct 1.300d toward the advancement of their synthetic 
efforts (Scheme 1.62).  In an additional 33 steps (0.1% overall yield), the tetracyclic 
compound 1.306 was synthesized bearing the fully functionalized caged core and the 
western macrocyclic ring of sarain A.  The Weinreb partial synthesis of sarain A was thus 
accomplished in 40 total synthetic steps and in <0.01% overall yield. 
Scheme 1.62. Weinreb – Advancement of Cycloadduct in Sarain A Partial Synthesis 
 
1.2.6.3 The Stemofoline Alkaloids 
The stemofoline alkaloids were isolated from the Stemona japonica plant and 
constitute a series of similarly substituted alkaloids, represented by stemofoline (1.117, 
Scheme 64).  As outlined in section 1.2.2.5 in this review, these alkaloids have an 
impressive array of biological properties.  The Martin and Gin groups have reported three 
separate accounts of the construction of these alkaloids using three separate novel 1,3-
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DPC methods reactions in the construction of the tricyclic core of these alkaloids (see 
section 1.2.4.5 for the first Martin group approach and section 1.2.2.5 for the Gin 
account).  The second generation approach reported by the Martin group, targeted the 
1,1-disubstituted azomethine ylide 1.308 as a reactive intermediate in the construction of 
the stemofoline core 1.307 (Scheme 1.63).40  The targeted azomethine ylide was 
envisioned coming from the thermolysis of a 2,2-unsubstituted oxazolidine following 
precedent from the Joucla group.55, 56 
Scheme 1.63. Retrosynthesis of Stemofoline  
 
 The modified Martin approach began with aldehyde 1.309xxi and chiral 
sulfonamide 1.310, which were subjected to a general strategy developed by Davis for 
the preparation of 5-substituted pyrrolidinones, to access pyrrolidine 1.311 over a 6 steps 
sequence (Scheme 1.64).  With pyrrolidinone 1.311 in hand, oxazolidine 1.312 was 
synthesized in 67% yield by treatment with excess TFA and dimethoxymethane.  
Cognizant of a method developed by Joucla for the preparation of azomethine ylides 
from the thermolytic decomposition of oxazolidines, they subjected oxazolidine 1.312 to 
similar thermolytic conditions to generate the azomethine ylide 1.308.  This ylide reacted 
via two regioisomeric transition states 1.308a and 1.308b to give a mixture (1:1) of 
                                                 
xxi Synthesized in 6 steps from 4-methoxycrotonic acid in 45% overall yield. 
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regioisomeric cycloadducts 1.313 and 1.314 in 95% yield.  Recall from the previously 
discussed Martin group cycloaddition (Section 1.2.4.5), that a very high regioisomeric 
ratio was obtained when the azomethine ylide was substituted at the termini with a cyano-
group, the presence of the cyano group was problematic for advancing the total synthesis 
due to its robust nature.  This approach by the Martin group aimed to access a nor-
cyanated stemofoline core in an asymmetric fashion; however, in now accessing the nor-
cyanated ylide 1.308 the corresponding cycloaddition was far less regioselective.  It is 
noteworthy that an advanced and appropriately functionalized tricyclic core of the 
stemofoline alkaloids 1.313 was obtained in asymmetric fashion in 15 total synthetic 
operations and in an impressive 7% overall yield (see Chapter 2 & 3 in this dissertation 
for a more in-depth discussion of this work). 




Quinocarcin (1.195) is a natural secondary metabolite isolated from Streptomyces 
melanovinaceus, which has been shown to exhibit antimicrobial and anti-tumor activities 
(See Sections 1.2.4.1, 1.2.5.1, & 1.2.7.2 for related discussions of this and related 
alkaloids).  The previous synthesis discussed in this review by Williams (Section 1.2.4.1) 
sought to construct the D-ring of the quinocarcin alkaloids via a 1,3-DPC.  Through their 
efforts, the concept of using a cyclic azomethine ylide to enforce the U-shaped geometry 
was successfully applied to construct the bridged azabicycle.  A similar strategy was 
adopted by Garner where the ylide 1.317, constituting the C-ring of quinocarcin, was 
used to construct the bridged azabicyclic scaffold 1.315 (Scheme 1.65).32, 57-61  Garner’s 
approach, however, was to use an aziridine photolysis as a way to access the targeted 
azomethine ylide, and to perform the cycloaddition in an asymmetric fashion.   The 
preparation of 1.315 set up the construction of the remaining ABE rings. 
Scheme 1.65. Retrosynthesis of Quinocarcin 
 
 Garner’s approach began with chiral amino alcohol 1.318xxii, which was 
converted to the bicyclic aziridine 1.319 in 5 steps, 35% overall yield (Scheme 1.66).  
Next, the aziridine 1.319 was subjected to photolysis at 2537 Å in a quartz vessel to give 
                                                 
xxii Synthesized in 8 steps from 2-methoxy-6-methylbenzaldehyde in 29% overall yield. 
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the corresponding azomethine ylide 1.317.  Initial model studies of the key cycloaddition 
reaction aimed to study the reaction parameters necessary to give, not only high exo-
selectivity, and high diastereoselectivity relative to the benzylic stereocenter.  These 
initial studies bore out the necessity of using a chiral dipolarophile, namely the 
Oppolzer’s sultam modified acrylic acid 1.52.  Attempts to use methyl acrylate in the 
cycloaddition led to good yields of the desired exo-products; however the benzylic 
stereocenter had no impact on the facial selectivity, delivering a mixture (1:1) of 
diastereomers.  The approach of tethering the dipolarophile to the benzylic alcohol side 
chain was also investigated, unfortunately a similar lack of facial selectivity was 
observed.  The use of Lewis acid additives/catalysts was also investigated to effect the 
stereoselectivity, however the Lewis acid/base adducts led to complex reaction mixtures 
due to the incompatible photophysical properties of these adducts under the required 
irradiation conditions.  Thus, the use of the chirally modified dipolarophile 1.52 was 
necessary to control the facial selectivity; and, in the event, the reaction of aziridine 1.319 
and 1.52 delivered the azabicycle 1.320 in 61% yield via the exo-si mode.  A further 10 
synthetic operations were then required to convert cycloadduct 1.320 into quinocarcin, 






Scheme 1.66. Asymmetric 1,3-DPC via Aziridine Photolysis in Quinocarcin Total 
Synthesis 
 
1.2.7 Applications Involving Conjugated Azomethine Ylides via Oxopyridinium & 
Oxopyrizinium Ions 
1.2.7.1 (-)-Quinocarcin/(-)-Lemonomycin:  Conjugated Azomethine Ylide via Oxo 
Pyrazinium Salt 
Quinocarcin (1.195) and related alkaloid lemonomycin (1.321), isolated from 
Streptomyces species, have been shown to exhibit antimicrobial, antibiotic and anti-tumor 
activities (See sections 1.2.4.1, 1.2.5.1, & 1.2.6.4 for discussions of these and related 
alkaloids).   The previous syntheses discussed in this review for quinocarcin by Williams 
(Section 1.2.4.1) and Garner (Section 1.2.6.4) sought to construct the D-ring of the 
quinocarcin via an intermolecular 1,3-DPC.  Through their efforts, the concept of using a 
cyclic azomethine ylide to enforce the U-shaped geometry was successfully applied to 
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construct the bridged azabicyclic portion of this molecule.  Furthermore, Garner 
employed the Oppolzer sultam-derived acrylamide 1.52 to control the diastereoselectivity 
of the cycloaddition event to effect an asymmetric synthesis.  This disconnect was also 
adopted by Stolz in his own syntheses of quinocarcin and lemonomycin, however Stoltz 
aimed to use a cycloaddition method originally developed by Joule which employed a 
oxopyrizinium ion 1.323 in an intermolecular 1,3-DPC cycloaddition reaction with a 
chirally modified dipolarophile (Scheme 1.67).62, 63  Cycloadduct 1.322, bearing the C 
and D rings of the target alkaloids would then serve as a common intermediate in the total 
syntheses of both quinocarcin and lemonomycin. 
Scheme 1.67. Retrosynthesis of Quinocarcin (1.195) and Lemonomycin (1.321) 
 
 Stoltz’s synthetic efforts began with the bromo pyrizium salt 1.324, which was 
quickly elaborated into the target bridged azabicyclic compound 1.326 by treatment with 
acrylamide 1.52 and N-methyl morpholine to effect an asymmetric intermolecular 1,3-
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DPC reaction via 1.325 (Scheme 1.68).  The cycloaddition reaction proceeded with great 
exo-selectivity (a common outcome of the Oppolzer sultam dipolarophile) and with high 
diastereoselectivity to give the enantiomerically enriched 1.326.  This intermediate was 
used in the synthesis of quinocarcin by treatment with sodium methoxide to give methyl 
ester 1.328 in 72% yield from 1.324.  The synthesis of quinocarcin (1.195) was 
completed over a 14 step total synthesis and in 7% overall yield. 
 The synthesis of the considerably more complicated lemonomycin was 
accomplished by using 1.326.  In this case, treatment of 1.326 with sodium borohydride 
gave alcohol 1.327 in 74% yield from 1.324.  An additional 29 steps were then required 
to complete the total synthesis of lemonomycin in <0.1% overall yield.  
Scheme 1.68. Asymmetric 1,3-DPC via Oxopyridinium Ylide in Quinocarcin (1.195) 
and Lemonomycin (1.321) Total Syntheses 
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1.2.7.2  (+)-Nominine:  Conjugated Azomethine Ylide via Oxo-Pyridinium Salt 
Nominine (1.329) belongs to a diverse class of alkaloids known as the hesitine 
natural products, which have been isolated across a number of genera of plants including: 
Aconitum, Consolida, Delphimium, Rumex, and Spiraea, which have all been widely used 
in traditional herbal medicine.  The hesitine alkaloids exhibit an array of biological 
activities in vivo, including potent vasodilating, antiarrhythmic, immunomodulating, and 
analgesic properties.  These alkaloids are structurally unique due to their hightly 
functionalized and densely caged architectures, making them intriguing synthetic targets.  
In that vein, the Gin group designed a synthetic approach to (+)-nominine (1.329) using 
an intramolecular 1,3-DPC of the conjugated oxopyridinium ion 1.331 with a tethered 
activated olefin (Scheme 1.69).64, 65  This 1,3-DPC would set up a subsequent 
intramolecular Diels-Alder reaction of 1.330 later in the synthesis that would lead to the 
fully caged nominine core. 
Scheme 1.69. Retrosynthesis of (+)-Nominine 
  
 The Gin approach first began with a cursory investigation of the guiding 
principles of the intramolecular cycloaddition reaction of simple oxopyridinium ions of 
type 1.332 (Scheme 1.70).  It was necessary to know the correct substitution of the 
dipolarophilic portion of the molecule that would lead to the best distribution of 
regioisomers 1.334 and 1.335, with cycloadduct 1.335 being the desired product.  
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Unfortunately, these initial systems did not give the desired product due to an inherent 
preference for the wrong regioisomer.  It was also discovered that the cycloadducts 
themselves, at the high temperature of the cycloaddition conditions, were formed 
reversibly and, in fact, under the reaction conditions, typically favored the starting 
materials. 
Scheme 1.70. Initial Screening of a Suitable Substrate Array for Critical 1,3-DPC 
 
 The next approach was to investigate the use of the bezofused analogues 1.331, in 
the hope that the cycloadducts formed from this reaction would be more 
thermodynamically stable (Scheme 1.71).  As such, the thermolysis of oxopyridinium 
1.331xxiii facilitated an intramolecular 1,3-DPC via regioisomeric transition states 1.331a 
and 1.331b to give a mixture (1:3.6) of cycloadducts 1.336 and 1.337 in 97% yield, 
favoring the undesired.  The ratio (1:3.6) of cycloaddition products represents the mixture 
at thermodynamic equilibrium, which was subsequently exploited for recycling the major 
undesired product 1.337 into the desired cycloadduct 1.336.  Resubjecting the isolated 
undesired cycloadduct 1.337 to the reaction conditions thus led to another mixture (1:3.6) 
                                                 
xxiii Synthesized in 8 steps from p-anisaldehyde dimethyl acetal and 3-methylcyclohexeneone in 23% 
overall yield. 
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of 1.336 and 1.337.  While this process was less than optimal, it did provide the 
functionalized core of nominine 1.336 in fairly short order. 
With cycloadduct 1.336 in hand, Gin completed the synthesis of nominine by first 
accessing vinyl compound 1.338 over a 6 step sequence (Scheme 1.72).  Treatment of 
ketone 1.338 with pyrrolidine gave rise to an electron rich dienamine, which underwent 
an intramolecular Diels-Alder reaction to give the fully caged nominine core.  Two 
additional steps were then required to finish the synthesis of nominine in 19 total 
synthetic steps and in 2% overall yield (counting the added yield of one recycling step of 
the undesired cycloadduct). 
Scheme 1.71. Asymmetric 1,3-DPC in (+)-Nominine Total Synthesis 
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 Scheme 1.72.  Completion of the Total Synthesis of Nominine 
 
1.3 CONCLUSION 
The reactions of azomethine ylides have proven a reliable way to construct 
complex molecular architectures of a variety of classic alkaloids for organic synthesis.  
These methods continue to find applications, not only as a way to construct basic 
pyrrolidine ring systems, but to anchor the synthesis of complex caged scaffolds through 
tandem, intramolecular processes.  Despite the huge body of work on this class of 
reaction, there continues to be novel methods developed to address the formation of 
azomethine ylides from a continually evolving set of different starting materials.  For the 
most part, a majority of these methods have not yet found application in natural product 
total synthesis, which provides a plentiful area for groups to explore new chemistries in 
the future.  The application and development of catalytic, asymmetric techniques to the 
formation and implementation of chiral azomethine ylides is also still underutilized in the 
field of natural products.  Also, the preparation of unstabilized azomethine ylides is 
sometimes problematic; as such, new general methods for addressing the formation and 
implementation of these types of ylides are still in demand. 
One of the most valuable aspects of the 1,3-dipolar cycloaddition of azomethine 
ylides is the ability of this reaction class to form four stereocenters simultaneously in a 
very convergent and highly controlled fashion.  Furthermore, with only a rudimentary 
understanding of the control elements of these reactions, the stereochemical and 
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regiochemical aspects can generally be predicted accurately before the embarkation of a 
total synthesis.  Depending on the substitution and stereochemistry that is desired, the 
choice of azomethine ylide and the manner in which the ylide is generated is a crucial 























Chapter 2 – The Stemofoline Alkaloids 
2.1 INTRODUCTION 
2.1.1 Isolation & Biological Activity 
The Stemonacea family contains approximately 30 different species of flowering 
plants native to various regions of Southeast Asia, from which a plethora of biologically 
active natural products have been isolated.66  The ground up leaves and tuberous roots of 
these plants have been used for centuries in traditional Asian medicine to prepare herbal 
teas in the treatment of chronic cough symptoms associated with respiratory diseases 
such as bronchitis and tuberculosis.  Additionally, these extracts can be applied as 
pesticidal remedies in both human and agricultural infestations.  The stemofoline 
alkaloids in particular, exhibit this high insecticidal activity, a consequence of their action 
as insect acetylcholine receptor antagonists.67, 68  Additionally, they exhibit activity 
against various human carcinoma cell lines and in vivo anti-oxytocin activity, with 2.3 
being the most potent in both cases.69-71  Extensive investigations into the active 
principles of these plants have revealed a wealth of important alkaloids that pose distinct 
challenges to chemical synthesis, the greatest of which is presented by the stemofoline 
alkaloids (Figure 2.1).  The first of these alkaloids, didehydrostemofoline (2.3), was 
isolated from the Stemona japonica species in 1970 and has since been joined by a family 
of alkaloids bearing the same caged hexacyclic architecture varying only in the oxidation 
of the C(3)-side chain and the geometry of the C(11)/C(12) olefin (Figure 2.1).66, 67, 69, 
70, 72   
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Figure 2.1 Selected Stemofoline Alkaloids 
 
The unique structural complexity of the stemofoline alkaloids has inspired 
numerous synthetic efforts, culminating in two total syntheses.  Kende reported the first 
total synthesis of (±)-isostemofoline (2.2) in 1999,73 which was then followed by the 
Overman total syntheses of (±)-didehydrostemofoline (2.3) and (±)-
isodidehydrostemofoline (2.4) in 2003.74  Of the partial synthetic efforts, Thomas 
reported an approach to stemofoline (2.1) in 199275 and has followed up with two 
subsequent reports on progress towards these alkaloids.76, 77  Gin has also divulged 
efforts towards stemofoline in 2002,15 along with a subsequent follow up.14 
2.1.2 Synthetic Approaches to the Stemofoline Alkaloids 
2.1.2.1 Kende Total Synthesis 
In 1999 Kende reported the total synthesis of isostemofoline (2.2), which focused 
on the construction of the full hexacyclic structure utilizing a cascade cyclization 
approach (Scheme 2.1).73  The early steps of the total synthesis were used to assemble an 
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initial bridged azabicyclic motif relying on a formal [4+3] cycloaddition of pyrrole 2.10 
and known vinyl diazo compound 2.11 (Scheme 2.1).  To set the stage for the initial 
cycloaddition, compound 2.10 was synthesized by first selectively oxidizing diol 2.6 with 
NaOCl in 65% yield, and protecting the primary alcohol as its methoxymethyl (MOM) 
ether to afford ketone 2.7 in 93% yield.  A Knoevenagel condensation between 2.7 and 
aldehyde 2.8 afforded the conjugated pyrrole precursor 2.9 in 80% yield.  The synthesis 
of 2.10 concluded with a low yielding cyclization of 2.9, followed by a Boc-protection of 
the resulting pyrrole to provide 2.10 in 72% yield. 
Scheme 2.1 
 
With compound 2.10 in hand, a modification of cycloaddition chemistry 
developed by Davies was applied.78  In this reaction a rhodium catalyzed 
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cyclopropantion of the more electron rich side of the pyrrole with vinyl diazo compound 
2.11 followed by a Cope rearrangement of intermediate 2.12 resulted in a formal [4+3] 
cycloaddition to yield the bridged azabicyclic compound 2.13 in 90% yield (Scheme 2.1).  
Scheme 2.2 
 
 Removal of the silyl enol ether of 2.13 with TBAF proceeded in 65% yield, and 
hydrogenation gave β-ketoester 2.14 in 90% yield (Scheme 2.2).  A subsequent Krapcho 
decarboxylation of 2.14 gave ketone 2.15 in 90% yield.  With 2.15 in hand, a two-step 
alkylation sequence was used to install the remaining carbon framework for the 
pentacyclic core of the stemofoline alkaloids.  A Knoevenagel condensation of 2.15 with 
2-furfural (2.16) followed by an allylation with LiHMDS and allyl iodide gave a mixture 
(2.4:1) of O- and C-alkylated products 2.18 and 2.19 in 91% yield.  A subsequent Claisen 
rearrangement of the O-alkylated product provided an 86% yield of the desired C-




The terminal alkene of 2.19 was converted to the TIPS-protected alcohol 2.20 by 
first subjecting 2.19 to Johnson-Lemieux conditions followed by selective reduction of 
the resulting aldehyde with zinc borohydride gave an intermediate alcohol in 52% yield 
over two steps (Scheme 2.3).  Protection of the primary alcohol as its TIPS ether 
proceeded in 93% yield to give enone 2.20.  In order to set the critical C(10)-methyl 
stereocenter, a conjugate addition of MeLi in DMPU was performed on enone 2.20 and 
gave an 85% of the desired C(10)-epimer as the only product.  The primary silyl 
protecting group was removed with TBAF, and the free alcohol was converted to the 
primary tosylate providing 2.21 in 90% yield.  Ozonolysis of the furan side chain of 2.21 
gave carboxylic acid 2.22 in 65% yield.  A three step sequence was then employed to 
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convert the carboxylic acid of 2.22 into the required aldehyde 2.23 via reduction of its 
mixed anhydride in 30% over the three steps. 
Scheme 2.4 
 
Installation of the butenolide side chain was accomplished by the aldol reaction of 
aldehyde 2.23 with the lithium furanone anion 2.24 to deliver an inconsequential mixture 
of alcohol diastereomers 2.25 in 56% yield (Scheme 2.4).  Oxidation of the 
diastereomeric alcohols 2.25 with Dess-Martin periodinane provided ketone 2.26 in 61%, 
thereby setting the stage for a key cascade cyclization reaction facilitated by 
trifluoroacetic acid.  Subjecting the bisprotected compound 2.26 to TFA resulted in 
concomitant Boc- and MOM-deprotection and initiated the desired key cascade reaction.  
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In the event, the resulting free amine cyclized in an SN2 fashion onto the axially disposed 
tosyl electrophile, and the resulting free alcohol underwent an acetalization cascade by 
cyclization into the C(8)-ketone then into the pendant ketone resulting in a 67% yield of 
the pentacyclic lactol 2.27.  At this stage, all that remained to complete the synthesis was 
the dehydration of lactol 2.27; this step, however, proved problematic resulting in either 
no product or a majority of the retro-aldol product 2.28 under a variety of conditions.  
The use of triflic anhydride as the dehydrating agent, however, did provide a 12% yield 
of isostemofoline (2.2) culminating in a 26 step total synthesis in an overall yield of 
0.007%. 
2.1.2.2 Overman Total Synthesis 
The Overman total synthesis of (±)-didehydrostemofoline (2.3) and (±)-
isodidehydrostemofoline (2.4), which was reported in 2003, sought to employ a cascade 
aza-Cope/Mannich approach to the azatricyclic natural product core (Scheme 2.5).  
Starting with a Diels-Alder cycloaddition between pyrrole 2.29 and ethyl-(E)-3-
nitroacylate followed by hydrogenation of the resulting enol ether gave the desired 
cycloadduct 2.30 in a two-step yield of 73% along with 13% of the undesired 
regioisomer.  Elimination of the β-nitro group of 2.30 was accomplished with DBU and 
resulted in an enoate that was further reduced by hydrogenation.  The primary alcohol 
was protected as its TIPS ether, and the ester was reduced with DIBAL to furnish alcohol 
2.31 in 51% yield over the four step sequence.  Oxidation of alcohol 2.31 using Dess-
Martin periodinane gave an intermediate aldehyde that was elaborated into its 
corresponding TIPS silyl enol ether in an additional step.  Ozonolysis of the intermediate 
silyl enol ether gave ketone 2.32 in 72% yield over three steps.  Reaction of ketone 2.32 
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with vinyl magnesium bromide followed by Boc-deprotection with TMS-I gave 
ammonium salt 2.33 in 85% yield over two steps.   
Scheme 2.5 
 
With 2.33 in hand, the key tandem aza-Cope/Mannich reaction could be 
performed to set up the tricyclic core of the stemofoline alkaloids (Scheme 2.5).  Heating 
2.33 with paraformaldehyde resulted in an intermediate iminium ion 2.34, which 
underwent the envisioned aza-Cope rearrangement to give iminium ion 2.35.  The 
resulting iminium ion then underwent an intramolecular Mannich reaction with the 








 Ketone 2.36 was then subjected to a three step protocol to install the necessary 
butenyl side chain (Scheme 2.6).  This sequence commenced with a silyl deprotection of 
2.36 which provided a primary alcohol that was oxidized under Parikh-Doering 
conditions to the corresponding aldehyde.  Finally a Julia-Kochienski olefination of the 
intermediate aldehyde with 2.37 gave olefin 2.38 with the required butenyl side chain in 
70% yield over three steps.  Alkylation of 2.38 with ethyl iodoacetate provided the 
axially substituted product, which was equilibrated with catalytic DBU to provide a 67% 
yield of the desired equatorially substituted ketone 2.39.  Formation of the first lactol ring 
was then accomplished by treating the methyl ether 2.39 with BBr3, which also induced 
cyclization, and the resulting lactol was protected as the TMS ether in an additional step.  
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Alkylation of the ester side chain with iodomethane to install the C(6)-methyl group, 
followed by a subsequent DIBAL reduction, gave alcohol 2.40 in 53% yield over four 
steps.  Dess-Martin oxidation of 2.40 gave the corresponding aldehyde as a 
diastereomeric mixture, which could be equilibrated on silica gel to give primarily the 
desired epimer 2.41 in 54% yield over two steps. 
Scheme 2.7 
 
 With aldehyde 2.41 in hand, the butenolide moiety was installed by an aldol 
reaction with lithium furanone 2.24, followed by hydrolysis of the TMS protecting group 
to furnish lactol 2.42 in 93% yield over two steps (Scheme 2.7).  Oxidation of alcohol 
 103 
2.42 with IBX facilitated the formation of the final lactol ring as well as γ-oxidation of 
the butenolide moiety to give diol 2.43 in 55% yield.  In order to complete the synthesis, 
Overman applied the Corey-Winter olefination, which addressed the problem Kende 
faced in a late stage dehydrative strategy.  Reaction of the diastereomeric mixture of diols 
2.43 with thiophosgene gave cyclic thiocarbonates 2.44 in a 68% yield as a mixture 
(3.5:1) of syn- and anti-diastereomers.  Phosphite mediated olefination on each of the 
purified thiocarbonates gave targets 2.3 (66% yield from the corresponding syn-product) 
and 2.4 (64% yield from the anti-product).  The total synthesis of didehydrostemofoline 
(2.3) was accomplished in 33 step total steps and in roughly 0.2% overall yield. 
2.1.2.3 Thomas - Partial Synthesis 
In 1992 a synthetic approach to the stemofoline core was reported by Thomas that 
utilized an intramolecular Mannich reaction to assemble an initial bridged azabicyclic 
scaffold, which served as a platform for construction of the tricyclic core.  This initial 
account has since been followed by two subsequent publications, one of which reported 
significant progress toward applying the following chemistry on enantioenriched 
substrates.75-77  The synthetic effort commenced by protecting the nitrogen of lactam 
2.45 as its t-butyl carbamate, followed by the addition of n-butyl magnesium bromide 
into the imide carbonyl to give ketone 2.46 in 69% yield over the two step sequence 
(Scheme 2.8).  Ketone 2.46 was then protected as an acetal and the terminal olefin was 
subjected to ozonolysis to provide aldehyde 2.47 in 73% yield (2 steps).  The addition of 
the enolate of methyl acetate, followed by oxidation of the resulting aldol product gave β-





 β-ketoester 2.48 provided the carbon and functional framework necessary to 
elaborate into the tricyclic core of stemofoline.  As such, the removal of the Boc-
protecting group with TFA unmasked the amine, which condensed spontaneously with 
the attached ketone to give the pyrroline 2.49 (Scheme 2.9).  The crude imine was then 
treated with methyl chloroformate to give a putative acyl iminium ion, which underwent 
an intramolecular Mannich with the β-ketoester moiety upon treatment with Et3N.  











 With the azabicycle 2.51 in hand, the ketone was reduced with zinc 
cyanoborohydride to give a mixture (75:25) of the axial and equatorial alcohols (Scheme 
2.9).  The axial alcohol was then protected as its t-butyldimethylsilyl ether to give 2.52 in 
58% yield over the two steps.  Reduction of the ester 2.52 to the corresponding alcohol 
with DIBAL-H and iodination delivered alkyl iodide 2.53 in 65% yield (2 steps).  
Lithium-halogen exchange of the iodide 2.53 with t-BuLi then gave an organolithium 
intermediate, which underwent intramolecular acylation with the carbamate moiety to 
give the azatricycle 2.54 in 81% yield.  With this compound in hand, a few different 







While lactam 2.54 contained the requisite carbon framework of stemofoline, 
additional experiments were performed to establish the viability of 2.54 with respect to a 
total synthesis (Scheme 2.10).  The superfluous lactam functionality was first removed by 
reducing 2.54 with LiAlH4 to provide the corresponding cyclic N,O-acetal.  The lactam 
did not fully reduce to the amine as is typical with lactams, and thus an additional 
activation with thionyl chloride was required.  The intermediate formed upon treatment 
with SOCl2 was reduced in the same pot an additional treatment with LiAlH4 to complete 
the reduction at C(5) providing amine 2.55 in 89% over the three step/two-pot sequence.  
The stability of the N,O-acetal intermediate and the presumed α-chloroamine, suggests 
that the bridged nitrogen is incapable of adopting an sp2-hybridized geometry, and thus 
the bridgehead nitrogen atom cannot contribute to the expulsion of the α-leaving group.  
The   α-chloroamine that is formed upon treatment with SOCl2 therefore behaves more 
like an alkyl chloride, which can be reduced to their corresponding alkanes by reduction 
with anionic hydride reagents.  With the C(5)-position refunctionalized, the C(8)-silanol 
was oxidized to the C(8)-ketone by desilylation and oxidation under Swern conditions.  
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The C(9)-substitution was then installed via allylation of the corresponding enolate to 
give mostly the axially substituted ketone 2.56.  Thermodynamic equilibration of the 
axially substituted compound gave the more thermodynamically stable equatorially 
substituted compound 2.57 in 88% yield. 
 Lactam 2.54 was also used to test the concept of oxidizing the C(2)-position using 
a remote functionalization (Scheme 2.10).  Deprotection of C(8)-silanol gave the alcohol 
2.58, which, upon treatment with lead tetracetate, gave an oxygen centered radical 
capable of extracting a hydrogen atom from the C(2)-carbon.  The reformation of the 
oxygen radical facilitated a recombination reaction to functionalized the C(2)-position as 
the ether 2.59 in 35% yield.  No functionalization of the C(3)-position was observed after 
the reaction; however, the starting material was recovered in 12% yield along with 16% 
of the oxidized C(8)-ketone product.  While the remote functionalization of the C(2)-
position in this way is noteworthy, it is not clear how this strategy will be adapted to 
achieve the higher acetal oxidation state at C(8)-position required for stemofoline. 
 Efforts are still ongoing in the Thomas group to expand this general strategy into 
a total synthesis of stemofoline.  Recent accounts from their group have demonstrated the 
efficacy of their approach to achieve an asymmetric synthesis; however, the preparation 
of the full tricyclic core has not yet been reported in that vein. 
2.1.2.4 Gin - Partial Synthesis 
The approach that was devised by Gin, first reported in 2002, focused on the 
construction of the stemofoline core via an intramolecular 1,3-dipolar cycloaddition of a 
azomethine ylide with an appended activated dipolarophile.14, 15  The initial 
cycloaddition substrate chosen was vinylogous amide 2.59, which possessed the required 
C(2)-alcohol, albeit in the opposite stereochemical conformation required for stemofoline 
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(Scheme 2.11).  Attempting to form an azomethine ylide from this substrate by first 
treating with triflic anhydride presumably gave the vinylogous iminium ion 2.60.  
Subsequent reaction of the iminium ion with t-butyl ammonium trifluorosilicate (TBAT), 
rather than generating the desired azomethine ylide, resulted first in a presumed 
epimerization of the C(2)-alcohol leading to iminium ion 2.61.  It was then postulated 
that the azomethine ylide 2.62, resulting from desilylation of iminium 2.61, was 
incapable of achieving the envisioned dipolar cycloaddition transition state 2.62 because 
of the severe steric interaction with the endo-silanol and the newly forming piperidine 
ring.  This attempted cycloaddition was reported to give a complex mixture, and none of 




 Due to the failure of their first approach, a second generation was devised, which 
targeted a cycloaddition substrate incapable of epimerization during the azomethine ylide 
formation (Scheme 2.12).  Using O-isopropylidine-D-erythronolactone (2.64) as the 
starting material, a cycloaddition substrate could be accessed bearing a 5,5-cis-fused ring 
system.  This modification would render the cycloaddition substrate incapable of 
epimerization during the cycloaddition since the product of epimerization would be a 5,5-
trans-fused ring system, which is not possible.  In order to test this hypothesis, 2.64 was 
first treated with (trimethylsilyl)methyl amine, and the resulting alcohol product was 
oxidized under Parikh-Doering conditions.  The resulting hemiaminal was then acetylated 
to give 2.65 in 67% yield over the three step sequence.  The aminal 2.65 was then treated 
with TMS-OTf and the silyl ketene acetal of ethyl acetate resulting in a Mannich reaction 
to install the acetate side chain, which was saponified to give carboxylic acid 2.66 in 69% 
overall yield.  The lactam 2.66 was converted to its thiolactam with Lawesson’s reagent, 














 With 2.67 in hand, the requisite functionality for the cycloaddition was swiftly 
installed (Scheme 2.13).  Over a three step sequence, 2.67 was first olefinated to give a 
vinylogous amide under Wittig conditions.  The dipolarophilic side chain was thus 
installed by addition of ethynyl Grignard reagent to give an ynone, which was activated 
as its vinylogous thioester by 1,4-addition of ethane thiol to give the cycloaddition 
precursor 2.68 in 47% overall yield.  Treatment of 2.68 with triflic anhydride and TBAT 
resulted in an azomethine ylide that underwent the desired intramolecular cycloaddition 
via the intramolecular transition state 2.69 to give cycloadduct 2.70 in 71% yield.  The 
tricyclic cycloadduct was then refunctionalized by first performing an exhaustive 
reduction of the C(3)-side chain.  The C(9)-side chain was then installed following the 
Overman protocol.  Finally, hydrolysis of the acetonide delivered diol 2.71 in 50% over 
the four step sequence.  This tricycle bears the required functionality in the stemofoline 
core; however, the superfluous C(6)-thiol and the C(1)-alcohol must be removed from the 
molecule selectively in the presence of the C(2)-alcohol.  Furthermore, the C(2)-
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stereocenter would have to be inverted for it to be clear that 2.71 is a viable intermediate 
in a total synthesis of stemofoline.   
Scheme 2.13 
 
 Despite the extra functionality in 2.71, it is noteworthy that the tricyclic core of 
the stemofoline alkaloids bearing the appropriate C(3) and C(9)-side chains was accessed 
in an asymmetric form in 15 total steps. 
2.1.2.5 Summary 
The synthetic approaches discussed in this first section represent a number of 
excellent tactics to access the stemofoline core.  The completed total syntheses, however, 
were rather long requiring >26 steps and provided low overall yields of the final natural 
product(s).  Furthermore, neither of these total syntheses were performed asymmetrically 
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which represent an opportunity for further development.  While Thomas has reported an 
asymmetric approach to the stemofoline core, the most advanced intermediate he has 
reported is not an intermediate which is clearly viable toward a total synthesis.  The 
Thomas intermediate 2.71 bears two extraneous functional groups at the C(6) and C(1)-
positions and inappropriate stereochemistry at the C(2)-carbon.  Thus the challenge of a 
viable asymmetric synthesis of the stemofoline alkaloids is an unsolved problem.   
2.1.3 Prior Art in the Martin Group 
2.1.3.1 Introduction/Early Studies 
Synthetic studies toward the stemofoline natural products have been ongoing in 
the Martin Group for approximately ten years,39, 40, 79-82 and is part of our group’s 
longstanding interest in the synthesis of the biologically and structural interesting family 
of stemona alkaloids.83, 84  While the proposed syntheses themselves have progress 
through a number of iterations, many of the critical disconnects have remained the same 
(Scheme 2.14).  We have long targeted lactone 2.73 as an intermediate that we felt could 
be used to directly install the butenolide moiety.  Kende reported that his group 
unsuccessfully attempted to elaborate a similar intermediate to stemofoline, but we felt 
that this intermediate still represents the most direct pathway to the stemofoline alkaloids.  
Although it may prove to be a considerable challenge, we felt that a coupling of either the 
lithium furanone anion or a siloxy furan of compound 2.72 with an oxonium ion 
generated from the reaction of 2.73 with Meerwein’s salt (or via a similar activation 
mode) would provide a highly reactive electrophile for this coupling.  The addition of the 
furanone nucleophile into the oxonium formed by reaction with Meerwein’s salt would 
not be susceptible to the “retro-aldol” process that Kende described because the product 
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formed upon addition would not be a free oxygen, thus the reformation of carbonyl 
would not be possible.  We envisioned that compound 2.73 would be ultimately obtained 
by a remote radical functionalization of the C(8)-position by an alcohol derived from 
ketone 2.74.  In this way we hoped to install an appropriate functional handle to install an 
appropriate C(9)-side chain.  This concept was essentially proven by Thomas in the 
reverse sense (Scheme 2.10); however, we sought to adopt chemistry developed by either 
Suarez or Barton because their chemistry would allow for a direct double 
functionalization.85-90  The tricyclic compound 2.74 would then be obtained from an 
intramolecular 1,3-dipolar cycloaddition of an azomethine ylide 2.75 derived from 
pyrrolidinone 2.76.  The pyrrolidinone intermediate could be accessed using chemistry 
extensively developed by Davis,91-96 whereby an intermolecular Mannich/cross-Claisen 
reaction of sulfoximine 2.78 would set the stage for a rhodium catalyzed intramolecular 















 The most notable challenge in the proposed synthesis is the 1,3-dipolar 
cycloaddition, and this reaction accounts for the majority of the effort our group has 
invested in endeavors toward the total synthesis of these challenging alkaloids.  We 
envisioned generating the targeted azomethine ylide by installing a leaving group alpha to 
the pyrrolidinone nitrogen atom so that expulsion of the leaving group would generate an 
iminium ion 2.81 (Scheme 2.15).  Deprotonation of this iminium ion would give the 
polarized azomethine ylide 2.75, which we hoped would then cyclize on the appended 







 In order to test the feasibility of our plan, the simplest conceivable substrate for 
this cycloaddition was targeted using chemistry developed by Davis for the synthesis of 
5-substituted pyrrolidinones (Scheme 2.16).  The synthesis of 2.86 commenced with 4-
pentenal (2.79), which was condensed with racemic sulfoxamide 2.82 to give sulfoximine 
2.83 in 92% yield.  A tandem Mannich/cross-Claisen reaction was performed with excess 
of the enolate of methyl acetate to give β-ketoester 2.84 in 52% yield.  The impending 
NH-insertion reaction has been shown to be incompatible with the sulfoxamide 
moiety,97, 98 and thus the sulfoxide must first be removed and replaced with a carbamate; 
in this case the t-butyl carbamate was installed.  A diazo transfer of β-ketoester 2.84 was 
then performed to give diazo-β-ketoester 2.85 in 87% yield over the three steps.  
Treatment of the diazo carbamate with catalytic rhodium acetate resulted in an NH-
insertion reaction to provide pyrrolidinone 2.86.  At this point a number of different 
strategies were screened in order to remove the Boc-protecting group and replace it with 
a methylene subunit capable of providing the required azomethine ylide.  These attempts, 
however, proved fruitless.  For the most part, the only isolable products were the 
corresponding pyrroles 2.88, either as the free pyrrole or the N-substituted variant.  These 
products presumably form as a result of rapid oxidation of the amino pyrrolidinones that 





In order to access a substrate such as 2.87, it was rationalized that the ketone 
would have to first be reduced to obviate the oxidation pathway (Scheme 2.17).  Ketone 
2.86 was thus reduced to give an inconsequential mixture of diastereomers, and the 
amino nitrile moiety was installed by removing the Boc-protecting group and subjecting 
the intermediate secondary amine to Strecker conditions.  The amino nitrile 2.89 in this 
case was air stable; however, attempts to ionize 2.89 by expulsion of HCN were again 









 The first successful cycloaddition to construct the stemofoline core was 
accomplished serendipitously by Dr. Jochen Dietz (Scheme 2.18).80  It was hoped that by 
oxidizing 2.89 to the β-ketoester under air-free conditions would result in the 
spontaneous generation of the originally targeted azomethine ylide.  While attempting to 
oxidize alcohol 2.89 under Swern conditions, not only did the oxidation occur, but the 
ketone reacted further to give a cyanated-azomethine ylide 2.102, which reacted via two 
regioisomeric transition states 2.91 and 2.93 to furnish a mixture (ca. 5:1) of cycloadducts 
2.92 and 2.94 in 69% combined yield.  The desired regioisomer 2.94 was obtained as the 
major product, but surprisingly the cyano “leaving group” was incorporated into the 









With the cyano-group being maintained in this cycloaddition reaction (Scheme 
2.18), it was clear that this particular cycloaddition was operating via an unprecedented 
type of reactivity.  A proposed mechanism can be formulated to account for this 
observation (Scheme 2.19), whereby alcohol 2.89 first underwent a typical Swern 
oxidation to form ketone 2.97.  Compound 2.97 was then reacted with an additional 
equivalent of chlorodimethylsulfonium chloride (2.96) to install a leaving group alpha to 
the nitrogen atom, which might be either a dimethyl sulfonium group or a chloride.  
Subsequent elimination of the leaving group generated an iminium ion that was 
deprotonated to give the trisubstituted azomethine ylide 2.102, bearing the S-shaped 
geometry with respect to the ester and cyano-groups.  This ylide then underwent a facile 
1,3-dipolar cycloaddition at -78 ºC to give the product 2.94 with the cyano- and ester 
groups anti to one another.  The S-shaped ylide geometry is presumed based on the 
confirmed stereochemistry of the cycloadduct; as discussed in the previous Chapter the 
ylide geometry relates directly to the observed stereochemistry of the pyrrolidine ring that 




 This initial cycloaddition provided important evidence that the proposed strategy 
to the stemofoline core was indeed possible; however, our inability to decyanate the 
tricycle 2.94 to give 2.59 under a variety of conditions obviated the use of this novel 
cycloaddition reaction for a total synthesis.39, 80  Due to the robust nature of the C(5)-
cyano group, the search for an optimal set of cycloaddition conditions was continued in 
order to access a functional stemofoline core without the superfluous functionality. 
It was of interest, however, to utilize the tricyclic molecule 2.94 to explore some 
of the proposed disconnects in our synthetic plan for the stemofoline alkaloids.  Further 
efforts by Dr. Dietz proved the viability of a proposed remote radical functionalization at 
the C(8)-position of the natural product core (Scheme 2.20).  In the event, a 
stereoselective reduction of ketone 2.94 set the critical C(2)-stereocenter so it could be 
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utilized as a handle to functionalize the C(8)-position.  Employing two different sets of 
conditions developed by Barton and Suarez, the C(8)-center was functionalized to give 
either iodoether 2.104 or nitrate 2.105.  Unfortunately, further attempts to decyanate any 
of these intermediates were again not successful.   
Scheme 2.20 
 
 In later work, Dr. Bjorn Ludolph was able to effect the key cycloaddition using a 
different set of cycloaddition conditions (Scheme 2.21).81  Based on work developed by 
Joucla, who showed that flash vacuum thermolysis (FVT) of oxazolidines generated 
azomethine ylides capable of both inter- and intramolecular cycloadditions,55, 56 we 
reasoned that a similar approach in our hands might facilitate the desired cycloaddition.  
Starting with Boc-protected pyrrolidinone 2.86, oxazolidine 2.106 was accessed via a 
one-pot procedure by treatment with TFA in the presence of dimethoxymethane.  Heating 
oxazolidine 2.106 in a sealed tube at 180 ºC resulted in a retro-cyclization (liberating 
formaldehyde) to give an azomethine ylide, which reacted through two regioisomeric 
transition states 2.107 and 2.109 to give a mixture (1:3) of cycloadducts 2.108 and 2.74 in 
96% yield.  While this reaction provided a good yield of the cycloaddition products, the 
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undesired cycloadduct was significantly favored in the reaction.  This precedent, 
however, provided a good starting point for the potential application of similar 
oxazolidines in future studies. 
Scheme 2.21 
 
  In order to improve the ratio of products to favor the desired tricycle, it was 
rationalized that a destabilizing steric interaction could be introduced in the undesired 
transition state 2.111 en route to the undesired tricycle 2.112 (Scheme 2.22).  We 
reasoned that by  incorporating a bulky substituent at the C(9)-position of the 
dipolarophilic side chain of oxazolidine 2.110, which mapped on to an advanced 
intermediate in a potential synthesis of the stemofoline alkaloids such as 2.114, that the 
increased steric hindrance would steer the cycloaddition toward the desired regioisomer 
by disfavoring the undesired trasition state 2.113.  To test this hypothesis, a new synthetic 




2.1.3.2 Approach to a Sterically Biased Cycloaddition Substrate 
The synthesis of a derivative of 2.110 that incorporated the C(9)-side chain in the 
targeted azomethine ylide was the focus of work by Dr. Nathan Fuller,82 who built upon 
preliminary studies by Dr. Bjoern Ludolph.81  The effort commenced with coupling the 
mixed anhydride derived from commercially available carboxylic acid 2.115 and the 
lithium anion of the D-phenylglycine derived Evan’s chiral auxiliary 2.116 to provide the 
α,β-unsaturated imide 2.117 in 87% yield (Scheme 2.23).  Conditions developed by 
Hruby99 and Bergdahl100 were used to install the desired methyl group via conjugate 
addition of dimethyl cuprate into 2.117 giving a mixture (7:1) of diastereomers favoring 
2.118 in 91% isolated yield.  The absolute stereochemistry of 2.118 was confirmed by X-
ray crystallography.  A subsequent alkylation using allyl iodide gave the disubstituted 







 With the requisite stereocenters of the eventual C(9)-side chain installed, a 
number of steps were required to elaborate 2.119 into the pyrrolidinone cycloaddition 
precursor (Scheme 2.24).  Removal of the chiral auxiliary from 2.119 was accomplished 
by the action of basic hydrogen peroxide followed by reduction of the resulting 
carboxylic acid with lithium aluminum hydride to provide alcohol 2.120 in 82% yield 
over two steps.  The hydrolysis step also provided an 86% recovery of the chiral auxiliary 
(protio-2.116), which was recycled for future use.  Oxidation of alcohol 2.120 with Dess-
Martin periodinane provided aldehyde 2.121.  At this point the second chiral auxiliary 
was installed by reacting sulfoxamide 2.122 with aldehyde 2.121 via a titanium mediated 
condensation reaction to give sulfoximine 2.123 in 73% yield over the two step sequence.   
Sulfoximine 2.123 was then subjected to a tandem Mannich/cross-Claisen reaction with 
excess sodium enolate of methyl acetate to provide the desired β-ketoester 2.125 in 58% 






 The sulfoxide of 2.125 was next removed, and the resulting amine 
refunctionalized with a Boc-protecting group providing carbamate 2.126 in 81% yield 
over two steps (Scheme 2.25).  Diazo transfer with tosyl azide (Ts-N3) provided diazo 
compound 2.167 in 95% yield, and a subsequent rhodium catalyzed NH- insertion 








 With a synthetic route to compound 2.168 developed, the stage was set to 
examine the pivotal cycloaddition (Scheme 2.26).  Pyrrolidinone 2.168 was first 
elaborated into the corresponding azomethine ylide precursor by removal of the Boc-
group and concomitant heterocycle formation using excess TFA and dimethoxymethane 
to give oxazolidine 2.169 in 67% yield, a reaction that was invariably accompanied by 
the formation of the undesired cycloadduct 2.172.  The undesired cycloadduct forms 
presumably from the generation of an azomethine ylide by acid catalyzed decomposition 
of the oxazolidine, which gives enol iminium ion 2.170b.  A reaction time of 7 h was 
critical to obtain good yields of this reaction, because longer reaction times resulted in 
increasing amounts of the undesired cycloadduct.  By subjecting 2.169 to thermolysis, the 
azomethine ylide 2.170a was formed and reacted to give a mixture (1:1) of desired and 
undesired cycloadducts 2.171 and 2.172 was obtained in a 95% yield.  It is interesting to 
note that attempts to improved the regioisomeric ratio of the cycloaddition never gave an 
increase over the 1:1 ratio, and under acidic conditions the only oberservable cycloadduct 
is the undesired 2.172.  While the reason for the inversion of selectivity is not clear, it 
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might be that the enol form of the azomethine ylide 2.170b is cabable of undergoing 
cyclization, but just not in the desired sense.  This thermolysis result under neutral 
conditions, however, compared to the previous substrate where a mixture (1:3) of desired 
to undesired cycloadducts was obtained (Scheme 2.21), clearly validates the hypothesis 
that steric effects can be exploited to favorably affect the population of each of the 
regioisomeric transition states during the cycloaddition reaction.  For the purposes of a 
total synthesis, however, we still felt that this increased selectivity still fell short of what 
we considered to be optimal.  Many attempts were made by Dr. Fuller to further improve 
upon this ratio, including varying the temperature, pH, and solvent, however, a 1:1 ratio 
remains the most favorable selectivity to date.  Performing the oxazolidine decomposition 
reaction under acidic conditions resulted exclusively in formation of the undesired 
cycloadduct.  This result is hard to rationalize but does seem to suggest that the 
cycloaddition reaction under acidic conditions might be mechanistically different than 
under neutral pH.  Despite the suboptimal selectivity in the cycloaddition of 2.169, does 
provide an encouraging result from which to build upon.  Subsequent work on the key 
step aimed to capitalize on this effect, however we were interested in investigating 
different structural modifications of the cycloaddition substrate to further enhance the 
selectivity.  It is noteworthy, however, that a fully functionalized advanced core structure 










At this point in our efforts, we were able to access the appropriately 
functionalized core of the stemofoline alkaloids bearing the C(9)-side chain with the 
C(10)-methyl stereocenter.  The synthesis of 2.168, however, was difficult to perform on 
large scale, and when combined with the lower than desired selectivity of the key 
cycloaddition step, we were having difficulties pushing significant amounts of material 
past the desired cycloadduct 2.171.  We felt that an a fully optimized route to 2.168 might 
help in, not only furnishing more advanced material, but in allowing us to further explore 
modifications to the cycloaddition reaction in the hopes of discovering procedural 
elements that might lead to higher regioisomeric ratios.  With the cycloaddition result to 
provide 2.171 in hand, we turned our attention to optimizing the steps leading up to the 
key cycloaddition step. 
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2.2 RESULTS & DISCUSSION 
2.2.1 Further Progress on the C(9)-Substituted Cycloaddition Substrate 
The Martin group cycloaddition strategy had thus evolved through a number of 
iterations as our understanding of the operative control elements of this key reaction 
continued to develop.  For example, we had discovered that the method used to generate 
the azomethine ylide had a profound effect on the regiochemistry of the cycloaddition 
and that steric influences could be used to favorably tune the key step.  What was missing 
at this point was a reliable and scalable synthesis which could provide useful quantities of 
advanced material.  My own role on this project began with an effort to optimize the 
synthesis of the C(9)-substituted cycloaddition substrate to maximize the group’s ability 
to advance the total synthesis via this cycloaddition reaction.  Along these lines, the first 
synthetic improvement that was made was applying the Mathre procedure for installing 
the chiral auxiliary,101 whereby addition of LiCl to a mixture of the oxizolidinone 2.173 
and the mixed anhydride of the carboxylic acid 2.115 facilitated a smooth coupling of 
these two fragments (Scheme 2.27).  Previously, we had been using n-BuLi to pre-form 
the anion of 2.173, but this procedure was difficult due to moisture sensitivity and the 
insolubility of the lithium anion.  Furthermore, the yield was improved to 87% over the 
previously established 70% average.  The steps used to advance 2.117 to 2.120 (vide 
supra) were not be improved through my work, however, this sequence remained one of 
the more difficult to scale up due to two consecutive steps which were air/moisture 
sensitive and provided mixtures of diastereomers.  In order to obtain 2.120 in 
diastereomerically pure form from 2.117, difficult chromatographic separations were 
required, which are only exacerbated on larger scales.  This four step sequence, however, 




 Further improvements in the overall synthetic approach for this series of 
substrates came first from the oxidation of the alcohol 2.120 (Scheme 2.28).  While the 
use of Dess-Martin periodinane was not necessarily problematic from the perspective of 
reaction yield, it is an expensive oxidant on large scale.  The use of PCC as well as a 
Swern oxidation resulted in some epimerization of the alpha stereocenter; however, the 
combination of PCC/SiO2 worked very well on large scale and, since the reaction was 
complete within 10 min, no epimerization was observed.  This set of conditions also 
provided the analytically pure aldehyde 2.121 after filtration through a plug of silica gel.  
Condensation of aldehyde 2.121 with the chiral sulfoxamide 2.122 provided sulfoximine 
2.123 in 74% yield as before.  An additional improvement came from an extensive study 
of the tandem Mannich/cross-Claisen reaction on sulfoximine 2.123.  This step in the past 
never provided yields above 58% for the desired β-ketoester, and a great deal of the 
Mannich product 2.124 was always isolated that had not undergone the Claisen reaction.  
This ester 2.124, despite being resubjected to the reaction conditions at -78 ºC, could 
never be efficiently converted to the targeted β-ketoester.  It was discovered, however, 
that warming the reaction to 0 ºC resulted in efficient conversion of 2.124 to 2.125.  Since 
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the cross-Claisen step involves the addition of an enolate into the sulfoxamide anion, 
temperatures below -20 ºC apparently could not provide the reaction with enough energy 
to form the required dianionic intermediate.  Furthermore, when forming simple ester 
enolates the reaction is always accompanied by variable amounts of homo-Claisen 
reaction resulting in the formation of methyl acetoacetate as a byproduct.  For our 
purposes, the lowering of the effective concentration of the enolate prior to introduction 
of the sulfoximine substrate was a troublesome variable to control and thus a large excess 
of methyl acetate and base was required (typically >10 eq).  The optimization of this 
reaction has since proved useful for other Claisen reactions on substrates of this type. 
Scheme 2.28 
 
 An additional practical improvement to the overall sequence involved changing 
the diazo transfer agent from tosyl azide to p-acetamidobenzesulfonyl azide (p-
ABSA),102 which provided comparable yields of 2.174 to the corresponding carbamate 
analogue (Scheme 2.29).  The p-ABSA reagent, however, is a more practically useful 
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reagent for synthesis due to the insolubility of the sulfonamide byproduct, which can be 
almost completely removed after the reaction via a precipitation and filtration.  The tosyl 
azide byproduct (p-tolylsulfonamide) is much more soluble and requires a careful column 
to separate from the diazo product.  One additional avenue that was investigated was 
inverting the order of the diazo transfer and reprotection steps.  Previously the protecting 
group was changed to a Boc-group prior to the diazo transfer; however, when these steps 
were reversed, the overall yield of the process to access 2.2.167 improved to 86% overall 
yield from 2.174. 
Scheme 2.29 
 
With an improved synthesis to the cycloaddition precursor 2.168, additional 
material was available and allowed for a brief study of the cycloaddition conditions; 
however, as mentioned earlier, any modification of the cycloaddition reaction that was 
made never resulted in an improvement of the already established 1:1 ratio.  One specific 
attempt that successfully resulted in a cycloaddition reaction was to lower the reaction 
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temperature (from the usual 150 ºC and above) by using BF3•OEt2 as a reagent to 
depolymerize paraformaldehyde and catalyze the formation of the desired azomethine 
ylide at 0 ºC (Scheme 2.30).  In this case, however, only the undesired cycloadduct was 
observed in the reaction.  In another attempt to lower the thermolysis reaction 
temperature, the reaction was held at 100 ºC for >5 days, but resulted in incomplete 
conversion and the regioisomeric ratio remained 1:1.  Some variations in solvent were 
also investigated, but did not have an effect on the regioisomeric ratio. 
Scheme 2.30 
 
The methyl ether moiety in the desired cycloadduct 2.171 was to eventually be 
utilized to access a carboxylic acid (or derivative thereof); but we were interested in the 
possibility of accessing the higher oxidation state at an early stage in the synthesis 
(Scheme 2.31).  We rationalized that this change would, not only provide a more 
advanced cycloadduct, but might also add extra bulk to the C(9)-side chain and possibly 
enhance the regioisomeric ratio of the eventual cycloaddition.  As part of our efforts to 
implement this plan, a novel method for the functionalization of desymmetrized 
fumarates such as imide 2.177 was discovered (Scheme 2.35).  By subjecting fumarate 
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derivative 2.177 to the Hruby/Bergdahl conjugate addition conditions99, 100 we were 
able to directly access succinate 2.178 in good yield and high diastereoselectivity. 
Scheme 2.31 
 
The most notable aspect of this reaction was the remarkable regioselectivity, 
where virtually none of the undesired conjugate addition product was observed (Scheme 
2.31).  This observation can most likely be rationalized by comparing the reactivity of the 
carbonyl groups activating the olefin.  An imide carbonyl group is more similar in 
electrophilicity to that of a ketone, making this the more reactive carbonyl compared to 
the ester carbonyl group.  In therefore stands to reason that the imide carbonyl being the 
more reactive carbonyl group might have a correspondingly more reactive β-position.  It 
is also important to consider the relative Lewis basicity of these carbonyl groups (Scheme 
2.32).  In the case of our conjugate addition example, TMS-I was used as the Lewis acid.  
If the Lewis acid/base adduct forms prior to addition of the nucleophile two adducts 
2.182 and 2.184 are conceivable, which would be active to conjugate addition.  The imide 
adduct 2.182 has one additional resonance structure compared to the ester adduct 2.184 
that can contribute to stabilizing the oxonium intermediate, and thus the imide carbonyl is 
 134 
the more basic.  It is also possible though that an initial reaction of TMS-I with the most 
basic urethane carbonyl giving 2.181 that would selectively deliver the TMS-group to the 
neighboring imide carbonyl, thus facilitating the observed conjugate addition.  Succinate 
2.178 was a potentially useful intermediate for a total synthesis (Scheme 2.31); however, 
a subsequent refocusing of the stemofoline project diverted our attention to more fruitful 
areas.  Despite the fact that 2.178 was not investigated further for a stemofoline synthesis 
we felt that this reaction was noteworthy in that it exhibited unprecedented reactivity to 
provide a potentially useful chiral succinate. Thus this reaction presents an opportunity 
for further development for accessing densely functionalized succinic acid and γ-
butyrolactone derivatives.  With these possibilities in mind, this method is currently 
under investigation in our group as a way to access important natural products targets 
such as the medicinally relevant pilocarpine (2.180) (via succinate 2.179).103 
Scheme 2.32 
 
 At this stage, we became convinced that the approach of biasing the cycloaddition 
with only the C(9)-side chain was not going to a sufficiently selective approach to the 
stemofoline core.  Not only did the key step provide no more than a 50% yield of the 
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desired product, but the route was difficult to perform on the large scale needed to 
advance material.  Furthermore, the approach we had adopted required the use of two 
different stoichiometric chiral auxiliaries, which we felt was not economical especially in 
light of the procedural limitations.  The results with the dipolar cycloaddition, however, 
encouraged us to remain confident that the strategy would ultimately succumb to 
optimization and be made synthetically viable.  To this point, we had only found two 
different methods that worked for generating an appropriate azomethine ylide (Scheme 
2.33).  The first of which was the Swern reaction that led to the formation of azomethine 
ylide 2.102, which underwent a dipolar cycloaddition to give the natural product core at   
-78 ºC with high regioselectivity.  The reactivity of this azomethine ylide is most 
interesting in that there was no clear steric interaction that could be used to explain the 
high regioselectivity.  It is clear, however, that the ylide 2.102 is considerably less 
polarized then the others, which suggested to us at the time that there was an electronic 
benefit in having an electron withdrawing group on the termini of the azomethine ylide.  
The second successful method we developed was the oxazolidine thermolysis reaction, 
which was used to access ylides 2.75 and 2.170.  This method allowed us to probe the 
efficacy of biasing the cycloaddition using steric effects, but, the manifestation of sterics 




 At this point we turned our attention to introducing substitution at the eventual 
C(8)-position of a cycloaddition substrate such as 2.185 based on the assumption that the 
steric interactions with this substituent would be more severe than the C(9)-substituent of 
2.185 proved to be (Scheme 2.34).  We were hopeful that the C(8)-substituent of 2.185 
would prove more effective in guiding the thermolytic cycloaddition because of what we 
observed in transition state models when looking at the Newman projections about the 
C(8)/C(7)-bonds (such as 2.187 and 2.190, Scheme 2.34).  The undesired transition state 
appeared to have unfavorable eclipsing interactions, while the desired transition state on 
the other hand put the C(8)-hydroxyl group in the equatorial position of the newly 
forming chair-like ring.  Targeting a cycloaddition substrate such as 2.185, we felt would 
also provide a functional handle for completing the functionalization of the C(8) and C(9) 
positions of the stemofoline core.  We also aimed to develop a more innovative synthetic 
strategy to access the cycloaddition precursor, which would prove more novel and 














2.2.2 C(8)-Substituted Cycloaddition Substrate 
2.2.2.1 Retrosynthesis 
Limitations to the overall synthetic past strategies included the use of costly 
stoichiometric chiral auxiliaries and in some cases more than one.  Also, due to lengthy 
and procedurally difficult synthetic sequences, the ability to advance material to the key 
cycloaddition addition step was cumbersome and limited further progress in the total 
synthesis.  This early work, however, was seminal in establishing the viability of the key 
cycloaddition strategy for constructing the core of the target natural products.  In 
redesigning our synthetic approach we hoped to access the tricyclic core of the 
stemofoline alkaloids by utilizing a “chiral pool” starting material.  This tactic would 
provide key stereocenter(s) allowing for the remaining chirality to be built into the 
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molecule by utilizing substrate-controlled, diastereoselective strategies.  As a result, this 
sort of approach would likely increase the overall efficiency of the synthesis by 
decreasing the number of synthetic operations.  For this purpose, we chose the 
commercially available and affordable 2-deoxy-D-ribose (2.196) as our starting material 
as it possessed the required chirality and a majority of the carbon framework necessary to 
construct the tricyclic core (Scheme 2.35). The new strategy presented a number of 
challenges including:  (1) The elaboration of 2-deoxy-D-ribose (2.196) into allylic alcohol 
2.195; (2) using allylic alcohol 2.195 to set up a diastereoselective aza-Michael reaction 
whereby the chirality of the allylic alcohol is directly utilized in setting the key nitrogen 
stereocenter to give 2.194; (3) the selective functionalization of the resulting 1,3-
aminoalcohol into the diazo compound 2.193; and (4) discovery of cycloaddition 












In designing this route, we were cognizant of a method developed by Hirama and 
Ito for the stereoselective intramolecular aza-Michael reactions of primary carbamates 
tethered to enoates (Scheme 2.36).104-108  Hirama investigated an array of systems 
bearing homoallylic enoate alcohols, which could be converted in one step to the 
corresponding carbamates 2.197.  Treatment of structures such as 2.197 with base (either 
NaH or KOt-Bu) results in a facile cyclization via transition state 2.198 to give the 
corresponding cyclic carbamate 2.199 with high 1,3-syn-diastereoselectivities.  The 
smallest R-group they investigated was a methyl group, which gave a diastereoselectivity 
of approximately 10:1.  In other cases where the R-group was larger the observed 
diastereoselectivity could be as high as 95:5.  We hoped to apply this reaction with a 
vinyl group as our R-group, which we expected to behave similar to the methyl-
 140 
substituted system.  Adopting this methodology, we sought to use the chirality of the 
internal alcohol stereocenter of 2-deoxy-D-ribose and apply the Hirama cyclization to 
install the N-stereocenter in a 1,3-syn fashion.  The dipolar cycloaddition event would 
then set the remaining stereocenters of the stemofoline core without the need to apply a 
single chiral auxiliary as was required with previous generations of our synthetic strategy.  
Scheme 2.36 
 
2.2.2.2 Synthetic Studies on the Conversion of 2-Deoxy-D-Ribose into Alcohol 2.195 
The syntheses of ester 2.201 (Scheme 2.37)109 and aldehyde 2.204 (Scheme 
2.38)110 are both precedented and have been reproduced following slightly modified 
procedures than those reported in the literature.  Starting from commercially available 2-
deoxy-D-ribose (2.196), the ester 2.201 was accessed in three steps (Scheme 2.37).  
During the initial oxidation of 2.196, the generation of catalytic amounts of acid 
facilitates the rearrangement to the intermediate five-membered lactol, which was then 
oxidized to the lactone 2.220.  The crude lactone 2.200 was treated with HBr/AcOH to 
form an acetylated primary bromide, which was treated with Zn, under buffered 
conditions, to furnish the corresponding acyclic carboxylic acid.  The crude carboxylic 
acid, obtained after acid/base extraction, was esterified under Fisher conditions to provide 
the ester 2.201 in a 60% yield over the three step sequence. 
 141 
Similarly, starting with 2-deoxy-D-ribose (2.196), the sugar can be 
refunctionalized by first performing an acid catalyzed isomerization to the five-
membered lactol 2.202 in 89% yield (Scheme 2.37).  Literature procedures for carrying 
out this sequence describe doing so on crude 2.202;110 however, it was found that 
distillation of this intermediate resulted in cleaner reaction mixtures during subsequent 
steps.  As such, purified 2.202 was then subjected to iodination conditions selective for 
the primary alcohol, and the resulting iodide was protected as its TBS-ether to give 2.203 
in an 85% yield over two steps.  It should be noted that the intermediate alcohol obtained 
after the iodination reaction was very unstable to light, especially in neat form.  Attempts 
to perform the elimination directly by subjecting this intermediate to the Boord 




The silyl ether 2.303 was then subjected to the reductive elimination step with 
chromium (II) chloride, which has been reported in the literature to be a mild reductant 
for this process (Scheme 2.38).110  Traditionally the Boord conditions call for the use of 
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zinc powder under aqueous conditions.111  It has been reported, however, that for certain 
substrates performing the reaction under anhydrous conditions is often optimal.  To that 
end, a number of anhydrous conditions have been developed including zinc-silver-
graphite alloys, organometallic reagents, activated Zn in alcoholic solvents, and 
chromium (II) chloride.112-116  The exact elimination with CrCl2 on compound 2.203 is 
known,110 so the chromium (II) was generated in situ by reduction of CrCl3•3THF with 
zinc metal.  However, the written procedure for this step is vague, and some 
complications arose in trying to repeat this reaction.  The procedure references a number 
of different procedures for preparing CrCl3•3THF, but does not specify which procedure 
they opted to use.  Also the literature procedure called for a 24 h reaction time, but it was 
found that stopping the reaction after 24 h resulted in reaction mixtures that yielded 
unclean 2.204, even after chromatography.  The literature procedure also failed to include 
necessary information as to the workup and isolation of the product, including 
chromatography conditions, which made initial success with this reaction difficult.  It was 
eventually found that increasing the reaction time to ~48 h yielded much cleaner product.  
The likely explanation is that the starting material co-spots with the product, and due to 
the lower reactivity of CrCl2, not all starting material was consumed after 24 hours, 
making isolation of pure 2.204 by chromatography virtually impossible.  Increasing the 
reaction time resulted in full conversion of the starting material, but lower than reported 
yields were still obtained (51% compared to the reported 83%).  While this step has yet to 
be efficiently reproduced as described in the literature, enough of the crude aldehyde was 





                                                                                                            
 
 We initially attempted accessing the β-ketoester moiety directly so the Wittig 
reagent 2.205 was chosen.  This reagent was found to be virtually unreactive with the 
aldehyde by itself and required activation as its sodium enolate (Scheme 2.38).  The 
deprotonated Wittig reagent then behaved more like an unstabilized Wittig reagent and 
thus gave enone 2.206 as the Z-olefin.  Attempts to remove the silyl protecting group 
resulted in complicated mixtures.  While it can be conceived that an olefin isomerization 
could be used to give the E-olefin or another Wittig reagent could be used to access a 
simplified enoate rather the β-ketoester, we were concurrently working on a 
complimentary strategy for advancing 2-deoxy-D-ribose.  Thus we diverted our attention 
to a more fruitful strategy. 
As indicated in the aforementioned retrosynthesis, we were ultimately interested 
in accessing the allylic alcohol 2.195.  The first generation synthesis began with the 
known protection of 2-deoxy-D-ribose (2.196) by treatment with 2-methoxypropene and 
PPTS to give acetonide 2.207 in variable yields (Scheme 2.39).117   The variable nature 
of this protection reaction was likely due to the insolubility of the sugar in the reaction 
solvent at the prescribed reaction concentration of 0.8 M.  More consistent results were 
obtained with higher dilution of the reaction at 0.3 M, however, the product was always 
accompanied by the formation of the protected furanoside (5-membered) form of the 
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sugar.  The protected lactol 2.207 was then subjected to a Wittig olefination to provide 
enoate 2.209 as a mixture (5:1 E:Z) of olefin isomers.  Some initial effort went in to 
increasing the E/Z-ratio of the olefination event, specifically the use of the 
tributylphosphorane has been shown in our group to increase the diastereoselectivity of 
these types of olefinations.118  Applying these conditions to 2.207 resulted in an 
improved ~9:1 ratio.  It is also known that molecular iodine can also catalyze 
thermodynamic equilibrations of enones and enoates,119 and since the impending 
iodination reaction required iodine we focused on this tactic.  With this reactivity in 
mind, we used a 10 mol % excess of I2 in the subsequent iodination of alcohol 2.209, and 
found that the E/Z-ratio of 5:1 converged to the more thermodynamically stable E-olefin 
during the iodination of the primary alcohol to provide exclusively iodoenoate 2.210 in 
73% yield.  Compound 2.210 was then treated with activated Zn (dust)/AcOH, resulting 
in a facile Boord elimination to give a mixture (1:2) of the desired allylic alcohol 2.195 
and cyclopentane 2.211 in 75% yield.  The formation of the cyclic product 2.179 was 
unexpected in this reaction as it is not typical for organozinc compounds to undergo such 
facile 1,4-addition.  However, it was even more surprising that in this case the cyclization 
reaction vastly outcompeted the presumably more entropically favored elimination 
process.  Although this first generation approach was far from optimal, it provided the 








 Generation Synthesis of 2.195:  4 Steps, 4 Columns, 10% Overall 
Yield 
 
Initial success in accessing 2.195 provided us with an avenue to test later 
chemistry in the total synthesis; however, there was a synchronized effort to optimize the 
synthesis of allylic alcohol 2.195.  The overall efforts to prepare 2.195 have progressed 
through a number of discrete synthetic generations.  Improvements to the overall process 
were continually measured by the overall yield (from 2.196), number of steps, number of 
days that the sequence took to complete, and the number of chromatographic 
purifications that were required to provide 2.195 in pure form.  We therefore 
hypothesized that the Boord elimination of acetonide 2.210 might be improved by 
refunctionalizing the diol to increase the leaving group ability of the alcohol beta to the 
organozinc and consequently favor more of the desired elimination (Scheme 2.40).  To 
that end, a second generation synthesis of 2.195 was devised in which the acetonide of 
2.210 was converted to 2.212 in 96% yield by treatment with Dowex/MeOH and 
acetylation.  Subjecting iodide 2.212 to the Boord elimination with Zn (dust)/AcOH 
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resulted in an improved ratio (1:1) of elimination and cyclization products as their 
acetylated derivatives.  It was subsequently discovered when elimination with Zn (dust) 
was performed in methanol rather than AcOH elimination and concomitant 
transesterification occurred to deliver alcohol 2.195, along with an equimolar amount of 
diol 2.213.  These improvements thus provided 2.195 in a slightly improved 16% overall 
yield from the previous 10%, but required six synthetic operations and four 
chromatographic purifications.  It was confirmed, however, that the Boord elimination 
could be further favored by adjusting the leaving group ability of the beta substituent. 
Scheme 2.40. 2
nd
 Generation Synthesis of 2.195:  6 Steps, 4 Columns, 16% Overall 
Yield 
 
 Many attempts were made to telescope different procedures in order to cut down 
on the number of steps and purifications that were required to synthesize 2.195.  In that 
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context, we discovered that the olefination and the iodination reactions could be 
performed as a one-pot procedure by simply adding the reagents for the second 
transformation to the flask upon completion of the first operation, thus providing iodide 
2.210 in 68% yield from 2.207 (Scheme 2.41).  This simple change provided a route that 
cut off one synthetic step, one chromatographic purification, and ~24 h from the overall 
process.  The overall yield of the sequence, however, remained roughly the same as the 
second generation approach.  
Scheme 2.41. 3
rd
 Generation Synthesis of 2.195: 5 Steps, 3 Columns, 18% Overall 
Yield 
 
 In the interest of further streamlining the synthesis, the diol protection strategy 
was more closely scrutinized.  It was known that 2-deoxy-D-ribose itself undergoes 
olefination without protection.120 Accordingly 2.196 was treated with Wittig reagent 
2.208 directly to give enoate triol 2.214 in 96% yield (Scheme 2.42).  The primary 
alcohol could then be selectively manipulated in a variety of different ways.  For 
example, iodination of 2.214 followed by acetylation of the intermediate iodo diol 
provided iodo diacetate 2.212 in 77% over two steps.  The use of Zn granules, rather Zn 
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dust, improved the elimination reaction and provided product 2.195 in an improved 62% 
yield.  This result bears further consideration because it is not clear why the physical state 
of the Zn would so drastically affect the product distribution.  This may suggest that trace 
metal impurities (such as copper) might affect the elimination reaction, placing 
importance on the source of the zinc metal.  This increase in product ratio and isolated 
yield, however, has been repeated many times on reaction scales up to 50 g, and thus we 
are confident in the viability of this process.  This third generation of the synthesis 
provided 2.195 in a much improved 45% overall yield and cut out one synthetic step and 
one chromatographic purification.  Furthermore, as a result of these improvements, the 
overall process of converting 2-deoxy-D-ribose into alcohol 2.195 was reduced by >48 h 
from the previous generation. 
Scheme 2.42. 4
th
 Generation Synthesis of 2.195:  4 Steps, 2 Columns, 45% Overall 
Yield 
 
 The synthetic process was fully optimized by capitalizing on the previously 
discovered tandem olefination/iodination strategy, but this time the procedure was 
performed on the unprotected sugar (Scheme 2.43).  Using this protocol, the synthesis of 
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the allylic alcohol 2.195 was shortened to three chemical operations, requiring only one 
chromatographic purification, and less than three days to provide the allylic alcohol 2.195 
in approximately 54% overall yield.  With this optimized protocol in place, the first 
crucial chiral intermediate in the synthesis was easily obtained in pure form.  
Scheme 2.43 Optimized Synthesis of 2.195:  3 Steps, 1 Column, 54% Overall Yield 
 
2.2.2.3 Synthetic Studies on the Application of the Hirama-Ito Cyclization to 
Construct the 1,3-syn-Aminoalcohol Moiety 
With an efficient, scalable route to the allylic alcohol 2.195, the Hirama-Ito 
cyclization was applied to construct the critical 1,3-aminoalcohol moiety.  The allylic 
alcohol 2.195 was first treated with chlorosulfonylisocyanate to give the primary 
carbamate 2.215 in nearly quantitative yield after a hydrolytic workup (Scheme 2.44).  
Compound 2.215 was treated with NaH at room temperature to give the cyclic carbamate 
2.194 in 75% yield and as a mixture (4:1) of syn- and anti-diastereomers via an 
intramolecular aza-Michael reaction.  Thus, the chirality of the alcohol could be exploited 
in a substrate controlled assembly of the eventual C(6)-nitrogen stereocenter.  We were 
nevertheless intrigued by the possibility of optimizing of this process in the hopes that we 
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could increase the diastereoselectivity.  Although the primary reports by Hirama 
indicated that the yield and diastereoselectivities could not be affected by changes in 
solvent and temperature, however, we found that a number of variables impacted the 
yield and diastereoselectivity of this process. 
Scheme 2.44 
 
 Some of our findings regarding the optimization of the Hirama cyclization 
method are outlined in Table 2.1.   The elimination product 2.217 was always observed in 
these reactions, although not always quantified.  This elimination has not been reported in 
any of the accounts by Hirama, but this side reaction often accounted for nearly 10-20% 
of the product distribution in our system.  It was found that elimination was enhanced 
when using more polar solvents, with DMF providing upwards of 20% of 2.217.  
Although not a standard solvent with NaH, the use of CH2Cl2 provided only trace 
amounts of the triene and provided good reactivity of NaH at lower temperatures.  The 
use of NaH in THF did not provide appreciable conversion at low temperature, but in 
CH2Cl2 the reactions were complete within 4 h.  Although temperature had no effect on 
the elimination amount, the diastereoselectivity did show remarkable response to changes 
in this variable.  At temperatures of -20 ºC and below, the diastereoselectivity peaked at 
10:1.  We also tested the counterion effects in this reaction and found that more Lewis 
acidic counterions led to increasing amounts of elimination, but the Lewis acidities had 
no influence on the diastereoselectivity.  In the case of KOt-Bu at -40 ºC (Table 2.1, 
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Entry 3), the diastereoselectivity (10:1) was good, but freshly sublimed base was required 
for obtaining high yields.  With NaH and CH2Cl2, the reaction at -10 ºC gave a slightly 
lower diastereoselectivity (8:1), but gave the cleanest reaction mixtures of any of those 
screened.  This allowed the product to be isolated from the reaction mixture very 
efficiently by recrystallization.  No other set of conditions we screened allowed for direct 
crystallization of the product because of the higher level of impurities in the reaction 
mixtures, and thus required chromatography.  As a result, the use of NaH in CH2Cl2 at    




2.2.2.4 Installation of the Diazo-β-ketoester Moiety 
With a scalable synthesis of carbamate 2.194 at our disposal, we next turned our 
attention to accessing an orthogonally protected amino alcohol bearing the required 
diazo-β-ketoester moiety.  This task, however, proved to more troublesome than 
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anticipated, and a number of different tactics were ultimately considered.  Conditions for 
removing the cyclic carbamate needed to be identified, but it was unclear at what stage it 
would be optimal to do so.  Carbamates of this type are notoriously difficult to cleave by 
means of nucleophilic addition, and, as such, the nitrogen atom has to be acylated to 
activate the cyclic carbamate to nucleophilic attack.   
Scheme 2.45 
 
We first decided to explore elaborating ester 2.194 into the corresponding β-
ketoesters 2.218 or 2.219 (Scheme 2.48).  The cross-Claisen reaction would therefore 
occur before refunctionalizing the amino alcohol.  To obtain good conversions, the 
reaction was warmed to room temperature upon complete addition of the enolate to a 
solution of 2.194 and provided the β-ketoesters in good yield.  Originally the use of t-
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butyl acetate was studied due the enolate of this ester being easier to form in high 
conversion and allowed access to 2.218 in 99% yield.  The use of methyl acetate was also 
studied since we realized that the t-butyl ester of 2.218, and its subsequent derivatives, 
would be incompatible with conditions later in the synthesis.  The cross-Claisen with the 
enolate of methyl acetate, however, was lower yielding than with t-butyl acetate 
providing 2.219 in only 79% yield.  Diazo transfer on 2.218 and 2.219 with p-ABSA then 
delivered the corresponding diazo-β-ketoesters 2.220 and 2.221 in high yields.  Next, the 
cyclic carbamates were activated by acylation of the nitrogen atom as the t-butyl 
carbamate to give 2.222a and 2.222b in >95% yields, and cleavage of the cyclic 
carbamate was attempted using catalytic amounts of Cs2CO3 in methanol.  Surprisingly 
the acidic nature of the α-protons of the diazo-β-ketoester 2.222a proved troublesome as 
rapid enolization and elimination of the biscarbamate moiety occured to give the highly 
conjugated diazo compound 2.224 as the major product.  This result clearly indicated that 
the cyclic carbamate would have to be cleaved at a stage prior to the installation of the 
diazo moiety. 
Based on the previous result, we anticipated that β-ketoester 2.225 would be a 
better substrate for the carbamate cleavage reaction due to the likely preference of the β-
ketoester moiety to be enolized under the basic reaction conditions (Scheme 2.46).  We 
felt that if the β-ketoester was fully enolized during the cleavage reaction, then the 
possibility of elimination of the biscarbate would be removed due to the inability of the 
ketone to enolize on the side opposite the ester.  Subjecting 2.225 to cesium carbonate in 
methanol, however, gave a complex product mixture.  We therefore decided that in order 
to further enforce the enolization of 2.225, excess sodium methoxide would be superior 
to catalytically generated cesium methoxide.  Activation of the carbamate 2.219 as its t-
butyl carbamate 2.225 then set up the methanolysis step.  Treatment of 2.225 with three 
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molar equivalents of sodium methoxide in MeOH partially cleaved the cyclic carbamate 
to provide what was tentatively assigned as 2.226, but a significant amount of an 
inseparable byproduct was formed that was tentatively assigned as the tricarbonyl 
compound 2.227.  The 1H NMR spectrum showed that two products were present and 
both still had the t-butyl group intact.  Also present in the NMR spectrum was a sharp 
singlet at ~6 ppm indicative of the NH of the deprotected cyclic carbamate, and a 
significant enol (OH) signal at ~12 ppm.  Furthermore, compound 2.226 has been 
authenticated by subsequent experiments, and it was clear by analysis of the NMR 
spectrum that this was not the major product.  It was presumed therefore that the enolate 
of 2.225 attacked the adjacent Boc-group through a 6-membered transition state resulting 
in acyl-transfer to the β-ketoester moiety.  Once the Boc-group was removed from the 
cyclic carbamate, it is no longer susceptible to methoxide cleavage and thus compound 
2.227 was tentatively assigned as the major product. 
Scheme 2.46 
 
 Finally, we considered cleaving the cyclic carbamate at an earlier stage before any 
attempts were made to elongate the carbon chain to the β-ketoester.  Thus, 2.194 was 
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converted to its Boc-carbamate 2.228 in 80% yield (Scheme 2.47).  Carbamate 2.228 was 
then subjected to the standard methanolysis conditions, using Cs2CO3/MeOH to cleanly 
deliver the desired untethered amino alcohol 2.229.  This intermediate was observed by 
NMR and TLC; however, attempts to purify this compound by silica gel chromatography 
resulted in mostly lactonization to give 2.230.  This process could also be initiated by 
treatment of the crude amino alcohol 2.229, after workup, with p-toluenesulfonic acid in 
benzene.  In the interest of preventing the lactonization, we also looked at protecting the 
crude amino alcohol as its TBS-ether.  Under the initial conditions screened, only trace 
amounts of the desired silanol 2.231 were observed.  Interestingly, these conditions also 
facilitated the lactonization process.  At this point we decided to try to utilize the lactone 
intermediate since we saw the lactone as a reasonable substrate for the impending Claisen 




Attempts to optimize the lactonization process using various combinations of acid 
catalysts, solvents, and additives led to the discovery that pre-adsorbing the crude amino 
alcohol 2.229 on SiO2 before the chromatography step and drying the SiO2 under high-
vacuum for 30 min, resulted in a facile lactonization to give lactone 2.230 in 80% yield 
from the biscarbamte 228 (Scheme 2.48).  The Claisen reaction was then performed on 
2.230 with the enolate of methyl acetate to furnish approximately 30% yield of 2.226 
along with the unexpected multiple addition product 2.232 in approximately 20% yield.  
This reaction was subject to a great deal of scrutiny and optimization; however, under all 
conditions screened this still represents the best result.  Attempting to lower the 
equivalencies of MeOAc and LDA only resulted in lower yields of the desired product.  
At temperatures below -20 ºC, there was no appreciable enolate addition due to the 
mechanistic requirement of adding the enolate to the already deprotonated carbamate 
anion.  Holding the reaction at 0 ºC for extended periods of time only resulted in 
increased amounts of 2.232 relative to the desired product.  The formation of 2.232 is a 
very unusual observation, since typically it is believed that the Claisen reaction, upon 
delivering the initial β-ketoester product, will result in a rapid enolization of the acidic β-
ketoester and thus no further enolate addition will occur.  In our system, however, the 
product that results after the initial enolate addition is presumably the dianion of 2.226, 
not the expected linear β-ketoester form.  Since the initial addition reaction requires 
elevated temperature, it is presumed that an extra equivalent of enolate adds to the 
diaionic ester to give 2.232.  In all cases this reaction was not clean, and a number of 
unidentified products were always formed.  Fortunately, the desired product was much 
less polar than any of these products.  Purification of 2.226 by chromatography proved 
difficult and, despite our best efforts, the methyl acetoacetate byproduct (formed from a 
homo-Claisen process during enolization of methyl acetate) partially co-eluted with the   
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product in all solvent systems that were screened.  Attempts were made to fully remove 
the methyl acetoacetate byproduct before purification, but the lactol product 2.226 proved 
too unstable to hold under high-vacuum for extended periods of time.  Thus, 2.226 was 




Despite the low efficiency of the above-mentioned Claisen reaction, we were still 
able to prepare a crucial intermediate for subsequent studies.  One additional operational 
improvement that deserves mention was the realization that the crude amino alcohol 
2.229 could be subjected directly to the Claisen reaction after removal of the methanol 
solvent from the previous step, and provided comparable yields of 2.226 to the preformed 
lactone 2.230 (Scheme 2.49).  Accordingly, the biscarbamate 2.228 was subjected to 
methanolysis, and once carbamate cleavage was complete, the mixture was concentrated. 
The residue was directly subjected to the Claisen reaction to give 2.226 in 32% overall 
yield.  This process managed to improve the overall yield by about 8% on average, but 




With enough lactol 2.226 in hand, we focused on proceeding forward to the 
cycloaddition step.  Subjecting lactol 2.226 to a diazo transfer reaction gave the acyclic 
diazo-β-ketoester 2.233 in 92% yield (Scheme 2.50).  Protection of the allylic alcohol 
2.233 as its TBS-ether proceeded smoothly to give compound 2.234 in 90% yield, which 
was subjected to a rhodium catalyzed NH-insertion reaction to give pyrrolidinone 2.235 
in 85% yield.  All attempts to elaborate 2.235 into oxazolidine 2.236, however, proved 
fruitless.  While the exact product distribution of this reaction was never fully 
established, it was determined that loss of the TBS-group was very rapid.  Considering 
that the oxazolidine formation conditions likely generate a great deal of methanol by 
decomposition of dimethoxymethane, it is not surprising that the conditions of excess 
TFA/MeOH resulted in the loss of the silyl protecting group.  With this in mind, we 











 Initially we looked at benzyl protection of the allylic alcohol 2.233, and after a 
thorough literature search it became clear that the selective O-alkylation of the 1,3-amino 
alcohol would not be trivial.  We spent a good deal of time screening various conditions 
including standard alkylation conditions with benzyl bromide (Scheme 2.51).  Attempts 
to form the dianion resulted in rapid decomposition of the starting material delivering 
only complex mixtures.  Benzyl trichloroacetimidate (Bn-TCA) with a camphorsulfonic 
acid catalyst proved unreactive, whereas the use of a tiflic acid catalyst led to complex 
mixtures presumably exacerbated by loss of the Boc-group.  Finally, the use of Dudley 
reagent (2-benzyloxy-1-methylpyridinium triflate) was investigated, but no reaction was 






 Considering that silylation had proven effective for protecting the allylic alcohol, 
we next tried to install a TBDPS-group hoping that this group would at least be stable 
enough to allow for some of the desired oxazolidine formation (Scheme 2.52).  Reacting 
alcohol 2.233 with TBDPS-Cl and imidazole furnished the silyl protected alcohol 2.238 
in 79% yield.  Reaction of 2.238 with rhodium supplied pyrrolidinone 2.239 in 86% 
yield.  Gratifyingly, the oxazolidine synthesis was effective at delivering the 
cycloaddition precursor 2.240 under standard conditions with dimethoxymethane and 
TFA, albeit in low yield.  The initial synthesis of 2.240 provided enough material to test 
the cycloaddition (see Section 2.2.2.5); however, our efforts to optimize the step leading 
up to the key cycloaddition were far from over.  We felt that a having a scalable route up 
to the cycloaddition step would not only be critical for optimizing and eventually solving 
the cycloaddition step, but would also provide ample material to begin advancing the 
synthesis beyond this key step.  Thus we continued our efforts of optimizing the 








The inefficiency of the Claisen reaction to install the β-ketoester moiety to 
provide 2.226 was troublesome, and thus our approach was revisited.  We reasoned that 
by doubly protecting the carbamate of 2.230 we could potentially lower the energy 
required to complete the enolate addition to the lactone since an anion of 2.230 would not 
be formed (Scheme 2.53).  We felt that by accessing a more reactive Claisen substrate 
that a cleaner and more selective reaction would result.  To that end, attempts to 
additionally protect 2.230 as the corresponding biscarbamate, thereby eliminating the 
acidic hydrogen atom, only resulted in a facile elimination reaction giving the α,β-
unsaturated lactone 2.241 in virtually quantitative yield. 
Scheme 2.53 
 
This elimination reaction (Scheme 2.53) raised our awareness of methods in the 
literature that accomplished highly stereoselective aza-Michael reactions on substrates 
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similar to 2.242 with amino nucleophiles (Scheme 2.54).  We therefore postulated that if 
we could prepare 2.241 more directly, an aza-Michael reaction could be utilized where 
the diastereoselectivity of this transformation was controlled merely by the 
stereoelectronics of the 6-membered transition state such as 2.243 (Scheme 2.54).  In the 
proposed transition state, the vinyl group in the 6-position would be positioned 
equatorially and thus axial attack of the incoming nucleophile would give the desired 1,3-
anti-relationship (i.e. 2.244). In considering this transformation, a number of literature 
examples on similar sugar-derived lactones such as 2.242 became apparent and gave very 
encouraging precedent for this strategy moving forward.121-125  This strategy would be 
more modular allowing direct access to amino lactones such as 2.244 bearing appropriate 
functionalization at R1 and R2 based on the amino nucleophile chosen.  In this way a 
series of Claisen substrates could be synthesize to help improve the enolate addition step.  
Also, by accessing an amine such as 2.244 rather than the more acidic carbamate 2.230, 
double protection of the nitrogen atom would most likely not be required because of the 
effective increase of the pKa of the nitrogen-hydrogen bond. 
Scheme 2.54 
 
By modifying the key step for installing the N-stereocenter, a new route could be 
devised to access lactone 2.241 in a more rapid fashion than was previously possible 
(Scheme 2.55).  Fortunately, allylic alcohol 2.195 was still envisioned as an intermediate 
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en route to lactone 2.241, and thus all the prior effort put into optimizing the synthesis of 
2.195 would still be constructive.  Thus, saponification of 2.195 followed by a known 
isomerization/lactonization protocol using Yamaguchi reagent (2.246) and pyridine 
provided the α,β-unsaturated lactone 2.241 in 71% yield over two steps.126  The key aza-
Michael reaction was then performed using O-benzyl hydroxylamine as the nucleophile. 
Gratifyingly, not only did the reaction proceed in virtually quantitative yield, but the 
diastereoselectivity (20:1 anti:syn) was higher than the Hirama-Ito strategy that gave at 
best a 10:1 ratio (cf. Table 2.1).  It is also important to note that the product of the aza-
Michael reaction was sufficiently clean that no additional purification was required after 
removal of the salts by trituration with ethyl ether. 
Scheme 2.55 
 
 We next tested the hypothesis that the use of an amine rather than a carbamate in 
the Claisen reaction would increase the efficiency of the reaction by raising the pKa of 
the NH-bond, thus resulting in a more facile enolate addition (Scheme 2.56).  In the 
event, the Claisen reaction of 2.247 gave amino lactol 2.248 in virtually quantitative yield 
and high purity after only an acid/base extraction.  The diazo transfer of lactol 2.248 then 
furnished diazo-β-ketoester 2.249 in 80% yield, which again was effectively purified by 
 164 
acid/base extraction.  In comparing the synthesis of 2.249 with that of the comparable 
diazo-β-ketoester 2.233 from the previous generation of this synthesis, it is clear that a 
number of significant improvements have been made.  The process for preparing 2.249 
was much more selective and, as a result of accessing basic amino derivatives, removed 
three chromatographic purifications.  Also, the increased efficiency of the Claisen 
reaction amounted to a much higher overall yield.  The challenge of cleaving the N,O-
bond and functionalizing the amino alcohol was still unsolved, however, and without an 




   With the acidity of the NH-bond now lowered, we reasoned that it should be 
possible to stoichiometrically generate the alkoxide anion and selectively alkylate with a 
benzyl electrophile.  Unfortunately, the generation of the sodium alkoxide with NaH at 
room temperature resulted in rapid decomposition of the starting material.  Although the 
reaction mixture was complicated, it appeared that 2.247 was forming during the 
reaction, presumably the product of attack of the alkoxide on the ketone followed by 
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expulsion of methyl diazoacetate anion.  Performing the deprotonation at -78 °C with 
ethyl magnesium bromide or n-BuLi proved mild enough for the diazo β-ketoester, 
however, no alkylation was observed using benzyl bromide at this temperature.  Attempts 
to alkylate 2.249 under acidic conditions using benzyl trichloroacetimidate (Bn-TCA) 
were somewhat successful.  Amino alcohol 2.249 was treated first with trifluoroacetic 
acid to pre-form the amine salt, thus rendering the nitrogen atom unreactive to alkylation.  
Treatment of the amine-TFA salt with Bn-TCA, in the presence of various acid catalysts, 
provided the benzyl ether 2.250 only in low yields along with recovered starting material.  
The best result was approximately 20% yield of 2.250 using triflic acid as the catalyst, 
but the reaction was irreproducible due to competitive decomposition of the 
trichloroacetimidate reagent.  This reaction also provided complex reaction mixtures, and 
isolation of pure 2.250 was difficult.  Before additional attempts were made to selectively 
protect the amino alcohol, initial screening was performed to test the N,O-bond cleavage 
step on the material we already had in hand.  
Scheme 2.57 
 
 Various standard reaction conditions were screened to cleave the N,O-bond of 
2.250 and 2.249, which included a variety of dissolving metal reductions (Scheme 2.57).  
Unfortunately, all of the conditions that were investigated illuminated the incompatibility 
of the diazo functionality with the conditions for N,O-bond cleavage.  It is possible that 
the N,O-bond cleavage would be possible on an earlier intermediate, however, prior to 
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the installation of the diazo group.  Preliminary studies to that end were investigated by 
Dr. Dan Paull.  Unfortunately, we have not been successful at discovering conditions for 
N,O-bond cleavage of any of the aforementioned synthetic intermediates. 
 Another intriguing strategy, which takes advantage of the stereoelectronically 
controlled aza-Michael reaction with lactone 2.241, involved the use of hydroxyl amine 
to give the lactone intermediate 2.253, which underwent a spontaneous intramolecular 
cyclization to give the isoxazolidinone 2.254 in an unoptimized 50% yield (Scheme 
2.58).  With this intermediate in hand, refunctionalization of the amino alcohol was 
accomplished without issue to give the doubly protected 2.256.  No additional attempts 
were made to advance this strategy; however, it would seem that the N,O-bond cleavage 
on this substrate would be more trivial than those with the diazo moiety in place.  The N-
Boc-group should also serve to weaken the N,O-bond and thus make the reduction more 
facile, however, a discovery made in parallel regarding our initial Hirama cyclization 














 During the efforts made by Dr. Dan Paull to advance material, the silylation of the 
initial amino alcohol 2.229 was revisited (Scheme 2.59).  It was discovered that the 
silylation of this intermediate could be accomplished in good yield by inverting the 
stoichiometry of the silyl chloride (1.5 eq) and the imidazole (1.3 eq); previous attempts 
at this reaction were performed with excess imidazole.  Dr. Paull was therefore able to 
synthesize the TBS-protected compound 2.231 in ~70% yield.    It was also discovered 
that the yields were consistently higher when the TBS-Cl was “preactivated” by stirring 
with imidazole in DMF for 15-20 min prior to introduction of the alcohol substrate.  
Elaborating on this discovery, I was able to increase the yield of the silylation further by 
employing DMAP as a catalyst to furnish the TBDPS-protected amino alcohol 2.259 in 
80% yield.  The use of DMAP removes the procedural requirement of preactivating the 
silyl chloride, presumably to pre-form the TBS-imidazole adduct.  With the ability to 
now access the appropriately protected amino alcohol, we were confident that the 
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impending Claisen condensation would be better behaved than with previous substrates 
lacking the O-protection. 
Scheme 2.59 
 
 With 2.259 in hand we focused on finding conditions for a high yielding Claisen 
reaction with a substrate bearing the acidic NH-bond (Table 2.2).  This reaction was the 
focus of a great deal of examination, as were most of the Claisen reactions we 
encountered.  However, we were excited by the fact that the use of the optimized 
conditions we had used for 2.230 when applied to 2.259 resulted in an increased yield 
without any initial effort to afford the β-ketoester 2.260 in 60% yield (Table 2.2, Entry 1).  
We were also able to identify a side reaction that might explain some of the problems we 
were having in some of our previous Claisen reactions.  With all of the trials using LDA 
as the base, we always isolated the free amino analogue 2.261.  In order to shed light on 
how we were losing the Boc-protecting under basic conditions, we ran control 
experiments with both the starting material 2.259 and the isolated product 2.260.  
Namely, when these materials were exposed to excess LDA in THF at 0 ºC, it became 
clear that the Boc-group of the starting material was stable.  The β-ketoester product 
2.260, however, immediately began generating the amino compound 2.261 corresponding 
to loss of the Boc-group.  Mechanistically it is not clear how this process occurs, but we 
rationalized that the excess Lewis-acidic lithium counterion might be responsible for the 
instability of the Boc-group in the product.  We therefore screened NaHMDS and in none 
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of these examples did we observe loss of the Boc-protecting group.  After optimization 
we found that using 13 equivalents of NaHMDS and 10 equivalents of methyl acetate 
was most effective at generating the enolate of methyl acetate (Table 2.2, Entry 7).  Due 
to dilution requirements in preparing the enolate, the reaction is much more facile when a 
large excess of base and methyl acetate is used.  Applying the optimized conditions, β-




 With the problem of the Claisen finally solved, the β-ketoester 2.260 was 
converted to the diazo-β-ketoester 2.238 in 92% yield using p-ABSA and NEt3 (Scheme 
2.60).  Compound 2.2.238 was employed in the synthesis of the oxazolidine 
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cycloaddition precursor 2.240, and thus the optimized synthesis of this intermediate was 
finally complete.  The synthesis of 2.238 from 2-deoxy-D-ribose (purchased in kilogram 
quantities for $0.5/gram) was accomplished in 10 synthetic steps and in 21% overall 
yield.  The synthesis of this compound has subsequently been reproduced multiple times 
on up to decagram scale, and only requires 4 chromatographic purifications.  One way to 
sum up the efficiency of this sequence is to consider that a 50 g batch of sugar should 




2.2.2.5 Efforts in Developing a Regioselective Cycloaddition Reaction 
The work described in the previous section focused on the development of a 
general synthetic strategy for utilizing 2-deoxy-D-ribose as a starting material toward a 
synthesis of the stemofoline alkaloids in enantiopure form.  With a synthesis of 
oxazolidine 2.240 in hand, the thermolytic cycloaddition reaction previously employed in 
the group could now be tested (Scheme 2.61).  In the event, thermolysis of 2.240 
delivered a mixture (1:2) of regioisomers 2.262 and 2.263 in a combined 95% yield.  
Unfortunately this ratio fell well short of the what we had hoped for with the C(8)-





A considerable amount research thus far had been committed to solving the 
problem of developing a regioselective intramolecular cycloaddition reaction to construct 
the stemofoline core using various sterically biased substrates.  From the onset, we hoped 
to identify a steric influence that could be exploited that would favorably affect the 
cycloaddition outcome; however, it was becoming clear that the effects of sterics alone 
were not as dramatic as we had hoped.  As illustrated by the Swern-mediated 
cycloaddition reaction, much better regioselectivity was achieved when the electronics of 
the cycloaddition reaction were adjusted (Scheme 2.18).  At this point we became 
interested in testing the Swern-mediated cycloaddition on a sterically biased system to 
probe if the effects of sterics plus electronics could be used in conjunction to facilitate a 
highly selective cycloaddition.   
Pyrrolidinone 2.239 was thus diverted to amino nitrile 2.264 by first reducing the 
ketone with NaBH4 to deliver a mixture of diastereomeric alcohols (Scheme 2.62).  The 
Boc-protecting group was removed, and the intermediate amine was alkylated with 
iodoacetonitrile in the presence of Hünig’s base.  Standard Strecker conditions to 
construct the aminonitrile resulted in loss of the silyl protecting group in this case.  When 
aminonitrile 2.264 was subjected to Swern conditions, the desired azatricycle 2.265 in 
was obtained in 75% yield as a single regioisomeric cycloadduct.  The remarkable 
selectivity in this example might suggest that the transition state leading to the undesired 
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cycloadduct 2.266 suffers from additional steric hindrance due to the spatial orientation 
of the cyano-group and the silyl protected alcohol.  In any case, it seems clear that the 
effects of sterics and electronics are more than just additive as they were first 
hypothesized to be.  It also seems reasonable that perhaps any removable group on the 
C(5)-position, predisposed towards the C(8)-silanol, might similarly affect the reaction 
outcome; therefore, we began considering options for replacing the cyano group with 
something more labile. 
Scheme 2.62 
 
Based on the hypothesis that a group at the C(5)-position, electron withdrawing or 
otherwise, has a profound effect on the cycloaddition outcome, we next sought to find a 
group that could be installed prior to cycloaddition that would prove to be more easily 
removed than the cyano functionality.  The main problem with the approach of 
electronically biasing the cycloaddition reaction has ultimately been the inability to 
remove the electronic auxiliary from the tricyclic cycloadduct.  While decyanation 
attempts have yet to yield the appropriately functionalized stemofoline core, it would 
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stand to reason that with further screening this sort of strategy could still be fruitful.  It is 
also of interest to look at other substituents to see if other electron withdrawing groups 
such as an ester could similarly benefit the cycloaddition (Scheme 2.63).  It was also of 
interest to vary the substitution of the pyrrolidinone ring by varying the R-group of 2.267. 
Scheme 2.63 
 
In order to address some of these questions, we returned to the original 
unsubstituted model system due to the ease in which pyrrolidinone 2.86 can be made to 
test the aforementioned cycloaddition strategies.  With a scalable route to the C(8)-
substituted series of compounds, any advancement on the model system could be quickly 
applied to the more advanced system.  A modified synthesis of 2.86 was investigated to 
facilitate its preparation with good success (Scheme 2.64).  Aldehyde 2.79 was first 
condensed with t-butylcarbamate and p-toluenesulfinic acid sodium salt to give α-
amidosulfone 2.270 in good yield.  The product of this reaction crystallized from the 
reaction mixture and was isolated in pure form by filtration.  Next the α-amidosulfone 
2.270 was elaborated to diazo-β-ketoester 2.85 by reaction with the lithium enolate of 
methyl diazomethylacetoacetate (2.271).  While the titanium enolate of 2.271 was known 
to react with sulfonimines to give similar tosyl protected Mannich products,97 the 
reaction of the lithium enolate of 2.271 with α-amidosulfones was not known.  Accessing 
racemic 2.86 under these new conditions provided the Boc-protected compound directly 
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making the overall process more economical.   Not only was the length of the synthesis 
shorted to three steps from the previously required six steps, but the overall yield of the 
new sequence was increased to 46% from the original 35%.   The modified synthesis also 
benefitted from shorter preparation time and three less chromatographic purifications. 
Scheme 2.64 
 
With gram quantities of pyrrolidinone 2.86 in hand, we examined varying the 
substitution of the azomethine ylide derived directly from this intermediate.  We sought 
to install the butyl side chain present in stemofoline and attempt a decarboxylative 
reaction to access a potentially more reactive azomethine ylide 2.274 (Scheme 2.65).  -
Ketoester 2.86 was first treated with n-butylbromide in the presence of sodium 
hydride/TBAI, and the C-alkylated product 2.272 was obtained in 46% yield; variable 
amounts of O-alkylation were also observed.  The carbamate moiety was then removed 
with TFA, and the methyl ester was saponified with LiOH/H2O to give aminocarboxylate 
2.273 in virtually quantitative overall yield.  The carboxylate salt was then used without 
purification in a number of cycloaddition attempts including: thermolysis with 
paraformaldehyde with no additional additives and with various amounts of p-TsOH.  
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The only observable product in any case was simply the decarboxylated product with no 
observable cycloadduct(s).  
Scheme 2.65 
 
 We then inquired whether an ester group in the azomethine ylide might lead to 
high regioselectivity in the dipolar cycloaddition with the Swern-like azomethine ylide 
formation (Scheme 2.66).  Accordingly, we reduced the -ketoester 2.86 with NaBH4, 
removed the Boc-protecting group with TFA, and N-alkylated the intermediate amine 











Aminoester 2.277 was then subjected to the established azomethine ylide 
formation under Swern oxidation conditions and, unfortunately, proved to be much less 
reactive than the comparable cyanated-analogue 2.102 (Scheme 2.66).  The starting 
material was consumed in the reaction, but gave low conversion to the two cycloadducts 
2.279 and 2.280.  The complexity of the reaction mixture made the ratio of the 
cycloadducts hard to elucidate, but was tentatively assigned as ~2:1 of 2.279:2.280 based 
on the 1H NMR of the reaction mixture.  While the full product distribution of this 
particular reaction is still not totally clear, the presence of both regioisomeric 
cycloadducts was confirmed, and it is seems that the reaction undergo complete 
conversion to azomethine ylide under the established conditions.  This would suggest that 
future trials of this reaction may require elevated temperatures if, for example, aziridine 
intermediates are forming from the azomethine ylide before it can react in the desired 
cycloaddition.  
Despite the low yield of cycloadducts, we were encouraged in that the reaction 
involving an azomethine ylide generated from 2.277 worked to some extent.   This was 
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an important breakthrough because there are a number of procedures for radical 
decarboxylation in the literature, a class of reactions that has shown great scope in 
organic synthesis.  The inherent regioisomeric ratio was not as high with 2.278 as the 
example with the cyano-substitution 2.102, a fact that may indicate the importance of 
electronics as a regiochemical control element since the t-butyl ester is considerably more 
hindered but less electronegative than the cyano group.  Despite the low conversion to 
cycloadducts and the lower than anticipated regioisomeric ratio, we felt confident that 
such an azomethine ylide would provide much higher selectivity when applied to the 
C(8)-substituted series of compounds, and thus we turned our attention to this series of 
compounds. 
We became interested forming an azomethine ylide related to 2.278 in a 
potentially more facile way.  Cognizant of the fact that metallocarbenoids react with 
imines to form azomethine ylides,127, 128 we became interested in applying such a 
reaction to our own system.  After a thorough literature search, however, we could only 
find one report of exploiting this reactivity in an intramolecular sense.   Padwa had shown 
that the azomethine ylide 2.282 could be formed from an intramolecular reaction of an 
imine with a tethered diazo--ketoester 2.281 catalyzed by Rh2(OAc)4 (Scheme 2.67).
127  
The azomethine ylide formed from this reaction was utilized in an intermolecular 1,3-
dipolar cycloaddition with N-phenylmaleidimide to give cycloadduct 2.283 in 65% yield.  
Padwa also utilized this 1,3-dipole cascade reaction on the comparable oxime (rather than 
imine) of 2.281 with similar results in forming the hydroxylamine variant of 2.283, but 
only applied this procedure to a limited set of cycloaddition examples.  No attempt has 
yet been made to apply this chemistry in the realm of natural product synthesis, thus we 




Our adaptation of Padwa’s 1,3-dipole cascade reaction would be considerably 
more aggressive, in that we were not only aiming to form the azomethine ylide 2.286 in 
an intramolecular sense using the dipole cascade reaction, but a tethered olefin would set 
up a significantly more demanding intramolecular dipolar cycloaddition (Scheme 2.68).  
Another significant modification is that the imine in our system would be exocyclic and 
used to form a 5-membered cyclic ylide, whereas in the Padwa example, the imine was 
endocyclic.  Our envisioned all-intramolecular cascade reaction would provide the 
stemofoline core in one single operation starting from the acyclic diazo--ketoester 
2.287, thus completely bypassing our usual pyrrolidinone intermediate.  Based on the 
aforementioned Swern-mediated cycloaddition that was used to access a similar 
carboxylated azomethine ylide 2.286, we were confident that if we could form the 
azomethine ylide under these conditions a favorable regioselectivity would result to give 







In order to assess the feasibility of this new route, we removed the Boc-protecting 
group from the diazo--ketoester 2.85 with TFA to give the corresponding amine-TFA 
salt (Scheme 2.69).   We next formed an imine with ethyl glyoxylate in the presence of 
NEt3 and 4 Å MS to provide diazoimine 2.288.  Analysis of the crude material revealed 
only the diazoimine and an equimolar amount of NEt3•TFA.  Due to the fact that 
NEt3•TFA is an oil, it was not possible to remove the salt by precipitation.  Since we 
were operating under the assumption that the imine was moisture sensitive, we decided to 
run our initial cycloaddition experiment with the salt contaminant in order to establish the 
basic reactivity of the targeted cycloaddition reaction.  We were excited to find that 
treatment of 2.288 with a catalytic amount of Rh2(OAc)4 in refluxing benzene provided a 
mixture (2:1) of the carboxylated cycloadducts 2.290 and 2.291 in approximately 53% 
combined yield over the three step sequence.  The isolated yield of the desired 
cycloadduct 2.290 was 35% from 2.288, which was very encouraging considering that 
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this sequence was still far from optimized.  Most importantly, a desirable regioselectivity 
was obtained, which we anticipated to only improve when applied to the real system.xxiv  
Scheme 2.69 
 
                                                 
xxiv It should be noted here that the two different regioisomers are easy to identify in the crude 1H NMR 
spectrum by identification of the C1-endo protons (labeled “Ha”).  These protons show up as distinct 
doublets in the 1H NMR spectrum and give very diagnostic J-coupling values.  The desired tricycle always 
gives a doublet with a J-coupling of 17.6 Hz, and the undesired has a J-coupling of 15.6 Hz.  These values 





With an efficient synthetic route to 2.238 already established, the application of 
our new cascade cycloaddition reaction to the real system could be quickly explored 
(Scheme 2.70).  The nitrogen atom of 2.238 was refunctionalized by removal of the Boc-
protecting group, and condensation of the intermediate amine with benzyl glyoxylatexxv 
gave crude diazo imine 2.292.  Analysis of the crude imine by 1H NMR spectroscopy, 
after a filtration through Celite, revealed quantitative conversion to the desired imine 
along with an equimolar amount of NEt3•TFA.  Since filtration of NEt3•TFA was not 
possible, we again carried the mixture to the cycloaddition step.  The crude diazoimine 
2.292 was thus treated with a catalytic amount of Rh2(OAc)4 in refluxing toluene, and the 
desired tricycle 2.293 was obtained in 56% isolated yield as the only observable 
regioisomer over the three-step/two-pot sequence.  That none of the undesired tricycle 
was observed in the NMR spectrum of the crude reaction mixture, is undoubtedly a 
testament to the multiplicative effect of combining the C(5)-electron withdrawing group 








                                                 
xxv Preparation of benzyl glyoxylate on large scale using established procedures had proven difficult and 
expensive.  Thus we developed a procedure which essentially solves the problem of the large scale 
preparation of high boiling glyoxylates by reaction of glyoxylic acid (2 eq) with benzyl alcohol (1 eq) in 
refluxing toluene under Dean-Stark conditions for ~24 h.  Excess glyoxylic acid serves as the acid catalyst 
for the esterification and is easily removed by acid/base extraction of the reaction mixture to give clean 




 In order to optimize this reaction, we wanted to see if removing the NEt3•TFA 
impurity from the crude diazo imine would increase the overall yield.  The crude 
diazoimine was then passed through an oven-dried plug of basic alumina and washed 
with anhydrous dichloromethane.  Attempts to perform this operation as a vacuum 
filtration led to significant loss of the imine, presumably the result of hydrolysis.  The 
best results were obtained by performing the filtration under an atmosphere of nitrogen 
gas, and the pure imine 2.292 was obtained in quantitative yield (Scheme 2.71).  Upon 
subjecting the purified diazoimine to the cycloaddition conditions, a slight increased 
conversion was observed; however, the regioisomeric ratio had greatly deteriorated.  
Analysis of the 1H NMR spectrum of the crude reaction mixture suggested a 
regioisomeric ratio of ~1.5:1 of 2.293 relative to 2.295, which were isolated in a 




 Scheme 2.71 
 
The stereochemistry at C(5) of the undesired regioisomer also merits comment.  
In the case of the cyano-substituted system 2.102 (Scheme 2.18) the anti-stereochemistry, 
relative to the C(3)-ester and the C(5)-cyano groups, was always observed in the 
products.  This is not surprising because the intermediate azomethine ylide should prefer 
the S-shaped geometry that would lead to the anti-orientation of the two ester groups.  
The S-shaped azomethine ylide would also correspond to the dipole minimized 
conformation making it electronically favorable as well.  In the cycloaddition example 
above (Scheme 2.71), however, it is believed that the stereochemistry of 2.295 is actually 
one in which the C(3)- and C(5)-ester groups are cis relative to one another.  While this 
assignment is still tentative, this is believed to be the case for a variety of reasons, 
including the fact chemical shift of the C(5)-proton was ~0.5 ppm upfield from typical 
values for these types of cycloadducts.  A similar shift in values has been observed with 
compound 2.102 (Scheme 2.18), when the epimerized product was obtained in an 
attempted silylation reaction in the presence of excess sodium hydride.  Also, as is 
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typically observed, the undesired regioisomers in all the cycloaddition reactions to date 
have been considerably less polar than the desired regioisomer (by TLC).  In this case, 
however, 2.293 and 2.295 had virtually the same Rf by TLC.  The relative increase in 
polarity of 2.295 might be a result of the 3,5-cis-orientation due to the additive nature of 
the both of the esters dipoles, an orientation that is likely lead to higher overall polarity of 
the molecule.  Also of note was the presence of ~10% of a third cycloadduct, the 1H 
NMR spectrum of which looked identical to 2.293 except for the chemical shift of the 
C(5)-proton that showed up ~0.5 ppm upfield, which seems to be a phenomenon 
indicative of epimerization of the C(5)-stereocenter.  Thus the third cycloadduct was 
assigned to be epimer 2.296. 
 While the result with the purified diazo imine (Scheme 2.71) is still somewhat 
puzzling, it has become clear that the presence of a proton source such as NEt3•TFA is 
essential to steering the reaction toward the desired cycloadduct.  In order to explain this 
observation, an analysis of the intermediate azomethine ylide geometry is necessary 
(Scheme 2.72).  It is widely accepted that 1,3-disubstituted azomethine ylides can react 
out of two discrete conformations, being the cis- and trans-ylide geometries (or the so 
called U- or S-shaped geometries).  With respect to our system, the initial trisubstituted 
ylide that should form from the imine reacting with the appended carbenoid 2.297 is the 
ylide where both the ester groups are oriented cis to one another (2.298, Scheme 2.75).  If 
this intermediate has enough energy to undergo the intramolecular cycloaddition reaction, 
then the regioisomeric product obtained would be those where the esters at the C(3)- and 
C(5)-positions are similarly in a cis-orientation (2.295 and 2.296). Presumably, in the 
case with the purified imine (Scheme 2.71), this U-shaped ylide is considerably more 
populated than in the initial example with the NEt3•TFA additive (Scheme 2.70).  The 
only significant difference between the reaction with the crude and purified imine is the 
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presence of the NEt3•TFA salt.  It would, therefore, seem that the presence of a proton 
source in the cycloaddition reaction leads to a rapid equilibration of the ylide geometries 
allowing the intermediate ylides to funnel to the more stable S-shaped ylide (2.299).  The 
product of reaction out of the S-shaped ylide geometry would therefore be cycloadducts 
2.293 and 2.294.  The formation of 2.294 has yet to be confirmed in any cycloaddition 
reaction, however, presumably not forming because of the severe interaction between the 
C(5)-ester and C(8)-silanol.  The undesired cycloadduct 2.295 does not suffer from this 
type of steric disadvantage, which would explain why more of this isomer forms when 
reacting out of the U-shaped geometry. 
Scheme 2.72 
 
 Whatever the operative principles of the new cycloaddition reaction truly are, it is 
clear that a proton source is necessary in the cycloaddition reaction in order to obtain 
high levels of regioselectivity.  With this fact determined, a series of experiments were 
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devised to probe the effect of further raising the reaction temperature in order to increase 
the yield of the cycloaddition reaction.  Summarized in Table 2.3 are the pertinent results 
to describe what has thus far been learned about the key dipole cascade cycloaddition.  
When the crude imine was heated at 150 ºC in the microwave over the course of 2 h 
(Table 2.3, Entry 3), a 74% yield of a mixture (1.5:1) of cycloadducts 2.293 and its C(5)-
epimer 2.296 was obtained.  Interestingly none of the undesired cycloadduct was 
observed in this reaction.  This may suggest that the undesired C(5)-epimer 2.296 may be 
forming in some cases by epimerization after the cycloaddition event rather than as a 
result of the U-shaped ylide.  This hypothesis was confirmed by reducing the reaction 
time in the microwave to 30 min (Table 1, Entry 4), where only trace amounts of the C5-
epimer 2.296 were observed in the NMR spectrum.  While the isolated yield of 2.293 was 
comparable to that of the initial cycloaddition reaction, it is noteworthy that the 
cycloaddition is virtually complete after only 30 minutes whereas conventional heating in 
refluxing toluene requires nearly 24 hours.   
 Further improvements to the key cycloaddition reaction came from increasing the 
reaction temperature from refluxing toluene (110 ºC) to refluxing xylenes (~135 ºC).  The 
increase in reaction temperature provided the desired cycloadduct in 65% yield from the 
carbamate 2.238 along with variable amounts of the C(5)-epimer 2.296.  Also the catalyst 
loading could be lowered to 2 mol % of the dirhodium catalyst (corresponding to an 
effective 4 mol % of rhodium) without loss in yield.  A number of reactions were 
performed at 1 mol % dirhodium, and in some cases the yield was 65%, but the reaction 
was less reproducible at this catalyst loading.  One final experiment that deserves 
consideration, is the example catalyzed by Cu(TBS)2 (TBS = t-butyl salicylimine), which 
provided a comparable yield to that in Entry 6.  This experiment, however, was only 
performed once and therefore the reproducibility is not certain.  The advantage copper 
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would provide as a catalyst is that it is considerably cheaper than rhodium, and therefore 




 The newly developed cycloaddition reaction was a huge victory for our overall 
research efforts on stemofoline due, not only to the inherent regioselectivity of the 
cycloaddition, but due to the preceding steps of the synthesis that provide a scalable 
approach to this key step.  The synthesis of azatricycle 2.293 is now 13 synthetic steps 
and 14% overall yield.  Furthermore, the process for the preparation of this tricyclic core 
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has been optimized with practicality in mind, and the route only requires six 
chromatography steps, and few steps are considered air or moisture sensitive.  The 
previous synthesis of the C(9)-substituted azatricycle 2.171 by comparison was 15 total 
steps and provided the stemofoline core in ~7% overall yield.  The previous approach 
was also far less operationally efficient since it required 11 chromatography steps, a 
number of which were used to separate closely eluting diastereomers.  Furthermore, the 
previous generation utilized two stoichiometric chiral auxiliaries to handle the challenge 
of stereochemical control, which further added to the cost of the synthesis.  Regardless of 
our ability to access 2.293 on scale, however, we still needed to prove that a radical 
decarboxylation was indeed possible to provide the appropriately functionalized natural 
product core.   
 With the practicalities of the overall synthesis aside, the new dipole cascade 
cycloaddition reaction is also unique in that only the Padwa precedent discussed earlier 
bears any resemblance to this type of reactivity.  Due to the novelty of this cycloaddition 
reaction, we became interested in exploring a bimolecular variant to probe the possibility 
of applying this reaction in a more general sense (Scheme 2.73).  To test this possibility, 
diazocarbamate 2.300 was treated with TFA to effect Boc-deprotection; subsequent imine 
formation with NEt3 and benzyl glyoxylate provided diazoimine 2.301 along with an 
equimolar amount of NEt3•TFA.  This mixture was then subjected to the standard 
cycloaddition conditions in the presence of the dipolarophile ethyl acetylenedicarboxylate 
and a mixture (~1:1) of cycloadducts 2.303 and 2.304 was isolated in 65% yield.  It is 
tentatively believed that the products isolated were the product of olefin isomerization to 
the more stable vinylogous carbamate after the cycloaddition reaction.  This conclusion 
was made based on a combination NMR, LCMS, and TLC analyses.  With respect to the 
TLC experiment, we were interested in trying to form the HCl-salts of the basic amino 
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cycloadducts, however upon exposure of the product mixture to 2 M HCl/MeOH, the 
TLC (SiO2, 1:1 Hex:EtOAc) revealed no change in Rf.  If the products were the amino 
cycloadducts then they would have protonated, and not eluted up the TLC plate; thus we 
assumed the product was likely the isomerized vinylogous carbamates 2.303 and 2.304 
which are not basic.  Based on this presumed isomerization, it is likely that the 1:1 ratio 
does not represent the actual diastereoselectivity of the cycloaddition.  Despite the fact 
that this combination of substrates was not the most synthetically interesting, it did 
establish the viability of a potential general method. 
Scheme 2.73 
 
2.2.2.6 Decarboxylation of the Azatricyclic Core 
With a reliable way to make the fully functionalized stemofoline core now at our 
disposal, the next critical challenge was to prove the feasibility of removing the ester at 
C(5) of tricycle 2.293.  In order to explore various possibilities, the benzyl ester was 
subjected to hydrogenolysis with Pd/C to furnish amino acid 2.305 in quantitative yield 
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(Scheme 2.74).  With acid 2.305 in hand, we next screened a variety of different 
conditions to effect a radical decarboxylation or decarbonylation.  A few different 
methods for synthesizing a Barton ester were screened, and on small scale reactions, the 
best procedure proved to be the reaction of tributylphosphine with disulfide 2.306a in the 
presence of the 2.305.  When Barton ester formation was complete, the reaction was 
irradiated with a Tungsten filament light bulb (200 W) under various conditions.  It was 
found that the decarboxylated product was unstable at high temperatures, thus precluding 
the use of standard AIBN initiated protocols.  When the reaction temperature was strictly 
controlled and maintained at room temperature, irradiation for 30 min was sufficient to 
consume the Barton ester.  This reaction mixture, however, was very complex and 
isolation of 2.262 proved difficult.  The formation of 2.262 was confirmed by comparison 
with an authentic sample by TLC (formed from the thermolytic cycloadditions, Scheme 
2.61), by analysis of the crude reaction mixture by LCMS, and comparison of the purified 
1H NMR to the previously acquired spectra.  Attempted purification of this mixture did 
provide a 50% yield of the cycloadduct; however, the isolated compound was 
contaminated by either tributylphosphine oxide or a tributylstannane by-product.  These 
experiments were performed on a small scale, and a larger scale experiment may yield 
better results.  Furthermore, the use of PBu3 to form the Barton ester was probably not 
optimal due to necessity to remove the excess by-products; thus another set of Barton 
ester formation conditions will probably prove more ideal.  These preliminary 
experiments, however, did unequivocally confirm that the desired decarboxylation was 






 A more recent advancement in the field of radical decarboxylations came from an 
account by the Williams group, which reported two very important breakthroughs with 
the Barton reaction.129  First, Williams established that chloroform is a competent and 
general hydrogen atom donor for use in the Barton decarboxylation reaction when used 
as the reaction solvent.  Furthermore, since chloroform was used as the solvent, they were 
able to perform a one-pot Barton ester formation/radical decarboxylation, essentially 
rendering the Barton reaction a one step process from the carboxylic acid.  This 
procedure was reported very recently, but undoubtedly due to the reduced “cost, smell, 
and toxicity” of this procedure it will likely become standard conditions for this type of 
reaction in the future.  Remarkably we had been screening conditions to accomplish the 
exact feat in using chloroform as a hydrogen atom donor when this paper was published.  
We therefore applied the reported conditions to our system by first forming the Barton 
ester from amino acid 2.305 with pyridine thione 2.306b and DCC in chloroform.  Upon 
complete consumption of the starting material, irradiation of reaction with a tungsten 
filament light bulb (200 W) for ~30 min at room temperature provided the 
decarboxylated tricycle 2.262 in ~60% yield.  Since this decarboxylation was performed 
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on a small scale, this yield is likely to improve in future work.  Compound 2.262 will 
likely prove an important compound going forward in the total synthesis; although it is 
also possible that the decarboxylation reaction could be performed on a number of 
different synthetic intermediates.  The point at which this operation will be synthetically 
optimal has yet to be decided; as such, we next turned our attention to the construction of 
the lactone moiety without further optimizing this transformation.  
Scheme 2.75 
 
2.2.2.7 Efforts towards the Application of a Novel CH-Insertion Reaction to 
Construct the Remainder of the Natural Product Core 
The next chapter in our efforts to access the final target didehydrostemofoline 
(2.3) now focused on the construction of the targeted lactone ring.  At this stage, we 
wanted to explore the feasibility of a unique and ambitious endgame to finalize our 
overall approach.  In particular, we targeted the construction of the lactone of type 2.307 
via a novel dirhodium catalyzed regioselective CH-insertion of diazoacetate 2.307.  
While this type of transformation is known, it has never been applied to a system as 
complex as the one at hand.  The key diazoacetate 2.307 would be derived from lactol 
2.308, which would be derived from the cycloadduct 2.293 using a remote 
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functionalization to oxide the C(8)-position and a Julia-Kocienski olefination to install 
the C(3)-butenyl side chain. 
Scheme 2.76 
 
The work of the Doyle group has established the underlying reactivity for our 
proposed CH-insertion step.  They were able to control the regioselection of 
intramolecular CH-insertion reactions to prepare butryroloactones with high 
diastereoselectivity.  In one relevant example, diazoacetate 2.309 could be diverted to 
two different products based on the chirality of the rhodium catalyst (Scheme 2.77).  
Treating 2.309 with dirhodium(II) tetrakis[methyl 2-oxopyrrolidine-5(S)-carboxylate] or 
Rh2(5(S)-MEPY)4 (2.312) resulted in a CH-insertion reaction with the tertiary hydrogen 
to give lactone 2.310 in 94% yield.  When using the opposite enantiomer of the catalyst 
Rh2(5(S)-MEPY)4, however, diazoacetate 2.309 provided the product of CH-insertion 
with the opposite secondary hydrogen atom to give 2.311 in 91% yield.  Doyle’s work on 
this class of reactions, has clearly established that these insertion reactions are always 
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selective for the equatorial hydrogens.  The established reactivity we feel bodes well for 
our envisioned application of this chemistry to stemofoline (Scheme 2.79).  The 
diazoacetate 2.307 we are looking to access has a number of unknowns built into it.  To 
our knowledge, there are no reported monosubstituted diazoacetates as part of a molecule 
bearing a basic nitrogen nor are there examples of diazoacetates of hemiacetals in the 
literature.  Both of these factors may present a challenge because the diazo hydrogen is 
considerably acidic, and can undergo deprotonation with amine bases. 
Scheme 2.77.  Doyle – Catalyst Controlled Stereoselective CH-Insertion of 
Diazoacetates 
 
With the CH-insertion reaction in mind, we turned our attention first to the 
functionalization of the C(8)-position while maintaining the C(5)-ester group for the time 
being.  Since 2.293 can conceivably be utilized in a number of different ways, we wanted 
to establish proof of principle for the proposed CH-insertion using it directly.  To that 
end, ketone 2.239 was stereoselectively reduced to give the alcohol 2.313 in 86% yield 
(Scheme 2.78).  This type reduction was precedented in the group, and has been shown to 
be entirely stereoselective.  Unfortunately, the C(5)-stereocenter underwent some 
epimerization under standard reduction conditions.  With 1.2 eq NaBH4, there was as 
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much as 17% of the epimer 2.314 isolated, which we rationalized was being produced 
from the small amounts of sodium methoxide generated during this reaction.  We 
therefore attempted to use 2-propanol as the solvent in the hope that a more sterically 
hindered alkoxide might be slower to effect the epimerization; however, the 
epimerization was actually more facile.  We finally reasoned that if we increased the 
equivalents of borohydride relative to the substrate that the reduction would be more 
rapid and thus give the epimerization less time to occur.  This tactic worked quite well to 




We next applied a Suarez remote radical functionalization that had proved 
successful in the past for functionalizing the C(8)-position (Scheme 2.79).  The difference 
between this system and the one previously explored is that the C(8)-position already 
bears an equatorial oxygen substituent, so remote functionalization would thus provide 
the oxidation state found in the natural product.  In the event, alcohol 2.313 was treated 
with iodobenzene diacetate and molecular iodine and irradiated with a tungsten filament 
light bulb (150 W) to give protected lactol 2.316 in 94% yield.  Deprotection of lactol 
2.315 was effected by TBAF buffered with AcOH to give the free lactol 2.316 in 95% 
yield.  CsF in DMF was also effective at completing the desilylation, however, the 
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reaction time was much longer and epimerization of the C(5)-ester stereocenter was 
significant.  The issues of epimerization of the C(5)-stereocenter would obviously not 
have been an issue if the decarboxylation was performed on the initial cycloadduct, 
however, we recognized that the decarboxylation of 2.315 is also possible.  
Scheme 2.79 
 
 We then turned our attention to functionalizing the acetal oxygen of 2.316 to 
install a diazoacetate which could be used to test the CH-insertion step (Scheme 2.80).  
We were aware of the difficulty that Overman had in functionalizing a similar acetal, 
where a silylation of this alcohol required TMS-imidazole at 130 ºC for 24 h to access the 
TMS-protected hydroxyl group.  We were therefore cognizant of the potential challenge 
in acylating this oxygen with a suitable precursor of a diazoacetate.  We tried a number of 
different techniques including the use of p-toluenesulfonylhydrazone of glyoxylic acid 
chloride (House reagent for direct installation of diazoacetates),130-132 
chloroacetylbromide/base, bromoacetylbromide/base, and bromoacetylbromide/HBr.  
However, in all cases, no reaction occurred.  In fact, during reactions with 
bromoacetylbromide, the starting material was consumed by TLC, but upon hydrolytic 
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workup the starting material was usually recovered.  On the assumption that the basic 
nitrogen was reacting with the acetyl bromide faster than the acetal oxygen and thus 
hindering the reaction, we tried an esterification under acidic conditions with HBr in the 
hope that protonating the nitrogen would allow for an acid catalyzed esterification of the 
acetal.  Indeed, we did observe small amounts of product; however, the conversion was 
never synthetically useful.  In the end, the Steglich esterification (bromoacetic acid, 
DCC/DMAP) was the first procedure to provide a high yield of the bromoacetate product 
2.317.133-135  While we could observe the bromoacetate product by TLC, we found it to 
be unstable to chromatographic purification.  The large amount of dicyclohexylurea 
byproduct was making interpretation of the NMR spectra difficult, and thus we sought a 
cleaner method for preparing 2.317.  The Steglich procedure is essentially the same as 
using an anhydride and DMAP catalyst, however, the anyhydride of bromacetic acid is 




When hemiacetal 2.316 was tested with bromoacetic anhydride in the presence of 
a catalytic amount of DMAP, bromoacetate 2.317 was obtained in >90% yield (Scheme 
2.80).  Another possible approach to this reaction would be to form a mixed anhydride 
with bromoacetic acid and either pivaloyl chloride or i-butylchloroformate, then perform 
the acylation with DMAP as a catalyst.  This approach would avoid the need to prepare 
the high boiling, hydroscopic bromoacetic anhydride since the mixed anhydride can be 
prepared in situ.  Purification of 2.317 by chromatography on silica was again not 
possible, but the product isolated after an acid/base extraction was sufficiently pure to 
provide a clean 1H NMR spectrum and was therefore used directly in the next step.  
Utilizing a procedure developed by Fukuyama for the preparation of diazoacetates, we 
next reacted bromoacetate 2.317 with bistosyl hydrazine and DBU at 0 ºC for 30 min 
provided the crude diazoacetate 2.318.136  The structural assignment of diazoacetate 
2.318 is still tentative at this point due to difficulties in isolating this compound in pure 
form.  The original procedure published by Fukuyama calls for the reaction to be 
quenched with dilute bicarbonate; however, we found that aqueous workup in our case 
gave a large amount of hydrolysis to the deacylated lactol product 2.316.  Analysis of the 
crude reaction mixture by TLC does not show any of the lactol after completion of the 
initial reaction (compared to an analytical standard); however, after workup the lactol 
2.316 is clearly the major constituent of the reaction mixture.  It is also unfortunate that 
the diazoacetate 2.318 is unstable during chromatography on silica gel, which makes 
accessing pure diazoacetate very difficult.  Attempts are currently underway to modify 
the Fukuyama procedure to exclude an aqueous workup; however, it will probably be 
necessary to carry a certain amount of impurities forward to the CH-insertion step. 
 Two initial attempts to perform the CH-insertion on the crude diazoacetate 2.318 
have been made (Scheme 2.81).  In each case the major component of the mixture that 
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was subjected to the insertion reaction was the lactol byproduct 2.316 from the previous 
step.  Since the conditions of the CH-insertion call for the reaction to be performed at 
high dilution (0.05 M), we reasoned that this compound would not likely inhibit the 
intramolecular CH-insertion reaction and thus we wanted to test the reaction using 
materials we had in hand.  Our first experiments were performed with the racemic 
catalyst Rh2(OAc)4 to simply test the reactivity of the presumed diazoacetate.  If the 
lactone products could be confirmed, we would have definitive proof that what we were 
assigning to be 2.318 was in fact the case.  In the event, crude 2.318 was treated with the 
dirhodium catalyst, and the compound we were tentatively presuming to be the 
diazoacetate was consumed by both TLC and NMR spectroscopy.  The 1H NMR 
spectrum of the crude reaction mixture was hard to interpret with respect to the presence 
of the lactone product(s) 2.319 and/or 2.320 because the major component of the mixture 
was still the lactol impurity 2.316.  Analysis of the crude reaction mixture by LCMS, 
however, revealed the mass of 400 m/z which would correspond to the product of CH-
insertion.   
Scheme 2.81 
 
While it is hard to be excited about these results due to their preliminary nature, 
the fact that the compound we were assuming to be diazoacetate 2.318 was consumed 
upon treatment with rhodium acetate seems to suggest that we had in fact prepared a 
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diazo compound related to our substrate.  Even if the CH-insertion reaction did work to 
give butyrolactone, it cannot be said at this point which of the regioisomers was the major 
product.  Based on precedent by the Doyle group, the CH-insertion reaction into the 
tertiary hydrogen should be inherently favored.  In his work (refer to Scheme 2.77), 
control reactions with Rh2(OAc)4 typically gave a mixture (~3:2) of lactone products 
favoring the tertiary insertion pathway.  Further experiments will ultimately require the 
use of both enantiomers of the chiral Rh-MEPY catalyst in order to assess the prospect of 
a selective reaction.   
 Efforts are currently underway to access the diazoacetate 2.318 in pure form so 
the regioselective CH-insertion can be tested with the chiral catalysts.  It is also important 
to note, that the system we are currently investigating is simply a model since we would 
first have to decarboxylate the core and install the C(3)-butenyl side chain to access the 
real system we are ultimately targeting. 
2.3 SUMMARY OF THE TOTAL SYNTHESIS TO DATE 
The following section is meant to be simply a schematic summary of the Martin 
group total synthesis of the stemofoline alkaloids as it currently stands.  The following set 
of reactions and conditions have been reproduced and optimized for implementation on 
preparative scale, and the corresponding synthetic intermediates have been fully 
characterized by 1H and 13C NMR spectroscopy, IR spectroscopy and high resolution 
mass spectrometry (HRMS).  This summary concludes with the decarboxylated core 
structure 2.273, and while the decarboxylation reaction has not yet been fully reproduced 
and optimized, this compound represents the most advanced intermediate with the most 
likelihood of being part of an eventual total synthesis of the stemofoline alkaloids.   
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2.4 CONCLUSIONS & FUTURE DIRECTIONS 
A majority of my efforts toward a total synthesis of the stemofoline alkaloids 
were applied to designing and implementing an innovative asymmetric synthesis of the 
fully functionalized and oxygenated core of these alkaloids.  Having accomplished that, 
this work has set the stage for a number of synthetic strategies going forward.  
Unfortunately, I have only had a little time working on the chemistry of the stemofoline 
core itself; however, in designing the foundation of the synthesis a number of key 
elements were held in mind with respect to the group’s eventual endgame.  By designing 
in the C(8)-alcohol a number of different credible synthetic plans are now at our disposal 
to finish the total synthesis.  One approach that has recently become high on our list of 
priorities is the utilization of a chiral dirhodium catalyzed regioselective CH-insertion 
reaction to install the pivotal lactone ring.  My efforts to this point have taken us up to a 
model diazoacetate 2.318, which is currently being used to scout conditions for this key 
step (Scheme 2.81), which could potentially be applied to a more advanced intermediate 
in future work.  This is where my efforts on the stemofoline project stand. 
Scheme 2.84 
 
 The following are my thoughts as to how one might approach finishing the total 
synthesis using the synthesis as it stands today.  This proposal focuses on the utilization 
of a common intermediate to test a number of potential strategies with the emphasis of 
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ultimately being the development of novel chemistry.  In order to complete the synthesis 
one will need to use the route outlined in Section 2.3 to synthesize a large quantity of the 
core structure 2.293.  After the initial scale up effort, compound 2.324 would be prepared 
as the logical next target in that it is envisioned to be a highly versatile intermediate 
(Scheme 2.85).   
With quantities of 2.293 in hand, a number of different pathways to access the 
targeted lactone 2.73 can be envisioned including, but not limited to, the CH-insertion 
centered approach.  Two obvious pathways to compound 2.324 are possible starting from 
cycloadduct 2.293.  The first pathway to access 2.324 has been partially scouted in that 
the stereoselective reduction of the pyrrolidinone ketone in the presence of the 
epimerizable ester has been solved.  A protection of the alcohol would then necessitate 
the application of a Barton decarboxylation approach on the doubly protected diol of the 
carboxylic acid of 2.293.  This process may we more well behaved then when ketone was 
applied to the radical decarboxylation, but other than a slight increase in overall yield this 
route does not necessarily present an advantage to accessing 2.324.  The route to 2.322 
would require an immediate Barton decarboxylation before the ketone is reduced and 
protected, which has already been successfully accomplished.  Some additional work will 
be required, however, to increase the yield of the Barton reaction on this intermediate.  
Both routes would inevitably access compound 2.323, but the order of steps is flexible.  
Ester 2.322 would then be reduced to give the aldehyde 2.323.  An exhaustive 
reduction/oxidation approach can be used, but here DIBAL-H is proposed to access the 
aldehyde directly.  Typically when partial reductions of esters with DIBAL-H works best 
to give the corresponding aldehyde an α- or β-heteroatom is present in the molecule, 
presumably helping to increase the longevity of the tetrahedral intermediate following the 
reduction.  Compound 2.322 has an α-nitrogen so it stands to reason that this compound, 
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and similar intermediates, would be ideally suited to a direct reduction.  With aldehyde 
2.323 in hand, a Julia-Kocienski olefination would deliver the key intermediate 2.324. 
Scheme 2.85 
 
Another approach to prepare 2.324 is slightly more aggressive and has the 
potential to cut two steps from the synthesis, but hinges on the eventual optimization of 
the Barton decarboxylation reaction on the cycloadduct 2.293 without having to reduce 
and protect the ketone moiety (Scheme 2.86).  An exhaustive reduction of the 
decarboxylated cycloadduct 2.262 with either DIBAL-H or LiBH4 would deliver a diol, 
which could be selectively oxidized at the primary alcohol to furnish aldehyde 2.325.  
The Julia-Kocienski olefination of 2.325 would likely require the reaction to be 
performed on the alkaloxide of 2.325 due to the basic nature of the reaction; however, it 
is possible that the sulfonamide anion of the olefination reagent would react selectively 
with the aldehyde before any interaction with the hindered alcohol.  If the alkoxide did 
form to some extent, it is likely that the acid/base equilibrium would still favor enough of 
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the sulfonamide anion to facilitate the overall transformation.  The olefination reaction of 
2.325 would thus deliver alcohol 2.326, which could be exploited to prepare either the 
key intermediate 2.324 or protected lactol 2.327.  The preparation of lactol 2.327 in this 
way would be the most efficient conceivable way to access this compound, which would 
be useful depending on the success of the CH-insertion strategy. 
Scheme 2.86 
 
 Once intermediate 2.234 is available, a number of different vectors can be 
investigated simultaneously to achieve the ultimate goal of preparing lactone 2.73.  The 
first approach, and arguably the most novel, would be the CH-insertion approach.  There 
are two conceivable ways to apply this key disconnect, the first being the preparation of a 
diazoacetate of hemiacetal 2.329 (Scheme 2.87).  Deprotection of the lower alcohol 
would provide alcohol 2.326, which could then be elaborated into lactol 2.328 by first 
applying the precedented Suarez remote functionalization of the C(8)-position followed 
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by disilylation.  There are a variety of ways to install the target diazoacetate moiety; 
however, preliminary studies suggest the Fukuyama approach might be viable to access 
2.329.  Implementation of the appropriate chiral dirhodium catalyst would provide 




 Another possibility for accessing lactone 2.330 would be to perform the CH-
insertion much earlier in the sequence on an alcohol derived diazoacetate 2.331 (Scheme 
2.88).  This approach does not provide an obvious advantage from the perspective of step 
count; however, diazoacetates of alcohols are very well known and would likely be easier 
to prepare and consequently more stable than the diazoacetate of the aforementioned 
lactol.  Increased stability would most likely allow for a simplified purification procedure 
since diazoacetates of alcohols are known to be stable to aqueous workup and 
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chromatography.  Also positioning the CH-insertion reaction earlier in the synthesis 
would inevitably make solving this problem easier due to an increased availability of 
material for study.  This strategy would begin with the deprotection of 2.324 to give a 
secondary alcohol, which could be subjected to a variety of synthetic methods to provide 
diazoacetate 2.331, including direct installation using the Corey modification of the 
House protocol.130-132  Next, the regioselective CH-insertion reaction could be studied 
on the potentially better behaved 2.331 to furnish lactone 2.332.  Deprotection of the 
alcohol would then allow a Suarez remote functionalization to provide 2.330 bearing the 
appropriately oxidized C(8)-center.  Moving the remote functionalization step to after the 
CH-insertion would not only make the CH-insertion reaction easier to test, but remote 
functionalization reactions into carbons bearing acetylated alcohols are very well 
precedented in the literature and should work comparably to the other examples of this 
reaction on similar substrates.  
Scheme 2.88 
 
 With the pentacyclic core of stemofoline 2.330 in hand, the next major concern 
would be the stereoselective installation of the C(10)-methyl stereocenter (Scheme 2.89).  
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While the alkylation of the lactone 2.330 should be fairly easy to perform, it is unclear 
what, if any, stereochemical preference will predominate.  Thus two possible 
diastereomers 2.73 and 2.335 should be expected.  In analyzing the Newman projection 
of the C(9)/C(10)-bond there are two possible steric interactions that can be identified to 
make an argument for either of the two products.  Attack from the bottom face appears to 
be the more hindered approach when considering a full 3D-model of enolate 2.334, 
however, 1,2-steric influences tend to preponderate other steric affects in most reactions.  
Assuming the approach of the electrophile is approximately 80-90º with respect to the 
enolate, then a clear interaction with the C(9)-hydrogen can be seen which may have the 
effect of ultimately favoring alkylation from the undesired bottom face.  Accurately 
predicting the outcome of this reaction cannot be done with any certainty; but, if any 
selectivity can be achieved one way or the other, a stereochemical inversion could be 




 One of the main reasons the intermediate 2.324 should be initially targeted in any 
future synthetic efforts is that this intermediate can also be used to explore 
complimentary avenues to install the C(9)-sidecain as well as the full pentacylcic core 
without the use of the CH-insertion reaction (Scheme 2.90).  The following can be 
thought of as back up plans should the CH-insertion reaction not work as proposed.  Also 
these additional routes are considerably more precedented for the stemofoline core, which 
might prove useful for simply advancing material to lactone 2.73 to study the ambitious 
final butenolide installation step while the details of the more challenging CH-insertion 
approach are investigated.  Compound 2.324 can quickly be advanced to ketone 2.336, by 
desilyation and oxidation of the secondary alcohol.  It should also be noted that the 
analogue of 2.336 where R=Me would constitute a formal total synthesis of 
didehydrostemofoline (2.3) by intercepting an Overman intermediate in asymmetric 
fashion.  Ketone 2.336 can also be manipulated borrowing from the Overman enolate 
alkylation strategy for installation of the C(9)-sidechain by first alkylating the enolate of 
2.336 with methyl iodoacetate, then performing a stereochemical inversion with DBU to 
provide 2.337.  Unmasking the alcohol by removal of the R-protecting group would 
facilitate an acetalization/lactonization cascade to give lactone 2.330, which could then 
be utilized in the abovementioned alkylation reaction to afford lactone 2.73 (refer to 
Scheme 2.89).  This approach, based on the precedent established by Overman, is a 
virtually guaranteed way to access quantities of 2.73, which again could be useful in 
studying the key final step while the details of the preceding CH-insertion strategy were 
worked out.  Ketone 2.335 could also be utilized in a strategy that borrows from the 
Kende endgame, however, in this case is seems likely that a Knovenagel condensation 
with methyl glyoxylate would give 2.338.  Kende utilized this same reaction to install the 
C(9)-sidechain with furfural to give an enone which was utilized in a highly 
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stereoselective conjugate addition to construct the C(10)-methyl stereocenter.  It is 
therefore conceivable that enone 2.338 could similarly be subjected to a conjugate 
addition utilizing Bergdahl conditions to effect a regioselective 1,4-addition into the 
doubly activated olefin.  We have previously applied these conditions to a similar 
conjugate addition where the olefin bared an imide and ester carbonyl and we showed 
that the conjugate addition was selective for the position beta to the more electrophilic 
carbonyl group (refer to Scheme 2.31).  In this case a regioselective conjugate addition 
into the position beta to the more electrophilic ketone also appears to be the less sterically 
encumbered mode of attack making 2.339 the most likely product from this reaction.  
Removal of the R-protecting group from 2.339 would facilitate an 




 Once an approach to 2.73 is devised, the final construction of the butenolide 
moiety can be implemented.  The approach of installing the butenolide by addition of a 
furanone into lactone 2.73, however, does not come with a complete reassurance.  Kende 
had inadvertently prepared a similar lactone racemic 2.28, and purportedly investigated 
the direct addition of the lithium furanone 2.24 as a way to access the butenolide moiety 
(Scheme 2.91).  The problem with this type of approach, however, is that the furanone 
only reversibly adds to the lactone to give the tetrahedral intermediate 2.340.  The reverse 
reaction of expulsion of the aromatic furanone anion is considerably more favored and 
thus obviated the use of this approach to the synthesis of racemic stemofoline (2.1).  
Scheme 2.91 
 
 A long standing goal in the Martin group sought to address the inherent problem 
of utilizing lactone 2.73 as a direct intermediate in a total synthesis (Scheme 2.92).  
While Kende’s work ruled out a direct furanone addition, we were aiming to preactivate 
the lactone in such as way at to directly access a capped tetrahedral intermediate such as 
2.343.  One such tactic would be the treatment of lactone 2.73, most likely as its 
ammonium salt, with Meirwein’s reagent, which would hopefully alkylate the lactone to 
provide an intermediate oxonium ion such as 2.344.137  This intermediate would then be 
reacted with either the lithium furanone or siloxyfuran of 2.342 to give 2.343 directly, 
which bears a capped oxygen atom, thus removing the possibility of the troublesome 
retro-addition reaction.  If the siloxyfuran of 2.342 is used then addition into the oxonium 
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ion 2.344 would deliver a silylated oxonium ion such as 2.345.  It is then conceivable that 
the tetrafluoroborate counterion anion could serve to desilylate the silyl oxonium ion thus 
liberating TMS-F and BF3•OEt2.  Tetrafluoroborate salts are known in the literature to 
desilylate labile silyl groups, and thus it would seem the silyl oxonium ion 2.345 would 
fall well within the reactivity of tetrafluoroborate.  This desilylation would produce an 
equimolar amount of a strong Lewis, which might therefore serve to eliminate a molecule 
of ethanol thus delivering the butenolide moiety of didehydrostemofoline (2.3). 
Scheme 2.92 
 
 A final, more direct approach to installing the butenolide moiety would bypass the 
problem of adding the furanone into the lactone thus delivering a potentially unstable 
intermediate such as 2.340 or 2.345.  Since the furanone anion itself is such a good 
leaving group due to its aromatic nature, it is likely that any attempt to add the furanone 
into the lactone directly will be met only with limited success.  To remove this problem 
altogether, the metallofuran ion 2.346 could be used as a nucleophile thus providing the 
considerably more stable furan addition product 2.347, which would not allow for the 
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retro-addition process to occur because the leaving group would have to be an sp2 anion 
(Scheme 2.93).  This addition reaction could conceivably be performed with the siloxy 
metallofuran of 2.346 or the dianion (either Li or Na/Li) of 2.346.  Activation of the 
alkoxide intermediate 2.347 would then facilitate the expulsion of the newly generated 
leaving group.  Considering that this leaving group is alpha to an oxygen atom and a very 
electron rich aromatic group, it should be very facile towards elimination and thus deliver 
didehydrostemofoline (2.3) in one single operation.  With the dianion (X = Li or Na), it is 
also possible that no activation will be required since elimination of lithium and sodium 
oxides is known to occur in certain circumstances.  In the proposed system the 
elimination reaction is highly geared to occurring, since the transition state involved in 
expulsion of the leaving group can be stabilized by four different electronically 




 The preceding discussion regarding the end game of the Martin group total 
synthesis of stemofoline was meant to serve as a guide for the next researcher who takes 
on this very challenging project.  Due to a great deal of effort that went into to developing 
an efficient, cost-effective, and scalable synthesis of the stemofoline core, the future of 
this project is indeed brighter that it has such a strong foundation from which to build 
upon.  It should also be noted that the reactivity established in the key dipole cascade 
cycloaddition reaction is unique among total syntheses involving the use of a 1,3-dipolar 
cycloaddition reaction of an azomethine ylide (see Chapter 1 for full discussion of this 
topic).  Not only did we successfully apply a 1,3-dipolar cycloaddition to access a very 
sterically demanding caged substrate, but the key cycloaddition was accomplished 
through a very efficient cascade reaction that assembled three rings and three 
stereocenters in a single operation from an acyclic starting material.  Upon completion of 
the total synthesis of these alkaloids, the Martin group synthesis will take its place among 
the premier examples of the application of 1,3-dipolar cycloaddition chemistry in the 












Chapter 3 – The Application of the Pauson-Khand Reaction as a Novel 
Entry into the Synthesis of Bridged Azabicyclic Scaffolds   
3.1 INTRODUCTION 
3.1.1 Naturally Occurring & Biologically Relevant Bridged Azabicyclic Molecules 
The first synthesis of tropinone (3.1) by Willstätter in 1903 spurred over a century 
of continuous study on the chemistry of bridged azabicyclic (BAzB) molecules;138-140 
and, to this day, continues to be the target of investigation by research groups interested 
in the synthesis of nitrogen containing natural products. The ubiquity of these types of 
ring systems in biologically active natural product skeletons makes it easy to understand 











Figure 3.1 - Selected Bridged Azabicyclic Natural Products 
 
3.1.2 Synthetic Approaches to Bridged Azabicyclic Ring Systems via Transition 
Metal Mediated Processes 
3.1.2.1 Classic Approaches 
While leaving a lot to be desired, the Willstätter synthesis of tropinone established 
the efficacy a transannular SN2 reaction to construct the BAzB motif.  To this day, the 
use of transannular substitution reactions of amines such as 3.11 remains one of the most 




In 1917, Robinson published his own approach to tropinone which accomplished 
the synthesis in one step from succinaldehde (3.13), acetonedicarboxylic acid (3.14), and 
methyl amine (Scheme 3.2).141  The Robinson tropinone synthesis, considered a veritable 
classic in organic synthesis, utilized the Mannich reaction as the key disconnect in 
constructing the tropinone core.  The Mannich reaction, being arguably one of the most 
widely used transformations in natural product synthesis, also continues to be of critical 
importance to the synthesis of BAzB systems. 
Scheme 3.2 
 
Another classic way to constructed BAzB structures is by the application of both 
inter- and intramolecular cycloaddition reactions of nitrogen containing compounds 
(Scheme 3.3).  The [4+2]-cycloadditions of pyrroles such as 3.15 and dipolarophiles for 
example, is a very useful technique for constructing bridged azobicyclo-[2.2.1]-scaffolds 
(Scheme 3.3, eq. 1).  Another type of cycloaddition, which is incredibly versatile, is the 
1,3-dipolar cycloaddition reactions of azomethine ylides such as 3.17.   This 
transformation can ultimately be used to access a larger variety of bicyclic frameworks in 
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that the starting heterocycles used to form the ylide is not limited to 5-membered rings 
(Scheme 3.3, eq. 2). 
Scheme 3.3 
 
 While this summary in no way does justice to the sheer breadth of work that has 
been done in the area of BAzB synthesis, it does serve to outline the basic reactivity that 
has been relied on most heavily.  The more modern approaches, discussed herein, which 
focus on the use of transition metal catalyzed/mediated processes, have brought a great 
deal to the table in this field, and provide a number of unique and versatile strategies to 
the synthetic organic chemist. 
3.1.2.2 Rhodium - Intramolecular Carbene Insertion Reaction 
The study of the chemistry and reactivity of diazo compounds has provided the 
synthetic community with a great deal of useful synthetic methodologies.142  The vast 
majority of these studies focused on harnessing the powerful reactivity of the carbene 
species resulting from metal mediated diazo decomposition reactions.  A variety of 
transition metals can be used to induce diazo decomposition to form metal carbenoid 
intermediates, including rhodium, copper, palladium, and ruthenium, among others.  The 
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most commonly studied catalysts for these types of transformation, however, tend to be 
dirhodium complexes.  While the use of dirhodium catalysis to form bridged carbocyclic 
and bridged oxobicyclic ring systems by CH-insertion reactions is well known, the use of 
CH-insertion reactions in the formation of BAzB has not been meanifully studied.  It is 
possible, however, to form BAzB ring systems by the process of intramolecular NH-
insertion reactions.   
A report by Aventis Pharmaceuticals illustrated that lactams tethered to diazo-β-
ketoesters such as 3.19, when treated with catalytic rhodium acetate, delivered the so-
called “anti-Bredt” lactam 3.20 in 40% yield along with the product of CH-insertion to 
form the fused bicycle 3.21 (Scheme 3.4).143  A number of other examples were also 
investigated in this study with varying substitution patterns, and all provided similar 
results for the BAzB ring system. 
Scheme 3.4 
 
 Another example comes out of the Kende total synthesis of isostemofoline (2.2) 
in which a rhodium catalyzed formal [4+3]-cycloaddition between pyrrole 2.14 and vinyl 
diazoacetate 2.15 provided the bridged azabicycle 2.17 (Scheme 3.5).73  The application 
of this reaction in the context of a isostemofoline total synthesis was discussed in the 
previous chapter (Chapter 2).  The general methodology used by Kende was developed 
by the Davies group for the synthesis of bridged oxabicyclic compounds;78 however, the 
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Kende variant remains the lone application of this method to a BAzB ring system.  It 
stands to reason, that this method could easily find an application in other settings.   
Scheme 3.5 
 
 The woprk of the Padwa group over the years have served to greatly expand the 
scope of diazo chemistry considerably.  One intriguing example of his work was in the 
reaction of the imine tethered diazo-β-keto ester 2.248 that, when exposed to catalytic 
rhodium acetate, reacted in an intramolecular fashion to provide an azomethine ylide that 
underwent a 1,3-dipolar cycloaddition with N-phenylmaleimide (Scheme 3.6).127  This 
reaction provided the BAzB compound 2.250 in 65% along with 25% of the CH-insertion 
product 2.251.  The application and expansion of this methodology was discussed in the 
previous chapter in the context of a Martin group total synthesis of the stemofoline 




3.1.2.3 Palladium - Intramolecular Heck Reaction 
The Overman group has championed the use of the intramolecular Heck reaction 
as a way of synthesizing a broad range of hetero- and carbocyclic frameworks.144-150  
Since the early studies on this methodology, the intramolecular Heck reaction has been 
applied successfully to many different natural product total syntheses.  In one of his early 
reports in this area, the Overman group applied this budding technology to the synthesis 
of the BAzB molecule 3.23 (Scheme 3.7).151  Treatment of aryl iodide 3.22 with 
Pd(OAc)2 and Ph3P facilitate an intramolecular Heck reaction onto the appended 
cyclohexene moiety to provide the bridged scaffold in 83% yield.  This initial reaction 
served to establish the efficacy of this methodology to the synthesis of BAzB ring 
systems, and has since been applied very broadly to tackle the synthesis of complex 
BAzB compounds. 
Scheme 3.7  
 
 The Pfizer laboratories reported the application of the intramolecular Heck 
reaction to the synthesis of the BAzB natural product cytisine (3.10, Scheme 3.8).152  
The N-alkyl gutarimide 3.24 was first converted to the corresponding vinyl phosphonate, 
and the crude material was treated with catalytic Pd(OAc)2 and P(o-tol)3 to facilitate an 
intramolecular Heck to furnish the BAzB compound 3.25.  In an effort to perform this 
Heck reaction in an asymmetric sense, they were also able to develop a one-step protocol 
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from 3.24 with a chiral phosphine ligand.  While the asymmetric Heck only provided low 
chiral induction (22% ee), the one-pot protocol shorted the overall total synthesis to a 
total of five steps providing racemic cytosine (3.10) in high overall efficiency. 
Scheme 3.8 
 
 The Bennasar group total synthesis of apparicine (3.6, Scheme 3.9) aimed to 
employ a very demanding intramolecular Heck reaction to the synthesis of the strained 
BAzB natural product scaffold.153  Treatment of vinyl iodide 3.26 with catalytic 
Pd(OAc)2 and Ph3P under cationic conditions managed to successfully effect a Heck 
reaction on the tethered olefin to construct the apparacine ring system, albeit in very low 
yield.  They surveyed a great deal of Heck conditions to accomplish this transformation; 
however, only the cationic conditions with silver carbonate provided any of the desired 
product.  This example of the intramolecular Heck reaction serves as encouragement that 
the Heck can be successfully used to apply very strained molecules while illustrating the 







 A notable synthetic method reported by Grigg, applied the intramolecular Heck 
reaction as part of a RCM/Heck cascade process for the construction of “anti-Bredt” 
lactams such as 3.31-3.32 (Scheme 3.10).154, 155  Treatment of dienylarylhalides of 
type 3.27-3.28 with Grubbs first generation catalyst provided an intermediate piperadine 
3.29-3.30, which was subjected to Heck conditions to effect formation of the BAzB 
scaffold.  When this sequence was performed sequentially (RCM then Heck), yields of 
48-55% were obtained for bicycles 3.21 and 3.22; however, by performing this sequence 
as a tandem bimetallic process the same products were attained in much improved yields 
of 73-80%.  Performing the cascade reaction with a Pd(OAc)2 precatalyst and Ph3P was 
unsuccessful due to poisoning of the ruthenium catalyst, thus the use of polystyrene 










 A recent example from the Martin group has illustrated the feasibility of the 
intramolecular Heck reaction to rapidly construct the norbenzomorphan skeleton 3.36 
(Scheme 3.11).156  In this approach, the Martin group multicomponent assembly strategy 
was utilized to quickly access diene 3.34, which was then subjected to RCM to provide 
the piperadine 3.35 in 83% overall yield.  Treatment of the bisarylhalide with Pd(OAc)2 
and P(o-tol)3 under microwave irradiation furnished the BAzB compound 3.36 in 
excellent yield.  This overall synthetic approach provides an excellent complement to the 
Grigg’s strategy, and it stands to reason that the bimetallic cascade reaction he developed 










3.1.2.4 Ruthenium - Ring Closing Metathesis 
As discussed in the previous section, the RCM reaction is an effective tool for the 
synthesis of heterocyclic compounds.  The featured RCM examples were used to set up 
intramolecular Heck reactions in the construction of BAzB scaffolds.  Significant work in 
the synthetic community has focused on use of the RCM itself as a general tool to 
directly construct BAzB molecules.  The first such feat was accomplished by the Martin 
group in the total synthesis of ircinal A (3.7) in 1999 and subsequently manzamine A in 
2002 (Scheme 3.12).157, 158  The treatment of triene 3.37 with Grubbs first generation 
catalyst facilitated an RCM to form the macrocyclic BAzB molecule 3.38, which was 
subsequently converted to ircinal A (3.7) and manzamine A.  This reaction served as 
useful precedent going forward that the RCM could be used to access structurally 






 Building upon the aforementioned RCM to access the manzamine core, the 
Martin group set out on a series of synthetic studies to develop a general synthetic 
method for the synthesis of BAzB ring systems using this reaction as the key 
disconnect.159-161  Cognizant of the fact that N-acyl-2,6-cis-disubstituted piperadines 
prefer to adopt a diaxial conformation such as 3.40a to avoid the significant pseudo-A1,3 
strain when in the diequatorial conformation 3.40b, it was hypothesized that a dienyl 
substrate such as 3.40 would therefore undergo facile RCM reaction when exposed to 
Grubbs catalyst (Scheme 3.13). 
Scheme 3.13 
 
 In order to access a series of piperadine derivatives to test this concept, the 
gutarimide derived hemiaminals 3.41a-b and amidosulfone 3.41c were treated with an 
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appropriate organometallic reagent to effect a Mannich reaction providing lactams 
3.3.42a-c, varying in the length of the newly installed olefin side chain (Scheme 3.14).  
Acylation of the lactam nitrogen, followed by reduction of the corresponding imide, 
provided the intermediate hemiaminals 3.43b-c.  Workup with benzotriazole (Bt-H) and 
tosic acid, rather than by hydrolysis, provided the more active benzotriazole leaving 
group 3.43a.  A second Mannich reaction with vinyl-Grignard or allyl-Grignard cleanly 
provided the 2,6-cis-disubstituted piperadines 3.46a-d.  Treatment of these dienyl 
piperadines with Grubbs first generation catalyst thus provided the bridged azabicyclo-
[3.2.1], [3.3.1], and [4.3.1]-scaffolds 3.47-3.49 in excellent yields.  All attempts to make 





 Further exploration into the scope of this reaction led the Martin group to adopt a 
general synthetic strategy developed by Commins for the synthesis of 2,6-cis-
disubstituted piperadones.  In applying the Commins strategy, 4-methoxypyridine (3.50) 
could be rapidly converted to a series of vinyl and allylated piperadones 3.51a-c by 
addition of the corresponding organometallic reagent into the Lewis acid activated 
pyridine ring followed by capping the product with Cbz-Cl.  A subsequent copper 
mediated conjugate addition provided the dienylpiperadones 3.52a-d, whereupon 
treatment with Grubbs first or second generation catalysts provided the corresponding 
BAzB molecules 3.53-3.56 in excellent yields.  This series of RCM reactions, not only 
illustrated the ability to incorporate additional functionality into the piperadine ring 
system, but demonstrated that various substitution patterns on the olefinic side chains 
could also be tolerated.  Notably, the sterically demanding tetrasubstituted olefin 3.56 












 A final extension of the Martin group RCM strategy was the synthesis of an 
azabridged tetrahydro-β-carboline ring system, which is an important motif in Sarpagine 
family of natural products (Scheme 3.16).  Starting with β-carboline 3.57, the imine 
moiety was first acylated, and resulting acyliminium ion was treated with MeOH to 
provide the aminal 3.58 in 76% yield as a mixture of diastereomers.  Next, a Sakurai 
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reaction furnished the allylated tetrahydro-β-carboline 3.59 in 72% yield bearing the 
essential 2,6-cis-stereochemistry.  The ester was then subjected to a one-pot 
reduction/olefination reaction to afford diene 3.60 in 62% yield.  Treatment of the diene 
with Grubbs first generation catalyst resulted in an RCM reaction to give the BAzB 
tetrahydro-β-carboline 3.61 in 90% yield.  Compound 3.61 is a conceivable intermediate 
en route to a number of natural products including akuammidine (3.9).  This approach to 
3.61 served, not only as critical precedent for our group going forward, but as inspiration 





 The general Martin group strategy for the synthesis of BAzB ring systems 
utilizing the RCM reaction has also served as inspiration for a number of other groups in 
their efforts to construct BAzB scaffolds.  Bubnov, for example, developed a bisallylation 
reaction with triallylborane and heterocycles such as pyridine, isoquinoline, and pyrrole 
(Scheme 3.17).162, 163  Treatment of various 4-substituted pyridines such as 3.62 with 
triallylborane and i-PrOH provided the 2,6-trans-diallyl compounds, which could 
effectively be epimerized by an additional reaction with triallylborane under thermolytic 
conditions.  This three step procedure ultimately provided the 2,6-cis-disubstituted 
piperadines 3.64 in short order.  Boc-protection of the piperadines allowed for the 
required diaxial conformation to be achieved, and resulted in a high yielding RCM 
reaction upon treatment with Grubbs catalyst.  This general strategy was also applied to 
access the BAzB tetrahydroisoquinoline 3.67 and the BAzB pyrrolidine 3.70.  While the 
Bubnov approach is very efficient, it can only provide access to the diallylated series of 















A number of natural product syntheses have been accomplished using the Martin 
group RCM approach to BAzB systems, including the 2002 report by the Kibayashi 
group on the total synthesis of (-)-adaline (3.5, Scheme 3.18).164    The chiral aminal 3.71 
was converted to the N-formyl-2,6-cis-diene 3.72 in three steps, which set up an RCM 
reaction with Grubbs second generation catalyst to furnish the BAzB compound 3.73 in 








 In 2004, the Martin group reported the synthesis of the BAzB natural product (+)-
anatoxin-a (3.4) using an expansion of their RCM methodology to include an enyne RCM 
reaction (Scheme 3.19).165  This account was joined by a paper from the Mori group on 
the synthesis of (-)-anatoxin-a using the same type of enyne RCM.166  Aggarwal also 
published a remarkably similar RCM approach to (+)-ferruguine (3.82, Scheme 3.20);167 
and notably, all three of these syntheses were submitted for publication within five days 
of each other.  Each synthesis began with a chiral pyrroglutamic acid derivative as the 
starting material, the stereochemistry of which was utilized to install the 2,5-cis-
substitution in asymmetric fashion.  The Martin group targeted enyne 3.75 in this way, 
which possessed a methyl substituted alkynyl group.  Treatment of 3.75 with Grubbs 
second generation catalyst provided the BAzB compound 3.77 which was subsequently 
converted to (+)-anatoxin-a (3.4).  Mori’s approach used the TMS-capped alkyne group, 
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which underwent a similarly facile RCM reaction to provide the anatoxin skeleton 3.78.  
The Mori intermediate was converted to (-)-anatoxin-a. 
Scheme 3.19 
 
 The Aggarwal synthesis utilized the lower homologue 3.80 to similarly access the 
azabicyclo-[3.2.1]-ring system of ferruguine (3.82, Scheme 3.20).  In the event, enyne 
3.80 underwent an enyne RCM with Grubbs first generation catalyst to afford 3.81 in 











3.1.3 The Pauson-Khand Reaction as an Entry into Bridged Azabicyclic 
Frameworks 
3.1.3.1 Introduction 
Subsequent to our group’s development of the RCM strategy to synthesize BAzB 
frameworks, we became interested in examining the possible application of the Pauson-
Khand reaction (PKR) toward this goal.168  The intramolecular version of the PKR has 
been applied to the syntheses of a few alkaloid natural products, but in each case, its use 
has been limited to the preparation of fused bicyclic molecules.  Our synthesis of 
tetrahydro-β-carboline 3.61 produced a particularly interesting scaffold (Scheme 3.16), 
which on the surface mapped closely on to a few different macroline/sarpagine indole 
alkaloids, including alstonerine (3.8, Scheme 3.21).  The use of an RCM to construct this 
scaffold we felt was a possible outlet to alstonerine, however, a successful application of 
a PKR reaction would provide a considerably more functionalized BAzB compound 
3.333.  With the ability to directly access the cyclopentenone moiety using this key 
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transformation we envisioned utilizing the inherent functional and carbon framework to 
elaborate 3.83 into the dihydropyran ring required for alstonerine. 
Scheme 3.21 
 
3.1.3.2 Prior Art in the Martin Group 
Considering that the PKR to form bridged azabicyclic structures lacked precedent, 
we undertook the synthesis of a number of 2,6-cis-disubstituted piperidine enynes which 
differed in the number of carbons separating the alkene and alkyne moieties from the 
bridging nitrogen atom.  We sought to use these enynes as substrates for Pauson-Khand 
reaction to assemble azabicyclo-[3.3.1] and azabicyclo-[3.2.1]-ring systems using 
chemistry previously utilized for the material preparation during the Martin group 
investigation of the comparable RCM methodology.  Following the work of Comins, 4-
methoxypyridine (3.50) was treated with the acetylide ion derived from TMS-acetylene 
in the presence of Cbz-Cl to provide the enone 3.86 following acidic workup (Scheme 
3.22).  Conjugate addition of allyl tributylstannane to 3.86 proceeded using TBS-OTf as a 
Lewis acid, followed by addition of TBAF to provide the enyne 3.87 in excellent yield 
 238 
and diastereoselectivity.  The enone 3.86 also underwent conjugate addition with a vinyl 




 Alternatively, treatment of 4-methoxypyridine (3.50) with the zinc reagent 
derived from 1-trimethylsilyl propargyl bromide in the presence of Cbz-Cl gave the 
homologated enone 3.89 in good yield (Scheme 3.23).  This enone underwent conjugate 
addition with a vinyl cuprate followed by treatment with TBAF to provide the enyne 3.91 








 With the 2,6-cis-disubstituted piperidines 3.87, 3.88, and 3.91 in hand, the PKR of 
was attempted utilizing Co2(CO)8 and a number of common promoters, including NMO, 
BuSMe, and 4 Å molecular sieves.  The conditions that gave the most efficient reaction 
involved treatment of enynes 3.92 with Co2(CO)8 to give an intermediate cobalt-complex 
that was then treated with six equivalents of DMSO and warmed to 65 ˚C to give the 
enones 3.93 in excellent yield (Table 3.1).  Optimization of this transformation revealed 
that use of high quality Co2(CO)8 was essential to obtain high yields.  Catalytic variants 
employing rhodium catalysts failed to provide any of the enone 14, and typically the 
starting enynes 3.92 were recovered.  We were comforted by the fact, however, that 
stoichiometric Co2(CO)8 was still generally less expensive than the rhodium catalysts.  
With the optimized PKR conditions at our disposal, the BAzB products 3.94, 3.95, 3.96 
were synthesized.  Both 3.94 and 3.95 proceeded in high yields and provided the products 
as a single diastereomers, however, the more strained system 3.96 was only obtained in 







 All of the PKR substrates above contained a C(4)-carbonyl group, and therefore 
we sought to determine the effect of modifying the C(4)-position.  Thus, enyne 3.87 was 
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treated with L-selectride to deliver the alcohol 3.97, which was protected as the 
corresponding TBS-ether 3.98 (Scheme 3.24).  
Scheme 3.24 
 
 We also wanted to obtain an enyne bearing no functionality at the C(4)-position 
(Scheme 3.25).  Thus, we resorted to a different strategy to prepare 3.102, which was 
based on previous work in the group.  Alkylation of the known amidosulphone 3.41c with 
the acetylide derived from TMS-acetylene gave the lactam 3.99, which was acylated to 
provide 3.100.  Reduction of the more electrophilic carbonyl group in 3.100 with 
DIBAL-H, followed by a Sakurai reaction gave the enyne 3.102 after cleavage of the silyl 













Subsequent study of the PKR strategy on these new substrates revealed that the 
substitution at C(4) in 3.12 had the potential to affect the diastereoselectivity of the PKR 
reaction (Table 3.2).  The PKR of the silyl ether 3.98 gave 3.105 in good yield as a single 
diastereomer (entry 1).  However, the substrate 3.102 containing a methylene group at 
C(4) underwent a PKR to give a mixture (4:1) of diastereomers in good yield favoring 












 Our plan for the total synthesis of alstonerine (3.8) hinged on the PKR of the 
enyne 3.85 to give the BAzB cyclopentenone 3.84 (Scheme 3.26).  Thus, following 
chemistry previously developed in our research group, the enyne 3.85 was prepared in 
four steps from L-tryptophan.  The PKR of 3.85 proceeded smoothly to give the 
cyclopentenone 3.84 in excellent yield as a single diastereomer bearing the required 
stereochemical arrangement necessary for a total synthesis of alstonerine; if fact, the total 







In the context of further studying the scope of the Pauson-Khand reaction, my role 
on the project was to develop a synthesis of 2,6-cis-disubstituted piperazines for 
application in the new methodology.  Unlike the synthesis of piperadines, piperadones, an 
pyrrolidines bearing this type of substitution pattern, which have been thoroughly studied 
from a synthetic standpoint, the synthesis of 2,6-disubstituted piperazines lacked 
precedent at the time we set out.  We thus had to investigate a number of different 
strategies to accomplish this goal. 
3.2.2 Application of the Martin Group Pauson-Khand Method to Access Bridged 
Bicyclic Piperazines 
We were initially interested in synthesizing chiral piperazine enyne substrates for 
use in the PKR reaction, and therefore we were attracted to a method reported by the Bols 
research group which used glucosamine (3.107) as a starting material for the synthesis of 
chiral piperazones.169  Their approach called for an initial DCC coupling of glucosamine 
and N-Cbz-glycine to give 3.108 (Scheme 2.37).  In our hands this reaction proved very 
difficult due to the highly polar nature of the coupled product, which made purification 
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very difficult.  Bols reported that the product precipitated from the reaction mixture, 
however, the best we could do was the formation of a gelatinous substance, which proved 
to fine to be filtered from the reaction.  We therefore decided to subject the crude product 
mixture to the next hydrogenolysis/reductive amination step to form piperazone 3.109 in 
the hopes that we could take advantage of the basic nitrogen during the 
isolation/purification.  They reported the use to extremely high pressures of hydrogen gas 
(>250 atm) for this reaction, however, with our equipment the best we could achieve was 
120 atm.  It was not clear what the outcome of this reaction was, but due to very 
complicated mixtures we decided to turn our attention to a modified synthetic approach. 
Scheme 3.27 
 
 We reasoned that peracylated glucosamine 3.110 would likely provide better 
material properties, and thus simplify the purification and isolation procedures (Scheme 
3.28).  We also wanted to remove the use of DCC as a coupling reagent for this sequence 
since the urea byproduct had been complicating the subsequent product mixtures.  To that 
end, we reacted 3.110 with the preformed mixed anhydride of Z-Gly-OH, which provide 
excellent yields of the amide product 3.333.  We still found the subsequent hydrogenation 
to be troublesome in that complex mixtures were always observed.  It is possible that our 
inability to achieve the prescribed 250 atm of hydrogen was to blame for the erratic 
results.  In an attempt to access our targeted aldehyde 3.113, we made an effort to carry 
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forward the crude product mixtures from the hydrogenation step.  We first Boc-protected 
the amine, then subjected the crude material to a periodate cleavage.  Analysis of the 
crude reaction by TLC, NMR, and MS revealed small quantities of the desired product 
(<10%), however, considering the difficulty and lack of efficiency of this sequence we 
decided to abandon our efforts to synthesize chiral material and move to a less 
complicated racemic approach. 
Scheme 3.28 
 
 We first looked to synthesize imide 3.117 with the idea in mind of borrowing 
from the chemistry developed in our group for accessing 2,6-cis-disubstituted 
piperadines, which relies on iterative Mannich reactions to install the 2,6-substituents 
(Scheme 3.29).  Beginning with N-Boc-aminodiacetic acid 3.114, we first formed an 
amide with triphosgene and p-methoxybenzylamine (PMB-NH2) to provide 3.115 in 
>90% yield.  Next a cyclization mediated by carbonyldiimidazole (CDI) was performed 
to provide the fully protected imide 3.116.  Unfortunately, all attempts to deprotect the 
imide nitrogen to give 3.117 failed in our hands.  We explored various different 
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hydrogenolysis, Lewis acid mediate, and oxidative PMB-deprotection conditions; 
however, the PMB-imide proved more robust than we had anticipated and returned only 
starting material in most cases.  
Scheme 3.29 
 
We were next drawn to a procedure reported for the synthesis of 2-substituted 
piperazines, which utilized chemistry developed by the Beak group.170, 171  In this paper 
they managed to accomplish a number of alkylation reactions of organolithium reagents 
prepared from directed lithiation of Boc-protected piperazines.  In only one example they 
attempted to take the mono-substituted piperazines and further substitute at the adjacent 
position.  They claimed in their paper that they achieved the 2,6-cis-disubstitution, 
however, in attempting to repeat this chemistry we found that the trans-stereochemistry 
was in fact obtained.  This was confirmed by failed attempts to perform an RCM reaction 








Despite that fact that the cis-orientation was not directly accessible, we were 
cognizant of reports by Beak where formylation of the carbanions of 2-substituted 
piperadines furnished the 2,6-trans-formyl compounds.171  Beak had discovered that the 
formyl products of these types of reactions could efficiently be epimerized on silica gel to 
supply the 2,6-cis-stereochemistry.  We therefore aimed to apply this type of approach to 
our targeted piperazine systems.  The synthesis of both the N-Me and N-Bn piperazine 
enynes 3.124 started from the corresponding 1,4-diprotected piperazine compounds 3.118 
(Scheme 3.31).  The allylation of both compounds relied on the carbamate directed α-
deprotonation using sec-butyllithium/TMEDA followed by transmetallation to the 
cuprate.  The cuprate of these compounds readily undergoes alkylation with allyl bromide 
to afford compounds 3.122a-b in 82% and 85% yields, respectively.  The subsequent 
formylations of 3.122a-b were also performed using sec-butyllithium/TMEDA, but 
without the need for an intermediate transmetallation.  The initial product mixture 
obtained in these reactions are a mixture of the cis- and trans-isomers (with trans being 
the major product), but equilibration of the resulting mixture cleanly yields the more 
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thermodynamically stable cis-products 3.123a-b in 78% and 81% yields.  Alkynylation 
using the Bestmann-Ohira reagent produces enynes 3.124a-b in 80% and 76% yiels, 
which provided the desired PKR substrates. 
Scheme 3.31 
 
With the piperazine enynes in hand, the use of the PKR for synthesizing the 
corresponding BAzB compounds could be investigated (Scheme 3.32).  Initial results, 
following methods previously established in the group, provided a 53% yield of the 
azabicycle 3.125a starting from methylated piperazine 3.124a.  It was found that the 
loading of cobalt onto this particular alkyne was considerable slower that what had been 
observed with comparable piperadine substrates.  Increasing the loading of the Co-
complex from 1.1 molar equivalents to 1.5 molar equivalents, as well as heating the 
reaction during this time to 40 °C (as opposed to rt), dramatically increased the efficiency 
of the cobalt-alkyne complexation and the yield of 3.125a increased to 85%.  Subjecting 
the benzylated piperazine compound 3.124a to the same conditions afforded 3.125b in 
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81% yield.  It is also important to note that the PKR products 3.125a-b were both 
obtained as a single diastereomer.  Based on the comparison of NMR data to previous 
examples (outlined in the Background section), we assigned the stereochemistry of these 




With the synthesis of the piperazino substrates, the Martin group methodology for 
the synthesis of bridged azabicyclic molecules using the Pauson-Khand reaction was 
completed.  It is noteworthy, that despite a lack of initial precedent, that the piperazine 
azabicycles 3.125a-b were ultimately accessible in only four synthetic operations in 










Chapter 4 – Experimental Procedures 
4.1 GENERAL METHODS 
Solvents and reagents were reagent grade and used without purification unless 
otherwise noted.  Zn granules were activated by stirring with 1M HCl for 10 min, 
filtering, rinsing with D.I. H2O, MeOH, then Et2O, and drying under vacuum before use.  
MgO was dried by heating under vacuum at 140 °C overnight before use.  
Dichloromethane (CH2Cl2) and triethylamine (Et3N) were distilled from calcium hydride 
and stored under nitrogen and methyl acetate was purified before each use by first drying 
over MgSO4 and then distilling from P2O5.  Tetrahydrofuran (THF) and diethyl ether 
(Et2O) were passed through a column of neutral alumina and stored under argon.  
Methanol (MeOH) and dimethylformamide (DMF) were passed through a column of 
molecular sieves and stored under argon.  Toluene was passed through a column of Q5 
reactant and stored under argon.  1H nuclear magnetic resonance (NMR) spectra were 
obtained at 500 or 400 MHz.  Chemical shifts are reported in parts per million (ppm, δ) 
and referenced to the solvent.  Coupling constants are reported in hertz (Hz).  Spectral 
splitting patterns are designated as: s, singlet; d, doublet; t, triplet; m, multiplet; comp, 
overlapping multiplets of magnetically non-equivalent protons; br, broad; and bs, broad 
singlet.  Infrared (IR) spectra were obtained using a Perkin-Elmer FTIR 1600 
spectrophotometer on sodium chloride plates and reported as wavenumbers (cm-1).  Low-
resolution chemical ionization mass spectra were obtained on a Finnigan TSQ-70 
instrument, and high-resolution measurements were obtained on a VG Analytical ZAB2-
E instrument.  Analytical thin layer chromatography was performed using Merck 250 
micron 60F-254 silica plates.  The plates were visualized with UV light, p-anisaldehyde, 
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and potassium permanganate.  Flash column chromatography was performed according 
to Still’s method using ICN Silitech 32-63 D 60A silica gel. 
4.2 EXPERIMENTALS 
 
(4R)-3-[(2E)-4-Methoxybut-2-enoyl]-4-phenyl-1,3-oxazolidin-2-one (2.117).  
Pivaloyl chloride (0.572 g, 4.74 mmol) was added dropwise to a solution of the acid 
2.115 (0.500 g, 4.31 mmol) in THF (15 mL) at -20 ºC.  After 1 h, 4-(R)-
phenyloxazolidinone (2.064 g, 12.6 mL) and LiCl (0.201 g, 4.74 mmol) were added in 
one portion, and the reaction was warmed to room temperature and stirred overnight.  
The reaction was diluted with H2O (5 mL) and extracted with EtOAc (2 x 10 mL).  The 
combined organic layers were then washed sat. aq. NaHCO3 (2 x 5 mL), brine (1 x 5 
mL), dried (Na2SO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash column chromatography eluting with Hex/EtOAc (1:1) to give 0.983 g 
(87%) of 2.117 as a white solid:  mp = 70-71 ºC; 1H NMR (CDCl3, 300 MHz) δ 7.49 
(ddd, J = 15.4, 2.0, 2.0 Hz, 1 H), 7.35 (comp, 5 H), 7.07 (ddd, J = 15.6, 4.4, 4.4 Hz, 1 H), 
5.51 (dd, J = 8.7, 4.1 Hz, 1 H), 4.73 (dd, J = 8.7, 8.7 Hz, 1 H), 4.30 (dd, J = 8.7, 3.8 Hz, 1 
H), 4.14 (dd, J = 4.6, 2.0 Hz, 2 H), 3.42 (s, 3 H); 
13
C NMR (CDCl3, 300 MHz) δ 164.4, 
153.8, 146.8, 139.3, 129.3, 128.8, 126.2, 120.4, 71.6, 70.2, 58.9, 57.9; MS (CI) m/z 261 
[C14H15NO4 (M) requires 261].   
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NMR Assignments.  
1
H NMR (CDCl3, 300 MHz) δ 7.49 (ddd, J = 15.4, 2.0, 2.0 
Hz, 1 H, C3-H), 7.35 (comp, 5 H, C10-H, C11-H, C12-H), 7.07 (ddd, J = 15.6, 4.4, 4.4 
Hz, 1 H, C2-H), 5.51 (dd, J = 8.7, 4.1 Hz, 1 H, C7-H), 4.73 (dd, J = 8.7, 8.7 Hz, 1 H, C8-
H), 4.30 (dd, J = 8.7, 3.8 Hz, 1 H, C7-H), 4.14 (dd, J = 4.6, 2.0 Hz, 2 H, C4-H), 3.42 (s, 3 
H, C5-H); 
13
C NMR (CDCl3, 300 MHz) δ 164.4 (C1), 153.8 (C6), 146.8 (C9), 139.3 
(C3), 129.3 (C11), 128.8 (C12), 126.2 (C10), 120.4 (C2), 71.6 (C4), 70.2 (C7), 58.9 (C5), 
57.9 (C8).  
 
(4R)-3-[(3S)-4-Methoxy-3-methylbutanoyl]-4-phenyl-1,3-oxazolidin-2-one 
(2.118).  A solution of methyllithium (0.91 M in hexanes, 15.7 mL, 14.2 mmol) was 
added dropwise to a slurry of (CuI)3(Me2S)4 (3.508 g, 14.8 mmol) in THF (63 mL) at -78 
ºC in the dark.  The mixture was stirred at -78 ºC for 20 min and iodotrimethylsilane (2 
mL, 14.2 mmol, freshly distilled in the dark over copper powder under argon) was added 
dropwise.  The resulting mixture was stirred in the dark for 10 min at -78 ºC, whereupon 
a solution of imide 2.117 (2.9769 g, 11.4 mmol) in THF (17 mL) was added dropwise.  
After 5 h, NEt3 (7.9 mL, 57.0 mmol) was added dropwise, and stirring was continued for 
an additional 1 h at -78 ºC.  The reaction was quenced conc. NH4OH (5 mL) and sat. aq. 
NH4Cl (5 mL) were added, and the reaction was warmed to room temperature.  The 
layers were separated and the aqueous layer was extracted with EtOAc (3 x 25 mL), then 
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the combined organic layers were washed with brine (25 mL), dried (MgSO4), filtered, 
and concentrated under reduced pressure.  The residue was purified by flash column 
chromatography eluting with hexanes/ethylacetate (4:1) to give 2.8723 g (91%) of 2.118 
as a pale yellow crystalline solid:  mp = 53-54 ºC; 1H NMR (CDCl3, 400 MHz) δ 7.30 
(comp, 4 H), 5.40 (dd, J = 8.5, 3.4 Hz, 1 H), 4.65 (dd, J = 12.0, 12.0 Hz, 1 H), 4.25 (dd, J 
= 8.9, 3.8 Hz, 1 H), 3.21 (s, 3 H), 3.08 (dd, J = 16.8, 5.8 Hz, 1 H), 2.72 (dd, J = 16.4, 7.9 
Hz, 1 H), 2.30 (m, 1 H), 0.88 (d, J = 6.5 Hz, 3 H); 13C NMR (CDCl3, 300 MHz) δ 172.2, 
153.9, 129.3, 128.9, 126.2, 77.5, 70.1, 58.9, 57.8, 39.7, 30.1, 17.1.   
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.30 (comp, 4 H, C11-H, 
C12-H, C13-H), 5.40 (dd, J = 8.5, 3.4 Hz, 1 H, C8-H), 4.65 (dd, J = 12.0, 12.0 Hz, 1 H), 
4.25 (dd, J = 8.9, 3.8 Hz, 1 H, C8-H), 3.21 (s, 3 H, C5-H), 3.08 (dd, J = 16.8, 5.8 Hz, 1 
H, C4-H), 2.72 (dd, J = 16.4, 7.9 Hz, 1 H, C4-H), 2.30 (m, 1 H, C3-H), 0.88 (d, J = 6.5 
Hz, 3 H, C6-H); 13C NMR (CDCl3, 300 MHz):  δ 172.2 (C1), 153.9 (C7), 129.3 (C12), 
128.9 (C13), 126.2 (C11), 77.5 (C4), 70.1 (C8), 58.9 (C5), 57.8 (C9), 39.7 (C2), 30.1 
(C3), 17.1 (C6). 
 
(4R)-3-[(2R)-2-[(2S)-1-Methoxypropan-2-yl]pent-4-enoyl]-4-phenyl-1,3-
oxazolidin-2-one (2.119).  A solution of n-BuLi (2.76 M in hexanes, 4.1 mL, 11 mmol) 
was added dropwise to a solution of hexamethyldisilazane (2.6 mL, 12 mmol) in THF (12 
mL) at     -78 ºC, and the reaction was stirred for 20 min at -78 ºC and then at 0 ºC for 20 
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min.  After returning to the -78 ºC bath, a solution of imide 2.118 (2.872 g, 10.4 mmol) in 
THF (21 mL) was added dropwise via syringe.  The reaction was stirred at -78 ºC for 1 h, 
then between -45 ºC and -35 ºC for 20 min before returning to -78 ºC and carrying out the 
dropwise addition of allyl iodide (2.8 mL, 31 mmol, freshly distilled in the dark over 
copper powder under argon).  The reaction was stirred at -78 ºC for 2 h, and then was 
transferred to a -45 ºC bath.  After maintaining the reaction temperature at -45 ºC for 30 
min, the reaction was allowed to gradually warm in a controlled manner to -10 ºC over a 
1 h period.  The reaction was stirred at -10 ºC for 3 h, then was quenched by the addition 
of saturated aqueous NH4Cl (15 mL).  EtOAc (30 mL) was added, the layers were 
separated.  The aqueous layer was extracted with EtOAc (3 x 25 mL), and the combined 
organic layers were washed with brine (15 mL), dried (MgSO4), filtered, and 
concentrated.  The residue was purified by flash column chromatography eluting with 
hexanes/EtOAc (4:1) to give 2.284 g (69%) of 2.119 as a colorless oil:  1H NMR (CDCl3, 
400 MHz) δ 7.30 (comp, 4 H), 5.56 (m, 1 H), 5.42 (dd, J = 8.9, 3.8 Hz, 1 H), 4.81 (dd, J 
= 16.4, 1.7 Hz, 1 H), 4.80 (d, J = 10.9 Hz), 4.63 (dd, J = 8.9, 8.9 Hz, 1 H), 4.23 (dd, J = 
8.9, 3.4 Hz, 1 H), 4.09 (ddd, J = 9.4, 6.5, 4.8 Hz, 1 H), 3.34 (dd, J = 4.8, 2.7 Hz, 2 H), 
3.29 (s, 3 H), 2.34 (ddd, J = 14.0, 14.0, 7.9 Hz, 1 H), 2.25 (ddd, J = 12.6, 12.6, 6.5 Hz, 1 
H), 2.06 (m, 1 H), 1.01 (d, J = 6.8 Hz, 3 H): 13C NMR (CDCl3, 300 MHz) δ 174.9, 
153.9, 139.5, 135.2, 129.2, 128.8, 126.3, 117.3, 75.9, 69.8, 59.1, 58.1, 44.7, 36.0, 34.4, 
15.2; LRMS (CI) m/z 318 [C18H23NO4 (M + 1) requires 318].   
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.30 (comp, 4 H, C14-H, 
C15-H, C16-H), 5.56 (m, 1 H, C8-H), 5.42 (dd, J = 8.9, 3.8 Hz, 1 H, C11-H), 4.81 (dd, J 
= 16.4, 1.7 Hz, 1 H, C9-H), 4.80 (d, J = 10.9 Hz, 1 H, C9-H), 4.63 (dd, J = 8.9, 8.9 Hz, 1 
H, C12-H), 4.23 (dd, J = 8.9, 3.4 Hz, 1 H, C11-H), 4.09 (ddd, J = 9.4, 6.5, 4.8 Hz, 1 H, 
C2-H), 3.34 (dd, J = 4.8, 2.7 Hz, 2 H, C4-H), 3.29 (s, 3 H, C5-H), 2.34 (ddd, J = 14.0, 
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14.0, 7.9 Hz, 1 H, C7-H), 2.25 (ddd, J = 12.6, 12.6, 6.5 Hz, 1 H, C7-H), 2.06 (m, 1 H, 
C3-H), 1.01 (d, J = 6.8 Hz, 3 H, C6-H); 13C NMR (CDCl3, 300 MHz) δ 174.9 (C1), 
153.9 (C10), 139.5 (C13), 135.2 (C8), 129.2 (C14), 128.8 (C16), 126.3 (C14), 117.3 
(C9), 75.9 (C4), 69.8 (C11), 59.1 (C5), 58.1 (C12), 44.7 (C2), 36.0 (C3), 34.4 (C7), 15.2 
(C6). 
 
(2R)-2-[(2S)-1-Methoxypropan-2-yl]pent-4-en-1-ol (2.120).  A solution of the 
imide 2.119 (2.889 g, 9.11 mmol) in THF (91 mL) and H2O (30 mL) was cooled to 0 ºC 
and treated successively with H2O2 (30% in H2O, 8.3 mL, 72.9 mmol) and a solution of 
LiOH•H2O (0.764 g, 18.2 mmol).  Once the addition was completed, the cooling bath 
was removed, and the reaction was stirred at room temperature for 9 h.  At this point, the 
reaction was cooled to 0 ºC, 1.5 M aq. Na2S2O3 (100 mL) was added, and the mixture 
was stirred for 1 h.  The THF was removed under reduced pressure and 15% aq. NaOH 
was added to adjust the pH to 12-13, whereupon the mixture was extracted with CH2Cl2 
(3 x 100 mL).  The combined organic layers were washed with brine (100 mL), dried 
(MgSO4), filtered, and concentrated under reduced pressure to recover 1.226 g (82%) of 
the chiral auxilliary 2.173 as a white solid.  The aqueous layer was then acidified to pH 1 
with 6 M HCl, and then extracted with EtOAc (3 x 150 mL).  The combined organic 
layers were washed with brine (150 mL), dried (MgSO4), filtered, and concentrated under 
reduced pressure.   The crude carboxylic acid was dissolved in THF (8 mL) and added 
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dropwise to a slurry of LiAlH4 (0.519 g, 13.67 mmol) in THF (25 mL) at 0 ºC.  The 
reaction mixture was allowed to warm to room temperature and stirred for 14 h.  The 
reaction was quenched by the sequential careful addition of H2O (14 mL), 15% aq. 
NaOH (14 mL), and H2O (30 mL) and the mixture extracted with EtOAc (4 x 40 mL).  
The combined organic layers were washed with brine (1 x 40 mL), dried (MgSO4), 
filtered, and concentrated under reduced pressure.  The crude residue was purified by 
column chromatography eluting with Hex:EtOAc (3:2) to provide 1.311 g (91%) of 
alcohol 2.120 as a colorless oil:  1H NMR (CDCl3, 300 MHz) δ 5.77 (app ddt, J = 17.2, 
10.0, 6.9, 6.9 Hz, 1 H), 5.04 (dt, J = 15.6, 2.1 Hz, 1 H), 4.98 (dt, J = 10.0, 2.0 Hz, 1 H), 
3.50 (app ddt, J = 30.5, 11.5, 11.5, 6.9 Hz, 2 H), 3.33 (s, 3 H), 3.30 (dddd, J = 19.5, 9.5, 
9.5, 6.7 Hz, 2 H), 3.08 (br, 1 H), 2.14 – 1.90 (comp, 3 H), 1.74 – 1.64 (m, 1 H), 0.89 (d, J 
= 7.2 Hz, 3 H); 13C NMR (CDCl3, 300 MHz)
 
δ 137.7, 116.4, 76.7, 63.4, 59.1, 44.4, 35.6, 
33.2, 13.6.  
NMR Assignments.  1H NMR (CDCl3, 300 MHz) δ 5.77 (app ddt, J = 17.2, 10.0, 
6.9, 6.9 Hz, 1 H, C8-H), 5.04 (dt, J = 15.6, 2.1 Hz, 1 H, C9-H), 4.98 (dt, J = 10.0, 2.0 Hz, 
1H, C9-H), 3.50 (app ddt, J = 30.5, 11.5, 11.5, 6.9 Hz, 2 H, C4-H), 3.33 (s, 3 H, C5-H), 
3.30 (dddd, J = 19.5, 9.5, 9.5, 6.7 Hz, 2 H, C1-H), 3.08 (br, 1 H, OH), 2.14 – 1.90 (comp, 
3 H, C7-H, C2-H), 1.74 – 1.64 (m, 1 H, C3-H), 0.89 (d, J = 7.2 Hz, 3 H, C6-H); 13C 
NMR (CDCl3, 300 MHz)
 
δ 137.7 (C8), 116.4 (C9), 76.7 (C4), 63.4 (C1), 59.1 (C5), 44.4 






(2R)-2-[(2S)-1-Methoxypropan-2-yl]pent-4-enal (2.121).  A solution of alcohol 
2.120 (1.00 g, 6.32 mmol), PCC (2.04 g, 9.48 mmol) and SiO2 (3 g) in CH2Cl2 (21 mL) 
was stirred at room temperature for 20 min.  The reaction was filtered through a 2 inch 
pad of SiO2 rinsing with CH2Cl2 (200 mL), and the filtrate and washings were 
concentrated under reduce pressure to provide 0.987 g (99%) of aldehyde 2.121 as a 
colorless oil:  1H NMR (CDCl3, 300 MHz) δ 9.64 (d, J = 2.0 Hz, 1 H), 5.73 (appt ddt, J = 
13.6, 6.9, 3.3 Hz, 1 H), 5.05 (dd, J = 18.4, 1.5 Hz, 1 H), 4.98 (dt, J = 11.5, 1.3 Hz, 1 H), 
3.28 (m, 2 H), 3.27 (s, 3 H), 2.42 (m, 1 H), 2.22 (m, 1 H), 0.94 (d, 3 H, J = 7.2 Hz); 13C 
NMR (CDCl3, 300 MHz) δ 204.9, 136.1, 116.9, 75.5, 58.9, 53.5, 34.5, 30.1, 14.3.   
NMR Assignments.  1H NMR (CDCl3, 300 MHz) δ 9.64 (d, J = 2.0 Hz, 1 H, C1-
H), 5.73 (appt ddt, J = 13.6, 6.9, 3.3 Hz, 1 H, C8-H), 5.05 (dd, J = 18.4, 1.5 Hz, 1 H, C9-
H), 4.98 (dt, J = 11.5, 1.3 Hz, 1 H, C9-H), 3.28 (m, 2 H, C4-H), 3.27 (s, 3 H, C5-H), 2.42 
(m, 1 H, C7-H), 2.22 (m, 1 H, C7-H), 0.94 (d, 3 H, J = 7.2 Hz, C6-H); 13C NMR (CDCl3, 
300 MHz) δ 204.9 (C1), 136.1 (C8), 116.9 (C9), 75.5 (C4), 58.9 (C5), 53.5 (C2), 34.5 





methylbenzene-1-sulfinamide (2.123).  To a solution of aldehyde 2.121 (0.158 g, 1.02 
mmol) in THF (10 mL) were added (R)-p-toluenesulfinamide (0.204 g, 1.33 mmol) and 
Ti(OEt)4 (0.53 mL, 2.5 mmol).  The reaction was stirred at room temperature for 22 h, 
whereupon CH2Cl2 (60 mL) and H2O (20 mL) were added, resulting in the formation of 
a white precipitate.  The reaction mixture was filtered through a pad of Celite, and 
washed with CH2Cl2 (50 mL).  The layers were separated, and the organic layer was 
dried (MgSO4), filtered, and concentrated.  The residue was purified by flash column 
chromatography in hexanes/EtOAc (7:1) to give 0.221 g (74%) of 2.123:  1H NMR 
(CDCl3, 400 MHz) δ 8.16 (d, J = 6.5 Hz, 1 H), 7..53 (d, J = 8.2 Hz, 2 H), 7.28 (d, J = 8.5 
Hz, 2 H), 5.63 (appt ddt, J = 17.1, 10.3, 6.8 Hz, 1 H), 4.99 (dd, J = 17.1, 1.7 Hz, 1 H), 
4.92 (dd, J = 11.6, 1.7 Hz, 1 H), 3.32 (dd, J = 12.0, 5.8 Hz, 1 H), 3.30 (s, 3 H), 3.25 (dd, J 
= 9.6, 5.8 Hz, 1 H), 2.77 (m, 1 H), 2.39 (s, 3 H), 2.39 (m, 1 H), 2.28 (m, 1 H), 2.08 (m, 1 
H), 0.88 (d, J = 7.2 Hz, 3 H); 13C NMR (CDCl3, 400 MHz) δ 168.9, 142.2, 141.8, 135.7, 
129.9, 124.8, 117.1, 75.9, 58.9, 46.4, 35.9, 33.7, 21.6, 13.5; MS (CI) m/z 294 
[C16H23NO2S (M + 1) requires 294].   
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 8.16 (d, J = 6.5 Hz, 1 H, C1-
H), 7..53 (d, J = 8.2 Hz, 2 H, C11-H), 7.28 (d, J = 8.5 Hz, 2 H, C12-H), 5.63 (appt ddt, J 
= 17.1, 10.3, 6.8 Hz, 1 H, C8-H), 4.99 (dd, J = 17.1, 1.7 Hz, 1 H, C9-H), 4.92 (dd, J = 
11.6, 1.7 Hz, 1 H, C9-H), 3.32 (dd, J = 12.0, 5.8 Hz, 1 H, C4-H), 3.30 (s, 3 H, C5-H), 
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3.25 (dd, J = 9.6, 5.8 Hz, 1 H, C4-H), 2.77 (m, 1 H, C2-H), 2.39 (s, 3 H, C14-H), 2.39 
(m, 1 H, C3-H), 2.28 (m, 1 H, C7-H), 2.08 (m, 1 H, C7-H), 0.88 (d, J = 7.2 Hz, 3 H, C6-
H); 13C NMR (CDCl3, 400 MHz) δ 168.9 (C1), 142.2 (C13), 141.8 (C8), 135.7 (C10), 
129.9 (C11), 124.8 (C12), 117.1 (C9), 75.9 (C4), 58.9 (C5), 46.4 (C3), 35.9 (C7), 33.7 
(C2), 21.6 (C14), 13.5 (C6).  
 
Methyl (5S,6R)-6-[(2S)-1-methoxypropan-2-yl]-5-{[(R)-(4-
methylbenzene)sulfinyl]amino}-3-oxonon-8-enoate (2.125):  A solution of methyl 
acetate (0.219 g, 2.95 mmol) in THF (2.5 mL) was added dropwise to a solution of 
NaHMDS (1.90 M in THF, 1.55 mL, 2.95 mmol) in THF (0.5 mL) at -78 ºC.  The 
reaction was stirred at -78 ºC for 45 min, and then Et2O (1 mL) followed by a solution of 
sulfinimide 2.123 (0.054 g, 0.17 mmol) in THF (0.5 mL) was added via syringe.  The 
reaction was stirred at -78 ºC for 3 h until the starting material was consumed by TLC 
(SiO2, 3:2 Hex:EtOAc) and the reaction was warmed to -20 ºC overnight.  The reaction 
was quenched with sat. aq. NH4Cl (5 mL) and H2O (1 mL), and then extracted with 
EtOAc (3 x 10 mL).  The combined organic layers were washed with brine (1 x 5 mL), 
dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue was 
purified by flash column chromatography eluting in Hex:EtOAc (1:1) to provide 0.220 g 
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(91%) of 2.125 as a mixture (8:1) of diastereomers:  1H NMR (CDCl3, 400 MHz) δ 7.53 
(d, J = 8.2 Hz, 2 H), 7.29 (d, J = 7.9 Hz, 2 H), 5.77 (app ddt, J = 17.1, 9.9, 6.8, 6.8 Hz, 1 
H), 5.05 (dd, J = 17.1, 1.7 Hz, 1 H), 4.97 (dd, J = 10.2, 1.7 Hz, 1 H), 4.95 (d, J = 8.5 Hz, 
1 H), 3.85 (m, 1 H), 3.73 (s, 3 H), 3.50 (s, 2 H), 3.16 (d, J = 5.8 Hz, 2 H), 3.14 (s, 3 H), 
3.09 (dd, J = 17.4, 5.1 Hz, 1 H), 2.94 (dd, J = 17.1, 5.5 Hz, 1 H), 2.40 (s, 3 H), 2.20 – 
2.02 (comp, 2 H), 1.90 – 1.82 (m, 1 H), 1.78 – 1.70 (m, 1 H), 0.80 (d, J = 7.2 Hz, 3 H); 
LRMS (CI) m/z 410 [C21H31NO5S (M + 1) requires 410].   
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.53 (d, J = 8.2 Hz, 2 H, 
C15-H), 7.29 (d, J = 7.9 Hz, 2 H, C16-H), 5.77 (app ddt, J = 17.1, 9.9, 6.8, 6.8 Hz, 1 H, 
C8-H), 5.05 (dd, J = 17.1, 1.7 Hz, 1 H, C9-H), 4.97 (dd, J = 10.2, 1.7 Hz, 1 H, C9-H), 
4.95 (d, J = 8.5 Hz, 1 H, NH), 3.85 (m, 1 H, C5-H), 3.73 (s, 3 H, C19-H), 3.50 (s, 2 H, 
C2-H), 3.16 (d, J = 5.8 Hz, 2 H, C11-H), 3.14 (s, 3 H, C12-H), 3.09 (dd, J = 17.4, 5.1 Hz, 
1 H, C4-H), 2.94 (dd, J = 17.1, 5.5 Hz, 1 H, C4-H), 2.40 (s, 3 H, C18-H), 2.20 – 2.02 
(comp, 2 H, C7-H), 1.90 – 1.82 (m, 1 H, C10-H), 1.78 – 1.70 (m, 1 H, C6-H), 0.80 (d, J = 
7.2 Hz, 3 H, C13-H). 
 
Methyl (5S,6R)-5-{[(tert-butoxy)carbonyl]amino}-6-[(2S)-1-methoxypropan-
2-yl]-3-oxonon-8-enoate (2.126).  A solution of the sulfinimide 2.125 (0.150 g, 0.366 
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mmol) in MeOH (3.7 mL) was cooled to 0 ºC, and TFA (0.14 mL, 1.83 mmol) was 
added.  After stirring at 0 ºC for 5 min, the cooling bath was removed, the reaction was 
stirred at room temperature for 2 h, and it was concentrated under reduced pressure.  The 
residue was dissolved in THF (3.7 mL), and DMAP (0.004 g, 0.04 mmol), NEt3 (0.15 
mL, 1.10 mmol), and Boc2O (0.11 mL, 0.475 mmol) were added.  The reaction mixture 
was stirred at room temperature for 4 h, and sat. aq. NH4Cl (1 mL) and the mixture was 
extracted with EtOAc (3 x 10 mL).  The combined organic layers were washed with brine 
(5 mL), dried (MgSO4), filtered, and concentrated under reduced pressure.  The residue 
was purified via flash column chromatography eluting with Hex:EtOAc (4:1) to give 
0.069 g (51%) of 2.126 as a colorless oil:  1HNMR (CDCl3, 400 MHz, rotamers) δ 6.28 
(br d, J = 8.4 Hz, 1 H), 5.84-5.73 (m, 1 H), 5.10-5.02 (comp, 2 H), 4.46 (bs, 1 H), 4.13-
4.04 (m, 1 H), 3.71 (s, 3 H), 3.60-3.48 (m, 1 H), 3.35 (s, 2 H), 3.31-3.29 (m, 1 H), 3.26-
3.16 (comp, 2 H), 2.81-2.67 (m, 1 H), 2.14-1.96 (comp, 2 H), 1.77-1.71 (m, 1 H), 1.46 (s, 
3 H), 1.42 (s, 3 H), 0.92 (d, J = 7.2 Hz, 3 H); LRMS (CI) m/z 372 [C19H34NO6 (M+1) 
requires 372].   
NMR Assignments:  1HNMR (CDCl3, 400 MHz, rotamers) δ 6.28 (br d, J = 8.4 
Hz, 1H), 5.84-5.73 (m, 1 H), 5.10-5.02 (comp, 2 H), 4.46 (bs, 1 H), 4.13-4.04 (m, 1 H), 
3.71 (s, 3 H), 3.60-3.48 (m, 1 H), 3.35 (s, 2 H), 3.31-3.29 (m, 1 H), 3.26-3.16 (comp, 2 
H), 2.81-2.67 (m, 1 H), 2.14-1.96 (comp, 2 H), 1.77-1.71 (m, 1 H), 1.46 (s, 3 H), 1.42 (s, 




methoxypropan-2-yl]-3-oxonon-8-enoate (2.167).  A solution of the 2.126 (0.326 g, 
0.878 mmol) and p-acetamidobenzenesulfonyl azide (0.316 g, 1.32 mmol) in CH3CN (2 
mL) was cooled to 0 ºC, whereupon NEt3 (0.267 g, 2.63 mmol) was added.  The reaction 
was stirred at 0 ºC for 4 h and the reaction mixture was triturated with Et2O (5 mL) and 
filtered, and the filtrant washed with Et2O (5 mL).  The filtrate and washings were 
concentrated and the crude residue was purified by column chromatography eluting with 
Hex/EtOAc (3:1) to give 0.328 g (94%) of 2.167 as a colorless oil:  1HNMR (CDCl3, 400 
MHz, rotamers) δ 6.11 (br d, J = 9.2 Hz, 1 H), 5.86-5.74 (m, 1 H), 5.10-5.00 (comp, 2 H),  
4.18-4.09 (m, 1 H), 3.84 (s, minor rotomer, 0.9 H), 3.83 (s, major rotomer, 2.1 H), 3.37-
3.24 (comp, 4 H), 3.20-3.16 (m, 1 H), 3.10-3.05 (m, 1 H), 2.92-2.87 (m, 1 H), 2.12-2.02 
(m, 1 H), 1.82-1.78 (m, 1 H), 1.40 (s, 3 H), 0.94 (d, J = 7.2 Hz, 3 H); LRMS (CI) m/z 398 
[C19H32N3O6 (M+1) requires 398].   
NMR Assignments.  1HNMR (CDCl3, 400 MHz, rotamers) δ 6.11 (br d, J = 9.2 
Hz, 1 H), 5.86-5.74 (m, 1 H), 5.10-5.00 (comp, 2 H),  4.18-4.09 (m, 1 H), 3.84 (s, minor 
rotomer, 0.9 H), 3.83 (s, major rotomer, 2.1 H), 3.37-3.24 (comp, 4 H), 3.20-3.16 (m, 1 
H), 3.10-3.05 (m, 1 H), 2.92-2.87 (m, 1 H), 2.12-2.02 (m, 1 H), 1.82-1.78 (m, 1 H), 1.40 




hexahydropyrrolo[1,2-c][1,3]oxazole-7a-carboxylate (2.169).  A solution of the 
diazoester 2.167 (0.269 g, 0.677 mmol) in CH2Cl2 (14 mL) was stirred with Rh2(OAc)4 
(0.015 g, 0.034 mmol) at room temperature overnight.  The reaction was concentrated the 
crude residue purifed by column chromatography eluting with Hex/EtOAc (4:1) to give 
0.217 g (87%) of 2.168 as a mixture (1:1) of diastereomers, which was taken on crude.  
TFA (1.85 g, 16.26 mmol) was then added to a solution of the pyrrolidinone 2.168 (0.217 
g, 0.588 mmol) and dimethoxymethane (1.12 g, 14.69 mmol) in CH2Cl2 (12 mL), and the 
reaction was stirred for 7 h at room temperature.  The solvent was removed under 
reduced pressure, and the residue was purified by flash column chromatography eluting 
with Hex/EtOAc (2:1) to give 0.124 g (67%) of 2.169 as a mixture (1:1) of diastereomers 
as a colorless oil: 1H NMR (CDCl3, 400 MHz) δ 5.85 – 5.74 (m, 1 H), 5.10 – 4.99 (comp, 
2 H), 4.72 (d, J = 7.2 Hz, 1 H), 4.21 (d, J = 7.2 Hz, 1 H), 4.13 (d, J = 9.2 Hz, 1 H), 4.05 
(d, J = 8.9 Hz, 1 H), 3.77 (s, 3 H), 3.32 (s, 3 H), 3.38 – 3.22 (comp, 2 H), 2.66 (dd, J = 
18.1, 9.9 Hz, 1 H), 2.60 – 2.56 (m, 1 H), 2.39 (dd, J =17.8, 6.8 Hz, 1 H), 2.26 – 2.10 (m, 
1 H), 2.06 – 1.94 (comp, 2 H, C7-H), 1.75 (dq, J = 6.8, 3.8 Hz, 1 H), 0.78 (d, J = 6.8 Hz, 
3 H); 13C NMR (CDCl3, 300 MHz) δ 209.2, 169.9, 138.2, 116.3, 87.3, 78.3, 76.1, 70.4, 
59.0, 53.4, 46.3, 42.3, 40.8, 33.3, 30.8, 13.6; LRMS (CI) m/z 312 [C16H25NO5 (M + 1) 
requires 312.17].   
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NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.85 – 5.74 (m, 1 H, C8-H), 
5.10 – 4.99 (comp, 2 H, C9-H), 4.72 (d, J = 7.2 Hz, 1 H, C14-H), 4.21 (d, J = 7.2 Hz, 1 H, 
C14-H), 4.13 (d, J = 9.2 Hz, 1 H, C15-H), 4.05 (d, J = 8.9 Hz, 1 H, C15-H), 3.77 (s, 3 H, 
C16-H), 3.32 (s, 3 H, C12-H), 3.38-3.22 (comp, 2 H, C11-H), 2.66 (dd, J = 18.1, 9.9 Hz, 
1 H, C4-H), 2.60 – 2.56 (m, 1 H, C5-H), 2.39 (dd, J =17.8, 6.8 Hz, 1 H, C4-H), 2.26 – 
2.10 (m, 1 H, C7-H), 2.06 – 1.94 (comp, 2 H, C7-H, C10-H), 1.75 (dq, J = 6.8, 3.8 Hz, 1 
H, C6-H), 0.78 (d, J = 6.8 Hz, 3 H, C13-H); 13C NMR (CDCl3, 300 MHz) δ 209.2 (C3), 
169.9 (C1), 138.2 (C8), 116.3 (C9), 87.3 (C2), 78.3 (C14), 76.1(C11), 70.4 (C15), 59.0 
(C16), 53.4 (C12), 46.3 (C4), 42.3 (C6), 40.8 (C5), 33.3 (C10), 30.8 (C7), 13.6 (C13). 
 
Methyl 2-[(2S)-1-methoxypropan-2-yl]-9-oxo-7-azatricyclo[5.3.0.04,8]decane-
8-carboxylate (2.171).  A solution of the oxazolidine 2.169 (0.010 g, 0.032 mmol) in 
toluene (2.5 mL) was stirred at 160 ºC in a sealed tube for 3 h.  After cooling to room 
temperature, the solvent was removed under reduced pressure, and the 
1
H NMR of the 
crude mixture showed a 1:1 mixture of regioisomers 2.171 and 2.172, which could be 
separated upon purification by flash column chromatography eluting with ethyl acetate to 
give 0.004 g (50%) 2.171 and 0.004 g (50%) 2.172:  1H NMR (C6D6, 400 MHz) δ 3.36 
(s, 3 H, C15-H), 3.32 (m, 1 H, C5-H), 3.00 (s, 3 H, C13-H), 2.96 (comp, 2 H, C10-H, C8-
H), 2.79 (d, J = 1.6 Hz, 1 H, C12-H), 2.79 (s, 1 H), 2.75 (ddd, 1 H, J = 13.5, 8.7, 5.6 Hz, 
1 H, C10-H), 2.46 (dd, J = 17.6, 7.2 Hz, 1 H, C4-H), 1.95 (d, J = 17.6 Hz, 1 H, C4-H), 
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1.83 (ddd, J = 17.2, 11.3, 5.9 Hz, 1 H, C9-H), 1.55 (ddd, J = 15.5, 9.5, 3.9 Hz, 1 H,, 1.33 
(ddd, J = 15.8, 9.9, 4.1 Hz, 1 H), 1.21 (ddd, J = 5.5, 3.6, 1.6 Hz, 1 H), 1.12 (m, 1 H), 0.80 
(m, 1 H, C11-H), 0.67 (d, J = 6.8 Hz, 3 H, C14-H). 
 
Methyl (7S)-3-[(2S)-1-methoxypropan-2-yl]-6-oxo-8-
azatricyclo[5.2.1.04,8]decane-7-carboxylate (2.172):  1H NMR (C6D6, 400 MHz) δ 
3.75 (s, 3 H), 3.54 (dd, J = 8.9, 6.2 Hz, 1 H), 3.29 (s, 3 H), 3.25 – 3.17 (comp, 2 H), 2.88 
(dd, J = 15.7, 5.8 Hz, 1 H), 2.84 – 2.80 (comp, 2 H), 2.70 (dd, J = 14.0, 6.5 Hz, 1 H), 2.45 
– 2.40 (m, 1 H), 2.31 (d, J = 15.7 Hz, 1 H), 1.80 (d, J = 14.3, 1 H), 1.71 – 1.62 (comp, 2 
H, C11-H), 1.52 (dd, J = 13.7, 2.4 Hz, 1 H), 1.32 – 1.24 (m, 1 H), 0.90 (d, J = 6.8 Hz, 
3H); 13C NMR (300 MHz) δ 210.9, 171.0, 78.7, 75.6, 59.0, 57.3, 57.2, 53.6, 49.9, 37.5, 
37.3, 36.7, 34.0, 33.4, 15.2; MS (CI) m/z 282 [C15H23NO4 (M + 1) requires 282.16].   
NMR Assignments.  1H NMR (400 MHz) δ 3.75 (s, 3 H, C15-H), 3.54 (dd, J = 
8.9, 6.2 Hz, 1 H, C5-H), 3.29 (s, 3 H, C13-H), 3.25 – 3.17 (comp, 2 H, C12-H), 2.88 (dd, 
J = 15.7, 5.8 Hz, 1 H, C4-H), 2.84 – 2.80 (comp, 2 H, C9-H), 2.70 (dd, J = 14.0, 6.5 Hz, 1 
H, C10-H), 2.45 – 2.40 (m, 1 H, C8-H), 2.31 (d, J = 15.7 Hz, 1 H, C4 H), 1.80 (d, J = 
14.3, 1 H, C10-H), 1.71 – 1.62 (comp, 2 H, C11-H, C7-H), 1.52 (dd, J = 13.7, 2.4 Hz, 1 
H, C7-H), 1.32 – 1.24 (m, 1 H, C6-H), 0.90 (d, J = 6.8 Hz, 3H, C14-H); 13C NMR (300 
MHz) δ 210.9 (C3), 171.0 (C1), 78.7 (C2), 75.6 (C12), 59.0 (C9), 57.3 (C13), 57.2 (C15), 




(2.177).  Triethylamine (1.9 mL, 13 mmol) and trimethylacetylchloride (1.6 mL, 12 
mmol) were added sequentially dropwise with stirring to a solution of the acid 2.176 
(1.47 g, 12.64 mmol) in THF (84 mL) at -78 ºC.  The reaction was stirred at -78 ºC for 1 
h, then at 0 ºC for 1 h before being returned to -78 ºC.  In a separate flask, n-BuLi (2.48 
M in hexanes, 5.11 mL, 12.6 mmol) was added dropwise to a solution of (R)-4-
phenyloxazolidinone (2.064 g, 12.6 mL) in THF (70 mL).  After stirring for 20 min at -78 
ºC, this mixture was transferred via cannula to the solution of mixed anhydride reaction at 
-78 ºC, and the flask which had contained deprotonated oxazolidinone was rinsed with 10 
mL of THF.  The reaction was stirred at -78 ºC for 1 h, and then was allowed to slowly 
warm to RT and stir overnight.  After 11 h the reaction was quenched by the addition of 
H2O2 (240 mL) and the layers were separated.  Following extraction of the aqueous layer 
with EtOAc (3 x 100 mL), the combined organic layers were washed with brine, dried 
(Na2SO4), filtered, and concentrated under reduced pressure.  The residue was purified 
by flash column chromatography eluting with hexanes/ethyl acetate (1:1) to give 3.248 g 
(98%) of 2.177 as a white solid:  mp = 92-94 ºC; 1H NMR (CDCl3, 300 MHz) 8.17 (d, J 
= 15.2 Hz, 1 H), 7.43-7.31 (comp, 5 H), 6.87 (d, J = 15.2 Hz, 1 H), 5.50 (dd, J = 4.0, 10.4 
Hz, 1 H), 4.76 (t, J = 8.8 Hz, 1 H), 4.35 (dd, J = 4.8, 8.0 Hz, 1 H), 3.81 (s, 3 H); 13C 
NMR (CDCl3, 100 MHz) δ 165.1, 163.1, 153.2, 138.2, 138.2, 133.8, 132.2, 129.1, 128.8, 
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125.9, 70.2, 57.7, 52.2; IR (neat) 2934, 2859, 1781, 1728, 1690, 1387, 1342, 1307, 1196, 
1172 cm-1; HRMS (CI) m/z 276.0869 [C14H14NO5 (M+1) requires 276.0872].   
NMR Assignments.  1H NMR (CDCl3, 300 MHz) 8.17 (d, J = 15.2 Hz, 1 H, C2-
H), 7.43-7.31 (comp, 5 H, C10-H, C11-H, C12-H), 6.87 (d, J = 15.2 Hz, 1 H, C3-H), 5.50 
(dd, J = 4.0, 10.4 Hz, 1 H, C7-H), 4.76 (t, J = 8.8 Hz, 1 H, C8-H), 4.35 (dd, J = 4.8, 8.0 
Hz, 1 H, C7-H), 3.81 (s, 3 H, C5-H); 13C NMR (CDCl3, 100 MHz) δ 165.1 (C4), 163.1 
(C1), 153.2 (C6), 138.2 (C9), 133.8 (C2), 132.2 (C3), 129.1 (C11), 128.8 (C12), 125.9 
(C10), 70.2 (C7), 57.7 (C5), 52.2 (C8).  
 
Methyl (2S)-2-methyl-4-oxo-4-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-
yl]butanoate (2.178).  A solution of methyllithium (0.91 M in hexanes, 15.7 mL, 14.2 
mmol) was added dropwise to a slurry of (CuI)3(Me2S)4 (3.508 g, 14.8 mmol) in THF 
(63 mL) at -78 ºC in the dark.  The mixture was stirred at -78 ºC for 20 min and 
iodotrimethylsilane (2 mL, 14.2 mmol, freshly distilled in the dark over copper powder 
under argon) was added dropwise.  The resulting mixture was stirred in the dark for 10 
min at -78 ºC, whereupon a solution of imide 2.177 (2.9769 g, 11.4 mmol) in THF (16.8 
mL) was added dropwise.  Stirring was continued at -78 ºC for 5 h, whereupon 
triethylamine (7.9 mL, 57.0 mmol) was added dropwise.  After stirring for an additional 1 
h at -78 ºC, saturated NH4OH (5 mL) and saturated NH4Cl (aq.) (5 mL) were added, and 
the reaction was removed from the cooling bath and allowed to warm to room 
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temperature and stirred for 20 min, forming a blue reaction mixture.  The layers were 
separated and the aqueous layer was extracted with EtOAc (3 x 25 mL), then the 
combined organic layers were washed with brine (25 mL), dried (MgSO4), filtered, and 
concentrated under reduced pressure.  The residue was purified by flash column 
chromatography eluting with Hex/EtOAc (4:1) to give 2.87 g (91%) of 2.178 as a white 
solid:  mp = 53–54 ºC; 1H NMR (CDCl3, 400 MHz) δ 7.40-7.26 (comp, 5 H), 5.43 (dd, J 
= 4.4, 8.0 Hz, 1 H), 4.72-4.68 (comp, 2 H), 4.24 (dd, J = 4.0, 8.8 Hz, 1 H), 3.54 (s, 3 H), 
3.48-3.41 (m, 1 H), 3.24-3.15 (m, 1 H), 3.03-2.90 (comp, 2 H), 1.45 (t, J = 7.2 Hz, 1 H), 
1.21 (d, J = 6.8 Hz, 3 H); 13C NMR (CDCl3, 100 MHz) δ 175.3, 170.8, 153.6, 138.6, 
128.9, 128.4, 125.5, 70.0, 57.3, 51.6, 46.2, 38.9, 34.9, 16.8, 8.5; LRMS (CI) m/z 292 
[C15H18O5 (M+1) requires 292]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.40-7.26 (comp, 5 H), 5.43 
(dd, J = 4.4, 8.0 Hz, 1 H), 4.72-4.68 (comp, 2 H), 4.24 (dd, J = 4.0, 8.8 Hz, 1 H), 3.54 (s, 
3 H), 3.48-3.41 (m, 1 H), 3.24-3.15 (m, 1 H), 3.03-2.90 (comp, 2 H), 1.45 (t, J = 7.2 Hz, 
1 H), 1.21 (d, J = 6.8 Hz, 3 H); 13C NMR (CDCl3, 100 MHz) δ 175.3, 170.8, 153.6, 
138.6, 128.9, 128.4, 125.5, 70.0, 57.3, 51.6, 46.2, 38.9, 34.9, 16.8, 8.5. 
 
Methyl (2E,5S,6S)-5,6-bis(acetyloxy)-7-iodohept-2-enoate (2.212). A solution 
of 2-deoxy-D-ribose (25.0 g, 186.4 mmol) and methyl (triphenylphosphoranylidene) 
acetate (74.8 g, 223.6 mmol) in THF (750 mL) was heated under reflux for 6 h and then 
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cooled to room temperature.  Imidazole (25.4 g, 372.7 mmol), PPh3 (53.8 g, 205 mmol), 
and I2 (54.4 g, 214.3 mmol) were then added sequentially to the reaction, and the mixture 
was stirred overnight in the dark at room temperature.  The reaction was quenched with 
10% aq. Na2S2O3 (500 mL) and diluted with EtOAc (250 mL).  The resulting layers were 
separated and the aq. layer extracted with CH2Cl2 (2 x 150 mL).  The combined organic 
layers were dried (MgSO4), filtered, and concentrated.  The crude residue was dissolved 
in CH2Cl2 (375 mL), and then acetic anhydride (57.1 g, 559.1 mmol, 52.9 mL), DMAP 
(2.28 g, 18.7 mmol), and pyridine (44.2 g, 559.1 mmol, 45.2 mL) were added and the 
reaction was stirred at room temperature for 3 h.  The reaction was then poured into a 
separatory funnel, and washed with 1 M aq. HCl (2 x 35 mL), saturated aqueous 
NaHCO3 (1 x 35 mL), dried (MgSO4), filtered and concentrated under reduced pressure.  
Trituration of the residue with Hex:Et2O (100 mL, 8:1) precipitated out the Ph3P=O 
byproduct formed during the olefination step.  The precipitate was removed by filtration, 
and rinsed with Hex:Et2O (150 mL, 8:1).  The filtrate was then concentrated, redissolved 
in Et2O (100 mL), and vacuum filtered through a 2.5 inch pad of SiO2 using a 3 inch 
diameter fritted funnel.  Once the initial filtrate had adsorbed onto the silica, the silica 
pad was rinsed with Et2O (3 x 100 mL).  The combined filtrate and washings were 
concentrated to give 62.3 g (87%) of 2.212 as a light yellow oil:  1H NMR (CDCl3, 400 
MHz) δ 6.89-6.81 (m, 1H), 5.88 (dt, J = 15.6, 1.2 Hz, 1H), 5.18-5.14 (m, 1H), 5.00-4.96 
(m, 1H), 3.73 (s, 3H), 3.38-3.23 (m, 2H), 2.61-2.47 (m, 2H), 2.12 (s, 3H), 2.07 (s, 3H); 
13C NMR (CDCl3, 100 MHz) δ 169.50, 169.45, 165.9, 142.4, 123.9, 72.1, 71.5, 51.4, 
32.4, 20.6, 2.1; IR (neat) 2952, 1747, 1660, 1436, 1372, 1223, 1040 cm-1; HRMS (ESI) 
m/z 406.9962 [C12H17INaO6 (M+Na) requires 406.9962]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.89-6.81 (m, 1H, C5-H), 
5.88 (dt, J = 15.6, 1.2 Hz, 1H, C6-H), 5.18-5.14 (m, 1H, C2-H), 5.00-4.96 (m, 1H, C3-
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H), 3.73 (s, 3H, C8-H), 3.38-3.23 (m, 2H, C1-H), 2.61-2.47 (m, 2H, C4-H), 2.12 (s, 3H, 
C10-H), 2.07 (s, 3H, C12-H); 13C NMR (CDCl3, 100 MHz) δ 169.50 (C9), 169.45 (C11), 
165.9 (C7), 142.4 (C5), 123.9 (C6), 72.1 (C2), 71.5 (C3), 51.4 (C8), 32.4 (C4), 20.63 
(C12), 20.61 (C10), 2.1 (C1) 
 
 Methyl (2E,5S)-5-hydroxyhepta-2,6-dienoate (2.195).  A mixture of 2.212 
(62.3 g, 162.2 mmol) and freshly activated Zn granules (53.0 g, 810.9 mmol) in 
anhydrous MeOH (635 mL) was heated under reflux for 16 h.  After cooling the reaction 
to room termperature, the suspension was filtered through a pad of Celite then rinsed with 
MeOH (190 mL).  The combined filtrate and washings were concentrated and the crude 
residue was purified by flash chromatography eluting with Hex:EtOAc (2:1) to give 15.7 
g (62%) of 2.195 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 7.01-6.93 (m, 1H), 
5.94-5.84 (comp, 2H), 5.27 (dt, J = 17.6, 1.2 Hz, 1H), 5.15 (dt, J = 10.4, 1.2 Hz, 1H), 
4.27 (q, J = 6.0 Hz, 1H), 3.72 (s, 3H), 2.72 (br s, 1H), 2.45 (td, J = 7.2, 1.6 Hz, 2H); 13C 
NMR (CDCl3, 100 MHz) δ 166.8, 145.0, 139.7, 123.3, 115.3, 71.3, 51.4, 39.7; IR (neat) 
3428, 2951, 1722, 1660, 1436 cm-1; HRMS (CI) m/z 157.0864 [C8H13O3 (M+1) requires 
157.0865]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.01-6.93 (m, 1H, C5-H), 
5.94-5.84 (comp, 2H, C6-H and C2-H), 5.27 (dt, J = 17.6, 1.2 Hz, 1H, C1-Ha), 5.15 (dt, J 
= 10.4, 1.2 Hz, 1H, C1-Hb), 4.27 (q, J = 6.0 Hz, 1H, C3-H), 3.72 (s, 3H, C8-H), 2.72 (br 
s, 1H, OH), 2.45 (td, J = 7.2, 1.6 Hz, 2H, C4-H); 13C NMR (CDCl3, 100 MHz) δ 166.8 
(C7), 145.0 (C5), 139.7 (C2), 123.3 (C6), 115.3 (C1), 71.3 (C3), 51.4 (C8), 39.7 (C4). 
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Methyl (2E,5S)-5-(carbamoyloxy)hepta-2,6-dienoate (2.215).  Chlorosulfonyl 
isocyanate (15.70 g, 110.5 mmol) was added dropwise to solution of 2.195 (15.70 g, 
100.5 mmol) in CH2Cl2 (1000 mL) at 0 °C.  The reaction was warmed to room 
temperature and stirred for 1 h, at which time H2O (300 mL) was added.  The reaction 
flask was then equipped with a short-path distillation apparatus and heated to 60 °C (bath 
temp) until all of the CH2Cl2 had distilled.  The remaining aqueous mixture was 
extracted with EtOAc (3 x 25 mL), and the combined organic layers were washed with 
sat. aq. NaHCO3 (1 x 25 mL), brine (1 x 25 mL), dried (Na2SO4), filtered, and 
concentrated to give 20.25 g (99%) of 2.215 as a light yellow oil:  1H NMR (CDCl3, 400 
MHz) δ 6.90 (dt, J = 15.6, 7.2, 1 H), 5.90 (dt, J = 15.6, 1.2 Hz, 1 H), 5.80 (ddd, J = 16.8, 
10.8, 6.4 Hz, 1 H), 5.33-5.20 (comp, 3 H), 4.94 (br s, 1 H), 3.74 (s, 3 H), 2.62-2.49 
(comp, 2 H); 13C NMR (CDCl3, 100 MHz) δ 166.5, 156.1, 143.4, 135.4, 123.8, 117.2, 
73.3, 51.5, 36.9; IR (neat) 3474, 3364, 3203, 2953, 2925, 1714, 1660, 1604, 1438, 1384, 
1320, 1041 cm-1; HRMS (CI) m/z 200.0925 [C9H14NO4 (M+H) requires 200.0923]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.90 (dt, J = 15.6, 7.2, 1 H, 
C5-H), 5.90 (dt, J = 15.6, 1.2 Hz, 1 H, C6-H), 5.80 (ddd, J = 16.8, 10.8, 6.4 Hz, 1 H, C2-
H), 5.33-5.20 (comp, 3 H, C1-H & C3-H), 4.94 (br s, 2 H, NH2), 3.74 (s, 3 H, C8-H), 
2.62-2.49 (comp, 2 H, C4-Ha & C4-Hb); 
13C NMR (CDCl3, 100 MHz) δ 166.5 (C9), 




Methyl 2-[(4R,6S)-6-ethenyl-2-oxo-1,3-oxazinan-4-yl]acetate (2.194).  
Compound 2.215 (20.25 g, 101.5 mmol) was dissolved in dry CH2Cl2 (895 mL) and 
cooled to -10 °C (bath temperature) in an ice/brine bath.  NaH (4.31 g, 180.1 mmol, 60% 
w/w dispersion in mineral oil) was added in one portion, and the mixture was stirred 
under an atmosphere of N2 (g) at -10 °C for 1.5 h.  The reaction was quenched by the 
slow addition of saturated aqueous NH4Cl (650 mL), and the aqueous layer was extracted 
with CH2Cl2 (4 x 300 mL).  The combined organic layers were dried (MgSO4), filtered, 
and concentrated under reduced pressure.  The crude residue was then purified by 
recrystallization from methyl tert-butylether to give 17.09 g (85%) of 2.194 as a 
crystalline mixture (dr = 8:1) of diastereomers:  1H NMR (CDCl3, 400 MHz, major 
diastereomer) δ 6.48 (br s, 1H), 5.92-5.83 (m, 1H), 5.41 (d, J = 17.2 Hz, 1H), 5.27 (d, J = 
10.8 Hz, 1H), 4.75 (q, J = 5.6 Hz, 1H), 3.98-3.91 (m, 1H), 3.72 (s, 3H), 2.57 (dd, J = 4.4, 
3.2 Hz, 2H), 1.60-1.51 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ 170.8, 153.8, 134.7, 
117.4, 76.6, 51.9, 47.0, 39.9, 33.1; IR (neat) 3428, 2951, 1722, 1660, 1436 cm-1; HRMS 
(CI) m/z 200.0924 [C9H14NO4 (M+H) requires 200.0923]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.48 (br s, 1H, NH), 5.92-
5.83 (m, 1H, C2-H), 5.41 (d, J = 17.2 Hz, 1H, C1-Ha), 5.27 (d, J = 10.8 Hz, 1H, C1-Hb), 
4.75 (q, J = 5.6 Hz, 1H, C3-H), 3.98-3.91 (m, 1H, C5-H), 3.72 (s, 3H, C8-H), 2.57 (dd, J 
= 4.4, 3.2 Hz, 2H, C6-H), 1.60-1.51 (m, 2H, C4-H); 13C NMR (CDCl3, 100 MHz) δ 
170.8 (C7), 153.8 (C9), 134.7 (C2), 117.4 (C1), 76.6 (C3), 51.9 (C8), 47.0 (C5), 39.9 




carboxylate (2.228).  A solution of 2.194 (17.09 g, 85.45 mmol), Boc2O (37.4 g, 170.9 
mmol), NEt3 (26.0 g, 256.9 mmol, 258.1 mL), and DMAP (1.03 g, 8.55 mmol) in 
CH2Cl2 (430 mL) was stirred at room temperature overnight.  The reaction was quenched 
with 1 M HCl (340 mL), and the layers were separated.  The aqueous layer was then 
extracted with CH2Cl2 (2 x 500 mL), and the combined organic layers were dried 
(Na2SO4), filtered, and concentrated under reduced pressure.  The crude residue was 
purified by flash chromatography eluting with hexanes:EtOAc (3:1) to give 22.22 g 
(87%) of 2.228 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 5.82 (ddd, J = 17.0, 
11.0, 6.0 Hz, 1H), 5.38 (d, J = 17.2 Hz, 1H), 5.26 (d, J = 10.8 Hz, 1H), 4.67-4.61 (m, 
1H), 4.48 (ddd, J = 17.8, 9.0, 2.8 Hz, 1H), 3.66 (s, 3H), 2.92 (dd, J = 16.2, 3.2 Hz, 1H), 
2.57 (dd, J = 16.6, 8.8 Hz, 1H), 2.54-2.48 (m, 1H), 2.74 (ddd, J = 14.0, 11.6, 9.2 Hz, 1H), 
1.49 (s, 9H); 13C NMR (CDCl3, 100 MHz) δ 170.5, 151.9, 150.6, 133.4, 118.3, 83.7, 
76.0, 51.8, 50.3, 40.0, 34.8, 27.9; IR (neat) 2982, 2955, 1792, 1759, 1736, 1438, 1393, 
1370, 1307, 1160 cm-1; HRMS (CI) 300.1453 [C14H22NO6 (M+H) requires 300.1447]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.82 (ddd, J = 6.0, 11.0, 17.0 
Hz, 1H, C2-H), 5.38 (d, J = 17.2 Hz, 1H, C1-Ha), 5.26 (d, J = 10.8 Hz, 1H, C1-Hb), 4.67-
4.61 (m, 1H, C3-H), 4.48 (ddd, J = 17.8, 9.0, 2.8 Hz, 1H, C5-H), 3.66 (s, 3H, C8-H), 2.92 
(dd, J = 16.2, 3.2 Hz, 1H, C6-Ha), 2.57 (dd, J = 16.6, 8.8 Hz, 1H, C6-Hb), 2.54-2.48 (m, 
1H, C4-Ha), 2.74  (ddd, J = 14.0, 11.6, 9.2 Hz, 1H, C4-Hb), 1.49 (s, 9H, C12-H); 
13C 
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NMR (CDCl3, 100 MHz) δ 170.5 (C9), 151.9 (C10), 150.6 (C7), 133.4 (C2), 118.3 (C1), 
83.7 (C5), 76.0 (C3), 51.8 (C11), 50.3 (C8), 40.0 (C4), 34.8 (C6), 27.9 (C12). 
 
Minor diastereomer:  1H NMR (CDCl3, 400 MHz) δ 5.87 (ddd, J = 17.2, 10.6, 
6.0 Hz, 1 H), 5.41 (d, J = 17.6 Hz, 1 H), 5.30 (d, J = 10.4 Hz, 1 H), 4.93-4.87 (m, 1 H), 
4.67 (ddd, J = 14.1, 6.0, 3.6 Hz, 1 H), 3.72 (s, 3H), 2.86 (dd, J = 15.8, 3.6 Hz, 1 H), 2.65 
(dd, J = 16.0, 10.0 Hz, 1 H), 2.19 (app dt, J = 14.4, 3.2 Hz, 1 H), 2.08 (ddd, J = 14.6, 
10.0, 5.2 Hz, 1 H), 1.54 (s, 9 H); 13C NMR (CDCl3, 100 MHz) δ 170.4, 151.6, 148.5, 
134.4, 117.9, 84.2, 74.9, 52.0, 49.6, 37.7, 31.2, 27.8. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.87 (ddd, J = 17.2, 10.6, 6.0 
Hz, 1 H, C2-H), 5.41 (d, J = 17.6 Hz, 1 H, C1-Ha), 5.30 (d, J = 10.4 Hz, 1 H, C1-Hb), 
4.93-4.87 (m, 1 H, C3-H), 4.67 (ddd, J = 14.1, 6.0, 3.6 Hz, 1 H, C5-H), 3.72 (s, 3 H, C8-
H), 2.86 (dd, J = 15.8, 3.6 Hz, 1 H, C6-Ha), 2.65 (dd, J = 16.0, 10.0 Hz, 1 H, C6-Hb), 
2.19 (app dt, J = 14.4, 3.2 Hz, 1 H, C4-Ha), 2.08 (ddd, J = 14.6, 10.0, 5.2 Hz, 1 H, C4-
Hb), 1.54 (s, 9 H, C12-H); 
13C NMR (CDCl3, 100 MHz) δ 170.4 (C9), 151.6 (C10), 
148.5 (C7), 134.4 (C2), 117.9 (C1), 84.2 (C5), 74.9 (C3), 52.0 (C11), 49.6 (C8), 37.7 




(2.229).  A solution of 2.228 (22.22 g, 74.2 mmol) and Cs2CO3 (2.86 g, 14.8 mmol) in 
MeOH (370 mL) was stirred at room temperature for 24-48 h until starting material was 
consumed by TLC (SiO2, Hex:EtOAc, 1:1).  The reaction was then concentrated under 
reduced pressure to provide 20.28 g of crude 2.229 as a colorless oil that was taken on 
without further purification:  1H NMR (CDCl3, 400 MHz) δ 5.82 (ddd, J = 17.0, 11.0, 6.0 
Hz, 1 H), 5.38 (d, J = 17.2 Hz, 1 H), 5.26 (d, J = 10.8 Hz, 1 H), 4.67-4.61 (m, 1 H), 4.48 
(ddd, J = 17.8, 9.0, 2.8 Hz, 1 H), 3.66 (s, 3 H), 2.92 (dd, J = 16.2, 3.2 Hz, 1 H), 2.57 (dd, 
J = 16.6, 8.8 Hz, 1 H), 2.54-2.48 (m, 1 H), 2.74 (ddd, J = 14.0, 11.6, 9.2 Hz, 1 H), 1.49 
(s, 9 H); 13C NMR (CDCl3, 100 MHz) δ 170.5, 151.9, 150.6, 133.4, 118.3, 83.7, 76.0, 
51.8, 50.3, 40.0, 34.8, 27.9; IR (neat) 2982, 2955, 1792, 1759, 1736, 1438, 1393, 1370, 
1307, 1160 cm-1; HRMS (CI) 300.1453 [C14H22NO6 (M+H) requires 300.1447]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.82 (ddd, J = 6.0, 11.0, 17.0 
Hz, 1 H, C2-H), 5.38 (d, J = 17.2 Hz, 1 H, C1-Ha), 5.26 (d, J = 10.8 Hz, 1 H, C1-Hb), 
4.67-4.61 (m, 1 H, C3-H), 4.48 (ddd, J = 17.8, 9.0, 2.8 Hz, 1 H, C5-H), 3.66 (s, 3 H, C8-
H), 2.92 (dd, J = 16.2, 3.2 Hz, 1 H, C6-Ha), 2.57 (dd, J = 16.6, 8.8 Hz, 1 H, C6-Hb), 2.54-
2.48 (m, 1 H, C4-Ha), 2.74  (ddd, J = 14.0, 11.6, 9.2 Hz, 1 H, C4-Hb), 1.49 (s, 9 H, C12-
H); 13C NMR (CDCl3, 100 MHz) δ 170.5 (C9), 151.9 (C10), 150.6 (C7), 133.4 (C2), 




butyldiphenylsilyl)oxy]hept-6-enoate (2.259).  A solution of crude 2.229 (20.28 g, 74.2 
mmol) from the previous step in DMF (50 mL) was added to a solution of TBDPS-Cl (-
30.59 g, 111.3 mmol), imidazole (6.57 g, 96.46 mmol), and DMAP (0.091 g, 0.742 
mmol) in DMF (320 mL), and the reaction was stirred at room temperature overnight.  
The reaction was quenched with 1 M HCl (300 mL), and the layers were separated.  The 
aqueous layer was extracted with Et2O (3 x 150 mL), and the combined organic layers 
were dried (MgSO4), filtered, and concentrated under reduced pressure.  The crude 
residue was purified by flash chromatography eluting with hexanes:EtOAc (5:1) to give 
30.38 g (80%) of 2.259 as a colorless oil:  1H NMR (CDCl3, 400 MHz, rotamers) δ 7.70-
7.63 (comp, 4 H), 7.47-7.33 (comp, 6 H), 5.85 (ddd, J = 17.2, 10.2, 6.4 Hz, 1 H), 5.10-
5.03 (comp, 2 H), 4.41 (app d, J = 8.8 Hz, 1 H), 4.17 (app q, J = 6.0 Hz, 1 H), 3.91-3.81 
(m, 1 H), 3.60 (s, 3 H), 2.40 (app d, J = 4.8 Hz, 2 H), 1.62 (app t, J = 6.4 Hz, 2 H), 1.36 
(s, 9 H), 1.07 (s, 9 H); 13C NMR (CDCl3, 100 MHz, rotamers) δ 171.8, 154.8, 139.4, 
135.90, 135.87, 134.1, 133.7, 129.8, 129.6, 127.6, 127.4, 115.5, 79.0, 72.2, 51.5, 44.2, 
42.3, 39.6, 28.3, 27.0, 19.2; IR (neat) 3423, 2959, 2932, 2858, 1737, 1716, 1502, 1170, 
1111 cm-1; HRMS (ESI) 512.2830 [C29H42NO5Si (M+H) requires 512.2754]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz, rotamers) δ 7.70-7.63 (comp, 4 
H), 7.47-7.33 (comp, 6 H), 5.85 (ddd, J = 17.2, 10.2, 6.4 Hz, 1 H), 5.10-5.03 (comp, 2 
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H), 4.41 (app d, J = 8.8 Hz, 1 H), 4.17 (app q, J = 6.0 Hz, 1 H), 3.91-3.81 (m, 1 H), 3.60 
(s, 3 H), 2.40 (app d, J = 4.8 Hz, 2 H), 1.62 (app t, J = 6.4 Hz, 2 H), 1.36 (s, 9 H), 1.07 (s, 
9 H); 13C NMR (CDCl3, 100 MHz, rotamers) δ 171.8, 154.8, 139.4, 135.90, 135.87, 




butyldiphenylsilyl)oxy]-3-oxonon-8-enoate (2.260).  A solution of freshly distilled 
methyl acetate (4.75 g, 64.10 mmol) in THF (128 mL) was added dropwise via syringe 
pump to a solution of NaHMDS (83.33 mmol, 1.8 M in hexane) in THF (167 mL) at -78 
ºC.  After 30 min, a solution of 2.259 (3.28 g, 6.41 mmol) in THF (13 mL) was added 
dropwise to the reaction via syringe pump.  During the syringe pump additions the metal 
needle used to transfer the substrate solutions was passed through a -78 ºC bath to precool 
the solutions before introduction into the reaction flask.  After 1 h at -78 ºC, the reaction 
was warmed to -10 ºC (ice/brine bath) and stirred for 6 h.  The reaction was then 
quenched by addition of saturated aqueous NH4Cl (300 mL) and warmed to room 
temperature.  The reaction mixture was extracted with EtOAc (5 x 100 mL), and the 
combined organic layers were dried (Na2SO4), filtered, and concentrated under reduced 
pressure.  The crude residue was purified by flash chromatography eluting with 
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hexanes:EtOAc (using a gradient from 9:1 to 5:1) to give 3.55 g (75%) of 2.260 as a 
colorless oil along with 0.56 g (17%) of recovered starting material:  1H NMR (CDCl3, 
400 MHz, rotamers) δ 7.69-7.62 (comp, 4 H), 7.47-7.33 (comp, 6 H), 5.83 (ddd, J = 17.1, 
10.4, 6.4 Hz, 1 H), 5.10-5.03 (comp, 2 H), 4.37 (app d, J = 8.0 Hz, 1 H), 4.15 (app q, J = 
4.0 Hz, 1 H), 3.92-3.83 (m, 1 H), 3.70 (s, 3 H), 3.37 (s, 2 H), 2.61 (app d, J = 2.8 Hz, 2 
H), 1.68-1.61 (m, 2 H), 1.35 (s, 9 H), 1.07 (s, 9 H); 13C NMR (CDCl3, 100 MHz, 
rotamers) δ 172.6, 167.6, 154.9, 139.4, 135.9, 135.8, 134.0, 133.6, 129.8, 129.6, 127.6, 
127.4, 115.5, 79.0, 72.3, 52.2, 49.0, 47.9, 43.9, 42.1, 28.2, 26.9, 19.1; IR (neat) 3417, 
2957, 2932, 2858, 1746, 1715, 1714, 1502, 1246, 1169, 1111 cm-1; HRMS (ESI) 
576.2750 [C31H43NO6SiNa (M+Na) requires 576.2757]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz, rotamers) δ 7.69-7.62 (comp, 4 
H), 7.47-7.33 (comp, 6 H), 5.83 (ddd, J = 17.1, 10.4, 6.4 Hz, 1 H), 5.10-5.03 (comp, 2 
H), 4.37 (app d, J = 8.0 Hz, 1 H), 4.15 (app q, J = 4.0 Hz, 1 H), 3.92-3.83 (m, 1 H), 3.70 
(s, 3 H), 3.37 (s, 2 H), 2.61 (app d, J = 2.8 Hz, 2 H), 1.68-1.61 (m, 2 H), 1.35 (s, 9 H), 
1.07 (s, 9 H); 13C NMR (CDCl3, 100 MHz, rotamers) δ 172.6, 167.6, 154.9, 139.4, 135.9, 
135.8, 134.0, 133.6, 129.8, 129.6, 127.6, 127.4, 115.5, 79.0, 72.3, 52.2, 49.0, 47.9, 43.9, 
42.1, 28.2, 26.9, 19.1 
 
Methyl (5R,7S)-5-{[(tert-butoxy)carbonyl]amino}-7-[(tert-
butyldiphenylsilyl)oxy]-2-diazo-3-oxonon-8-enoate (2.238).  A solution of 2.260 (3.55 
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g, 1.97 mmol), p-ABSA (0.708 g, 2.95 mmol), and NEt3 (0.598 g, 5.91 mmol) in MeCN 
(6.6 mL) was stirred at room temperature for 16 h.  The reaction was then concentrated 
and the crude residue was triturated with Et2O (25 mL).  The precipitate was filtered and 
rinsed with Et2O/CH2Cl2 (25 mL, 2:1), and the combined filtrate and washings were 
concentrated under reduced pressure.  The crude residue was purified by column 
chromatography eluting with Hex:EtOAc (2:1) to give 1.14 g (92%) of 2.238 as a yellow 
oil:  1H NMR (CDCl3, 400 MHz, rotamers) δ 7.71-7.63 (comp, 4 H), 7.46-7.33 (comp, 6 
H), 5.83 (ddd, J = 17.0, 10.2, 6.4 Hz, 1 H), 5.10-5.03 (comp, 2 H), 4.31 (app d, J = 9.6 
Hz, 1 H), 4.21-4.13 (m, 1 H), 3.99-3.92 (m, 1 H), 3.81 (s, 3 H), 2.96-2.83 (comp, 2 H), 
1.71-1.56 (comp, 2 H), 1.34 (s, 9 H), 1.06 (s, 9 H); 13C NMR (CDCl3, 100 MHz, 
rotamers) δ 190.6, 161.6, 154.9, 139.4, 135.9, 134.1, 133.7, 129.7, 129.6, 128.2, 127.5, 
127.4, 115.4, 78.8, 76.2, 72.2, 52.1, 45.6, 44.5, 42.7, 28.2, 26.9, 19.1; IR (neat) 3417, 
2959, 2932, 2856, 2136, 1716, 1655, 1500, 1313, 1171, 1112 cm-1; HRMS (ESI) 
580.2838 [C31H42N3O6Si (M+H) requires 580.2843]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz, rotamers) δ 7.71-7.63 (comp, 4 
H), 7.46-7.33 (comp, 6 H), 5.83 (ddd, J = 17.0, 10.2, 6.4 Hz, 1 H), 5.10-5.03 (comp, 2 
H), 4.31 (app d, J = 9.6 Hz, 1 H), 4.21-4.13 (m, 1 H), 3.99-3.92 (m, 1 H), 3.81 (s, 3 H), 
2.96-2.83 (comp, 2 H), 1.71-1.56 (comp, 2 H), 1.34 (s, 9 H), 1.06 (s, 9 H); 13C NMR 
(CDCl3, 100 MHz, rotamers) δ 190.6, 161.6, 154.9, 139.4, 135.9, 134.1, 133.7, 129.7, 




butyldiphenylsilyl)oxy]-2-diazo-3-oxonon-8-enoate (2.292).  Trifluroroacetic acid 
(0.315 g, 2.76 mmol) was added to a precooled solution of 2.238 (0.160 g, 0.276 mmol) 
in CH2Cl2 (1.5 mL) at 0 ºC.  The reaction was then warmed to room temperature and 
stirred for 2 h.  The reaction was then concentrated to dryness and pumped down under 
high vacuum for 2 h to ensure the removal of all excess TFA.  4 Å molecular sieves 
(0.100 g) were added to a solution of the crude residue in CH2Cl2 (1.5 mL) and the 
mixture was cooled to 0 ºC.  NEt3 (0.028 g, 0.276 mmol) was then added dropwise, and 
upon completion of the addition, the reaction was warmed to room temperature.  A 1 M 
solution of benzyl glyoxylate (0.068 g, 0.414 mmol) in toluene was then added, and the 
reaction was stirred for 12 h at room temperature.  The reaction mixture was then passed 
through a short pad of oven dried basic alumina, rinsing with CH2Cl2 (10 mL), and the 
combined filtrate and washings were concentrated under reduced pressure to give 0.173 g 
(>99%) of 2.292 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 7.66 (s, 1 H), 7.63-
7.59 (comp, 4 H), 7.39-7.28 (comp, 11 H), 5.75-5.67 (m, 1 H), 5.27 (s, 2 H), 4.93 (app d, 
J = 10.4 Hz, 1 H), 4.84 (app d, J = 17.2 Hz, 1 H), 4.10-4.05 (m, 1 H), 4.04-3.96 (m, 1 H), 
3.79 (s, 3 H), 3.31 (dd, J = 18.0, 9.2 Hz, 1 H), 2.82 (dd, J = 16.0, 3.6 Hz, 1 H), 1.95-1.88 
(m, 1 H), 1.84-1.77 (m, 1 H), 1.04 (s, 9 H). 
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NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.66 (s, 1 H, C11-H), 7.63-
7.59 (comp, 4 H, Ar-H), 7.39-7.28 (comp, 11 H, Ar-H), 5.75-5.67 (m, 1 H, C2-H), 5.27 
(s, 2 H, C13-H), 4.93 (app d, J = 10.4 Hz, 1 H, C1-H), 4.84 (app d, J = 17.2 Hz, 1 H, C1-
H), 4.10-4.05 (m, 1 H, C3-H), 4.04-3.96 (m, 1 H, C5-H), 3.79 (s, 3 H, C10-H), 3.31 (dd, 
J = 18.0, 9.2 Hz, 1 H, C6-H), 2.82 (dd, J = 16.0, 3.6 Hz, 1 H, C6-H), 1.95-1.88 (m, 1 H, 
C4-H), 1.84-1.77 (m, 1 H, C4-H), 1.04 (s, 9 H, C16-H). 
 
6-Benzyl-8-methyl-(6R)-3-[(tert-butyldiphenylsilyl)oxy]-9-oxo-7-azatricyclo 
[5.3.0.04,8]decane-6,8-dicarboxylate (2.293).  Trifluroroacetic acid (1.36 g, 11.94 
mmol) was added to a precooled solution of 2.238 (0.692 g, 1.19 mmol) in CH2Cl2 (6 
mL) at 0 ºC.  The reaction was warmed to room temperature and stirred for 2 h.  The 
reaction was then concentrated to dryness and pumped down under high vacuum for 2 h 
to ensure the removal of all excess TFA.  4 Å molecular sieves (0.600 g) were added to a 
solution of the crude residue in CH2Cl2 (6 mL) and the mixture was cooled to 0 ºC.  NEt3 
(0.132 g, 1.31 mmol) was then added dropwise, and upon complete of the addition, the 
reaction was warmed to room temperature.  A 1 M solution of benzyl glyoxylate (0.293 
g, 1.79 mmol) in toluene was then added, and the reaction was stirred for 16 h at room 
temperature.  The reaction was filtered through Celite and rinsed with CH2Cl2 (6 mL) to 
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give 2.292 as a colorless oil along with an equimolar amount of NEt3•TFA.  The crude 
residue was dissolved in xylenes (24 mL), Rh2(OAc)4 (0.026 g, 0.0595 mmol) was 
added, and the mixture was heated under reflux for 24 h.  The reaction was concentrated 
to under reduced pressure, and the crude residue was purified by column chromatography 
eluting with Hex:EtOAc (3:1, with 1% v/v NEt3) to give 0.462 g (65%) of 2.293 as a light 
yellow oil: 1H NMR (CDCl3, 400 MHz) δ 7.59-7.55 (comp, 4 H), 7.45-7.35 (comp, 11 
H), 5.28 (d, J = 3.2 Hz, 2 H), 4.15 (app q, J = 6.0 Hz, 1 H), 4.08-4.04 (m, 1 H), 3.94-3.89 
(m, 1 H), 3.72 (s, 3 H), 2.96 (app q, J = 3.2 Hz, 1 H), 2.68 (dd, J = 13.6, 5.6 Hz, 1 H), 
2.61 (dd, J = 16.0, 6.4 Hz, 1 H), 2.15-2.07 (m, 1 H), 1.80 (d, J = 17.6 Hz, 1 H), 1.35-1.19 
(comp, 2 H), 1.04 (s, 9 H); 13C NMR (CDCl3, 100 MHz) δ 207.0, 172.5, 169.7, 167.4, 
135.5, 135.5, 135.3, 134.7, 133.5, 133.0, 130.0, 129.9, 128.6, 128.5, 127.8, 127.6, 82.4, 
67.0, 66.2, 62.3, 54.2, 53.1, 49.7, 44.0, 33.6, 27.0, 26.8, 19.0; IR (neat) 2953, 2857, 1738, 
1741, 1428, 1228, 1112 cm-1; HRMS (ESI) m/z 598.2614 [C35H40NO6Si (M+H) requires 
598.2625]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.59-7.55 (comp, 4 H, Ar-
H), 7.45-7.35 (comp, 11 H, Ar-H), 5.28 (d, J = 3.2 Hz, 2 H, C13-H), 4.15 (app q, J = 6.0 
Hz, 1 H, C5-H), 4.08-4.04 (m, 1 H, C8-H), 3.94-3.89 (m, 1 H, C9a-H), 3.72 (s, 3 H, C11-
H), 2.96 (app q, J = 3.2 Hz, 1 H, C7-H), 2.68 (dd, J = 13.6, 5.6 Hz, 1 H, C6-H), 2.61 (dd, 
J = 16.0, 6.4 Hz, 1 H, C6-H), 2.15-2.07 (m, 1 H, C1-Hb), 1.80 (d, J = 17.6 Hz, 1 H, C1-




azatricyclo [5.3.0.04,8]decane-6-carboxylic acid (2.305).  A suspension of compound 
2.293 (0.052 g, 0.870 mmol) and 10 % w/w Pd/C (10 mg) in EtOH (0.5 mL) was stirred 
under an atmosphere of H2 (gas) at room temperature for 3 h.  The mixture was filtered 
through a short pad of Celite, rinsed with EtOH (5 mL), and the filtrate and washings 
were concentrated to dryness to give 0.044 g (>99%) of 2.305 as an amorphous solid, 
which was carried on without further purification:  1H NMR (CDCl3, 400 MHz) δ 7.60-
7.57 (comp, 4 H), 7.47-7.34 (comp, 11 H), 4.26-4.81 (comp, 2 H), 3.99-3.93 (m, 1 H), 
3.73 (s, 3 H), 2.96 (app q, J = 3.2 Hz, 1 H), 2.78-2.70 (comp, 2 H), 2.16-2.08 (m, 1 H), 
1.83 (d, J = 17.6 Hz, 1 H), 1.58-1.52 (m, 1 H), 1.40-1.35 (m, 1 H), 1.04 (s, 9 H); LCMS 
(ESI) m/z 506 [C28H32NO6Si (M+H) requires 506]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.60-7.57 (comp, 4 H, Ar-
H), 7.47-7.34 (comp, 11 H, Ar-H), 4.26-4.81 (comp, 2 H, C5-H/C8-H), 3.99-3.93 (m, 1 
H, C9a-H), 3.73 (s, 3 H, C11-H), 2.96 (app q, J = 3.2 Hz, 1 H, C7-H), 2.78-2.70 (comp, 2 
H, C6-H), 2.16-2.08 (m, 1 H, C1-Hb), 1.83 (d, J = 17.6 Hz, 1 H, C1-Ha), 1.58-1.52 (m, 1 




8-carboxylate (2.262).  A mixture of acid 2.305 (0.011 g, 0.0217 mmol), disulfide 
2.306a (0.008 g, 0.0303 mmol), and Bu3SnH (0.032 g, 0.109 mmol) in THF (0.4 mL) 
was treated with PBu3 (0.012 g, 0.0586 mmol) and the reaction was stirred in the dark at 
room temperature for 4 h.  The resulting canary yellow solution was irradiated with a 
tungsten filament light bulb (200 W) at room temperature for 30 min until the solution 
became colorless.  During the irradiation step it is important to maintain the reaction 
temperature carefully, as any elevation in temperature results in product consumption.  
The reaction was then concentrated, and the crude residue was dissolved in EtOAc (5 
mL), washed with brine (1 x 5 mL), dried (Na2SO4), filtered, and concentrated under 
reduced pressure.  The crude residue was purified by column chromatography to give 
0.05 g 2.262 (50%) as a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 7.62-7.58 (comp, 
4H), 7.46-7.34 (comp, 6H), 3.96-3.91 (m, 1H), 3.75 (s, 3H), 3.55-3.52 (m, 1H), 3.14 
(ddd, J = 13.4, 11.4, 4.4 Hz, 1H), 3.02 (dt, J = 8.4, 6.0 Hz, 1H), 2.97 (dd, J = 6.2, 3.6 Hz, 
1H), 2.66-2.60 (m, 1H), 2.36 (ddd, J = 13.4, 8.8, 4.4 Hz, 1H), 1.84 (d, J = 18.0 Hz, 1H), 
1.71 (ddd, J = 18.2, 11.0, 5.2 Hz, 1H), 1.65-1.57 (comp, 2H), 1.37-1.32 (comp, 2H), 1.05 
(s, 9H); LRMS (CI) m/z 464 [C27H34NO4Si (M+H) requires 464]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.62-7.58 (comp, 4H), 7.46-
7.34 (comp, 6H), 3.96-3.91 (m, 1H), 3.75 (s, 3H), 3.55-3.52 (m, 1H), 3.14 (ddd, J = 13.4, 
11.4, 4.4 Hz, 1H), 3.02 (dt, J = 8.4, 6.0 Hz, 1H), 2.97 (dd, J = 6.2, 3.6 Hz, 1H), 2.66-2.60 
 286 
(m, 1H), 2.36 (ddd, J = 13.4, 8.8, 4.4 Hz, 1H), 1.84 (d, J = 18.0 Hz, 1H), 1.71 (ddd, J = 
18.2, 11.0, 5.2 Hz, 1H), 1.65-1.57 (comp, 2H), 1.37-1.32 (comp, 2H), 1.05 (s, 9H). 
 
Methyl 3-[(tert-butyldiphenylsilyl)oxy]-9-oxo-7-azatricyclo[5.3.0.04,8]decane-
8-carboxylate (2.262).  A mixture of acid 2.305 (0.012 g, 0.0236 mmol), pyridine thione 
2.306b (0.004 g, 0.0284 mmol), and DCC (0.004 g, 0.0354 mmol) in CHCl3 (0.5 mL) 
was stirred at room temperature for 30 min.  The resulting canary yellow solution was 
irradiated with a tungsten filament light bulb (200 W) at room temperature for 1 h.  The 
reaction was then diluted with CH2Cl2 and washed with H2O (1 x 5 mL).  The organic 
layer was dried (Na2SO4), filtered, and concentrated under reduced pressure.  The crude 
crude residue was purified by column chromatography eluting with EtOAc to give 0.0065 
g (59%) of 2.262 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 7.62-7.58 (comp, 4 
H), 7.46-7.34 (comp, 6 H), 3.96-3.91 (m, 1 H), 3.75 (s, 3 H), 3.55-3.52 (m, 1 H), 3.14 
(ddd, J = 13.4, 11.4, 4.4 Hz, 1 H), 3.02 (dt, J = 8.4, 6.0 Hz, 1 H), 2.97 (dd, J = 6.2, 3.6 
Hz, 1 H), 2.66-2.60 (m, 1H), 2.36 (ddd, J = 13.4, 8.8, 4.4 Hz, 1 H), 1.84 (d, J = 18.0 Hz, 
1 H), 1.71 (ddd, J = 18.2, 11.0, 5.2 Hz, 1 H), 1.65-1.57 (comp, 2 H), 1.37-1.32 (comp, 2 
H), 1.05 (s, 9 H); LRMS (CI) m/z 464 [C27H34NO4Si (M+H) requires 464]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.62-7.58 (comp, 4H), 7.46-
7.34 (comp, 6H), 3.96-3.91 (m, 1H), 3.75 (s, 3H), 3.55-3.52 (m, 1H), 3.14 (ddd, J = 13.4, 
11.4, 4.4 Hz, 1H), 3.02 (dt, J = 8.4, 6.0 Hz, 1H), 2.97 (dd, J = 6.2, 3.6 Hz, 1H), 2.66-2.60 
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(m, 1H), 2.36 (ddd, J = 13.4, 8.8, 4.4 Hz, 1H), 1.84 (d, J = 18.0 Hz, 1H), 1.71 (ddd, J = 
18.2, 11.0, 5.2 Hz, 1H), 1.65-1.57 (comp, 2H), 1.37-1.32 (comp, 2H), 1.05 (s, 9H). 
 
6-Benzyl-8-methyl-(6R)-3-[(tert-butyldiphenylsilyl)oxy]-9-hydroxy-7-
azatricyclo[5.3.0.04,8]decane-6,8-dicarboxylate (2.313).  A solution of 2.293 (0.085 g, 
0.142 mmol) in MeOH (4.7 mL) was cooled to -30 ºC and NaBH4 (0.011 g, 0.284 mmol) 
was added in one portion.  The reaction was stirred at -30 ºC for 2 h then warmed slowly 
to rt over the course of an hour.  The reaction was quenched with aq. 1 M HCl (4 mL), 
and the resulting mixture was concentrated to remove all EtOH.  The crude aq. mixture 
was neutralized with solid K2CO3, and then extracted with EtOAc (4 x 10 mL).  The 
combined organic layers were dried (Na2SO4), filtered, and concentrated. The crude 
residue was purified by column chromatography eluting with 4:1 Hex:EtOAc to give 
0.063 g (74%) of 2.313 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 7.67-7.61 
(comp, 4H), 7.44-7.31 (comp, 11 H), 5.24 (q, J = 13.2 Hz, 2 H), 4.77-4.72 (m, 1 H), 4.37 
(dd, J = 10.4, 3.2 Hz, 1 H), 4.30 (dd, J = 11.2, 5.6 Hz, 1 H), 3.70 (s, 3 H), 3.67-3.62 (m, 1 
H), 2.66 (dd, J = 14.0, 5.6 Hz, 1 H), 2.51 (dd, J = 6.0, 3.2 Hz, 1 H), 2.43-2.35 (m, 1 H), 
1.97-1.88 (comp, 2 H), 1.64-1.57 (m, 1 H), 1.43-1.35 (m, 1 H), 1.33-1.09 (comp, 3 H), 
1.06 (s, 9 H); 13C NMR (CDCl3, 100 MHz) δ 173.3, 170.9, 135.75, 135.66, 135.6, 134.4, 
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134.2, 129.5, 129.5, 128.52, 128.48, 128.3, 127.4, 127.4, 80.5, 73.2, 66.7, 65.8, 61.6, 
57.0, 52.4, 46.4, 37.4, 35.0, 27.3, 26.9, 19.1; IR (neat) 3233, 2955, 2892, 2857, 1736, 
1471, 1225, 1108 cm-1; HRMS (ESI) m/z 600.2777 [C35H42NO6Si (M+H) requires 
600.2781]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.67-7.61 (comp, 4H, Ar-H), 
7.44-7.31 (comp, 11 H, Ar-H), 5.24 (q, J = 13.2 Hz, 2 H, C13-H), 4.77-4.72 (m, 1 H, C5-
H), 4.37 (dd, J = 10.4, 3.2 Hz, 1 H, C8-H), 4.30 (dd, J = 11.2, 5.6 Hz, 1 H, C9a-H), 3.70 
(s, 3 H, C11-H), 3.67-3.62 (m, 1 H, C2-H), 2.66 (dd, J = 14.0, 5.6 Hz, 1 H), 2.51 (dd, J = 
6.0, 3.2 Hz, 1 H), 2.43-2.35 (m, 1 H), 1.97-1.88 (comp, 2 H), 1.64-1.57 (m, 1 H), 1.43-
1.35 (m, 1 H), 1.33-1.09 (comp, 3 H), 1.06 (s, 9 H). 
 
4-Benzyl-2-methyl-(4R)-7-[(tert-butyldiphenylsilyl)oxy]-11-oxa-3-
azatetracyclo[5.3.1.02,6.03,9]undecane-2,4-dicarboxylate (2.315).  A solution of 2.313 
(0.032 g, 0.0534 mmol), PhI(OAc)2 (0.026 g, 0.0800 mmol), and I2 (0.0136 g, 0.0534 
mmol) in CH2Cl2 (2.7 mL) was irradiated with at tungsten filament light bulb (150 W) at 
rt for 1.5 h.  The reaction was quenched with 10% aq. sodium thiosulfate (3 mL), and 
extracted with EtOAc (4 x 5 mL).  The combined organic layers were dried (MgSO4), 
filtered, and concentrated.  The crude residue was purified by column chromatography 
 289 
eluting with Hex:EtOAc (1:1) to give 0.029 g (91 %) of 2.315 as a light yellow oil:  1H 
NMR (CDCl3, 400 MHz) δ 7.74-7.69 (comp, 4 H), 7.44-7.32 (comp, 11 H), 5.16 (app q, 
J = 8.4 Hz, 2 H), 4.64 (app t, J = 2.4 Hz, 1 H), 4.29 (app t, J = 9.2 Hz, 1 H), 3.69 (s, 3 H), 
3.68-3.64 (m, 1 H), 2.73 (m, 1 H), 2.15-2.10 (comp, 2 H), 1.73-1.66 (comp, 2 H), 1.59 (d, 
J = 11.6 Hz, 1 H), 1.60-1.54 (comp, 2 H), 1.32 (d, J = 13.6 Hz, 1 H), 1.27-1.24 (m, 1 H), 
1.05 (s, 9 H); 13C NMR (CDCl3, 100 MHz) δ 171.2, 170.3, 136.0, 135.9, 135.4, 134.3, 
134.2, 129.6, 129.6, 128.5, 128.4, 127.33, 127.29, 106.3, 85.0, 79.5, 77.2, 66.7, 63.7, 
57.2, 56.9, 52.4, 37.9, 35.7, 29.4, 26.9, 19.1; IR (neat) 2955, 2858, 1736, 1457, 1214 cm-
1; HRMS (ESI) m/z 598.2623 [C35H40NO6Si (M+H) requires 598.2625]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.74-7.69 (comp, 4 H, Ar-
H), 7.44-7.32 (comp, 11 H, Ar-H), 5.16 (app q, J = 8.4 Hz, 2 H, C13-H), 4.64 (app t, J = 
2.4 Hz, 1 H, C5-H), 4.29 (app t, J = 9.2 Hz, 1 H, C9a-H), 3.69 (s, 3 H, C11-H), 3.68-3.64 
(m, 1 H, C2-H), 2.73 (m, 1 H), 2.15-2.10 (comp, 2 H), 1.73-1.66 (comp, 2 H), 1.59 (d, J 
= 11.6 Hz, 1 H, C1-Hendo), 1.60-1.54 (comp, 2 H), 1.32 (d, J = 13.6 Hz, 1 H, C7-H), 
1.27-1.24 (m, 1 H), 1.05 (s, 9 H, C16-H). 
 
4-Benzyl-2-methyl-(4R)-7-hydroxy-11-oxa-3-azatetracyclo[5.3.1.02,6.03,9] 
undecane-2,4-dicarboxylate (2.316).  A solution of 2.315 (0.017 g, 0.0284 mmol) and 
glacial acetic acid (0.003 g, 0.0427 mmol) in THF (0.3 mL) was treated with a solution of 
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TBAF•3H2O (0.013 g, 0.0427 mmol), and the resulting solution was stirred at room 
temperature for 30 min.  NEt3 (0.5 mL) was added to the reaction and the solution was 
filtered through a short pad of SiO2, and rinsed with EtOAc:MeOH (10:1 with 1% NEt3, 
30 mL).  The filtrate and washings were concentrated to dryness to give 0.095 g (96%) of 
2.316 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 7.74-7.69 (comp, 4 H), 7.44-7.32 
(comp, 11 H), 5.16 (app q, J = 8.4 Hz, 2 H), 4.64 (app t, J = 2.4 Hz, 1 H), 4.29 (app t, J = 
9.2 Hz, 1 H), 3.69 (s, 3 H), 3.68-3.64 (m, 1 H), 2.73 (m, 1 H), 2.15-2.10 (comp, 2 H), 
1.73-1.66 (comp, 2 H), 1.59 (d, J = 11.6 Hz, 1 H), 1.60-1.54 (comp, 2 H), 1.32 (d, J = 
13.6 Hz, 1 H), 1.27-1.24 (m, 1 H), 1.05 (s, 9 H); 13C NMR (CDCl3, 100 MHz, rotamers) 
δ 171.0, 170.3, 135.3, 128.6, 128.6, 128.5, 105.3, 85.2, 79.6, 67.0, 63.6, 57.3, 55.8, 52.6, 
37.9, 34.4, 29.6, 29.4; IR (neat) 3368, 2955, 2850, 1735, 1734, 1455, 1283, 1227, 1134, 
1072 cm-1; HRMS (ESI) m/z 360.1444 [C19H22NO6 (M+H) requires 360.1447]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.74-7.69 (comp, 4 H, Ar-
H), 7.44-7.32 (comp, 11 H, Ar-H), 5.16 (app q, J = 8.4 Hz, 2 H, C13-H), 4.64 (app t, J = 
2.4 Hz, 1 H, C5-H), 4.29 (app t, J = 9.2 Hz, 1 H, C9a-H), 3.69 (s, 3 H, C11-H), 3.68-3.64 
(m, 1 H, C2-H), 2.73 (m, 1 H), 2.15-2.10 (comp, 2 H), 1.73-1.66 (comp, 2 H), 1.59 (d, J 
= 11.6 Hz, 1 H, C1-Hendo), 1.60-1.54 (comp, 2 H), 1.32 (d, J = 13.6 Hz, 1 H, C7-H), 





azatetracyclo[5.3.1.02,6.03,9]undecane-2,4-dicarboxylate (2.317).  A solution of 2.316 
(0.018 g, 0.0501 mmol), bromoacetic anhydride (0.026 g, 0.100 mmol), NEt3 (0.010 g, 
0.100 mmol), and DMAP (0.001 g, 0.0025 mmol) in CH2Cl2 (0.5 mL) was stirred at 
room temperature for 30 min.  The reaction was quenched with saturated aqueous 
NaHCO3 (3 mL), and the mixture was extracted with CH2Cl2 (3 x 3 mL).  The combined 
organic layers were washed with half saturated NaHCO3 (3 mL), brine (3 mL).  The 
organic layer was dried (Na2SO4), filtered, and concentrated under reduced pressure to 
provide 0.034 g (>90%) of 2.317 as a crude oil, which was taken on without further 
purification:  1H NMR (CDCl3, 400 MHz) δ 7.39-7.32 (comp, 5 H), 5.23 (app q, J = 14.0 
Hz, 2 H), 4.93-4.91 (m, 1 H), 4.40 (dd, J = 6.8, 10.2 Hz, 1 H), 3.88-3.84 (m, 1 H), 3.79 
(s, 2 H), 3.77 (s, 3 H), 3.23 (app d, J = 6.4 Hz, 1 H), 2.37-2.32 (comp, 2 H), 2.27-2.22 (m, 
1 H), 2.01-1.84 (comp, 3 H). 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.39-7.32 (comp, 5 H, C15-
17-H)), 5.23 (app q, J = 14.0 Hz, 2 H, C13-H), 4.93-4.91 (m, 1 H, C5-H), 4.40 (dd, J = 
6.8, 10.2 Hz, 1 H), 3.88-3.84 (m, 1 H), 3.79 (s, 2 H, C19-H), 3.77 (s, 3 H, C11-H), 3.23 





azatetracyclo[5.3.1.02,6.03,9]undecane-2,4-dicarboxylate (2.318).  A solution of crude 
2.317 from the previous experimental (0.024 g, 0.0501 mmol) and TsNHNHTs (0.341 g, 
0.100 mmol) in THF (1 mL) was cooled to 0 ºC, and then DBU (0.038 g, 0.251 mmol) 
was added dropwise.  The reaction was stirred at 0 ºC for 30 min, then it was quenched 
with half saturated NaHCO3 (1 mL), and the mixture was extracted with Et2O (3 x 5 
mL). Th combined organic layers were dried (Na2SO4), filtered, and concentrated under 
reduced pressure to provide a mixture (1:3) of 2.318 and 2.316. 
 
(3R)-3-[(2S)-2-Hydroxybut-3-en-1-yl]-1,2-oxazolidin-5-one (2.254).  A solution 
of 2.241 (0.080 g, 0.644 mmol), recrystallized hydroxylamine•HCl (0.054 g, 0.773 
mmol), and NEt3 (0.085 g, 0.837 mmol) in EtOH (6.5 mL) was stirred at room 
temperature for 16 h.  The reaction was concentrated under reduced pressure, triturated 
with Et2O (10 mL), and the precipitate removed by filtration rinsing with Et2O (10 mL).  
The combined filtrate and washings were concentrated under reduced pressure, and the 
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crude residue was purified by column chromatography eluting with Hex:EtOAc (using a 
gradient from 1:1 to 3:2) to give 0.049 g (53%) of 2.254 as a light yellow oil:  1H NMR 
(CDCl3, 400 MHz) δ 5.87 (ddd, J = 16.8, 10.6, 6.0 Hz, 1 H), 5.29 (app d, J = 16.6 Hz, 1 
H), 5.16 (app d, J = 10.4 Hz, 1 H), 4.33-4.28 (m, 1 H), 4.09-4.02 (m, 1 H), 2.90 (dd, J = 
7.2, 17 Hz, 1 H), 2.52 (dd, J = 6.8, 17.2 Hz, 1 H), 1.92-1.76 (comp, 2 H), 1.28-1.22 (m, 1 
H); LRMS (CI) m/z 158 [C7H12NO3 (M+H) requires 158]. 
NMR Assignments1H NMR (CDCl3, 400 MHz) δ 5.87 (ddd, J = 16.8, 10.6, 6.0 
Hz, 1 H), 5.29 (app d, J = 16.6 Hz, 1 H), 5.16 (app d, J = 10.4 Hz, 1 H), 4.33-4.28 (m, 1 
H), 4.09-4.02 (m, 1 H), 2.90 (dd, J = 7.2, 17 Hz, 1 H), 2.52 (dd, J = 6.8, 17.2 Hz, 1 H), 




one (2.255).  A solution of 2.254 (0.052 g, 0.363 mmol), TBDPS-Cl (0.250 g, 0.908 
mmol), imidazole (0.074 g, 1.09 mmol), and DMAP (0.004 g, 0.363 mmol) in CH2Cl2 (2 
mL) was stirred at room temperature for 48 h.  The reaction was filtered through a pad of 
Celite rinsing with CH2Cl2 (5 mL).  The combined filtrate and washings were washed 
with 0.5 M aqueous HCl (3 x 5 mL).  The combined aqueous layers were neutralized with 
solid K2CO3 and extracted with CH2Cl2 (3 x 5 mL).  The combined organic layers were 
concentrated under reduced pressure, and the crude residue was purified by column 
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chromatography eluting with Hex:EtOAc (5:1) to give 0.104 g (72%) of 2.255 as a 
colorless oil:  1H NMR (CDCl3, 400 MHz) δ 7.68-7.61 (comp, 4 H), 7.47-7.35 (comp, 6 
H), 5.81 (ddd, J = 16.6, 10.4, 5.8 Hz, 1 H), 5.17-5.06 (comp, 2 H), 4.72-4.65 (m, 1 H), 
4.33 (app q, J = 5.6 Hz, 1 H), 3.92-3.82 (m, 1 H), 2.54 (dd, J = 4.8, 17 Hz, 1 H), 2.30-
2.24 (m, 1 H), 1.82-1.73 (m, 1 H), 1.63-1.56 (m, 1 H), 1.08 (s, 9 H); LRMS (CI) m/z 396 
[C23H30NO3Si (M+H) requires 396]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.68-7.61 (comp, 4 H), 7.47-
7.35 (comp, 6 H), 5.81 (ddd, J = 16.6, 10.4, 5.8 Hz, 1 H), 5.17-5.06 (comp, 2 H), 4.72-
4.65 (m, 1 H), 4.33 (app q, J = 5.6 Hz, 1 H), 3.92-3.82 (m, 1 H), 2.54 (dd, J = 4.8, 17 Hz, 
1 H), 2.30-2.24 (m, 1 H), 1.82-1.73 (m, 1 H), 1.63-1.56 (m, 1 H), 1.08 (s, 9 H). 
 
tert-Butyl (3R)-3-[(2S)-2-[(tert-butyldiphenylsilyl)oxy]but-3-en-1-yl]-5-oxo-
1,2-oxazolidine-2-carboxylate (2.255).  A solution of 2.255 (0.093 g, 0.235 mmol), 
Boc2O (0.154 g, 0.705 mmol), NEt3 (0.071 g, 0.705 mmol), and DMAP (0.003 g, 0.0235 
mmol) in CH2Cl2 (2.4 mL) was stirred at room temperature for 48 h.  The reaction was 
diluted with CH2Cl2 (10 mL) and washed with saturated aqueous NH4Cl (1 x 10 mL), 
saturated aqueous NaHCO3 (2 x 10 mL), and brine (1 x 10 mL).  The organic layer was 
dried (MgSO4), filtered, and concentrated under reduced pressure.  The crude residue was 
then purified by column chromatography eluting with Hex:EtOAc (6:1) to give 0.093 g 
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(79%) of 2.256 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 7.68-7.61 (comp, 4 H), 
7.47-7.34 (comp, 6 H), 5.85 (ddd, J = 16.8, 10.6, 6.0 Hz, 1 H), 5.16-5.07 (comp, 2 H), 
4.56-4.49 (m, 1 H), 4.34-4.29 (m, 1 H), 2.66 (dd, J = 8.4, 17.6 Hz, 1 H), 2.39 (dd, J = 3.2, 
18.0 Hz, 1 H), 2.12-2.06 (m, 1 H), 1.62-1.55 (m, 1 H), 1.47 (s, 9 H), 1.08 (s, 9 H); LRMS 
(CI) m/z 496 [C28H38NO5Si (M+H) requires 496]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.68-7.61 (comp, 4 H), 7.47-
7.34 (comp, 6 H), 5.85 (ddd, J = 16.8, 10.6, 6.0 Hz, 1 H), 5.16-5.07 (comp, 2 H), 4.56-
4.49 (m, 1 H), 4.34-4.29 (m, 1 H), 2.66 (dd, J = 8.4, 17.6 Hz, 1 H), 2.39 (dd, J = 3.2, 18.0 
Hz, 1 H), 2.12-2.06 (m, 1 H), 1.62-1.55 (m, 1 H), 1.47 (s, 9 H), 1.08 (s, 9 H). 
 
(E)-Methyl 4-((4S,5S)-5-(iodomethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-
enoate (2.178).  Iodine (0.764 g, 3.01 mmol) was added to a solution of 
triphenylphosphine (0.781 g, 2.98 mmol) and imidazole (0.270 g, 3.96 mmol) in THF (15 
mL) and the reaction was stirred at room temperature for 10 min.  A solution of 2.177 
(0.457 g, 1.98 mmol) in THF (6.5 mL) was added and the solution was refluxed for 3.5 h 
until complete consumption of 2.177 was observed by TLC.  The reaction was cooled to 
rt, and poured into a stirred solution of aq. Na2S2O3 (5% w/w, 25 mL).  EtOAc (25 mL) 
was added, and the organic layer was removed.  The aqueous layer was then extracted 
with CH2Cl2 (2 x 15 mL), and the combined organic layers were dried (Na2SO4), 
filtered, and concentrated.  The crude residue was dissolved in Et2O (50 mL) and the 
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precipitate was removed by filteration and rinsed with an additional portion of Et2O (50 
mL).  After concentrating the filtrate and washings, the crude residue was purified by 
flash chromatography eluting with hexanes:Et2O (4:1) to give 0.490 g (73% yield) of 
2.178 as a light yellow oil: 1H NMR (CDCl3, 400 MHz) δ 7.03-6.95 (m, 1H), 5.95 (dt, J 
= 15.6, 1.2 Hz, 1H), 4.41 (app q, J = 5.2 Hz, 1H), 4.27 (app p, J = 4.0 Hz, 1H), 3.73 (s, 
3H), 3.23-3.10 (m, 2H), 2.56-2.42 (m, 2H), 1.47 (s, 3H), 1.36 (s, 3H); 13C NMR (CDCl3, 
100 MHz) δ 166.2, 144.2, 123.2, 108.8, 77.8, 76.0, 51.4, 32.2, 28.2, 28.2, 25.5, 2.3; IR 
(neat) 2987, 2948, 1721, 1660, 1436, 1381, 1041 cm-1; HRMS (ESI) 363.0080 
[C11H17O4INa (M+Na) requires 363.0064]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.03-6.95 (m, 1H, C5-H), 
5.95 (dt, J = 15.6, 1.2 Hz, 1H, C6-H), 4.41 (app q, J = 5.2 Hz, 1H, C2-H), 4.27 (app p, J 
= 4.0 Hz, 1H, C3-H), 3.73 (s, 3H, C8-H), 3.23-3.10 (m, 2H, C1-H), 2.56-2.42 (m, 2H, 
C4-H), 1.47 (s, 3H, C10-H), 1.36 (s, 3H, C11-H); 13C NMR (CDCl3, 100 MHz) δ 166.2 
(C7), 144.2 (C5), 123.2 (C6), 108.8 (C9), 77.8 (C2), 76.0 (C3), 51.4 (C8), 32.2 (C4), 28.2 
(C10), 25.5 (C11), 2.3 (C1). 
 
(2S,3S,E)-1-Iodo-7-methoxy-7-oxohept-5-ene-2,3-diyl diacetate (2.180).  A 
suspension of 2.178 (1.38 g, 3.59 mmol) and “activated” Dowex-50 resin (4 g) in 
anhydrous MeOH (18 mL) was stirred for 24 h at rt.  The resin was removed by filtration 
through a pad of celite, which was rinsed with MeOH (50 mL).  The filtrate and washings 
 297 
were concentrated and a solution of the crude residue, Ac2O (2 mL), pyridine (4 mL), 
and DMAP (0.028 g, 0.232 mmol) was stirred at rt for 4 h.  EtOAc (20 mL) was added 
and the solution was washed successively with 1 M HCl (3 x 10 mL), sat. aq. NaHCO3 (1 
x 10 mL), and brine (1 x 10 mL).  The combined organic layers were dried (MgSO4), 
filtered, and concentrated.  The resulting crude residue was purified by dissolving in Et2O 
(10 mL) and filtering through a short pad of SiO2 eluting with Et2O (25 mL) to give 
0.857 g (96% yield, 2 steps) of 2.180 as a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 
6.89-6.81 (m, 1H), 5.88 (dt, J = 15.6, 1.2 Hz, 1H), 5.18-5.14 (m, 1H), 5.00-4.96 (m, 1H), 
3.73 (s, 3H), 3.36 (dd, J = 10.8, 4.0 Hz, 1H), 3.25 (dd, J = 11.2, 7.2 Hz, 1H), 2.61-2.47 
(m, 2H), 2.12 (s, 3H), 2.07 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 169.5, 169.5, 165.9, 
142.4, 123.9, 72.1, 71.5, 51.4, 32.4, 20.6, 20.6, 2.1; IR (neat) 2952, 1746, 1740, 1660, 
1436, 1372, 1223, 1040 cm-1; HRMS (ESI) 406.9962 [C12H17O6INa (M+Na) requires 
406.9962]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.89-6.81 (m, 1H, C5-H), 
5.88 (dt, J = 15.6, 1.2 Hz, 1H, C6-H), 5.18-5.14 (m, 1H, C2-H), 5.00-4.96 (m, 1H, C3-
H), 3.73 (s, 3H, C8-H), 3.36 (dd, J = 10.8, 4.0 Hz, 1H, C1-Ha), 3.25 (dd, J = 11.2, 7.2 
Hz, 1H, C1-Hb), 2.61-2.47 (m, 2H, C4), 2.12 (s, 3H, C10), 2.07 (s, 3H, C12); 13C NMR 
(CDCl3, 100 MHz) δ 169.5 (C9), 169.5 (C11), 165.9 (C7), 142.4 (C5), 123.9 (C6), 72.1 





Methyl 3-oxo-4-((4R,6S)-2-oxo-6-vinyl-1,3-oxazinan-4-yl)butanoate (2.219).  
Methyl acetate (0.112 g, 1.51 mmol) was added dropwise to a freshly prepared solution 
of the LDA (1.51 mmol) in THF (1.5 mL) at -78 °C and the solution was stirred for 1 h.  
The solution was then transferred by cannula into a flask containing a solution of 2.194 
(0.050 g, 0.25 mmol) in THF (0.3 mL) at 0 °C.  The resulting solution was stirred at 0 °C 
for 1 h then warmed to rt and stirred for an additional 1 h.  The reaction was quenched 
with sat. aq. NH4Cl (5 mL), and EtOAc (5 mL) was added.  The layers were separated, 
and the aqueous layer was extracted with CH2Cl2 (2 x 10 mL).  The combined organic 
layers were dried (Na2SO4), filtered, and concentrated.  The crude residue was then 
purified by flash chromatography eluting with EtOAc to give 0.048 g (79%) of 2.219 as a 
white solid:  1H NMR (CDCl3, 400 MHz) δ 6.84 (br s, 1H), 5.91-5.82 (m, 1H), 5.39 (d, J 
= 17.2 Hz, 1H), 5.26 (d, J = 10.8 Hz, 1H), 4.75 (q, J = 5.2 Hz, 1H), 4.04-3.97 (m, 1H), 
3.74 (s, 3H), 3.51 (d, J = 4.4 Hz, 2H), 2.85 (d, J = 6.4 Hz, 2H), 2.20 (dt, J = 14.0, 2.0 Hz, 
1H), 1.50 (q, J = 13.2 Hz, 1H); LRMS (ESI) 242 [C11H16NO5 (M+H) requires 242.10]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.84 (br s, 1H, NH), 5.91-
5.82 (m, 1H, C2-H), 5.39 (d, J = 17.2 Hz, 1H, C1-Ha), 5.26 (d, J = 10.8 Hz, 1H, C1-Hb), 
4.75 (q, J = 5.2 Hz, 1H, C3-H), 4.04-3.97 (m, 1H, C5-H), 3.74 (s, 3H, C10-H), 3.51 (d, J 
= 4.4 Hz, 2H, C8-H), 2.85 (d, J = 6.4 Hz, 2H, C6-H), 2.20 (dt, J = 14.0, 2.0 Hz, 1H, C4-




(2.221).  NEt3 (0.185 g, 1.83 mmol) was added dropwise to a solution of 2.219 (0.147 g, 
0.609 mmol) and p-acetamidobenzenesulfonyl azide (0.220 g, 0.914 mmol) in 
MeCN:CH2Cl2 (1.5 mL, 4:1) and the reaction was stirred at room temperature overnight.  
Et2O (5 mL) was then added and the precipitate was removed by filtration and washed 
with Et2O (10 mL).  The filtrate and washings were concentrated and the crude residue 
was purified by flash chromatography eluting with EtOAc to give 0.163 g (99 %) of 
2.221 as a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 6.38 (br s, 1H), 5.92-5.82 (m, 1H), 
5.40 (d, J = 17.6 Hz, 1H), 5.26 (d, J = 10.4 Hz, 1H), 4.76 (q, J = 5.2 Hz, 1H), 4.07-4.00 
(m, 1H), 3.85 (s, 3H), 3.24 (dd, J = 17.6, 4.4 Hz, 1H), 2.95 (dd, J = 17.8, 8.4 Hz, 1H), 
2.15 (dt, J = 14.4, 2.4 Hz, 1H), 1.60 (q, J = 11.6 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ 
189.7, 161.2, 134.8, 117.2, 76.5, 76.4, 52.2, 46.6, 45.6, 33.0; IR (neat) 3263, 2957, 2924, 
2140, 1714, 1649, 1650, 1437, 1327 cm-1; HRMS (ESI) 268.0933 [C11H14N3O5 (M+H) 
requires 268.0928]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.38 (br s, 1H, NH), 5.92-
5.82 (m, 1H, C2-H), 5.40 (d, J = 17.6 Hz, 1H, C1-Ha), 5.26 (d, J = 10.4 Hz, 1H, C1-Hb), 
4.76 (q, J = 5.2 Hz, 1H, C3-H), 4.07-4.00 (m, 1H, C5-H), 3.85 (s, 3H, C10-H), 3.24 (dd, 
J = 17.6, 4.4 Hz, 1H, C6-Ha), 2.95 (dd, J = 17.8, 8.4 Hz, 1H, C6-Hb), 2.15 (dt, J = 14.4, 
2.4 Hz, 1H, C4-Ha), 1.60 (q, J = 11.6 Hz, 1H, C4-Hb); 
13C NMR (CDCl3, 100 MHz) δ 
189.7 (C7), 161.2 (C9), 134.8 (C11), 117.2 (C1), 76.5 (C3), 76.4 (C8), 52.2 (C5), 46.6 




oxazinane-3-carboxylate (2.222b).  A solution of 2.221 (0.050 g, 0.162 mmol), NEt3 
(0.049 g, 0.486 mmol), Boc2O (0.071 g, 0.323 mmol), and DMAP (0.002 g, 0.0162 
mmol) in CH2Cl2 (0.5 mL) was stirred at room temperature overnight.  CH2Cl2 (2 mL) 
was added to the reaction and washed with sat. aq. NaHCO3 (1 x 3 mL), brine (1 x 3 
mL).  The combined organic layers were dried (MgSO4), filtered, and concentrated.  The 
crude residue was purified by flash chromatography eluting with hexanes:EtOAc (5:1) to 
give 0.064 g (97 %) of 2.222b as a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 5.85 (ddd, 
J = 17.6, 11.2, 5.6 Hz, 1H), 5.41 (d, J = 17.2 Hz, 1H), 5.28 (d, J = 10.8 Hz, 1H), 4.72-
4.60 (comp, 2H), 3.84 (s, 3H), 3.40 (dd, J = 18.0, 3.6 Hz, 1H), 3.21 (dd, J = 18.0, 8.4 Hz, 
1H), 2.61 (ddd, J = 14.0, 8.8, 2.4 Hz, 1H), 1.73 (ddd, J = 15.0, 11.6, 8.8 Hz, 1H), 1.52 (s, 
9H); LRMS (ESI) 368 [C16H22N3O7 (M+H) requires 368.15]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.85 (ddd, J = 17.6, 11.2, 5.6 
Hz, 1H, C2-H), 5.41 (d, J = 17.2 Hz, 1H, C1-Ha), 5.28 (d, J = 10.8 Hz, 1H, C1-Hb), 
4.72-4.60 (comp, 2H, C3-H & C5-H), 3.84 (s, 3H, C10-H), 3.40 (dd, J = 18.0, 3.6 Hz, 
1H, C6-Ha), 3.21 (dd, J = 18.0, 8.4 Hz, 1H, C6-Hb), 2.61 (ddd, J = 14.0, 8.8, 2.4 Hz, 1H, 
C4-Ha), 1.73 (ddd, J = 15.0, 11.6, 8.8 Hz, 1H, C4-Hb), 1.52 (s, 9H, C14). 
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tert-Butyl 3-oxo-4-((4R,6S)-2-oxo-6-vinyl-1,3-oxazinan-4-yl)butanoate (2.218).  
t-Butyl acetate (0.962 g, 8.28 mmol) was added dropwise to a freshly prepared solution 
of LDA (8.28 mmol) in THF (8.8 mL) at -78 ºC and the solution was stirred for 1 h.  The 
solution was then transferred by cannula into a flask containing a solution of 2.194 (0.275 
g, 1.38 mmol) in THF (1.4 mL) at 0 ºC.  The resulting solution was stirred at 0 ºC for 1 h 
then warmed to rt and stirred for an additional 30 min.  The reaction was quenched with 
sat. aq. NH4Cl (5 mL), and EtOAc (5 mL) was added.  The layers were separated, and the 
aqueous layer was extracted with CH2Cl2 (2 x 10 mL).  The combined organic layers 
were dried (Na2SO4), filtered, and concentrated.  The crude residue was then purified by 
flash chromatography eluting with EtOAc to give 0.391 g (99%) of 2.218 as a colorless 
oil:  1H NMR (CDCl3, 400 MHz) δ 6.84 (br s, 1H), 5.80-5.72 (m, 1H), 5.29 (d, J = 16.8 
Hz, 1H), 5.14 (d, J = 10.8 Hz, 1H), 4.65 (q, J = 6.0 Hz, 1H), 3.92-3.85 (m, 1H), 3.29 (d, J 
= 7.2 Hz, 2H), 2.73 (d, J = 6.4 Hz, 2H), 2.11 (dt, J = 14.0, 2.0 Hz, 1H), 1.42-1.33 (comp, 
10H); 13C NMR (CDCl3, 100 MHz) δ 201.0, 165.8, 154.0, 134.7, 117.1, 82.1, 76.7, 50.3, 
48.0, 46.0, 32.7, 27.7; LRMS (CI) m/z 284 [C14H22NO5 (M+H) requires 284.15]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.84 (br s, 1H, NH), 5.80-
5.72 (m, 1H, C2-H), 5.29 (d, J = 16.8 Hz, 1H, C1-Ha), 5.14 (d, J = 10.8 Hz, 1H, C1-Hb), 
4.65 (q, J = 6.0 Hz, 1H, C3-H), 3.92-3.85 (m, 1H, C5-H), 3.29 (d, J = 7.2 Hz, 2H, C8-H), 
2.73 (d, J = 6.4 Hz, 2H, C6-H), 2.11 (dt, J = 14.0, 2.0 Hz, 1H, C4-Ha), 1.42-1.33 (comp, 
10H, C11-H & C4-Hb); 
13C NMR (CDCl3, 100 MHz) δ 201.0 (C7), 165.8 (C9), 154.0 
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(C12), 134.7 (C2), 117.1 (C1), 82.1 (C3), 76.7 (C10), 50.3 (C8), 48.0 (C6), 46.0 (C5), 
32.7 (C4), 27.7 (C11). 
 
tert-Butyl 2-diazo-3-oxo-4-((4R,6S)-2-oxo-6-vinyl-1,3-oxazinan-4-yl)butanoate 
(2.220).  NEt3 (0.107 g, 1.06 mmol) was added dropwise to a solution of 2.220 (0.100 g, 
0.353 mmol) and p-acetamidobenzenesulfonyl azide (0.127 g, 0.529 mmol) in MeCN (1 
mL) and the reaction was stirred at room temperature overnight.  Et2O (5 mL) was then 
added to the reaction and the precipitate was removed by filtration and washed with Et2O 
(10 mL).  The filtrate and washings were concentrated and the crude residue was purified 
by flash chromatography eluting with EtOAc:hexanes (2:1) to give 0.109 g (99 %) of 
2.220 as a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 6.12 (br s, 1H), 5.85-5.76 (m, 1H), 
5.33 (d, J = 17.2 Hz, 1H), 5.22 (d, J = 10.4 Hz, 1H), 4.72 (q, J = 5.2 Hz, 1H), 4.02-3.95 
(m, 1H), 3.27 (dd, J = 20.0, 3.6 Hz, 1H), 2.81 (dd, J = 17.6, 9.2 Hz, 1H), 2.10 (dt, J = 
14.0, 2.0 Hz, 1H), 1.58 (q, J = 14.0 Hz, 1H), 1.48 (s, 9H); LRMS (ESI) 310 
[C14H20N3O5 (M+1) requires 310]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.12 (br s, 1H, NH), 5.85-
5.76 (m, 1H, C2-H), 5.33 (d, J = 17.2 Hz, 1H, C1-Ha), 5.22 (d, J = 10.4 Hz, 1H, C1-Hb), 
4.72 (q, J = 5.2 Hz, 1H, C3-H), 4.02-3.95 (m, 1H, C5-H), 3.27 (dd, J = 20.0, 3.6 Hz, 1H, 
C6-Ha), 2.81 (dd, J = 17.6, 9.2 Hz, 1H, C6-Hb), 2.10 (dt, J = 14.0, 2.0 Hz, 1H, C4-Ha), 




oxazinane-3-carboxylate (2.222a).  A solution of 2.220 (0.050 g, 0.162 mmol), NEt3 
(0.049 g, 0.486 mmol), Boc2O (0.071 g, 0.323 mmol), and DMAP (0.002 g, 0.0162 
mmol) in CH2Cl2 (0.5 mL) was stirred at room temperature overnight.  CH2Cl2 (2 mL) 
was added to the reaction and washed with sat. aq. NaHCO3 (1 x 3 mL), brine (1 x 3 
mL).  The combined organic layers were dried (MgSO4), filtered, and concentrated.  The 
crude residue was purified by flash chromatography eluting with hexanes:EtOAc (5:1) to 
give 0.064 g (97 %) of 2.222a as a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 5.89-5.81 
(m, 1H), 5.40 (d, J = 17.6 Hz, 1H), 5.27 (d, J = 10.8 Hz, 1H), 4.69-4.60 (comp, 2H), 3.41 
(dd, J = 18.4, 3.2 Hz, 1H), 3.18 (dd, J = 17.6, 8.8 Hz, 1H), 2.68-2.59 (m, 1H), 1.76-1.67 
(m, 1H), 1.55-1.48 (comp, 18H). LRMS (ESI) 410 [C19H28N3O7 (M+H) requires 
410.19]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.89-5.81 (m, 1H, C2-H), 
5.40 (d, J = 17.6 Hz, 1H, C1-Ha), 5.27 (d, J = 10.8 Hz, 1H, C1-Hb), 4.69-4.60 (comp, 2H, 
C3-H & C5-H), 3.41 (dd, J = 18.4, 3.2 Hz, 1H, C6-Ha), 3.18 (dd, J = 17.6, 8.8 Hz, 1H, 
C6-Hb), 2.68-2.59 (m, 1H, C4-Ha), 1.76-1.67 (m, 1H, C4-Hb), 1.55-1.48 (comp, 18H, 
C11-H & C15-H). 
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tert-Butyl (4R,6S)-2-oxo-6-vinyltetrahydro-2H-pyran-4-ylcarbamate (2.230).  
A solution of 2.228 (0.150 g, 0.500 mmol) and Cs2CO3 (0.02 g, 0.100 mmol) in MeOH 
(20 mL) was stirred at room temperature for 24 h.  The reaction was concentrated and a 
slurry of the crude residue and SiO2 (0.150 g) was created and the suspension was 
concentrated to dryness.  The substrate adsorbed silica was dried under high vacuum for 
1 h, and then purified by column chromatography eluting with hexanes:EtOAc (2:1) to 
give 0.103 g (85%) of 2.230 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 5.93-5.85 
(m, 1 H), 5.36 (d, J = 17.2 Hz, 1H), 5.29 (d, J = 9.6 Hz, 1 H), 5.08-5.03 (m, 1 H), 4.99 (br 
s, 1 H), 4.09 (br s, 1 H), 2.87 (dd, J = 17.6 Hz, 6.8 Hz, 1 H), 2.52 (dd, J = 18.0, 6.8 Hz, 1 
H), 2.08-1.97 (m, 2 H), 1.47 (s, 9H). 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.93-5.85 (m, 1 H, C2-H), 
5.36 (d, J = 17.2 Hz, 1 H, C1-Ha), 5.29 (d, J = 9.6 Hz, 1 H, C1-Hb), 5.08-5.03 (m, 1 H, 
C3-H), 4.99 (br s, 1 H, NH), 4.09 (br s, 1 H, C5-H), 2.87 (dd, J = 17.6 Hz, 6.8 Hz, 1 H, 





8-enoate (2.233).  A solution of 2.228 (0.388 g, 1.30 mmol) and Cs2CO3 (0.052 g, 0.259 
mmol) in MeOH (52 mL) was stirred at room temperature for 24 h, and then the reaction 
was concentrated to dryness.  In a separate flask, methyl acetate (0.577 g, 7.80 mmol) 
was added dropwise to a freshly prepared solution of LDA (7.80 mmol) in THF (7.4 mL) 
at -78 ºC and the solution was stirred for 1 h.  The enolate solution was then cannulated 
into a flask containing a solution of the crude residue from the previous step that had 
been precooled to 0 ºC.  The resulting solution was stirred at 0 °C for 1 h then it was 
warmed to room temperature and stirred for an additional 1 h.  The reaction was 
quenched with saturated aqueous NH4Cl (40 mL) and diluted with EtOAc (50 mL).  The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x 50 mL).  
The combined ordanic layers were dried (Na2SO4), filtered, and concentrated, and the 
crude residue was purified by flash chromatography eluting with Hex:EtOAc (4:1) to 
give ~0.144 g of 2.226 as crude oil contaminated with ~10% methyl acetoacetate.  A 
solution of crude 2.226, p-acetamidobenzenesulfonyl azide (0.127 g, 0.546 mmol), and 
NEt3 (0.254 g, 2.52 mmol) in MeCN (5 mL) was stirred at room temperature overnight.  
The reaction mixture was concentrated, triturated with Et2O (20 mL), filtered, and 
concentrated.  The crude residue was purified by column chromatography eluting with 
Hex:EtOAc (1:1) to give 0.045 g (29%) of 2.233 as a yellow oil:  1H NMR (CDCl3, 400 
MHz) δ 5.93-5.85 (m, 1H), 5.27 (dt, J = 17.2, 1.2 Hz, 1H), 5.12 (dt, J = 10.4, 1.2 Hz, 
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1H), 5.08 (bs, 1H), 4.25-4.22 (m, 1H), 4.21-4.13 (m, 1H), 3.84 (s, 3H), 3.14 (dd, J = 15.6, 
4.0 Hz, 1H), 3.02 (dd, J = 15.8, 6.0 Hz, 1H), 2.61 (bs, 1H), 1.86-171 (comp, 2H), 1.42 (s, 
3H); LRMS (CI) m/z 342 [C15H24N3O6 (M+1) requires 342]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.93-5.85 (m, 1H, C2-H), 
5.27 (dt, J = 17.2, 1.2 Hz, 1H, C1-H), 5.12 (dt, J = 10.4, 1.2 Hz, 1H, C1-H), 5.08 (bs, 1H, 
NH), 4.25-4.22 (m, 1H, C3-H), 4.21-4.13 (m, 1H, C5-H), 3.84 (s, 3H, C10-H), 3.14 (dd, J 
= 15.6, 4.0 Hz, 1H, C6-H), 3.02 (dd, J = 15.8, 6.0 Hz, 1H, C6-H), 2.61 (bs, 1H, OH), 
1.86-171 (comp, 2H, C4-H), 1.42 (s, 3H, C13-H). 
 
(5R,7S)-Methyl 5-(tert-butoxycarbonylamino)-7-(tert-butyldimethylsilyloxy)-
2-diazo-3-oxonon-8-enoate (2.234).  A solution of 2.233 (0.014 g, 0.041 mmol), TBS-Cl 
(0.012 g, 0.0821 mmol), and imidazole (0.008 g, 0.123 mmol) in CH2Cl2 (0.2 mL) was 
stirred at rt overnight.  The reaction was concentrated and the crude residue purified by 
column chromatography eluting with Hex:EtOAc (3:1) to give 0.017g (90%) of 2.234 as 
a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 5.86-5.77 (m, 1H), 5.18 (dt, J = 17.6, 1.2 
Hz, 1H), 5.13 (bs, 1H), 5.07 (dt, J = 10.4, 1.2 Hz, 1H), 4.19 (q, J = 6.0 Hz, 1H), 4.07-4.00 
(m, 1H), 3.81 (s, 3H), 3.16 (dd, J = 16.0, 6.0 Hz, 1H), 2.99 (dd, J = 16.4, 4.8 Hz, 1H), 
1.84-1.70 (comp, 2H), 1.39 (s, 9H), 0.87 (s, 9H), 0.04 (s, 3H), 0.01 (s, 3H); 13C NMR 
(CDCl3, 100 MHz) δ 191.1, 161.6, 155.1, 140.5, 114.7, 78.9, 76.4, 72.1, 52.2, 45.4, 45.0, 
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42.5, 28.3, 25.8, 18.1, -4.4, -5.0; LRMS (CI) m/z 457 [C21H38N3O6Si (M+1) requires 
457]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 5.86-5.77 (m, 1 H, C2-H), 
5.18 (dt, J = 17.6, 1.2 Hz, 1 H, C1-H), 5.13 (bs, 1 H, NH), 5.07 (dt, J = 10.4, 1.2 Hz, 1 H, 
C1-H), 4.19 (q, J = 6.0 Hz, 1 H, C3-H), 4.07-4.00 (m, 1 H, C5-H), 3.81 (s, 3 H, C10-H), 
3.16 (dd, J = 16.0, 6.0 Hz, 1 H, C6-H), 2.99 (dd, J = 16.4, 4.8 Hz, 1 H, C6-H), 1.84-1.70 
(comp, 2 H, C4-H), 1.39 (s, 9 H, C13-H), 0.87 (s, 9 H, C16-H)), 0.04 (s, 3 H, C14-H), 
0.01 (s, 3 H, C14-H); 13C NMR (CDCl3, 100 MHz) δ 191.1 (C7), 161.6 (C9), 155.1 
(C11), 140.5 (C2), 114.7 (C1), 78.9 (C12), 76.4 (C3), 72.1 (C8), 52.2 (C10), 45.4 (C4), 
45.0, (C6), 42.5 (C5), 28.3 (C13), 25.8 (C16), 18.1 (C15), -4.4 (C14), -5.0 (C14). 
 
Methyl (5R,7S)-5-{[(tert-butoxy)carbonyl]amino}-7-[(tert-
butyldiphenylsilyl)oxy]-2-diazo-3-oxonon-8-enoate (2.238).  A solution of 2.233 
(0.142 g, 0.416 mmol), TBDPS-Cl (0.229 g, 0.832 mmol), DMAP (0.006 g, 0.0416 
mmol), and imidazole (0.085 g, 1.25 mmol) in CH2Cl2 (2.0 mL) was stirred at rt for 24 h.  
The reaction was filtered through Celite and rinsed with CH2Cl2 (2 x 5 mL).  The filtrate 
and washings were then washed with 0.5 M aq HCl (1 x 10 mL), and brine (1 x 10 mL), 
and the organic layer was dried (MgSO4), filtered, and concentrated.  The crude residue 
was purified by column chromatography eluting with Hex:EtOAc (4:1) to give 0.190 g 
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(79%) of 2.238 as a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 7.64-7.60 (comp, 4H), 
7.45-7.35 (comp, 6H), 5.86-5.77 (m, 1H), 5.18 (dt, J = 17.6, 1.2 Hz, 1H), 5.13 (bs, 1H), 
5.07 (dt, J = 10.4, 1.2 Hz, 1H), 4.19 (q, J = 6.0 Hz, 1H), 4.07-4.00 (m, 1H), 3.81 (s, 3H), 
3.16 (dd, J = 16.0, 6.0 Hz, 1H), 2.99 (dd, J = 16.4, 4.8 Hz, 1H), 1.84-1.70 (comp, 2H), 
1.39 (s, 9H), 1.07 (s, 9H); LRMS (CI) m/z 580 [C31H42N3O6Si (M+H) requires 580]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.64-7.60 (comp, 4H, C17-
H), 7.45-7.35 (comp, 6H, C18/C19-H), 5.86-5.77 (m, 1H, C2-H), 5.18 (dt, J = 17.6, 1.2 
Hz, 1H, C1-H), 5.12 (bs, 1H, NH), 5.07 (dt, J = 10.4, 1.2 Hz, 1H, C1-H), 4.20 (q, J = 6.0 
Hz, 1H, C3-H), 4.07-4.00 (m, 1H, C5-H), 3.81 (s, 3H, C10-H), 3.16 (dd, J = 16.0, 6.0 Hz, 
1H, C6-H), 2.99 (dd, J = 16.4, 4.8 Hz, 1H, C6-H), 1.84-1.70 (comp, 2H, C4-H), 1.39 (s, 
9H, C13-H), 0.87 (s, 9H, C15-H). 
 
Methyl (5R)-5-[(2S)-2-[(tert-butyldiphenylsilyl)oxy]but-3-en-1-yl]-7-oxo-
hexahydropyrrolo[1,2-c][1,3]oxazole-7a-carboxylate (2.240).  A mixture of 2.238 
(0.190 g, 0.328 mmol) and Rh2(OAc)4 (0.007 g, 0.016 mmol) in CH2Cl2 (6.6 mL) was 
stirred at room temperature for 16 h.  The reaction mixture was concentrated and the 
crude residue purified by column chromatography eluting with Hex:EtOAc (5:1) to give 
0.181 g (86%) of 2.239 as a mixture (1:1) of diastereomers and rotamers.  A solution 
2.239 and dimethoxymethane (0.138 g, 1.82 mmol) in TFA:CH2Cl2 (1:10, 8.6 mL) was 
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stirred at room temperature for 6 h.  The reaction was poured into a separatory funnel, 
diluted with CH2Cl2 (30 mL) and washed with saturate aq. NaHCO3 (2 x 15 mL).  The 
combined organic layers were dried (Na2SO4), filtered, and concentrated and the crude 
residue was then purified by column chromatography eluting with Hex:EtOAc (using a 
gradient elution from 1:0 to 6:1) to give 0.017 g (33%) of 2.240 as a mixture (1:1) of 
diastereomers as a colorless oil :  1H NMR (CDCl3, 400 MHz) δ 7.68-7.60 (comp, 4H), 
7.47-7.33 (comp, 6H), 5.86-5.78 (m, 1H), 5.05 (dt, J = 17.2, 1.2 Hz, 1H), 5.03 (dt, J = 
10.4, 1.2 Hz, 1H), 4.51 (d, J = 7.2 Hz, 1H), 4.23 (dt, J = 6.4, 4.8 Hz, 1H), 4.15 (d, J = 7.2 
Hz, 1H), 4.08 (d, J = 9.2 Hz, 1H), 3.92 (d, J = 9.2 Hz, 1H), 3.73 (s, 3H), 3.08-3.01 (m, 
1H), 2.26 (d, J = 7.2 Hz, 1H), 2.25 (d, J = 10.0 Hz, 1H), 1.98 (ddd, J = 13.8, 6.4, 3.6 Hz, 
1H), 1.72 (ddd, J = 13.8, 9.4, 4.8 Hz, 1H), 1.07 (s, 9H); LCMS (ESI) m/z 494.87 
[C28H36NO5Si (M+H) requires 494.67]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.68-7.60 (comp, 4H, C16-
H), 7.47-7.33 (comp, 6H, C17/C18-H), 5.86-5.78 (m, 1H, C2-H), 5.05 (dt, J = 17.2, 1.2 
Hz, 1H, C1-H), 5.03 (dt, J = 10.4, 1.2 Hz, 1H, C1-H), 4.51 (d, J = 7.2 Hz, 1H, C12-H), 
4.23 (dt, J = 6.4, 4.8 Hz, 1H, C3-H), 4.15 (d, J = 7.2 Hz, 1H, C12-H), 4.08 (d, J = 9.2 Hz, 
1H, C11-H), 3.92 (d, J = 9.2 Hz, 1H, C11-H), 3.73 (s, 3H, C10-H), 3.08-3.01 (m, 1H, C5-
H), 2.26 (d, J = 7.2 Hz, 1H, C4-H), 2.25 (d, J = 10.0 Hz, 1H, C4-H), 1.98 (ddd, J = 13.8, 





Minor Cycloadduct:  Methyl 3-[(tert-butyldiphenylsilyl)oxy]-9-oxo-7- 
azatricyclo[5.3.0.04,8]decane-8-carboxylate (2.262).  A solution of 2.240 (0.019 g, 
0.038 mmol) in toluene (3.8 mL) in a sealed tube reaction vessel was heated to 160 °C for 
4 h.  The reaction was cooled to rt, concentrated, and the crude residue was then purified 
by column chromatography eluting with Hex:EtOAc (1:1) to give 0.0057 g (32%) of 
2.263 as a colorless oil along with 0.011 g (62%) of 2.263 as a colorless oil: 1H NMR 
(CDCl3, 400 MHz) δ 7.62-7.58 (comp, 4H), 7.46-7.34 (comp, 6H), 3.96-3.91 (m, 1H), 
3.75 (s, 3H), 3.55-3.52 (m, 1H), 3.14 (ddd, J = 13.4, 11.4, 4.4 Hz, 1H), 3.02 (dt, J = 8.4, 
6.0 Hz, 1H), 2.97 (dd, J = 6.2, 3.6 Hz, 1H), 2.66-2.60 (m, 1H), 2.36 (ddd, J = 13.4, 8.8, 
4.4 Hz, 1H), 1.84 (d, J = 18.0 Hz, 1H), 1.71 (ddd, J = 18.2, 11.0, 5.2 Hz, 1H), 1.65-1.57 
(comp, 2H), 1.37-1.32 (comp, 2H), 1.05 (s, 9H); LRMS (CI) m/z 464 [C27H34NO4Si 
(M+H) requires 464]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.62-7.58 (comp, 4H), 7.46-
7.34 (comp, 6H), 3.96-3.91 (m, 1H), 3.75 (s, 3H), 3.55-3.52 (m, 1H), 3.14 (ddd, J = 13.4, 
11.4, 4.4 Hz, 1H), 3.02 (dt, J = 8.4, 6.0 Hz, 1H), 2.97 (dd, J = 6.2, 3.6 Hz, 1H), 2.66-2.60 
(m, 1H), 2.36 (ddd, J = 13.4, 8.8, 4.4 Hz, 1H), 1.84 (d, J = 18.0 Hz, 1H), 1.71 (ddd, J = 




azatricyclo[5.2.1.04,8]decane-7-carboxylate (2.263).  1H NMR (CDCl3, 400 MHz) δ 
7.64-7.60 (comp, 4 H), 7.46-7.35 (comp, 6 H), 3.85-3.79 (comp, 3 H), 3.74 (s, 3 H), 2.81 
(dd, J = 15.8, 6.8 Hz, 1 H), 2.63-2.54 (comp, 2 H), 2.28-2.24 (m, 1 H), 2.05 (d, J = 15.6 
Hz, 1 H), 1.66-1.60 (m, 1 H), 1.51 (d, J = 14.4 Hz, 1 H), 1.08 (s, 9 H), 0.9 (ddd, J = 15.6, 
9.0, 5.2 Hz, 1H); LRMS (CI) m/z 464 [C27H34NO4Si (M+H) requires 464]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.64-7.60 (comp, 4H, C15-
H), 7.46-7.35 (comp, 6H, C16/C17-H), 3.85-3.79 (comp, 3H, C6/C8-H), 3.74 (s, 3H, C1-
H), 2.81 (dd, J = 15.8, 6.8 Hz, 1H, C5-H), 2.63-2.54 (comp, 2H, C11-H), 2.28-2.24 (m, 
1H, C9-H), 2.05 (d, J = 15.6 Hz, C5-H), 1.66-1.60 (m, 1H, C10-H), 1.51 (d, J = 14.4 Hz, 
1H, C10-H), 1.08 (s, 9H, C13-H), 0.9 (ddd, J = 15.6, 9.0, 5.2 Hz, 1H, C7-H). 
 
(S,E)-5-Hydroxyhepta-2,6-dienoic acid (2.245).  A solution of 2.162 (2.39 g, 
15.30 mmol) in 2-propanol:2 M aq. NaOH (46 mL, 2:1) was stirred at rt overnight.  The 
reaction was then concentrated to remove the 2-propanol and the aqueous mixture was 
washed with CH2Cl2 (2 x 20 mL).  The aqueous layer was then acidified with 1 M HCl 
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and extracted with CH2Cl2 (4 x 15 mL).  The combined org. layers were dried (Na2SO4), 
filtered and concentrated to give 1.75 g (81%) of 2.245 as a light yellow oil requiring no 
further purification:  1H NMR (CDCl3, 400 MHz) δ 7.04 (dt, J = 15.6, 7.2 Hz, 1H), 5.92-
5.82 (comp, 2H), 5.26 (dt, J = 16.8, 1.6 Hz, 1H), 5.15 (dt, J = 10.8, 0.8 Hz, 1H), 4.60 (q, 
J = 6.4 Hz, 1H), 2.47 (app t, J = 7.2 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ 171.1, 
147.1, 139.4, 123.4, 115.8, 71.5, 39.7; IR (neat) 3382, 3083, 2669, 1697, 1657, 1424, 
1257, 982, 929 cm-1; HRMS (CI) m/z 143.0705 [C7H11O3 (M+H) requires 143.0708]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.04 (dt, J = 15.6, 7.2 Hz, 
1H, C5-H), 5.92-5.82 (comp, 2H, C6-H & C2-H), 5.26 (dt, J = 16.8, 1.6 Hz, 1H, C1-H), 
5.15 (dt, J = 10.8, 0.8 Hz, 1H, C1-H), 4.60 (q, J = 6.4 Hz, 1H, C3-H), 2.47 (app t, J = 7.2 
Hz, 2H, C4-H); 13C NMR (CDCl3, 100 MHz) δ 171.1 (C7), 147.1 (C5), 139.4 (C2), 
123.4 (C6), 115.8 (C1), 71.5 (C3), 39.7 (C4). 
 
(S)-6-Vinyl-5,6-dihydro-2H-pyran-2-one (2.241).  A solution of 2.245 (1.75 g, 
12.31 mmol) in pyridine (25 mL) was added 2,4,6-trichlorobenzoyl chloride (3.30 g, 
13.54 mmol) dropwise over a 30 min period at 0 ºC.  Reaction was then warmed to room 
temperature and stirred for 3 h.  The reaction mixture was diluted with Et2O (50 mL) and 
washed with half saturated aqueous NaHCO3 (1 x 25 mL), dried (MgSO4), filtered, and 
concentrated to remove all excess pyridine.  The crude residue was purified by column 
chromatography eluting with Hex:EtOAc (4:1) to give 1.33 g (87%) of 2.241 as a light 
yellow oil:  1H NMR (CDCl3, 400 MHz) δ 6.95-6.91 (ddd, J = 10.0, 5.8, 2.8 Hz, 1 H), 
 313 
6.03 (ddd, J = 9.8, 2.4, 1.6 Hz, 1 H), 6.00-5.92 (m, 1 H), 5.41 (dt, J = 17.2, 1.2 Hz, 1 H), 
5.30 (dt, J = 10.4, 1.2 Hz, 1 H), 4.97-4.92 (m, 1 H), 2.57-2.39 (m, 2 H); 13C NMR 
(CDCl3, 100 MHz) δ 163.6, 144.6, 134.6, 121.1, 117.5, 77.6, 29.0; IR (neat) 2916, 1721, 
1419, 1385, 1247, 1031 cm-1; HRMS (CI) m/z 125.0602 [C7H9O2 (M+H) requires 
125.0603]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.95-6.91 (ddd, J = 10.0, 5.8, 
2.8 Hz, 1 H, C5-H), 6.03 (ddd, J = 9.8, 2.4, 1.6 Hz, 1 H, C6-H), 6.00-5.92 (m, 1 H, C2-
H), 5.41 (dt, J = 17.2, 1.2 Hz, 1 H, C1-H), 5.30 (dt, J = 10.4, 1.2 Hz, 1 H, C1-H), 4.97-
4.92 (m, 1 H, C3-H), 2.57-2.39 (m, 2 H, C4-H); 13C NMR (CDCl3, 100 MHz) δ 163.6 
(C7), 144.6 (C5), 134.6 (C2), 121.1 (C6), 117.5 (C1), 77.6 (C3), 29.0 (C4). 
 
(4R,6S)-4-[(Benzyloxy)amino]-6-ethenyloxan-2-one (2.247).  A solution of 
2.241 (0.385 g, 3.10 mmol), O-benzylhydroxylamine hydrochloride (0.990 g, 6.20 
mmol), and NEt3 (0.690 g, 6.82 mmol, 0.95 mL) in absolute EtOH (31 mL) was stirred at 
rt for 48 h.  The reaction mixture was concentrated and triturated with Et2O (30 mL) and 
the precipitate filtered off.  The filtrate was concentrated to dyness to give 0.767 g (99%) 
of 2.247 as a colorless oil:  1H NMR (CDCl3, 400 MHz) δ 7.38-7.25 (comp, 5H), 5.85-
5.76 (m, 1H), 5.45 (bs, 1H), 5.31 (dt, J = 17.6, 0.8 Hz, 1H), 5.22 (dt, J = 10.0, 1.6 Hz, 
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1H), 4.97-4.93 (m, 1H), 4.68 (app d, J = 2.8, 2H), 3.54 (dt, J = 10.4, 5.6 Hz, 1H), 2.68 
(dd, J = 17.2, 6.0 Hz, 1H), 2.47 (dd, J = 17.2, 5.6 Hz, 1H), 1.96 (dt, J = 10.0, 4.4 Hz, 1H), 
1.80 (ddd, J = 14.8, 9.6, 4.8, 1H); 13C NMR (CDCl3, 100 MHz) δ 170.2, 137.1, 135.6, 
128.6, 128.4, 128.4, 116.9, 77.9, 76.7, 51.0, 33.5, 31.6; LRMS (ESI) m/z 270 
[C14H17NO3Na (M+Na) requires 270]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.38-7.25 (comp, 5H, C10-
H, &, C11-H, & C12-H), 5.85-5.76 (m, 1H, C2-H), 5.45 (bs, 1H, NH), 5.31 (dt, J = 17.6, 
0.8 Hz, 1H, C1-H), 5.22 (dt, J = 10.0, 1.6 Hz, 1H, C1-H), 4.97-4.93 (m, 1H, C3-H), 4.68 
(app d, J = 2.8, 2H, C8-H), 3.54 (dt, J = 10.4, 5.6 Hz, 1H, C5-H), 2.68 (dd, J = 17.2, 6.0 
Hz, 1H, C6-H), 2.47 (dd, J = 17.2, 5.6 Hz, 1H, C6-H), 1.96 (dt, J = 10.0, 4.4 Hz, 1H, C4-
H), 1.80 (ddd, J = 14.8, 9.6, 4.8, 1H, C4-H); 13C NMR (CDCl3, 100 MHz) δ 170.2 (C7), 
137.1 (C9), 135.6 (C2), 128.6 (C10), 128.4 (C11), 128.4 (C12), 116.9 (C1), 77.9 (C3), 
76.7 (C8), 51.0 (C5), 33.5 (C4), 31.6 (C6). 
 
Methyl (5R,7S)-5-[(benzyloxy)amino]-2-diazo-7-hydroxy-3-oxonon-8-enoate 
(2.249).  A solution of methyl acetate (0.689 g, 9.30 mmol, 0.74 mL) in THF (9.3 mL) 
was added dropwise at a rate of 30 mL/h (using a syringe pump) to a freshly prepared 
solution of LDA (9.3 mmol) in THF (9.3 mL) at -78 °C.  The reaction was then stirred for 
30 min and then a solution of 2.247 (0.767 g, 3.10 mmol) in THF (12 mL) was added 
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dropwise at a rate of 50 mL/h (using a syringe pump) and the reaction was stirred for an 
additional 4 h at -78 °C.  The reaction was then quenched with 1 M aq. HCl, warmed to 
rt, and diluted with Et2O (50mL).  The resulting layers were separated and the org. layer 
was extracted with 1 M aq. HCl (3 x 15 mL).  The combined aq. layers were neutralized 
with solid K2CO3 and extracted with CH2Cl2 (5 x 10 mL).  The combined org. layers 
were dried (Na2SO4), filtered, and concentrated to give the crude crude lactol 2.248 
(0.988 g) as a colorless oil requiring no further purification.  A solution of the crude 
residue, p-acetamidobenzenesulfonyl azide (0.894 g, 3.72 mmol), and NEt3 (0.941 g, 9.3 
mmol) in MeCN (15.5 mL) was stirred at room temperature for 12 h.  The reaction 
mixture was concentrated and triturated with Et2O (30 mL) and the precipitate filtered.  
The filtrate was concentrated and the crude residue was purified by column 
chromatography eluting with Hex:EtOAc (gradient from 4:1 to 2:1) to give 0.948 g 
(88%) of 2.249 as a yellow oil:  1H NMR (CDCl3, 400 MHz) δ 7.38-7.28 (comp, 5H), 
5.86-5.78 (m, 1H), 5.26 (dt, J = 17.6, 0.8 Hz, 1H), 5.07 (dt, J = 10.0, 1.6 Hz, 1H), 4.71 
(dd, J = 18.4, 11.6 Hz, 2H), 4.32-4.28 (m, 1H), 3.82 (s, 3H), 3.66-3.60 (m, 1H), 3.35 (dd, 
J = 17.0, 7.2 Hz, 1H), 2.91 (dd, J = 17.0, 5.6 Hz, 1H), 1.72-1.55 (comp, 2H); LRMS 
(ESI) m/z 348 [C17H22N3O5 (M+Na) requires 348]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 7.38-7.28 (comp, 5H, C13-
H, C14-H, & C15-H), 5.86-5.78 (m, 1H, C2-H), 5.26 (dt, J = 17.6, 0.8 Hz, 1H, C1-H), 
5.07 (dt, J = 10.0, 1.6 Hz, 1H, C1-H), 4.71 (dd, J = 18.4, 11.6 Hz, 2H, C11-H), 4.32-4.28 
(m, 1H, C3-H), 3.82 (s, 3H, C10-H), 3.66-3.60 (m, 1H, C5-H), 3.35 (dd, J = 17.0, 7.2 Hz, 




(cyanomethyl)-3-hydroxypyrrolidine-2-carboxylate (2.264).  A solution of 2.239 
(0.055 g, 0.0997 mmol) and NaBH4 (0.004 g, 0.0997 mmol) in MeOH (1 mL) was stirred 
at room temperature for 0.5 h.  The reaction was quenched with 0.5 M aq HCl and 
concentrated to remove all MeOH.  The aq. mixture was then extracted with CH2Cl2 (3 x 
5 mL), and the combined organic layers were dried (Na2SO4), filtered, and concentrated.  
The crude residue was dissolved in CH2Cl2 (0.5 mL), cooled to 0 °C, and neat TFA 
(0.226 g, 1.99 mmol, 150 L) was added dropwise.  The reaction was then warmed to rt 
and stirred for 2 h.  The reaction was concentrated to dryness and pumped down under 
high vac for 2 h to remove all volatile components.  The crude residue was then dissolved 
in MeCN (1 mL), cooled to 0 °C, and NEt(i-Pr)2 (0.032 g, 0.248 mmol, 43 L) and 
iodoacetonitrile (0.017 g, 0.100 mmol, 7 L) were added sequentially to the reaction.  
The reaction was warmed to rt and stirred for 12 h.  The reaction was then diluted with 
sat. aq. NaHCO3 (5 mL) and extracted with CH2Cl2 (3 x 5 mL).  The combined organic 
layers were dried (Na2SO4), filtered, and concentrated.  The crude residue was then 
purified by column chromatography eluting with Hex:EtOAc (2:1) to give 0.011 g (22%, 
3 steps) of 2.264 as a light yellow oil:  Compound is a mixture of diastereomers, which 




azatricyclo[5.3.0.04,8]decane-8-carboxylate (2.265).  A solution of DMSO (0.015 mL, 
0.195 mmol, 14 L) in CH2Cl2 (0.2 mL) was added dropwise to solution of oxalyl 
chloride (0.015 g, 0.122 mmol, 11 L) in CH2Cl2 (1.2 mL) at -78 °C.  After 10 min, a 
solution of 2.264 (0.012 g, 0.0244 mmol) in CH2Cl2 (0.25 mL) was added dropwise to 
the reaction and stirring was continued at -78 °C for 1 h.  NEt3 (0.035 g, 0.342 mmol, 48 
L) was then added and the reaction was stirred at -78 °C for 16 h.  H2O (1 mL) was then 
added, the reaction was warmed to room temperature, and the layers separated.  The aq. 
layer was extracted with CH2Cl2 (2 x 2 mL), and the combined organic layers were dried 
(MgSO4), filtered, and concentrated to give 0.009 g (75%) of 2.265 as a light yellow oil:  
1H NMR (CDCl3, 400 MHz) δ 7.61-7.57 (m, 4H), 7.47-7.34 (m, 6H), 4.20-4.11 (m, 1H), 
3.93-3.90 (m, 1H), 3.75 (s, 3H), 3.00-2.96 (m, 1H), 2.71-2.62 (m, 2H), 2.24-2.16 (m, 
1H), 1.96-1.90 (comp, 2H), 1.55-1.43 (comp, 3H), 1.28-1.25 (comp, 2H), 1.06 (s, 9H). 
 
Methyl 5-{[(tert-butoxy)carbonyl]amino}-2-diazo-3-oxonon-8-enoate (2.85).  
A solution of 2.270 (0.279 g, 0.822 mmol) and 2.271 (0.111 g, 0.781 mmol) in Et2O (12 
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mL) was added dropwise to a freshly prepared solution of LiHMDS (1.73 mmol) in Et2O 
(4 mL) at -78 °C, and the reaction was stirred at -78 °C for 2 h.  The reaction was then 
quenched with sat. aq. NH4Cl (10 mL) and the reaction was warmed to rt with vigorous 
stirring.  The resulting layers were separated and the aq. layer was extracted with CH2Cl2 
(2 x 10 mL).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated.  The crude residue was purified by column chromatography eluting with 
Hex:EtOAc (4:1) to give 0.142 g, (56%) of 2.85 as a bright yellow oil:  1H NMR (CDCl3, 
400 MHz) spectral data agrees with that previously reported in the group. 
 
1-tert-Butyl-2-methyl-5-(but-3-en-1-yl)-2-butyl-3-oxopyrrolidine-1,2-
dicarboxylate (2.272).  A flask containing NaH (0.017 g, 0.706 mmol) was charged with 
a solution of 2.86 (0.210 g, 0706 mmol) in DMF (2.0 mL) and the resulting mixture was 
stirred at rt.  Meanwhile a solution of TBAI (0.313 g, 0.847 mmol) and butylbromide 
(0.145 g, 1.06 mmol, 114 L) in DMF (0.5 mL) was prepared and allowed to stir during 
the course of the deprotonation.  After 0.5 h, the butylbromide/TBAI solution was added 
dropwise to the preformed enolate and the resulting mixture was stirred at rt for 4 h.  The 
reaction was quenched with sat. aq. NH4Cl (3 mL) and extracted with CH2Cl2 (4 x 5 
mL).  The combined organic layers were dried (MgSO4), filtered, and concentrated.  The 
crude residue was purified by column chromatography eluting with Hex:EtOAc (using a 
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gradient elution from 1:0 to 6:1) to give 0.116 g (46%) of 2.272 as a colorless oil:  1H 
NMR (CDCl3, 400 MHz,  rotamers) δ 5.89-5.79 (m, 1H), 5.08-4.98 (comp, 2H), 4.26-
4.14 (m, 1H), 3.73 (s, 3 H), 2.78 (m, 1H), 2.59-2.44 (m, 1H), 2.39-2.27 (m, 1H), 2.17-
1.96 (comp, 3H), 1.50 (s, 2 H), 1.43 (s, 7 H), 1.37-1.24 (comp, 2H), 1.21-1.06 (m, 1H), 
0.99-0.85 (comp, 4H); LRMS (CI) m/z 354 [C19H32NO5 (M+H) requires 354]. 
NMR Assignments.  :  1H NMR (CDCl3, 400 MHz, rotamers) δ 5.89-5.79 (m, 
1H), 5.08-4.98 (comp, 2H), 4.26-4.14 (m, 1H), 3.73 (s, 3H), 2.78 (m, 1H), 2.59-2.44 (m, 
1H), 2.39-2.27 (m, 1H), 2.17-1.96 (comp, 3H), 1.50 (s, 2H, minor rotamer/diastereomer), 
1.43 (s, 7H, major rotamer/diastereomer), 1.37-1.24 (comp, 2H), 1.21-1.06 (m, 1H), 0.99-
0.85 (comp, 4H). 
 
Lithium 5-but-3-enyl-2-butyl 3-oxo-pyrrolidine 2-carboxylate (68).  TFA 
(0.0742 g, 0.651 mmol, 48 L) was added to a solution of 2.272 (0.023 g, 0.065 mmol) in 
CH2Cl2 (0.2 mL) and the reaction was stirred at rt for 4 h.  The reaction was diluted with 
CH2Cl2 (5 mL), washed with sat. aq. NaHCO3 (1 x 5 mL), dried (Na2SO4), filtered, and 
concentrated.  The crude residue was dissolved in THF (0.8 mL) and a 0.33 M solution of 
LiOH in H2O (0.004 g, 0.0955 mmol, 8 L) was added and the reaction was stirred at rt 
for 12 h.  The reaction was concentrated to dryness, dissolved in chloroform, and filtered 
to give 0.017 g (>99%) of 2.273 as a crude yellow oil which was used without further 
purification:  1H NMR (CDCl3, 400 MHz) δ 5.87-5.77 (m, 1H), 5.06 (dd, J = 17.0, 1.6 
Hz, 1H), 5.00 (dd, J = 10.0, 1.4 Hz, 1H), 3.38-3.31 (m, 1H), 2.57 (dd, J = 17.6, 6.0 Hz, 
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1H), 2.22-2.16 (m, 1H), 2.11 (dd, J = 17.8, 9.6 Hz, 1H), 1.96-1.89 (m, 1H), 1.85-1.76 (m, 
1H), 1.67-1.58 (m, 1H), 1.35-1.15 (comp, 6H), 0.96-0.87 (comp, 3H).  
 
Major Cycloadduct:  6-Ethyl-8-methyl (6R)-9-oxo-7- 
azatricyclo[5.3.0.04,8]decane-6,8-dicarboxylate (2.290).  TFA (0.210 g, 1.84 mmol, 
137 L) was added dropwise to a solution of 2.85 (0.060 g, 0.184 mmol) in CH2Cl2 (0.9 
mL) at 0 °C and the reaction was warmed to rt and stirred for 1.5 h.  The reaction was 
then concentrated to dryness and pumped down under high vac for 2 h to remove all 
volatile components.  The crude residue was dissolved in CH2Cl2 (0.9 mL) and cooled to 
0 °C.  NEt3 (0.019 g, 0.184 mmol, 14 mL) was added dropwise and the reaction was 
warmed to rt and stirred for 0.5 h.  4Å M.S (0.06 g, in ball form) and ethyl glyoxylate 
(0.028 g, 0.276 mmol) were then added and the reaction was stirred at rt for 16 h.  The 
reaction was filtered through Celite, rinsed with CH2Cl2 (5 mL) and the filtrate 
concentrated to dryness.  The crude residue was dissolved in benzene (3.6 mL) and 
Rh2(OAc)4 (0.004 g, 0.0091 mmol) was added and the mixture was refluxed for 12 h.  
The reaction was concentrated and the crude residue purified by column chromatography 
eluting with Hex:EtOAc:NEt3 (1:1:0.001) to give 0.016 g (34%) of 2.290 as a light 
yellow oil along with minor cycloadduct 2.291: 1H NMR (CDCl3, 400 MHz) δ 4.37-4.28 
(comp, 2H), 4.26-4.19 (m, 1H), 4.14 (dd, J = 7.4, 6.0 Hz, 1H), 3.77 (s, 3H), 3.04-3.00 (m, 
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1H), 2.94-2.87 (m, 1H), 2.35-2.28 (m, 1H), 2.26 (d, J = 18.0 Hz, 1H), 2.21 (dd, J = 13.2, 
6.4 Hz, 1H), 1.95-1.85 (m, 1H), 1.79-1.68 (m, 1H), 1.56-1.48 (m, 1H), 1.34 (t, J = 7.2 
Hz, 3H), 1.35-1.25 (m, 1H); LCMS (ESI) m/z 282.2 [C14H20NO5 (M+H) requires 
282.13]. 
NMR Assignments.  1H NMR (CDCl3, 400 MHz) δ 6.89-6.81 (m, 1H, C5-H), 
5.88 (dt, J = 15.6, 1.2 Hz, 1H, C6-H), 5.18-5.14 (m, 1H, C2-H), 5.00-4.96 (m, 1H, C3-
H), 3.73 (s, 3H, C8-H), 3.38-3.23 (m, 2H, C1-H), 2.61-2.47 (m, 2H, C4-H), 2.12 (s, 3H, 
C10-H), 2.07 (s, 3H, C12-H); 13C NMR (CDCl3, 100 MHz) δ 169.50 (C9), 169.45 (C11), 
165.9 (C7), 142.4 (C5), 123.9 (C6), 72.1 (C2), 71.5 (C3), 51.4 (C8), 32.4 (C4), 20.63 
(C12), 20.61 (C10), 2.1 (C1) 
 
Minor Cycloadduct:  9-Ethyl-7-methyl (4R,7S)-6-oxo-8- 
azatricyclo[5.2.1.04,8]decane-7,9-dicarboxylate (2.291).  Did not isolate enough of this 
material to get a good NMR spectrum, however the following signals are indicative of 
this regioisomeric structure in the NMR spectrum of the reaction mixture:  1H NMR 






 tert-Butyl 4-methyl-2-(prop-2-en-1-yl)piperazine-1-carboxylate (3.122b).  
Compound 3.118a (1 g, 4.99 mmol), s-BuLi (20 mL of a 0.6 M solution in n-hexane, 
11.98 mmol), TMEDA (1.39 g, 11.98 mmol), CuCN (1.07 g, 11.98 mmol), LiCl (1.02 g, 
23.97 mmol), and allyl bromide (1.45 g, 11.98 mmol) in Et2O (150 mL) were reacted as 
reported in literature.  Purification via flash chromatography eluting with CH2Cl2-MeOH 
(20:1) gave 0.997 g (83%) of 3.122b as a light yellow oil:  
1
H NMR (400 MHz, CDCl3) δ 
5.65-5.77 (m, 1H), 5.03 (d, J = 16.8 Hz, 1H), 4.96 (d, J = 10.0 Hz, 1H), 4.05 (bs, 1H), 
3.81 (d, J = 9.6 Hz, 1H), 2.30 (t, J = 12.4 Hz, 1H), 2.65 (t, J =  10.8 Hz, 2H), 2.34-2.47 
(m, 2H), 2.18 (s, 3H), 1.97 (d, J = 11.2 Hz, 1H), 1.86 (t, J = 12.0 Hz, 1H), 1.40 (s, 9H); 
13
C NMR (CDCl3, 75 MHz) δ 154.7, 135.3, 116.9, 79.4, 77.2, 57.1, 55.0, 50.7, 46.4, 39.1, 
34.6, 28.3; IR (neat) cm
-1
 2358, 1698, 1458, 1409, 1365, 1247, 1174, 1106; HRMS (CI) 
m/z 241.1919 [C13H25N2O2 (M+H) requires 241.1916]. 
NMR Assignments.  
1
H NMR (400 MHz, CDCl3) δ 5.65-5.77 (m, 1H), 5.03 (d, J 
= 16.8 Hz, 1H), 4.96 (d, J = 10.0 Hz, 1H), 4.05 (bs, 1H), 3.81 (d, J = 9.6 Hz, 1H), 2.30 (t, 
J = 12.4 Hz, 1H), 2.65 (t, J =  10.8 Hz, 2H), 2.34-2.47 (m, 2H), 2.18 (s, 3H), 1.97 (d, J = 
11.2 Hz, 1H), 1.86 (t, J = 12.0 Hz, 1H), 1.40 (s, 9H); 
13
C NMR (CDCl3, 75 MHz) δ 




carboxylate (3.123b).  To a mixture of 3.122b (0.210 g, 0.874 mmol), TMEDA (0.132 g, 
1.14 mmol) in Et2O (20 mL) at -78 °C was added s-BuLi (0.95 mL of a 1.2M solution in 
n-hexane, 1.14 mmol).  The reaction was warmed to -30 °C and stirred for 1 hr.  After 
cooling reaction back down to -78 °C, DMF (0.96 g, 1.31 mL) was quickly added and 
reaction was stirred for 1 hr.  The reaction was quenched at -78 °C with satd. NH4Cl, 
allowed to warm to rt, extracted with Et2O (4 x 10 mL), and concentrated.  The crude oil 
was then dissolved in hexanes/EtOAc/NEt3 (98:2:1, 20 mL) and SiO2 (1.4 g) was added.  
The reaction was allowed to stir until the disappearance of the trans- isomer was observed 
by TLC (eluting with CH2Cl2:MeOH, 20:1).  The reaction was filtered, concentrated, and 
the residue purified via flash chromatography eluting with CH2Cl2:MeOH (30:1) to give 
0.183 g (78%) of 3.123b as a light yellow oil:  
1
H NMR (400 MHz, CDCl3) δ 9.63 (s, 
1H), 5.68-5.79 (m, 1H), 5.98-5.04 (comp, 2H), 4.35 (bs, 1H), 4.00 (bs, 1H), 3.30 (d, J = 
11.6 Hz, 1H), 2.65 (d, J = 10.8 Hz, 1H), 2.21-2.28 (m, 2H), 2.18 (s, 3H), 2.01 (dd, J = 
6.4, 5.2 Hz, 1H), 1.95 (dd, J = 7.6, 4.0 Hz, 1H), 1.48 (s, 9H); 
13
C NMR (75 MHz, CDCl3) 
δ 200.4, 154.7, 136.1, 117.1, 79.6, 68.7, 61.2, 54.6, 50.5, 46.5, 39.3, 28.3; ; IR (neat) cm
-1
 
2968, 2790, 1731, 1690, 1455, 1402, 1367, 1331, 1296, 1173, 1049; HRMS (CI) m/z 
269.1867 [C14H25N2O3 (M+H) requires 269.1865] 
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NMR Assignments.  
1
H NMR (400 MHz, CDCl3) δ 9.63 (s, 1H), 5.68-5.79 (m, 
1H), 5.98-5.04 (comp, 2H), 4.35 (bs, 1H), 4.00 (bs, 1H), 3.30 (d, J = 11.6 Hz, 1H), 2.65 
(d, J = 10.8 Hz, 1H), 2.21-2.28 (m, 2H), 2.18 (s, 3H), 2.01 (dd, J = 6.4, 5.2 Hz, 1H), 1.95 
(dd, J = 7.6, 4.0 Hz, 1H), 1.48 (s, 9H); 
13
C NMR (75 MHz, CDCl3) δ 200.4, 154.7, 136.1, 
117.1, 79.6, 68.7, 61.2, 54.6, 50.5, 46.5, 39.3, 28.3. 
 
 tert-Butyl (2,6-cis)-2-ethynyl-4-methyl-6-(prop-2-en-1-yl)piperazine-1-
carboxylate (3.124b).  To a mixture of 3.123b (0.480 g, 1.79 mmol), K2CO3 (0.742 g, 
5.37 mmol) in MeOH (20 mL) at 0 °C was added Bestmann-Ohira reagent (0.688 g, 3.58 
mmol).  The reaction was warmed to rt and stirred under argon for 16 hr.  The reaction 
was concentrated, dissolved in EtOAc (30 mL), washed with brine H2O (1 x 10 mL), 
satd. NaHCO3 (2 x 10 mL), brine (1 x 10 mL).  The organic layer was dried (MgSO4), 
filtered, concentrated, and the residue was purified via flash chromatography eluting with 
CH2Cl2:MeOH (30:1) to give 0.379 g (80%) of 3.124b as a colorless oil:  
1
H NMR (400 
MHz, CDCl3) δ 5.74-5.85 (m, 1 H), 5.14 (d, J = 17.2, 1 H), 5.05 (d, J = 10.4, 1 H), 4.85 
(bs, 1 H), 4.00 (m, 1 H), 2.93 (dt, J = 11.6, 2.0 Hz, 1 H), 2.72-2.82 (comp, 2 H), 2.60-
2.67 (m, 1 H), 2.28 (s, 3 H), 2.22 (d, J = 2.4 Hz, 1 H), 2.09 (dd, J = 7.2, 4.0 Hz, 1 H), 
1.95 (dd, J = 7.2, 4.0, 1 H), 1.45 (s, 9 H); 
13
C NMR (75 MHz, CDCl3) δ 154.2, 135.1, 




2942, 2802, 1696, 1455, 1390, 1337, 1296, 1249, 1179, 1044; HRMS (CI) m/z 265.1912 
[C15H25N2O2 (M+H) requires 265.1916]. 
NMR Assignments.  
1
H NMR (400 MHz, CDCl3) δ 5.74-5.85 (m, 1 H), 5.14 (d, J 
= 17.2, 1 H), 5.05 (d, J = 10.4, 1 H), 4.85 (bs, 1 H), 4.00 (m, 1 H), 2.93 (dt, J = 11.6, 2.0 
Hz, 1 H), 2.72-2.82 (comp, 2 H), 2.60-2.67 (m, 1 H), 2.28 (s, 3 H), 2.22 (d, J = 2.4 Hz, 1 
H), 2.09 (dd, J = 7.2, 4.0 Hz, 1 H), 1.95 (dd, J = 7.2, 4.0, 1 H), 1.45 (s, 9 H); 
13
C NMR 
(75 MHz, CDCl3) δ 154.2, 135.1, 117.0, 85.2, 77.5, 67.7, 61.5, 60.4, 50.4, 45.1, 39.4, 
39.1, 28.7; LRMS (CI) m/z 265 [C15H25N2O2 (M+1) requires 265.19], 249, 237, 223, 
209, 165, 154.154.7, 135.3, 116.9, 79.4, 77.2, 57.1, 55.0, 50.7, 46.4, 39.1, 34.6, 28.3. 
  
tert-Butyl 10-methyl-4-oxo-10,12-diazatricyclo[6.3.1.02,6]dodec-2-ene-12- 
carboxylate (3.125b).  To a mixture of 3.124b (0.147 g, 0.556 mmol) in THF (18 mL) 
was added Co2(CO)8 (0.289 g, 0.834 mmol) and the resulting mixture was warmed to 40 
ºC for 1 hr until the consumption of the starting material was observed by TLC (eluting 
with Hex:EtOAc, 3:1).  To the reaction was added DMSO (0.260 g, 3.34 mmol) and the 
reaction was heated at 50 ºC for 16 h.  Concentrated reaction mixture and purified via 
flash chromatography eluting with hexanes:EtOAc (2:1) to give 0.137 g (85%) of 3.125b 
as a colorless oil:  
1
H NMR (500 MHz, d6-DMSO, 100 °C) δ 5.86 (d, J = 2.1 Hz, 1H), 
4.92 (s, 1H), 4.14 (s, 1H), 3.99-4.05 (m, 1H), 2.92 (d, J = 11.2 Hz, 1H), 2.87 (d, J = 11.6 
Hz, 1H), 2.48 (dd, J = 18.2, 6.5, 1H), 2.32 (dd, J = 11.5, 3.3 Hz, 1H), 2.26 (dd, J = 1.8, 
1.7 Hz, 1H), 2.24 (dd, J = 1.8, 1.7 Hz, 1H), 2.19 (s, 3H), 2.17 (m, 1H), 1.79 (dd, J = 18.2, 
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3.3 Hz, 1H), 1.87 (m, 1H), 1.40 (s, 9H); 
13
C NMR (125 MHz, d6-DMSO, 100 °C) 206.1, 
178.6, 152.5, 127.6, 125.4, 79.0, 57.9, 56.4, 57.9, 56.4, 44.6, 42.6, 38.0, 37.6, 27.5; IR 
(neat) cm
-1
 2973, 2920, 2791, 1696, 1623, 1458, 1407, 1322, 1173, 1046; HRMS (CI) 
m/z 293.1866 [C16H25N2O3 (M+1) requires 293.1865]. 
NMR Assignments.  
1
H NMR (500 MHz, d6-DMSO, 100 °C) δ 5.86 (d, J = 2.1 
Hz, 1H), 4.92 (s, 1H), 4.14 (s, 1H), 3.99-4.05 (m, 1H), 2.92 (d, J = 11.2 Hz, 1H), 2.87 (d, 
J = 11.6 Hz, 1H), 2.48 (dd, J = 18.2, 6.5, 1H), 2.32 (dd, J = 11.5, 3.3 Hz, 1H), 2.26 (dd, J 
= 1.8, 1.7 Hz, 1H), 2.24 (dd, J = 1.8, 1.7 Hz, 1H), 2.19 (s, 3H), 2.17 (m, 1H), 1.79 (dd, J 
= 18.2, 3.3 Hz, 1H), 1.87 (m, 1H), 1.40 (s, 9H); 
13
C NMR (125 MHz, d6-DMSO, 100 °C) 
206.1, 178.6, 152.5, 127.6, 125.4, 79.0, 57.9, 56.4, 57.9, 56.4, 44.6, 42.6, 38.0, 37.6, 27.5. 
 
tert-Butyl 4-benzyl-2-(prop-2-en-1-yl)piperazine-1-carboxylate (3.122a).  
Following the procedure outlined for 3.122b:  Compound 3.118a (0.20 g, 0.724 mmol), 
s-BuLi (1.19 mL of a 1.46 M solution in n-hexane, 1.74 mmol), TMEDA (0.202 g, 1.74 
mmol), CuCN (0.156 g, 1.74 mmol), LiCl (0.148 g, 3.48 mmol), and allyl bromide (0.114 
g, 0.941 mmol) in Et2O (25 mL) were allowed to react.  Purification via flash 
chromatography eluting with CH2Cl2-MeOH (20:1) yielded 0.193 g (85%) of 3.122a as a 
colorless oil:  
1
H NMR (400 MHz, CDCl3) δ 7.22-7.33 (comp, 5H), 5.64-5.74 (m, 1H), 
5.00 (d, J = 16.8 Hz, 1H), 4.94 (d, J = 10.0 Hz, 1H), 4.06 (bs, 1H), 3.84 (d, J = 9.6 Hz, 
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1H), 3.53 (d, J = 13.2 Hz, 1H), 3.38 (d, J = 13.2 Hz, 1H), 3.07 (td, J = 12.6, 2.8 Hz, 1H), 
2.76 (d, J =  10.8 Hz, 1H), 2.70 (d, J = 11.2 Hz, 1H), 2.41-2.53 (m, 1H), 1.99-2.07 
(comp, 2H), 1.45 (s, 9H); 
13
C NMR (100 MHz, CDCl3) δ 154.8, 138.4, 135.5, 128.8, 
128.2, 127.0, 117.0, 79.4, 62.8, 54.7, 53.2, 34.6, 28.4; IR (neat) cm
-1
 3064, 2975, 2807, 
1694, 1455, 1410, 1364, 1174; HRMS (CI) m/z 317.2229 [C19H29N2O2 (M+1) requires 
317.2229]. 
NMR Assignments.  
1
H NMR (400 MHz, CDCl3) δ 7.22-7.33 (comp, 5H), 5.64-
5.74 (m, 1H), 5.00 (d, J = 16.8 Hz, 1H), 4.94 (d, J = 10.0 Hz, 1H), 4.06 (bs, 1H), 3.84 (d, 
J = 9.6 Hz, 1H), 3.53 (d, J = 13.2 Hz, 1H), 3.38 (d, J = 13.2 Hz, 1H), 3.07 (td, J = 12.6, 
2.8 Hz, 1H), 2.76 (d, J =  10.8 Hz, 1H), 2.70 (d, J = 11.2 Hz, 1H), 2.41-2.53 (m, 1H), 
1.99-2.07 (comp, 2H), 1.45 (s, 9H); 
13
C NMR (100 MHz, CDCl3) δ 154.8, 138.4, 135.5, 
128.8, 128.2, 127.0, 117.0, 79.4, 62.8, 54.7, 53.2, 34.6, 28.4. 
 
tert-Butyl (2,6-cis)-2-formyl-4-benzyl-6-(prop-2-en-1-yl)piperazine-1-
carboxylate (3.123a).  Following the procedure outlined for 3.123b:  Compound 3.122a 
(0.123 g, 0.389 mmol), TMEDA (0.068 g, 0.584 mmol), Et2O (13 mL), s-BuLi (0.4 mL 
of a 1.46 M solution in n-hexane, 0.584 mmol), and DMF (0.043 g, 0.944 mL) were 
allowed to react.  The crude oil was then dissolved in hexanes/EtOAc/NEt3 (98:2:1, 20 
mL) and SiO2 (0.9 g) was added.  The reaction was allowed to stir until the disappearance 
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of the trans- isomer was observed by TLC (eluting with CH2Cl2:MeOH, 20:1).  The 
reaction was filtered, concentrated, and the residue purified via flash chromatography 
eluting with CH2Cl2:MeOH (30:1) to yield 0.109 g (81%) of 3.123a as a light yellow oil:  
1
H NMR (400 MHz, CDCl3) δ 9.61 (s, 1H), 7.20-7.31 (comp, 5H), 5.59-5.74 (m, 1H), 
4.83-5.03 (comp, 2H), 4.46 (bs, 1H), 3.99 (bs, 2H), 3.55 (t, J = 16.4 Hz, 1H), 3.35-3.46 
(comp, 2H), 2.68-2.77 (m, 1H), 2.41-2.53 (m, 1H), 2.26-3.27 (comp, 2H), 2.21 (dd, J = 
6.4, 5.2 Hz, 1H), 2.01-2.06 (m, 1H), 1.45-1.48 (rotamers, comp, 9H); 
13
C NMR (100 
MHz, CDCl3) δ 201.9, 154.7, 138.3, 137.6, 135.4, 135.2, 128.7, 128.2, 128.1, 127.2, 
117.5, 116.9, 80.6, 79.3, 62.7, 62.4, 53.1, 51.3, 28.2; IR (neat) cm
-1
 3072, 2966, 2912, 
2801, 2707, 1731, 1690, 1455, 1390, 1367, 1249, 1173; HRMS (CI) m/z 345.2179 
[C20H29N2O3 (M+1) requires 345.2178]. 
NMR Assignments.  
1
H NMR (400 MHz, CDCl3) δ 9.61 (s, 1H), 7.20-7.31 
(comp, 5H), 5.59-5.74 (m, 1H), 4.83-5.03 (comp, 2H), 4.46 (bs, 1H), 3.99 (bs, 2H), 3.55 
(t, J = 16.4 Hz, 1H), 3.35-3.46 (comp, 2H), 2.68-2.77 (m, 1H), 2.41-2.53 (m, 1H), 2.26-
3.27 (comp, 2H), 2.21 (dd, J = 6.4, 5.2 Hz, 1H), 2.01-2.06 (m, 1H), 1.45-1.48 (rotamers, 
comp, 9H); 
13
C NMR (100 MHz, CDCl3) δ 201.9, 154.7, 138.3, 137.6, 135.4, 135.2, 







carboxylate (3.124a).  Following the procedure outlined for 3.124b:  To a mixture of 
3.123a (0.094 g, 0.273 mmol), K2CO3 (0.113 g, 0.819 mmol), MeOH (3 mL), Bestmann-
Ohira reagent (0.105 g, 0.546 mmol).  Purification via flash chromatography eluting with 
CH2Cl2:MeOH (30:1) gave 0.071 g (76%) of 3.124a as a colorless oil:  
1
H NMR (400 
MHz, CDCl3) δ 7.20-7.31 (comp, 5H), 5.64-5.74 (m, 1H), 5.01 (d, J = 16.1, 1H), 4.95 (d, 
J = 10.0, 1H), 4.07 (bs, 1H), 3.84 (bs, 1H), 3.54 (d, J = 13.2 Hz, 1H), 3.38 (d, J =  13.2 
Hz, 1H), 3.07 (t, J = 12.4 Hz, 1H), 2.68-2.79 (comp, 2H), 2.42-2.54 (m, 1H), 2.05 (dd, J 
= 7.6, 4.0 Hz, 1H), 2.00 (d, J = 3.6 Hz, 1H), 1.45 (rotamers, comp, 9H): 
13
C NMR (100 
MHz, CDCl3) δ 138.6, 135.7, 129.1, 128.4, 127.3, 117.2, 79.7, 63.1, 54.6, 53.4, 51.6, 
28.6; IR (neat) cm
-1
 3304, 3074, 2975, 2811, 2773, 1697, 1640, 1454, 1399, 1367, 1336, 
1302, 1255, 1175; HRMS (CI) m/z 341.2226 [C21H29N2O2 (M+1) requires 341.2229]. 
NMR Assignments.  
1
H NMR (400 MHz, CDCl3) δ 7.20-7.31 (comp, 5H), 5.64-
5.74 (m, 1H), 5.01 (d, J = 16.1, 1H), 4.95 (d, J = 10.0, 1H), 4.07 (bs, 1H), 3.84 (bs, 1H), 
3.54 (d, J = 13.2 Hz, 1H), 3.38 (d, J =  13.2 Hz, 1H), 3.07 (t, J = 12.4 Hz, 1H), 2.68-2.79 
(comp, 2H), 2.42-2.54 (m, 1H), 2.05 (dd, J = 7.6, 4.0 Hz, 1H), 2.00 (d, J = 3.6 Hz, 1H), 
1.45 (rotamers, comp, 9H); 
13
C NMR (100 MHz, CDCl3) δ 138.6, 135.7, 129.1, 128.4, 




carboxylate (3.125a).  Following the procedure outlined for 3.125b:  Compound 3.124a 
(0.034 g, 0.100 mmol), THF (1 mL), Co2(CO)8 (0.098 g, 0.282 mmol), and DMSO (0.088 
g, 1.13 mmol) were allowed to react.  Purification of the crude residut via flash 
chromatography eluting with hexanes:EtOAc (2:1) provided 0.030 g (81%) of 3.125a as a 
colorless oil:  
1
H NMR (400MHz, CDCl3) δ 7.24-7.35 (comp, 5H), 5.93 (s, 1H), 5.86 (s, 
1H), 5.07 (s, 1H), 4.90 (s, 1H), 4.20-2.29 (comp, 2H), 3.51 (d, J = 12.8 Hz, 1H), 3.46 (d, 
J = 12.8 Hz, 1H), 2.89-2.95 (m, 2H), 2.67 (dd, J = 12.0, 6.4 Hz, 1H), 2.50 (dd, J = 8.4, 2.8 
Hz, 1H), 2.41 (d, J = 11.2 Hz, 1H), 2.12-2.18 (m, 1H), 1.91 (d, J = 16.0 Hz, 1H), 1.59-
1.75 (comp, 2H), 1.43 (s, 9H); 
13
C NMR (100 MHz, CDCl3) 208.5, 179.6, 179.0, 153.7, 
137.5, 128.7, 128.5, 127.3, 126.4, 80.5, 62.9, 56.7, 55.4, 48.9, 47.6, 43.9, 38.7, 28.3; IR 
(neat) cm
-1
 2967, 2920, 2803, 2768, 1692, 1621, 1451, 1315, 1287, 1246, 1175; HRMS 
(CI) m/z 369.2175 [C22H29N2O3 (M+1) requires 369.2178]. 
NMR Assignments.  
1
H NMR (400MHz, CDCl3) δ 7.24-7.35 (comp, 5H), 5.93 
(s, 1H), 5.86 (s, 1H), 5.07 (s, 1H), 4.90 (s, 1H), 4.20-2.29 (comp, 2H), 3.51 (d, J = 12.8 
Hz, 1H), 3.46 (d, J = 12.8 Hz, 1H), 2.89-2.95 (m, 2H), 2.67 (dd, J = 12.0, 6.4 Hz, 1H), 
2.50 (dd, J = 8.4, 2.8 Hz, 1H), 2.41 (d, J = 11.2 Hz, 1H), 2.12-2.18 (m, 1H), 1.91 (d, J = 
16.0 Hz, 1H), 1.59-1.75 (comp, 2H), 1.43 (s, 9H); 
13
C NMR (100 MHz, CDCl3) 208.5, 
179.6, 179.0, 153.7, 137.5, 128.7, 128.5, 127.3, 126.4, 80.5, 62.9, 56.7, 55.4, 48.9, 47.6, 
43.9, 38.7, 28.3. 
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